,entities,start_tokens,end_tokens,start_chars,end_chars,text,pmid,olabel,orig_index,label,prob_0
0,adenomatous polyposis coli tumour,8,12,43,76,"Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor.",10021369_0,-1,0,-1,0.342416
1,adenomatous polyposis coli,1,4,5,31,"
The adenomatous polyposis coli (APC) tumour-suppressor protein controls the Wnt signalling pathway by forming a complex with glycogen synthase kinase 3beta (GSK-3beta), axin/conductin and betacatenin.",10021369_1,-1,1,-1,0.35087895
2,colon carcinoma,1,3,3,18,"In colon carcinoma cells, loss of APC leads to the accumulation of betacatenin in the nucleus, where it binds to and activates the Tcf-4 transcription factor (reviewed in [1] [2]).",10021369_3,-1,2,-1,0.27819297
3,colon carcinoma,22,24,153,168,"Like APC, APC2 regulates the formation of active betacatenin-Tcf complexes, as demonstrated using transient transcriptional activation assays in APC -/- colon carcinoma cells.",10021369_6,-1,3,-1,0.2851779
5,colorectal cancer,22,24,132,149,"A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.",10051005_0,-1,5,-1,0.2813643
6,cancer syndrome,22,24,153,168,"
The frequency, origin, and phenotypic expression of a germline MSH2 gene mutation previously identified in seven kindreds with hereditary non-polyposis cancer syndrome (HNPCC) was investigated.",10051005_1,-1,6,-1,0.27979282
7,colorectal cancer,10,12,60,77,"Although this mutation was initially detected in four of 33 colorectal cancer families analysed from eastern England, more extensive analysis has reduced the frequency to four of 52 (8%) English HNPCC kindreds analysed.",10051005_3,-1,7,-1,0.28766996
8,contrast,1,2,3,11,"In contrast, the MSH2 mutation was identified in 10 of 20 (50%) separately identified colorectal families from Newfoundland.",10051005_4,-1,8,-1,0.34061873
9,colorectal cancer,8,10,46,63,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,9,-1,0.28024814
10,n,14,15,87,88,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,10,-1,0.41781524
11,n,21,22,109,110,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,11,-1,0.42651126
12,n,31,32,141,142,"To investigate the origin of this mutation in colorectal cancer families from England (n = 4), Newfoundland (n = 10), and the United States (n = 3), haplotype analysis using microsatellite markers linked to MSH2 was performed.",10051005_5,-1,12,-1,0.4045883
13,contrast,1,2,3,11,"In contrast, a common haplotype was identified at the two flanking markers (CA5 and D2S288) in eight of the Newfoundland families.",10051005_7,-1,13,-1,0.34510955
15,n,26,27,130,131,"We calculated age related risks of all, colorectal, endometrial, and ovarian cancers in nt943 + 3 A-- > T MSH2 mutation carriers (n = 76) for all patients and for men and women separately.",10051005_9,-1,15,-1,0.41932985
17,colorectal cancer,17,19,82,99,"For both sexes combined, the penetrances at age 60 years for all cancers  and for colorectal cancer were 0.",10051005_10,-1,17,-1,0.30140337
18,colorectal cancer,3,5,12,29,The risk of colorectal cancer was significantly higher (p < 0. 01) in males than females (0. 63 v 0. 30 and 0.,10051005_12,-1,18,-1,0.30353802
19,p,9,10,56,57,The risk of colorectal cancer was significantly higher (p < 0. 01) in males than females (0. 63 v 0. 30 and 0.,10051005_12,-1,19,-1,0.43622008
22,colorectal cancer,4,6,30,47,These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers.,10051005_16,-1,22,-1,0.28340027
23,colorectal cancer,17,19,126,143,These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers.,10051005_16,-1,23,-1,0.2875004
24,Huntington disease,4,6,16,34,Age of onset in Huntington disease : sex specific influence of apolipoprotein E genotype and normal CAG repeat length.,10051007_0,-1,24,-1,0.32726672
25,E,12,13,78,79,Age of onset in Huntington disease : sex specific influence of apolipoprotein E genotype and normal CAG repeat length.,10051007_0,-1,25,-1,0.43721268
26,Huntington disease,7,9,22,40,"
Age of onset (AO) of Huntington disease (HD) is known to be correlated with the length of an expanded CAG repeat in the HD gene.",10051007_1,-1,26,-1,0.33559018
27,E,1,2,15,16,"Apolipoprotein E (APOE) genotype, in turn, is known to influence AO in Alzheimer disease, rendering the APOE gene a likely candidate to affect AO in other neurological diseases too.",10051007_2,-1,27,-1,0.4385001
28,Alzheimer disease,16,18,71,88,"Apolipoprotein E (APOE) genotype, in turn, is known to influence AO in Alzheimer disease, rendering the APOE gene a likely candidate to affect AO in other neurological diseases too.",10051007_2,-1,28,-1,0.33240017
29,diseases,32,33,168,176,"Apolipoprotein E (APOE) genotype, in turn, is known to influence AO in Alzheimer disease, rendering the APOE gene a likely candidate to affect AO in other neurological diseases too.",10051007_2,-1,29,-1,0.36494422
30,blind,5,6,34,39,Genotyping for APOE was performed blind to clinical information.,10051007_4,-1,30,-1,0.360636
31,neurodegeneration,11,12,66,83,Our findings suggest that subtle differences in the course of the neurodegeneration  in HD  may allow interacting genes to exert gender specific effects upon AO.,10051007_7,-1,31,-1,0.36022678
36,hemolytic,31,32,184,193,"
The serum of a 29-year old woman with a recent episode of disseminated gonococcal infection and a history of meningococcal meningitis and arthritis as a child was found to lack serum hemolytic complement activity.",100562_1,-1,36,-1,0.34207538
37,hemolytic,23,24,138,147,"The seventh component of complement (C7) was not detected by functional or immunochemical assays, whereas other components were normal by hemolytic and immunochemical assessment.",100562_2,-1,37,-1,0.3792767
38,hemolytic,27,28,192,201,"Her fresh serum lacked complement-mediated bactericidal activity against Neisseria gonorrhoeae, but the addition of fresh normal serum or purified C7 restored bactericidal activity as well as hemolytic activity.",100562_3,-1,38,-1,0.329372
39,syndrome,14,15,74,82,Complete absence of C7 was also found in one sibling who had the clinical syndrome of meningococcal meningitis and arthritis  as a child and in this siblings clinically well eight-year-old son.,100562_6,-1,39,-1,0.3611884
44,cartilage-hair hypoplasia,7,9,47,72,Increased incidence of cancer in patients with cartilage-hair hypoplasia.,10064668_0,-1,44,-1,0.34493124
46,cartilage-hair hypoplasia,14,16,92,117,"
OBJECTIVE  Previous reports have suggested an increased risk of cancer among patients with cartilage-hair hypoplasia (CHH).",10064668_1,-1,46,-1,0.3313218
50,lymphoma,41,42,215,223,"RESULTS  A statistically significant excess risk of cancer was seen among the patients with CHH (standardized incidence ratio 6. 9, 95% confidence interval 2. 3 to 16), which was mainly attributable to non-Hodgkins lymphoma  (standardized incidence ratio 90, 95% confidence interval 18 to 264).",10064668_6,-1,50,-1,0.302565
51,basal cell carcinoma,8,11,42,62,"In addition, a significant excess risk of basal cell carcinoma was seen (standardized incidence ratio 35, 95% confidence interval 7. 2 to 102).",10064668_7,-1,51,-1,0.31112877
55,lymphoma,13,14,86,94,"CONCLUSIONS  This study confirms an increased risk of cancer, especially non-Hodgkins lymphoma, probably attributable to defective immunity, among patients with CHH.",10064668_9,-1,55,-1,0.30052024
56,dihydropyrimidine dehydrogenase deficiency,6,9,40,82,Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency.,10071185_0,-1,56,-1,0.3428227
57,Dihydropyrimidine,0,1,1,18,"
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterised by thymine-uraciluria in homozygous deficient patients and has been associated with a variable clinical phenotype.",10071185_1,-1,57,-1,0.34992355
58,disease,10,11,76,83,"
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterised by thymine-uraciluria in homozygous deficient patients and has been associated with a variable clinical phenotype.",10071185_1,-1,58,-1,0.3700014
59,C,44,45,194,195,"In this group of patients, 7 different mutations have been identified, including 2 deletions [295-298delTCAT, 1897delC], 1 splice-site mutation [IVS14 + 1G > A)] and 4 missense mutations (85T > C, 703C > T, 2658G > A, 2983G > T).",10071185_3,-1,59,-1,0.4175141
60,703C,46,47,197,201,"In this group of patients, 7 different mutations have been identified, including 2 deletions [295-298delTCAT, 1897delC], 1 splice-site mutation [IVS14 + 1G > A)] and 4 missense mutations (85T > C, 703C > T, 2658G > A, 2983G > T).",10071185_3,-1,60,-1,0.37171066
62,mental retardation,15,17,99,117,"A large phenotypic variability has been observed, with convulsive disorders, motor retardation and mental retardation being the most abundant manifestations.",10071185_5,-1,62,-1,0.33353296
63,Borjeson-Forssman-Lehmann syndrome,17,19,99,133,"Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient.",10071193_0,-1,63,-1,0.3412411
64,Borjeson-Forssman-Lehmann syndrome,0,2,1,35,"
Borjeson-Forssman-Lehmann syndrome (BFLS) is a syndromal X-linked mental retardation, which maps by linkage to the q26 region of the human X chromosome.",10071193_1,-1,64,-1,0.36226678
65,mental retardation,9,11,67,85,"
Borjeson-Forssman-Lehmann syndrome (BFLS) is a syndromal X-linked mental retardation, which maps by linkage to the q26 region of the human X chromosome.",10071193_1,-1,65,-1,0.32836217
66,BFLS,20,21,126,130,The FHF2 gene localisation and tissue-specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non-specific forms of X-linked mental retardation mapping to the region.,10071193_11,-1,66,-1,0.3593755
67,syndrome,21,22,131,139,The FHF2 gene localisation and tissue-specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non-specific forms of X-linked mental retardation mapping to the region.,10071193_11,-1,67,-1,0.30700967
68,mental retardation,30,32,195,213,The FHF2 gene localisation and tissue-specific expression pattern suggest it to be a candidate gene for familial cases of the BFLS syndrome and other syndromal and non-specific forms of X-linked mental retardation mapping to the region.,10071193_11,-1,68,-1,0.30051506
69,gastric cancer,10,12,65,79,Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.,10072428_0,-1,69,-1,0.29049036
70,colorectal cancer,13,15,84,101,Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.,10072428_0,-1,70,-1,0.2652588
71,gastric cancer,18,20,113,127,"
Inherited mutations in the E-cadherin gene (CDH1) were described recently in three Maori kindreds with familial gastric cancer.",10072428_1,-1,71,-1,0.27476168
72,gastric cancer,1,3,9,23,Familial gastric cancer is genetically heterogeneous and it is not clear what proportion of gastric cancer susceptibility in non-Maori populations is due to germline CDH1 mutations.,10072428_2,-1,72,-1,0.27108377
73,gastric cancer,14,16,92,106,Familial gastric cancer is genetically heterogeneous and it is not clear what proportion of gastric cancer susceptibility in non-Maori populations is due to germline CDH1 mutations.,10072428_2,-1,73,-1,0.28612363
74,gastric cancer,6,8,38,52,"Therefore, we screened eight familial gastric cancer kindreds of British and Irish origin for germline CDH1 mutations, by SSCP analysis of all 16 exons and flanking sequences.",10072428_3,-1,74,-1,0.28431964
75,gastric cancer,10,12,40,54,Each family contained  (i) two cases of gastric cancer in first degree relatives with one affected before age 50 years; or (ii) three or more cases of gastric cancer.,10072428_4,-1,75,-1,0.26730022
76,gastric cancer,33,35,151,165,Each family contained  (i) two cases of gastric cancer in first degree relatives with one affected before age 50 years; or (ii) three or more cases of gastric cancer.,10072428_4,-1,76,-1,0.2671493
77,colorectal cancer,14,16,90,107,"In one family there was evidence of non-penetrance and susceptibility to both gastric and colorectal cancer; thus, in addition to six cases of gastric cancer, a CDH1 mutation carrier developed colorectal cancer at age 30 years.",10072428_7,-1,77,-1,0.2537995
78,gastric cancer,25,27,143,157,"In one family there was evidence of non-penetrance and susceptibility to both gastric and colorectal cancer; thus, in addition to six cases of gastric cancer, a CDH1 mutation carrier developed colorectal cancer at age 30 years.",10072428_7,-1,78,-1,0.2699287
79,colorectal cancer,33,35,193,210,"In one family there was evidence of non-penetrance and susceptibility to both gastric and colorectal cancer; thus, in addition to six cases of gastric cancer, a CDH1 mutation carrier developed colorectal cancer at age 30 years.",10072428_7,-1,79,-1,0.263314
80,gastric cancer,12,14,74,88,We have confirmed that germline mutations in the CDH1 gene cause familial gastric cancer in non-Maori populations.,10072428_8,-1,80,-1,0.28824374
83,colorectal cancer,30,32,199,216,"Loss of E-cadherin function has been implicated in the pathogenesis of sporadic colorectal and other cancers, and our findings provide evidence that germline CDH1 mutations predispose to early onset colorectal cancer.",10072428_10,-1,83,-1,0.24694258
85,zinc,1,2,2,6,A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome .,10077614_0,-1,85,-1,0.3618823
86,urogenital abnormalities,11,13,69,93,A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome .,10077614_0,-1,86,-1,0.3473035
87,Denys-Drash syndrome,14,16,97,117,A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome .,10077614_0,-1,87,-1,0.3870643
88,Wilms,1,2,5,10,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,88,-1,0.2925458
89,Wilms tumor,25,27,138,149,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,89,-1,0.31302023
90,mesothelioma,28,29,151,163,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,90,-1,0.30551255
93,disease,41,42,234,241,"
The Wilms tumor -suppressor gene, WT1, plays a key role in urogenital development, and WT1 dysfunction is implicated in both neoplastic (Wilms tumor, mesothelioma, leukemias, and breast cancer) and nonneoplastic (glomerulosclerosis) disease.",10077614_1,-1,93,-1,0.31768468
94,diseases,3,4,16,24,"The analysis of diseases linked specifically with WT1 mutations, such as Denys-Drash syndrome (DDS), can provide valuable insight concerning the role of WT1 in development and disease.",10077614_2,-1,94,-1,0.36478883
95,Denys-Drash syndrome,12,14,73,93,"The analysis of diseases linked specifically with WT1 mutations, such as Denys-Drash syndrome (DDS), can provide valuable insight concerning the role of WT1 in development and disease.",10077614_2,-1,95,-1,0.40473074
96,disease,30,31,176,183,"The analysis of diseases linked specifically with WT1 mutations, such as Denys-Drash syndrome (DDS), can provide valuable insight concerning the role of WT1 in development and disease.",10077614_2,-1,96,-1,0.3392895
97,disease,5,6,24,31,"DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis, XY pseudohermaphroditism, and/or Wilms tumor (WT).",10077614_3,-1,97,-1,0.32006854
99,sclerosis,12,13,83,92,"DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis, XY pseudohermaphroditism, and/or Wilms tumor (WT).",10077614_3,-1,99,-1,0.31997755
100,Wilms tumor,18,20,127,138,"DDS is a rare childhood disease characterized by a nephropathy involving mesangial sclerosis, XY pseudohermaphroditism, and/or Wilms tumor (WT).",10077614_3,-1,100,-1,0.32923436
101,zinc,23,24,162,166,"DDS patients are constitutionally heterozygous for exonic point mutations in WT1, which include mutations predicted to truncate the protein within the C-terminal zinc finger (ZF) region.",10077614_4,-1,101,-1,0.3651932
102,sclerosis,25,26,130,139,"We report that heterozygosity for a targeted murine Wt1 allele, Wt1 (tmT396), which truncates ZF3 at codon 396, induces mesangial sclerosis characteristic of DDS in adult heterozygous and chimeric mice.",10077614_5,-1,102,-1,0.34188616
103,Wilms tumor,13,15,70,81,"Male genital defects also were evident and there was a single case of Wilms tumor in which the transcript of the nontargeted allele showed an exon 9 skipping event, implying a causal link between Wt1 dysfunction and Wilms tumorigenesis in mice.",10077614_6,-1,103,-1,0.30348724
104,iron,3,4,23,27,Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1.,10077651_0,-1,104,-1,0.32508886
105,hemochromatosis,10,11,69,84,Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1.,10077651_0,-1,105,-1,0.32684997
106,iron,17,18,124,128,Mechanism of increased iron absorption in murine model of hereditary hemochromatosis : increased duodenal expression of the iron transporter DMT1.,10077651_0,-1,106,-1,0.3358603
107,hemochromatosis,1,2,12,27,"
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption.",10077651_1,-1,107,-1,0.32159054
108,iron,14,15,98,102,"
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption.",10077651_1,-1,108,-1,0.3438521
109,iron,20,21,145,149,"
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption.",10077651_1,-1,109,-1,0.3193059
110,iron,37,38,223,227,"We recently reported that HFE, the protein defective in HH, was physically associated with the transferrin receptor (TfR) in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin-bound iron from plasma by duodenal crypt cells, leading to up-regulation of transporters for dietary iron.",10077651_2,-1,110,-1,0.3010456
111,iron,52,53,318,322,"We recently reported that HFE, the protein defective in HH, was physically associated with the transferrin receptor (TfR) in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin-bound iron from plasma by duodenal crypt cells, leading to up-regulation of transporters for dietary iron.",10077651_2,-1,111,-1,0.28816807
112,iron,10,11,48,52,"By 4 weeks of age, the HFE-/- mice demonstrated iron loading when compared with HFE +/+ littermates, with elevated transferrin saturations (68. 4% vs. 49. 8%) and elevated liver iron concentrations (985 micrograms vs. 381 micrograms).",10077651_4,-1,112,-1,0.3293713
113,iron,38,39,178,182,"By 4 weeks of age, the HFE-/- mice demonstrated iron loading when compared with HFE +/+ littermates, with elevated transferrin saturations (68. 4% vs. 49. 8%) and elevated liver iron concentrations (985 micrograms vs. 381 micrograms).",10077651_4,-1,113,-1,0.33171916
114,iron,20,21,123,127,"By using Northern blot analyses, we quantitated duodenal expression of both classes of DMT1 transcripts  one containing an iron responsive element (IRE), called DMT1 (IRE), and one containing no IRE, called DMT1 (non-IRE).",10077651_5,-1,114,-1,0.36071497
115,iron,12,13,74,78,The positive control for DMT1 up-regulation was a murine model of dietary iron deficiency that demonstrated greatly increased levels of duodenal DMT1 (IRE) mRNA.,10077651_6,-1,115,-1,0.33168873
116,iron,27,28,149,153,"HFE-/- mice also demonstrated an increase in duodenal DMT1 (IRE) mRNA (average 7. 7-fold), despite their elevated transferrin saturation and hepatic iron content.",10077651_7,-1,116,-1,0.32107723
117,lead,11,12,59,63,"These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1 (IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron.",10077651_9,-1,117,-1,0.39257
118,iron,17,18,98,102,"These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1 (IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron.",10077651_9,-1,118,-1,0.31991184
119,iron,38,39,212,216,"These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1 (IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron.",10077651_9,-1,119,-1,0.27706796
120,adrenoleukodystrophy,8,9,73,93,Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy.,10078732_0,-1,120,-1,0.3171976
121,adrenoleukodystrophy,11,12,71,91,"
OBJECTIVE  To monitor the effects of dietary treatment in adult-onset adrenoleukodystrophy (ALD) by means of somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs).",10078732_1,-1,121,-1,0.34054065
122,disease,26,27,170,177,"After treatment, the three patients with pure spinal abnormalities showed clinical and neurophysiologic worsening, whereas the two patients with a more advanced stage of disease (exhibited by SEPs) showed substantially unchanged clinical and neurophysiologic features.",10078732_6,-1,122,-1,0.36430115
123,disease,22,23,137,144,"Moreover, in patients without clear signs of inflammatory damage, this treatment does not modify significantly the natural course of the disease.",10078732_9,-1,123,-1,0.37865856
124,oromandibular dystonia,7,9,44,66,GCH1 mutation in a patient with adult-onset oromandibular dystonia.,10078749_0,-1,124,-1,0.3944594
125,oromandibular dystonia,15,17,79,101,"
The authors report a mutation in exon 5 of GCH1 in a patient with adult-onset oromandibular dystonia and no obvious family history of dystonia.",10078749_1,-1,125,-1,0.3997656
127,dystonic,13,14,88,96,These findings demonstrate that GCH1 mutations must be considered even in patients with dystonic symptoms not typical of dopa-responsive dystonia.,10078749_3,-1,127,-1,0.32056475
129,adenomatous polyposis coli,27,30,169,195,"
We extensively analyzed genomic DNA and messenger RNA (mRNA) from 62 unrelated Korean patients with familial adenomatous polyposis (FAP) for identification of germline adenomatous polyposis coli (APC) gene mutations.",10083733_1,-1,129,-1,0.33980092
130,C9 deficiency,3,5,26,39,Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan.,10083734_0,-1,130,-1,0.32723704
131,C9 deficiency,4,6,29,42,Genetic analyses of Japanese C9 deficiency have shown that a C-to-T transition leading to TGA stop codon for Arg95 in exon 4 of the C9 gene (Arg95Stop) is common in Japanese C9 deficiency.,10083734_2,-1,131,-1,0.3550763
132,C9 deficiency,33,35,174,187,Genetic analyses of Japanese C9 deficiency have shown that a C-to-T transition leading to TGA stop codon for Arg95 in exon 4 of the C9 gene (Arg95Stop) is common in Japanese C9 deficiency.,10083734_2,-1,132,-1,0.3439978
133,C9 deficiency,11,13,44,57,An estimated frequency (0. 12%) of complete C9 deficiency due to homozygous Arg95Stop mutation was consistent with frequencies determined by serological studies,10083734_9,-1,133,-1,0.35878178
134,hemochromatosis,2,3,15,30,"The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells.",10085150_0,-1,134,-1,0.35466263
135,iron,10,11,89,93,"The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells.",10085150_0,-1,135,-1,0.32985327
136,disease,13,14,75,82,"
HFE is the protein product of the gene mutated in the autosomal recessive disease hereditary hemochromatosis (Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R. J., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prasss, C. E ., Quintana, L., Starnes, S. M ., Schatzman, R. C ., Brunke, K. J ., Drayna, D. T., Risch, N. J ., Bacon, B. R ., and Wolff, R. R . (1996) Nat.",10085150_1,-1,136,-1,0.35674068
137,hemochromatosis,15,16,94,109,"
HFE is the protein product of the gene mutated in the autosomal recessive disease hereditary hemochromatosis (Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R. J., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prasss, C. E ., Quintana, L., Starnes, S. M ., Schatzman, R. C ., Brunke, K. J ., Drayna, D. T., Risch, N. J ., Bacon, B. R ., and Wolff, R. R . (1996) Nat.",10085150_1,-1,137,-1,0.340005
138,E,129,130,454,455,"
HFE is the protein product of the gene mutated in the autosomal recessive disease hereditary hemochromatosis (Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R. J., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prasss, C. E ., Quintana, L., Starnes, S. M ., Schatzman, R. C ., Brunke, K. J ., Drayna, D. T., Risch, N. J ., Bacon, B. R ., and Wolff, R. R . (1996) Nat.",10085150_1,-1,138,-1,0.40627655
139,tetracycline,14,15,71,83,"Using a HeLa cell line in which the expression of HFE is controlled by tetracycline, we show that the expression of HFE reduces 55Fe uptake from Tf by 33% but does not affect the endocytic or exocytic rates of TfR cycling.",10085150_8,-1,139,-1,0.318625
140,iron,9,10,57,61,"Therefore, HFE appears to reduce cellular acquisition of iron from Tf within endocytic compartments.",10085150_9,-1,140,-1,0.33206114
141,iron,3,4,25,29,"HFE specifically reduces iron uptake from Tf, as non-Tf-mediated iron uptake from Fe-nitrilotriacetic acid is not altered.",10085150_10,-1,141,-1,0.3166748
142,iron,10,11,65,69,"HFE specifically reduces iron uptake from Tf, as non-Tf-mediated iron uptake from Fe-nitrilotriacetic acid is not altered.",10085150_10,-1,142,-1,0.31091705
143,iron,25,26,157,161,These results explain the decreased ferritin levels seen in our HeLa cell system and demonstrate the specific control of HFE over the Tf-mediated pathway of iron uptake.,10085150_11,-1,143,-1,0.3352477
144,iron,10,11,71,75,"These results also have implications for the understanding of cellular iron homeostasis in organs such as the liver, pancreas, heart, and spleen that are iron loaded in hereditary hemochromatotic individuals lacking functional HFE.",10085150_12,-1,144,-1,0.36216715
145,iron,27,28,154,158,"These results also have implications for the understanding of cellular iron homeostasis in organs such as the liver, pancreas, heart, and spleen that are iron loaded in hereditary hemochromatotic individuals lacking functional HFE.",10085150_12,-1,145,-1,0.3339429
146,familial Mediterranean fever,5,8,34,62,Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.,10090880_0,-1,146,-1,0.3513322
147,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10090880_1,-1,147,-1,0.34602875
149,serositis,16,17,100,109,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10090880_1,-1,149,-1,0.30656236
150,synovitis,18,19,113,122,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10090880_1,-1,150,-1,0.3391121
151,Autoimmune lymphoproliferative syndrome,0,3,0,39,Autoimmune lymphoproliferative syndrome  with defective Fas: genotype influences penetrance.,10090885_0,-1,151,-1,0.34706026
152,Autoimmune lymphoproliferative syndrome,0,3,1,40,"
Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of lymphocyte homeostasis and immunological tolerance.",10090885_1,-1,152,-1,0.37217876
154,hemochromatosis,3,4,23,38,Multicentric origin of hemochromatosis gene (HFE) mutations.,10090890_0,-1,154,-1,0.32971117
155,hemochromatosis,1,2,9,24,"
Genetic hemochromatosis (GH) is believed to be a disease restricted to those of European ancestry.",10090890_1,-1,155,-1,0.32681617
156,disease,10,11,50,57,"
Genetic hemochromatosis (GH) is believed to be a disease restricted to those of European ancestry.",10090890_1,-1,156,-1,0.35462546
157,tyrosine,19,20,98,106,"In northwestern Europe, > 80% of GH patients are homozygous for one mutation, the substitution of tyrosine for cysteine at position 282 (C282Y) in the unprocessed protein.",10090890_2,-1,157,-1,0.37286153
158,cysteine,21,22,111,119,"In northwestern Europe, > 80% of GH patients are homozygous for one mutation, the substitution of tyrosine for cysteine at position 282 (C282Y) in the unprocessed protein.",10090890_2,-1,158,-1,0.37036952
159,disease,25,26,142,149,The clinical significance of this second mutation is such that it appears to predispose 1% -2% of compound heterozygotes to expression of the disease.,10090890_4,-1,159,-1,0.35935625
160,Mb,12,13,60,62,"The C282Y mutation occurs on a haplotype that extends </= 6 Mb, suggesting that this mutation has arisen during the past 2, 000 years.",10090890_6,-1,160,-1,0.3577056
161,diseases,8,9,53,61,"These selection pressures could be due to infectious diseases, environmental conditions,  or other genetic disorders such as anemia.",10090890_11,-1,161,-1,0.37174848
163,hemochromatosis,29,30,180,195,"
We have retrospectively analyzed 837 random anonymized dried blood spot (DBS) samples from neonatal screening programs in Scandinavia for mutations in HFE, the candidate gene for hemochromatosis.",10094552_1,-1,163,-1,0.3138645
164,alkaptonuria,6,7,38,50,Identification of the mutation in the alkaptonuria mouse model.,10094559_0,-1,164,-1,0.33310315
165,Alkaptonuria,0,1,1,13,"
Alkaptonuria (aku), an inborn error of metabolism caused by the loss of homogentisate 1, 2-dioxygenase (HGD), has been described in a mouse model created by ethylnitrosourea mutagenesis but the mutation in these mice has not previously been identified.",10094559_1,-1,165,-1,0.33406577
166,hearing loss,1,3,14,26,Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations.,10190331_0,-1,166,-1,0.37514183
168,Pendred syndrome,22,24,125,141,"The locus for non-syndromic sensorineural hearing loss with EVA has been mapped to the same chromosomal region, 7q31, as the Pendred syndrome locus.",10190331_2,-1,168,-1,0.35975596
169,Pendred syndrome,19,21,86,102,"In the present study, seven mutations in the PDS gene (PDS), the gene responsible for Pendred syndrome, have been found in families of non-syndromic sensorineural hearing loss with EVA.",10190331_3,-1,169,-1,0.33999658
171,hearing loss,14,16,98,110,The present results provide evidence that mutations in PDS cause both syndromic and non-syndromic hearing loss..,10190331_5,-1,171,-1,0.3598863
172,adrenoleukodystrophy,12,13,103,123,Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy.,10190819_0,-1,172,-1,0.32483006
173,adrenoleukodystrophy,3,4,22,42,"
BACKGROUND  X-linked adrenoleukodystrophy (ALD) is an inherited disease characterized by progressive neurologic dysfunction, occasionally associated with adrenal insufficiency.",10190819_1,-1,173,-1,0.36056572
174,disease,10,11,65,72,"
BACKGROUND  X-linked adrenoleukodystrophy (ALD) is an inherited disease characterized by progressive neurologic dysfunction, occasionally associated with adrenal insufficiency.",10190819_1,-1,174,-1,0.34842893
175,adrenal insufficiency,20,22,155,176,"
BACKGROUND  X-linked adrenoleukodystrophy (ALD) is an inherited disease characterized by progressive neurologic dysfunction, occasionally associated with adrenal insufficiency.",10190819_1,-1,175,-1,0.32431254
176,neurologic deterioration,18,20,92,116,"The classic form of ALD usually has onset in childhood (childhood cerebral ALD), with rapid neurologic deterioration leading to a vegetative state.",10190819_2,-1,176,-1,0.35448223
177,Addison disease,6,8,52,67,Milder phenotypes such as adrenomyeloneuropathy and Addison disease only also have been recognized.,10190819_4,-1,177,-1,0.36694172
178,nucleotide,19,20,130,140,"We conducted detailed mutational analyses of 29 unrelated Japanese patients with ALD by genomic Southern blot analysis and direct nucleotide sequence analysis of reverse transcriptase-polymerase chain reaction products derived from total RNA that was extracted from cultured skin fibroblasts, lymphoblastoid cells, or peripheral blood leukocytes.",10190819_8,-1,178,-1,0.34093663
179,nucleotide,19,20,126,136,"The remaining 26 patients were identified as having 21 independent mutations, including 12 novel mutations resulting in small nucleotide alterations in the ALD gene.",10190819_10,-1,179,-1,0.35582274
180,amino acids,4,6,33,44,"Most missense mutations involved amino acids conserved in homologous gene products, including PMP70, mALDRP, and Pxa1p.",10190819_12,-1,180,-1,0.34671694
181,AG,1,2,4,6,"The AG dinucleotide deletion at position 1081-1082, which has been reported previously to be the most common mutation in white patients (12% -17%), was also identified as the most common mutation in Japanese patients (12%).",10190819_13,-1,181,-1,0.41311583
182,amino acid,12,14,88,98,All phenotypes were associated with mutations resulting in protein truncation or subtle amino acid changes.,10190819_14,-1,182,-1,0.35085368
183,amino acids,12,14,99,110,There were no differences in phenotypic expressions between missense mutations involving conserved amino acids and those involving nonconserved amino acids.,10190819_15,-1,183,-1,0.34362122
184,amino acids,18,20,144,155,There were no differences in phenotypic expressions between missense mutations involving conserved amino acids and those involving nonconserved amino acids.,10190819_15,-1,184,-1,0.3289707
185,tumour,4,5,20,26,A common human skin tumour is caused by activating mutations in beta-catenin.,10192393_0,-1,185,-1,0.29289794
186,lead,19,20,122,126,"One of the target genes for beta-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon.",10192393_3,-1,186,-1,0.38954833
189,adenomatous polyposis coli,10,13,61,87,"Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli (APC), a protein required for ubiquitin-mediated degradation of beta-catenin, but a small percentage of colon and some other cancers harbour beta-catenin-stabilizing mutations.",10192393_4,-1,189,-1,0.3366307
191,tumours,16,17,117,124,"Recently, we discovered that transgenic mice expressing an activated beta-catenin are predisposed to developing skin tumours resembling pilomatricomas.",10192393_5,-1,191,-1,0.31223214
192,tumour,14,15,73,79,"Here, we explore the cell origin and aetiology of this common human skin tumour.",10192393_7,-1,192,-1,0.31263745
193,tumour,7,8,39,45,"We found nuclear LEF-1 in the dividing tumour cells, providing biochemical evidence that pilomatricomas are derived from hair matrix cells.",10192393_8,-1,193,-1,0.29149806
194,tumours,6,7,22,29,"At least 75% of these tumours possess mutations affecting the amino-terminal segment, normally involved in phosphorylation-dependent, ubiquitin-mediated degradation of the protein.",10192393_9,-1,194,-1,0.33676043
195,tumours,12,13,71,78,"This percentage of CTNNB1 mutations is greater than in all other human tumours examined thus far, and directly implicates beta-catenin/LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans..",10192393_10,-1,195,-1,0.25636998
196,Pendred syndrome,1,3,4,20,The Pendred syndrome gene encodes a chloride-iodide transport protein.,10192399_0,-1,196,-1,0.37768397
197,Pendred syndrome,0,2,1,17,"
Pendred syndrome is the most common form of syndromic deafness and characterized by congenital sensorineural hearing loss and goitre.",10192399_1,-1,197,-1,0.35058874
198,deafness,9,10,55,63,"
Pendred syndrome is the most common form of syndromic deafness and characterized by congenital sensorineural hearing loss and goitre.",10192399_1,-1,198,-1,0.29012835
200,Pendred syndrome,11,13,62,78,This disorder was mapped to chromosome 7 and the gene causing Pendred syndrome (PDS) was subsequently identified by positional cloning.,10192399_2,-1,200,-1,0.37228563
201,amino acid,24,26,140,150,"Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate-anion transporter (encoded by Sat-1; 29% amino acid sequence identity), the human diastrophic dysplasia sulfate transporter (encoded by DTD; 32%) and the human sulfate transporter downregulated in adenoma (encoded by DRA; 45%).",10192399_4,-1,201,-1,0.38629338
202,diastrophic dysplasia,32,34,181,202,"Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate-anion transporter (encoded by Sat-1; 29% amino acid sequence identity), the human diastrophic dysplasia sulfate transporter (encoded by DTD; 32%) and the human sulfate transporter downregulated in adenoma (encoded by DRA; 45%).",10192399_4,-1,202,-1,0.3985936
203,adenoma,51,52,296,303,"Pendrin is closely related to a family of sulfate transport proteins that includes the rat sulfate-anion transporter (encoded by Sat-1; 29% amino acid sequence identity), the human diastrophic dysplasia sulfate transporter (encoded by DTD; 32%) and the human sulfate transporter downregulated in adenoma (encoded by DRA; 45%).",10192399_4,-1,203,-1,0.27732262
205,chloride,7,8,38,46,The rates of transport for iodide and chloride were significantly increased following the expression of pendrin in both cell systems.,10192399_7,-1,205,-1,0.34909225
206,chloride,10,11,67,75,"Our results demonstrate that pendrin functions as a transporter of chloride and iodide, but not sulfate, and may provide insight into thyroid physiology and the pathophysiology of Pendred syndrome..",10192399_8,-1,206,-1,0.36706463
207,Pendred syndrome,29,31,180,196,"Our results demonstrate that pendrin functions as a transporter of chloride and iodide, but not sulfate, and may provide insight into thyroid physiology and the pathophysiology of Pendred syndrome..",10192399_8,-1,207,-1,0.35104012
208,hemochromatosis,5,6,30,45,HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.,10194428_0,-1,208,-1,0.32055938
209,hemochromatosis,16,17,102,117,HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.,10194428_0,-1,209,-1,0.28471774
210,hemochromatosis,1,2,12,27,"
Hereditary hemochromatosis (HH) is a common autosomal recessive genetic disorder of iron metabolism.",10194428_1,-1,210,-1,0.31874418
211,iron,13,14,85,89,"
Hereditary hemochromatosis (HH) is a common autosomal recessive genetic disorder of iron metabolism.",10194428_1,-1,211,-1,0.33348775
212,disease,32,33,152,159,"Two missense mutations have been described  C282Y, accounting for 80% to 90% of HH chromosomes, and H63D, which is associated with a milder form of the disease representing 40% to 70% of non-C282Y HH chromosomes.",10194428_3,-1,212,-1,0.34973603
213,hemochromatosis,13,14,82,97,"The results confirm that the C282Y substitution was the main mutation involved in hemochromatosis, accounting for 85% of carrier chromosomes, whereas the H63D substitution represented 39% of the HH chromosomes that did not carry the C282Y mutation.",10194428_5,-1,213,-1,0.31957585
214,hemochromatosis,19,20,117,132,This enrichment of S65C among HH chromosomes suggests that the S65C substitution is associated with the mild form of hemochromatosis.,10194428_9,-1,214,-1,0.28450617
224,P,10,11,59,60,"The rare form of the Q356R polymorphism was significantly (P = 0. 03) associated with a family history of ovarian cancer, suggesting that this polymorphism may influence ovarian cancer risk.",10196379_9,-1,224,-1,0.4035035
228,adrenoleukodystrophy protein deficiency,6,9,69,108,Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.,10196381_0,-1,228,-1,0.37753707
229,adrenoleukodystrophy,11,12,77,97,"
Inherited defects in the peroxisomal ATP-binding cassette (ABC) transporter adrenoleukodystrophy protein (ALDP) lead to the lethal peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), for which no efficient treatment has been established so far.",10196381_1,-1,229,-1,0.36985046
230,lead,16,17,113,117,"
Inherited defects in the peroxisomal ATP-binding cassette (ABC) transporter adrenoleukodystrophy protein (ALDP) lead to the lethal peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), for which no efficient treatment has been established so far.",10196381_1,-1,230,-1,0.40801877
231,adrenoleukodystrophy,23,24,162,182,"
Inherited defects in the peroxisomal ATP-binding cassette (ABC) transporter adrenoleukodystrophy protein (ALDP) lead to the lethal peroxisomal disorder X-linked adrenoleukodystrophy (X-ALD), for which no efficient treatment has been established so far.",10196381_1,-1,231,-1,0.33703655
232,fatty acids,7,9,50,61,The pathognomonic accumulation of very long chain fatty acids could also be prevented by overexpression of ALDRP in immortalized X-ALD cells.,10196381_4,-1,232,-1,0.34317756
235,lead,9,10,67,71,"Mutant fibroblasts contain multiple, functional centrosomes, which lead to unequal chromosome segregation, abnormal nuclear division, and aneuploidy.",10198641_5,-1,235,-1,0.41088083
236,aneuploidy,20,21,138,148,"Mutant fibroblasts contain multiple, functional centrosomes, which lead to unequal chromosome segregation, abnormal nuclear division, and aneuploidy.",10198641_5,-1,236,-1,0.347524
237,autoimmune lymphoproliferative syndrome,8,11,63,102,"Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Heterozygous mutations in the CD95 (APO-1/Fas) receptor occur in most individuals with autoimmune lymphoproliferative syndrome (ALPS) and dominantly interfere with apoptosis by an unknown mechanism.",10200300_0,-1,237,-1,0.32990748
238,autoimmune lymphoproliferative syndrome,28,31,200,239,"Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Heterozygous mutations in the CD95 (APO-1/Fas) receptor occur in most individuals with autoimmune lymphoproliferative syndrome (ALPS) and dominantly interfere with apoptosis by an unknown mechanism.",10200300_0,-1,238,-1,0.33320424
240,alkaptonuria,2,3,12,24,"Analysis of alkaptonuria (AKU) mutations and polymorphisms reveals that the CCC sequence motif is a mutational hot spot in the homogentisate 1,2 dioxygenase gene (HGO).",10205262_0,-1,240,-1,0.3545718
241,alkaptonuria,4,5,25,37,"
We recently showed that alkaptonuria (AKU) is caused by loss-of-function mutations in the homogentisate 1, 2 dioxygenase gene (HGO).",10205262_1,-1,241,-1,0.33790687
242,nucleotide,15,16,95,105,"Reexamination of all 29 mutations and polymorphisms thus far described in HGO shows that these nucleotide changes are not randomly distributed; the CCC sequence motif and its inverted complement, GGG, are preferentially mutated.",10205262_4,-1,242,-1,0.37072685
243,nucleotide,6,7,42,52,"These analyses also demonstrated that the nucleotide substitutions in HGO do not involve CpG dinucleotides, which illustrates important differences between HGO and other genes for the occurrence of mutation at specific short-sequence motifs.",10205262_5,-1,243,-1,0.37155446
244,Fabry disease,0,2,0,13,Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.,10208848_0,-1,244,-1,0.355251
245,Fabry disease,0,2,1,14,"
Fabry disease (FD) (angiokeratoma corporis diffusum) is an X-linked inborn error of glycosphingolipid metabolism caused by defects in the lysosomal alpha-galactosidase A gene (GLA).",10208848_1,-1,245,-1,0.36546066
246,angiokeratoma,6,7,21,34,"
Fabry disease (FD) (angiokeratoma corporis diffusum) is an X-linked inborn error of glycosphingolipid metabolism caused by defects in the lysosomal alpha-galactosidase A gene (GLA).",10208848_1,-1,246,-1,0.36243036
247,angiokeratoma,6,7,43,56,"Clinically, affected hemizygous males have angiokeratoma, severe acroparesthesia, renal failure, and vasculopathy of the heart and brain.",10208848_3,-1,247,-1,0.35388997
248,renal failure,11,13,82,95,"Clinically, affected hemizygous males have angiokeratoma, severe acroparesthesia, renal failure, and vasculopathy of the heart and brain.",10208848_3,-1,248,-1,0.35452497
249,K,19,20,94,95,"The mutational spectrum included five missense mutations (C202W, C223G, N224D, R301Q, and Q327K) and one splice-site mutation [IVS3 G (-1) -- > C].",10208848_6,-1,249,-1,0.37310457
250,C,33,34,144,145,"The mutational spectrum included five missense mutations (C202W, C223G, N224D, R301Q, and Q327K) and one splice-site mutation [IVS3 G (-1) -- > C].",10208848_6,-1,250,-1,0.37026492
251,Pelizaeus-Merzbacher disease,8,10,44,72,Prenatal diagnosis by FISH in a family with Pelizaeus-Merzbacher disease caused by duplication of PLP gene.,10210128_0,-1,251,-1,0.36287308
252,Pelizaeus-Merzbacher disease,3,5,16,44,"
A diagnosis of Pelizaeus-Merzbacher disease (MIM 312080) was made in a young boy.",10210128_1,-1,252,-1,0.3427208
253,disease,16,17,102,109,"The proband was found to carry the duplication, thus confirming the diagnosis of Pelizaeus Merzbacher disease, but neither the aunt nor the fetus carried a duplication..",10210128_5,-1,253,-1,0.3546689
254,adenomatous polyposis coli,3,6,21,47,"
Inactivation of the adenomatous polyposis coli (APC) gene product initiates colorectal tumorigenesis.",10213492_1,-1,254,-1,0.3200439
255,colorectal adenomas,17,19,96,115,Patients with familial APC (FAP) carry germ-line mutations in the APC gene and develop multiple colorectal adenomas and subsequent carcinomas early in life.,10213492_2,-1,255,-1,0.2722491
256,disease,4,5,20,27,The severity of the disease correlates with the position of the inherited APC mutation (genotype-phenotype correlation).,10213492_3,-1,256,-1,0.35067594
257,contrast,1,2,3,11,"In contrast, mutant APC gene products that are associated with attenuated polyposis (codon 386 or 1465) interfered only weakly with wild-type APC activity.",10213492_8,-1,257,-1,0.35896504
260,disease,2,3,12,19,"No clinical disease was associated with this deficiency which was transmitted through the subjects family as a single genetic characteristic, the C6 deficiency being associated with a silent allele at the structural locus.",102474_2,-1,260,-1,0.40810707
261,X-linked Emery-Dreifuss muscular dystrophy,11,15,79,121,Changes at P183 of emerin weaken its protein-protein interactions resulting in X-linked Emery-Dreifuss muscular dystrophy.,10323252_0,-1,261,-1,0.37052026
262,muscular dystrophy,1,3,16,34,"
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive muscular dystrophy characterized by early contractures of the elbows, Achilles tendons and spine, slowly progressive muscle wasting and weakness, and cardiomyopathy associated with cardiac conduction defects.",10323252_1,-1,262,-1,0.35872936
263,muscular dystrophy,10,12,67,85,"
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive muscular dystrophy characterized by early contractures of the elbows, Achilles tendons and spine, slowly progressive muscle wasting and weakness, and cardiomyopathy associated with cardiac conduction defects.",10323252_1,-1,263,-1,0.34611127
264,contractures,15,16,109,121,"
Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive muscular dystrophy characterized by early contractures of the elbows, Achilles tendons and spine, slowly progressive muscle wasting and weakness, and cardiomyopathy associated with cardiac conduction defects.",10323252_1,-1,264,-1,0.40964833
267,contractures,24,25,134,146,"In comparison with the usual EDMD phenotype, patients with P183 missense mutations have a later age at onset of first symptoms, elbow contractures, ankle contractures, upper limb weakness and lower limb weakness, but there is no difference for the age at onset of cardiac involvement.",10323252_7,-1,267,-1,0.37578368
268,contractures,27,28,154,166,"In comparison with the usual EDMD phenotype, patients with P183 missense mutations have a later age at onset of first symptoms, elbow contractures, ankle contractures, upper limb weakness and lower limb weakness, but there is no difference for the age at onset of cardiac involvement.",10323252_7,-1,268,-1,0.38161543
271,Van der Woude syndrome,9,13,58,80,Microdeletions at chromosome bands 1q32-q41 as a cause of Van der Woude syndrome.,10323740_0,-1,271,-1,0.35277355
272,Van der Woude syndrome,0,4,1,23,"
Van der Woude syndrome (VWS) is an autosomal dominant disorder comprising cleft lip and/or cleft palate and lip pits.",10323740_1,-1,272,-1,0.34922865
273,cleft lip,13,15,75,84,"
Van der Woude syndrome (VWS) is an autosomal dominant disorder comprising cleft lip and/or cleft palate and lip pits.",10323740_1,-1,273,-1,0.29812843
274,cleft palate,16,18,92,104,"
Van der Woude syndrome (VWS) is an autosomal dominant disorder comprising cleft lip and/or cleft palate and lip pits.",10323740_1,-1,274,-1,0.32347876
275,cleft,2,3,11,16,"Along with cleft lip/palate and lip pits, affected relatives exhibit developmental delays, suggesting that the function of a gene nearby may also be disrupted.",10323740_3,-1,275,-1,0.33437702
276,Mb,16,17,73,75,"Surprisingly, mapping of the new deletion showed that it extended 0. 2-1 Mb beyond the proximal breakpoint for the deletion described previously.",10323740_8,-1,276,-1,0.36567158
277,syndrome,10,11,64,72,"No deletions were detected in seven cases of popliteal pterygia syndrome, 76 cases of mixed syndromic forms of cleft lip and palate, and 178 cases of nonsyndromic cleft lip and palate.",10323740_9,-1,277,-1,0.29022175
278,cleft lip,19,21,111,120,"No deletions were detected in seven cases of popliteal pterygia syndrome, 76 cases of mixed syndromic forms of cleft lip and palate, and 178 cases of nonsyndromic cleft lip and palate.",10323740_9,-1,278,-1,0.27962002
279,cleft lip,29,31,163,172,"No deletions were detected in seven cases of popliteal pterygia syndrome, 76 cases of mixed syndromic forms of cleft lip and palate, and 178 cases of nonsyndromic cleft lip and palate.",10323740_9,-1,279,-1,0.28205067
280,AG,10,11,65,67,Fewer than half of the splicing mutations involved the canonical AG splice-acceptor site or GT splice-donor site.,10330348_2,-1,280,-1,0.38873452
281,nucleotide,18,19,118,128,"A higher percentage of mutations occurred at less stringently conserved sites, including silent mutations of the last nucleotide of exons, mutations in nucleotides other than the conserved AG and GT in the consensus splice sites, and creation of splice-acceptor or splice-donor sites in either introns or exons.",10330348_3,-1,281,-1,0.36922607
282,AG,29,30,189,191,"A higher percentage of mutations occurred at less stringently conserved sites, including silent mutations of the last nucleotide of exons, mutations in nucleotides other than the conserved AG and GT in the consensus splice sites, and creation of splice-acceptor or splice-donor sites in either introns or exons.",10330348_3,-1,282,-1,0.39927477
283,disease,5,6,31,38,Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy.,10330430_0,-1,283,-1,0.3676367
284,hypertrophic cardiomyopathy,9,11,56,83,Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy.,10330430_0,-1,284,-1,0.3501323
285,disease,12,13,62,69,"
We identified the alpha-cardiac actin gene (ACTC) as a novel disease gene in a pedigree suffering from familial hypertrophic cardiomyopathy (FHC).",10330430_1,-1,285,-1,0.36943686
286,hypertrophic cardiomyopathy,20,22,113,140,"
We identified the alpha-cardiac actin gene (ACTC) as a novel disease gene in a pedigree suffering from familial hypertrophic cardiomyopathy (FHC).",10330430_1,-1,286,-1,0.3513477
287,disease,11,12,75,82,"Linkage analyses excluded all the previously reported FHC loci as possible disease loci in the family studied, with lod scores varying between -2.",10330430_2,-1,287,-1,0.3958493
288,disease,20,21,131,138,"Further linkage analyses of plausible candidate genes highly expressed in the adult human heart identified ACTC as the most likely disease gene, showing a maximal lod score of 3.",10330430_4,-1,288,-1,0.39130285
289,idiopathic dilated cardiomyopathy,24,27,147,180,Mutation analysis of ACTC revealed an Ala295Ser mutation in exon 5 close to 2 missense mutations recently described to cause the inherited form of idiopathic dilated cardiomyopathy (IDC).,10330430_6,-1,289,-1,0.3741529
290,aspartylglucosaminuria,12,13,62,84,"Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.",10353787_0,-1,290,-1,0.32378325
291,Aspartylglucosaminuria,0,1,1,23,"
Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase (AGA).",10353787_1,-1,291,-1,0.33265284
292,aspartylglucosaminidase,13,14,86,109,"
Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase (AGA).",10353787_1,-1,292,-1,0.34517792
293,mental retardation,5,7,32,50,The main symptom is progressive mental retardation.,10353787_2,-1,293,-1,0.34755263
294,disease,10,11,60,67,"A spectrum of different mutations has been reported in this disease, one missense mutation (Cys163Ser) being responsible for the majority of Finnish cases.",10353787_3,-1,294,-1,0.35262004
295,erythema,10,11,60,68,"Skin was seborrhoeic in adolescent and adult patients, with erythema of the facial skin already common in childhood.",10353787_7,-1,295,-1,0.34376773
296,tumours,13,14,53,60,"Of 44 patients, nine (20%) had facial angiofibromas, tumours primarily occurring in association with tuberous sclerosis.",10353787_8,-1,296,-1,0.37319052
297,sclerosis,20,21,110,119,"Of 44 patients, nine (20%) had facial angiofibromas, tumours primarily occurring in association with tuberous sclerosis.",10353787_8,-1,297,-1,0.3264242
298,p,19,20,113,114,Oedemic buccal mucosa (leucoedema) and gingival overgrowths were more frequent in AGU patients than in controls (p < 0. 001).,10353787_9,-1,298,-1,0.43305779
299,syndrome,9,10,63,71,"Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene.",10364518_0,-1,299,-1,0.3101488
300,oculocerebrorenal syndrome,1,3,5,31,"
The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder characterized by major abnormalities of eyes, nervous system, and kidneys.",10364518_1,-1,300,-1,0.3529232
301,disease,10,11,58,65,Mutations in the OCRL1 gene have been associated with the disease.,10364518_2,-1,301,-1,0.3471805
302,amino acids,20,22,108,119,"Finally, one frameshift mutation, 2799delC, modifies the C-terminal part of OCRL1, with an extension of six amino acids.",10364518_7,-1,302,-1,0.36349925
303,syndrome,10,11,72,80,This observation has direct implications for genetic counseling of Lowe syndrome families..,10364518_10,-1,303,-1,0.3161452
304,Familial Mediterranean fever,6,9,45,73,MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications.,10364520_0,-1,304,-1,0.3242331
305,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessively inherited disorder that is common in patients of Armenian ancestry.",10364520_1,-1,305,-1,0.3441149
307,lead,32,33,181,185,"To date, its diagnosis, which can be made only retrospectively, is one of exclusion, based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery.",10364520_2,-1,307,-1,0.48395273
308,amyloidosis,1,2,6,17,"Renal amyloidosis, prevented by colchicine, is the most severe complication of FMF, a disorder associated with mutations in the MEFV gene.",10364520_3,-1,308,-1,0.32128102
309,disease,17,18,130,137,"In several instances, family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype.",10364520_6,-1,309,-1,0.38498184
310,amyloidosis,15,16,91,102,"The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P =.",10364520_7,-1,310,-1,0.32273668
312,P,24,25,149,150,"The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P =.",10364520_7,-1,312,-1,0.41970956
313,P,2,3,9,10,0002 and P =.,10364520_8,-1,313,-1,0.43696606
314,lead,18,19,122,126,The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF-including genetic counseling and therapeutic decisions in affected families.,10364520_10,-1,314,-1,0.4195541
315,fragile X syndrome,3,6,21,39,"Noninvasive test for fragile X syndrome, using hair root analysis.",10364521_0,-1,315,-1,0.30648094
316,fragile X syndrome,10,13,80,98,"
Identification of the FMR1 gene and the repeat-amplification mechanism causing fragile X syndrome led to development of reliable DNA-based diagnostic methods, including Southern blot hybridization and PCR.",10364521_1,-1,316,-1,0.3248151
317,fragile X syndrome,19,22,126,144,"Using an immunocytochemical technique on blood smears, we recently developed a novel test for identification of patients with fragile X syndrome.",10364521_3,-1,317,-1,0.3100195
318,fragile X syndrome,12,15,70,88,"Here we describe a new diagnostic test to identify male patients with fragile X syndrome, on the basis of lack of FMRP in their hair roots.",10364521_5,-1,318,-1,0.30857643
324,P,4,5,14,15,64 at D1S202 (P =.,10364525_6,-1,324,-1,0.40946108
325,P,4,5,14,15,95 at D1S422 (P =. 03).,10364525_10,-1,325,-1,0.37230653
327,mucopolysaccharidosis,11,12,76,97,Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII.,10366443_0,-1,327,-1,0.31216577
328,mucopolysaccharidosis VII,15,17,107,132,"
A family of domestic cats was found that exhibited clinical and biochemical abnormalities consistent with mucopolysaccharidosis VII, an autosomal recessive lysosomal storage disorder caused by beta-glucuronidase deficiency.",10366443_1,-1,328,-1,0.33783928
329,K,14,15,77,78,"There was a G-to-A transition in the affected cat cDNA that predicted an E351K substitution, destroyed a BssSI site, and eliminated GUSB enzymatic activity in expression studies.",10366443_5,-1,329,-1,0.34451842
331,syndrome,6,7,44,52,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,331,-1,0.29889375
332,syndrome,11,12,61,69,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,332,-1,0.31601778
333,syndrome,15,16,111,119,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,333,-1,0.29273146
334,tetrasomy,22,23,151,160,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,334,-1,0.35675898
335,trisomy,24,25,162,169,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,335,-1,0.35633543
336,monosomy,26,27,173,181,"Three congenital anomaly disorders, cat-eye syndrome, der () syndrome and velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) are associated with tetrasomy, trisomy or monosomy, respectively, for part of chromosome 22q11.",10369860_2,-1,336,-1,0.3388027
337,syndrome,5,6,28,36,VCFS/DGS is the most common syndrome associated with 22q11 rearrangements.,10369860_3,-1,337,-1,0.29095775
338,Mb,7,8,40,42,"Most VCFS/DGS patients have a similar 3 Mb deletion, some have a nested distal deletion breakpoint resulting in a 1. 5 Mb deletion and a few rare patients have unique deletions or translocations.",10369860_5,-1,338,-1,0.33931932
339,Mb,23,24,119,121,"Most VCFS/DGS patients have a similar 3 Mb deletion, some have a nested distal deletion breakpoint resulting in a 1. 5 Mb deletion and a few rare patients have unique deletions or translocations.",10369860_5,-1,339,-1,0.34400752
340,Mb,19,20,108,110,"To support this idea further, we identified a family that carries an interstitial duplication of the same 3 Mb region that is deleted in VCFS/DGS patients.",10369860_8,-1,340,-1,0.38960534
341,disease,17,18,108,115,We identified five additional copies of the LCR22 on 22q11 that may mediate other rearrangements leading to disease.,10369860_10,-1,341,-1,0.33224103
342,neuropathies,14,15,93,105,"Mutations in the human EGR2 gene have recently been associated with the inherited peripheral neuropathies Charcot-Marie-Tooth type 1, Dejerine-Sottas syndrome and congenital hypomyelinating neuropathy.",10369870_3,-1,342,-1,0.33158928
343,syndrome,20,21,150,158,"Mutations in the human EGR2 gene have recently been associated with the inherited peripheral neuropathies Charcot-Marie-Tooth type 1, Dejerine-Sottas syndrome and congenital hypomyelinating neuropathy.",10369870_3,-1,343,-1,0.3363009
345,zinc,12,13,67,71,Three of the four EGR2 mutations are dominant and occur within the zinc finger DNA-binding domain.,10369870_4,-1,345,-1,0.3646037
346,zinc,1,2,4,8,The zinc finger mutations affect DNA binding and the amount of residual binding directly correlates with disease severity.,10369870_7,-1,346,-1,0.37735963
347,disease,16,17,105,112,The zinc finger mutations affect DNA binding and the amount of residual binding directly correlates with disease severity.,10369870_7,-1,347,-1,0.37117827
348,disease,7,8,45,52,These data provide insight into the possible disease mechanisms underlying EGR2 mutations and the reason for varying severity and differences in inheritance patterns..,10369870_9,-1,348,-1,0.3771096
349,diabetes insipidus,4,6,46,64,Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.,10369876_0,-1,349,-1,0.32517564
350,vasopressin,13,14,114,125,Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.,10369876_0,-1,350,-1,0.29952544
351,diabetes insipidus,2,4,27,45,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,351,-1,0.34323615
352,arginine vasopressin,14,16,123,143,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,352,-1,0.32626438
353,AVP,17,18,145,148,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,353,-1,0.35318816
354,AVP,25,26,185,188,"
Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post-natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene.",10369876_1,-1,354,-1,0.34491843
356,diabetes insipidus,18,20,139,157,"We studied an unusual Palestinian family consisting of asymptomatic first cousin parents and three children affected with neurohypophyseal diabetes insipidus, suggesting autosomal recessive inheritance.",10369876_3,-1,356,-1,0.34108162
357,AVP,28,29,149,152,"All three affected children were homozygous and the parents heterozygous for a single novel mutation (C301- > T) in exon 1, replacing Pro7 of mature AVP with Leu (Leu-AVP).",10369876_4,-1,357,-1,0.31479627
358,Leu-AVP,32,33,163,170,"All three affected children were homozygous and the parents heterozygous for a single novel mutation (C301- > T) in exon 1, replacing Pro7 of mature AVP with Leu (Leu-AVP).",10369876_4,-1,358,-1,0.319475
359,Leu-AVP,0,1,0,7,Leu-AVP was a weak agonist with approximately 30-fold reduced binding to the human V2 receptor.,10369876_5,-1,359,-1,0.33557802
360,AVP,36,37,221,224,"The youngest child (2 years old) was only mildly affected but had Leu-AVP levels similar to her severely affected 8-year-old brother, suggesting that unknown mechanisms may partially compensate for a deficiency of active AVP in very young children..",10369876_7,-1,360,-1,0.3129068
361,hemoglobinuria,30,31,193,207,"
A somatic mutation in the X linked PIGA gene is responsible for the deficiency of glycosyl phosphatidylinositol (GPI) -anchored proteins on blood cells from patients with paroxysmal nocturnal hemoglobinuria.",10377440_1,-1,361,-1,0.32611153
362,hemochromatosis,5,6,38,53,The C282Y mutation causing hereditary hemochromatosis does not produce a null allele.,10381492_0,-1,362,-1,0.3278444
363,hemochromatosis,11,12,70,85,"
Targeted mutagenesis was used to produce two mutations in the murine hemochromatosis gene (Hfe) locus.",10381492_1,-1,363,-1,0.33858886
364,hemochromatosis,12,13,87,102,This mutation is identical to the disease-causing mutation in patients with hereditary hemochromatosis.,10381492_4,-1,364,-1,0.3156872
365,iron,7,8,54,58,Homozygosity for either mutation results in postnatal iron loading.,10381492_6,-1,365,-1,0.33422676
366,iron,7,8,54,58,Mice heterozygous for either mutation accumulate more iron than normal controls.,10381492_8,-1,366,-1,0.33443815
367,iron,4,5,30,34,"Interestingly, although liver iron stores are greatly increased, splenic iron is decreased.",10381492_9,-1,367,-1,0.34115624
368,iron,11,12,73,77,"Interestingly, although liver iron stores are greatly increased, splenic iron is decreased.",10381492_9,-1,368,-1,0.32988632
369,X-linked Emery-Dreifuss muscular dystrophy,3,7,31,73,Genotype-phenotype analysis in X-linked Emery-Dreifuss muscular dystrophy and identification of a missense mutation associated with a milder phenotype.,10382909_0,-1,369,-1,0.37165055
370,muscular dystrophy,11,13,73,91,"
Direct sequencing of the emerin gene in 22 families with Emery-Dreifuss muscular dystrophy (EMD) revealed mutations in 21 (95%), confirming that emerin mutations can be identified in the majority of families with X-linked EMD.",10382909_1,-1,370,-1,0.36876374
371,X-linked EMD,38,40,214,226,"
Direct sequencing of the emerin gene in 22 families with Emery-Dreifuss muscular dystrophy (EMD) revealed mutations in 21 (95%), confirming that emerin mutations can be identified in the majority of families with X-linked EMD.",10382909_1,-1,371,-1,0.33999956
372,contractures,13,14,71,83,Age at onset was later for first symptoms and for development of ankle contractures and muscle weakness.,10382909_7,-1,372,-1,0.38681749
373,muscle weakness,15,17,88,103,Age at onset was later for first symptoms and for development of ankle contractures and muscle weakness.,10382909_7,-1,373,-1,0.34262046
374,X-linked Emery-Dreifuss muscular dystrophy,4,8,30,72,Severe clinical expression in X-linked Emery-Dreifuss muscular dystrophy.,10382910_0,-1,374,-1,0.3491396
375,X-linked Emery-Dreifuss muscular dystrophy,0,4,1,43,"
X-linked Emery-Dreifuss muscular dystrophy (EDMD) is a relatively rare benign neuromuscular disorder which can vary remarkably in onset, course and severity.",10382910_1,-1,375,-1,0.3792229
376,disease,22,23,118,125,"In the present study, a TCTAC deletion spanning the nucleotides 631-635 of the emerin gene caused an unusually severe disease phenotype including loss of ambulation and severe muscle wasting in two affected brothers.",10382910_2,-1,376,-1,0.38155353
377,muscular dystrophy,29,31,202,220,The interfamilial heterogeneity in distribution and in severity of the features in the two families point to environmental or genetic modification as the cause of clinical variability in Emery-Dreifuss muscular dystrophy..,10382910_4,-1,377,-1,0.33905208
386,hepatoblastoma,9,10,61,75,Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.,10398436_0,-1,386,-1,0.29026952
387,Hepatoblastoma,0,1,1,15,"
Hepatoblastoma is a rare malignant tumor of the liver that occurs in children at an average age of 2 to 3 years.",10398436_1,-1,387,-1,0.3535596
388,malignant tumor,4,6,26,41,"
Hepatoblastoma is a rare malignant tumor of the liver that occurs in children at an average age of 2 to 3 years.",10398436_1,-1,388,-1,0.28793067
390,adenomatous polyposis coli,15,18,99,125,Epidemiologic studies have shown an increased frequency of this tumor type in families affected by adenomatous polyposis coli.,10398436_2,-1,390,-1,0.30237246
392,hepatoblastoma,22,23,138,152,"In addition to the epidemiologic data, molecular genetic studies suggest that inactivation of the APC tumor suppressor may be involved in hepatoblastoma tumorigenesis.",10398436_3,-1,392,-1,0.2968386
394,adenomatous polyposis coli,18,21,125,151,"In an ongoing immunohistochemical study of beta-catenin expression in sporadic cases of tumor types that are associated with adenomatous polyposis coli, we observed increased beta-catenin levels in the cytoplasm and in the nuclei of three investigated hepatoblastomas.",10398436_5,-1,394,-1,0.3065709
396,hepatoblastoma,18,19,106,120,Our data indicate for the first time that beta-catenin accumulation may play a role in the development of hepatoblastoma and that activating mutations of the beta-catenin gene may substitute biallelic APC inactivation in this tumor type.,10398436_7,-1,396,-1,0.28621587
402,pendred syndrome,6,8,37,53,Sulfate transport is not impaired in pendred syndrome thyrocytes.,10404839_0,-1,402,-1,0.3592289
403,Pendred syndrome,0,2,1,17,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,403,-1,0.34840447
404,deafness,9,10,55,63,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,404,-1,0.2808706
405,goiter,14,15,98,104,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,405,-1,0.34582722
406,deafness,18,19,136,144,"
Pendred syndrome is the most common form of syndromic deafness, characterized by dyshormonogenic goiter associated with sensory-neural deafness.",10404839_1,-1,406,-1,0.2932088
407,disease,5,6,29,36,"The gene responsible for the disease (PDS) has been cloned, but its function is as yet unknown and the connection between thyroid goiter and sensory-neural deafness remains an enigma.",10404839_2,-1,407,-1,0.35254997
408,goiter,25,26,130,136,"The gene responsible for the disease (PDS) has been cloned, but its function is as yet unknown and the connection between thyroid goiter and sensory-neural deafness remains an enigma.",10404839_2,-1,408,-1,0.35410535
409,deafness,28,29,156,164,"The gene responsible for the disease (PDS) has been cloned, but its function is as yet unknown and the connection between thyroid goiter and sensory-neural deafness remains an enigma.",10404839_2,-1,409,-1,0.3083258
410,Pendred syndrome,8,10,56,72,We tested sulfate transport in thyrocytes obtained from Pendred syndrome patients and found that it was not defective.,10404839_5,-1,410,-1,0.36591926
411,kniest dysplasia,10,12,61,77,Small deletions in the type II collagen triple helix produce kniest dysplasia.,10406661_0,-1,411,-1,0.34192902
412,myopia,23,24,148,154,"
Kniest dysplasia is a moderately severe type II collagenopathy, characterized by short trunk and limbs, kyphoscoliosis, midface hypoplasia, severe myopia, and hearing loss.",10406661_1,-1,412,-1,0.3756005
413,hearing loss,26,28,160,172,"
Kniest dysplasia is a moderately severe type II collagenopathy, characterized by short trunk and limbs, kyphoscoliosis, midface hypoplasia, severe myopia, and hearing loss.",10406661_1,-1,413,-1,0.35914725
414,Kniest dysplasia,28,30,153,169,"Mutations in the gene that encodes type II collagen (COL2A1), the predominant protein of cartilage, have been identified in a number of individuals with Kniest dysplasia.",10406661_2,-1,414,-1,0.3324332
415,Kniest dysplasia,12,14,86,102,We used heteroduplex analysis to identify sequence anomalies in five individuals with Kniest dysplasia.,10406661_5,-1,415,-1,0.3341223
416,Kniest dysplasia,17,19,109,125,"Sequencing of the index patients genomic DNA identified four new dominant mutations in COL2A1 that result in Kniest dysplasia  a 21-bp deletion in exon 16, an 18-bp deletion in exon 19, and 4-bp deletions in the splice donor sites of introns 14 and 20.",10406661_6,-1,416,-1,0.3478806
417,Kniest dysplasia,4,6,24,40,"These data suggest that Kniest dysplasia results from shorter type II collagen monomers, and support the hypothesis that alteration of a specific COL2A1 domain, which may span from exons 12 to 24, leads to the Kniest dysplasia phenotype..",10406661_9,-1,417,-1,0.36788237
418,Kniest dysplasia,38,40,210,226,"These data suggest that Kniest dysplasia results from shorter type II collagen monomers, and support the hypothesis that alteration of a specific COL2A1 domain, which may span from exons 12 to 24, leads to the Kniest dysplasia phenotype..",10406661_9,-1,418,-1,0.35741714
419,Los,4,5,13,16,"Duarte 1 (or Los Angeles) and Duarte 2 (or Duarte) variants carry the same amino acid substitution, N314D, even though D1 is associated with increased erythrocyte GALT activity and D2 with reduced activity.",10408771_11,-1,419,-1,0.38601443
420,amino acid,18,20,75,85,"Duarte 1 (or Los Angeles) and Duarte 2 (or Duarte) variants carry the same amino acid substitution, N314D, even though D1 is associated with increased erythrocyte GALT activity and D2 with reduced activity.",10408771_11,-1,420,-1,0.38147452
421,renal cell carcinoma,7,10,38,58,Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.,10408776_0,-1,421,-1,0.2851412
423,renal cell carcinoma,8,11,50,70,"VHL mutations were found only in the nonpapillary renal cell carcinoma (RCC) subtype, as previously reported.",10408776_5,-1,423,-1,0.306087
424,P,35,36,221,222,The study of mutational events revealed a significant difference between somatic and germline mutations with mutations leading to truncated proteins observed in 78% of somatic mutations vs only 37% in germline mutations (P < 0. 001).,10408776_7,-1,424,-1,0.42513418
425,P,32,33,165,166,We observed RCC in at least one member of the VHL families in 77% of cases with mutations leading to truncated proteins versus 55% in cases with missense mutations (P < 0. 05).,10408776_11,-1,425,-1,0.424237
426,lead,8,9,52,56,"Thus, mutations resulting in truncated proteins may lead to a higher risk of RCC in VHL patients",10408776_12,-1,426,-1,0.368425
427,Chediak-Higashi syndrome,5,7,36,60,Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation.,10411929_0,-1,427,-1,0.41624165
428,Chediak-Higashi syndrome,0,2,0,24,"Chediak-Higashi syndrome (CHS) is an inherited disorder caused by mutations in the lysosomal trafficking regulator gene, LYST.",10411929_3,-1,428,-1,0.4145739
429,syndrome,27,28,172,180,"It results in defective membrane targeting of the proteins present in secretory lysosomes, and it is associated with a variety of features, including a lymphoproliferative syndrome with hemophagocytosis.",10411929_4,-1,429,-1,0.30652845
430,syndrome,18,19,117,125,"The murine equivalent of CHS, beige mice, present similar characteristics but do not develop the lymphoproliferative syndrome.",10411929_5,-1,430,-1,0.33375895
431,disease,22,23,141,148,It is therefore proposed that the defective surface expression of CTLA-4 by CHS T cells is involved in the generation of lymphoproliferative disease.,10411929_7,-1,431,-1,0.34907967
432,Pelizaeus-Merzbacher Disease,8,10,61,89,"Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not.",10417279_0,-1,432,-1,0.3456981
433,disease,18,19,128,135,"Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not.",10417279_0,-1,433,-1,0.3324703
434,Disease,7,8,54,61,The Clinical European Network on Brain Dysmyelinating Disease.,10417279_1,-1,434,-1,0.37422433
435,Pelizaeus-Merzbacher Disease,0,2,1,29,"
Pelizaeus-Merzbacher Disease (PMD) is an X-linked developmental defect of myelination affecting the central nervous system and segregating with the proteolipoprotein (PLP) locus.",10417279_2,-1,435,-1,0.385964
436,contrast,2,3,9,17,"In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2 = 9. 20, P <. 01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.",10417279_6,-1,436,-1,0.3339516
437,P,27,28,117,118,"In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2 = 9. 20, P <. 01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.",10417279_6,-1,437,-1,0.43878132
438,k,48,49,209,210,"In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2 = 9. 20, P <. 01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.",10417279_6,-1,438,-1,0.38376096
439,k,27,28,179,180,"Moreover, we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families, which allowed a direct estimation of the k value (k = 11).",10417279_8,-1,439,-1,0.37324837
440,k,30,31,188,189,"Moreover, we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families, which allowed a direct estimation of the k value (k = 11).",10417279_8,-1,440,-1,0.40204054
441,Chromosome breakage,0,2,0,19,"Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints.",10417280_0,-1,441,-1,0.34244823
442,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct neurobehavioral disorders that most often arise from a 4-Mb deletion of chromosome 15q11-q13 during paternal or maternal gametogenesis, respectively.",10417280_1,-1,442,-1,0.39696056
443,Angelman syndrome,6,8,33,50,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct neurobehavioral disorders that most often arise from a 4-Mb deletion of chromosome 15q11-q13 during paternal or maternal gametogenesis, respectively.",10417280_1,-1,443,-1,0.34065497
444,van der Woude syndrome,8,12,50,72,Linkage analysis in a large Brazilian family with van der Woude syndrome suggests the existence of a susceptibility locus for cleft palate at 17p11.2-11.1.,10417286_0,-1,444,-1,0.35543153
445,cleft palate,20,22,126,138,Linkage analysis in a large Brazilian family with van der Woude syndrome suggests the existence of a susceptibility locus for cleft palate at 17p11.2-11.1.,10417286_0,-1,445,-1,0.32361892
446,van der Woude syndrome,0,4,1,23,"
van der Woude syndrome (VWS), which has been mapped to 1q32-41, is characterized by pits and/or sinuses of the lower lip, cleft lip/palate (CL/P), cleft palate (CP), bifid uvula, and hypodontia (H).",10417286_1,-1,446,-1,0.3526691
447,cleft palate,34,36,148,160,"
van der Woude syndrome (VWS), which has been mapped to 1q32-41, is characterized by pits and/or sinuses of the lower lip, cleft lip/palate (CL/P), cleft palate (CP), bifid uvula, and hypodontia (H).",10417286_1,-1,447,-1,0.3256719
448,CP,37,38,162,164,"
van der Woude syndrome (VWS), which has been mapped to 1q32-41, is characterized by pits and/or sinuses of the lower lip, cleft lip/palate (CL/P), cleft palate (CP), bifid uvula, and hypodontia (H).",10417286_1,-1,448,-1,0.35206163
449,CP,6,7,32,34,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,449,-1,0.30121934
450,recurrence,13,14,67,77,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,450,-1,0.39671674
451,CP,19,20,93,95,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,451,-1,0.32038662
452,syndrome,33,34,177,185,Both the occurrence of CL/P and CP within the same genealogy and a recurrence risk < 40% for CP among descendants with VWS have suggested that the development of clefts in this syndrome is influenced by modifying genes at other loci.,10417286_3,-1,452,-1,0.3146161
453,CP,24,25,144,146,"To test this hypothesis, we have conducted linkage analysis in a large Brazilian kindred with VWS, considering as affected the individuals with CP, regardless of whether it is associated with other clinical signs of VWS.",10417286_4,-1,453,-1,0.31714132
454,CP,32,33,123,125,"Our results suggest that a gene at 17p11. 2-11 2-11. 1, together with the VWS gene at 1p32-41, enhances the probability of CP in an individual carrying the two at-risk genes.",10417286_5,-1,454,-1,0.35689303
455,syndrome,7,8,42,50,A novel frameshift mutation in the McLeod syndrome gene in a Japanese family.,10426139_0,-1,455,-1,0.32024306
456,syndrome,18,19,82,90,"
We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.",10426139_1,-1,456,-1,0.31361505
457,muscular atrophy,5,7,37,53,"A 50-year-old man showed progressive muscular atrophy, choreic movement, elevated level of serum creatinine kinase, and acanthocytosis.",10426139_2,-1,457,-1,0.36847994
458,creatinine,15,16,97,107,"A 50-year-old man showed progressive muscular atrophy, choreic movement, elevated level of serum creatinine kinase, and acanthocytosis.",10426139_2,-1,458,-1,0.33280876
459,nucleotide,24,25,141,151,The expression level of all the Kell antigens in erythrocyte was decreased and molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK.,10426139_3,-1,459,-1,0.38582417
460,amino acid,16,18,91,101,"This deletion caused a frameshift in translation, leading to a premature stop codon at the amino acid position 408.",10426139_4,-1,460,-1,0.40336555
464,phenylalanine,13,14,94,107,"Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the Maternal Phenylketonuria Collaborative Study.",10429004_0,-1,464,-1,0.3474714
465,phenylalanine,7,8,43,56,"
OBJECTIVE  To examine the relationship of phenylalanine hydroxylase (PAH) genotypes to biochemical phenotype and cognitive development in maternal phenylketonuria (PKU).",10429004_1,-1,465,-1,0.3587983
466,PAH,10,11,70,73,"
OBJECTIVE  To examine the relationship of phenylalanine hydroxylase (PAH) genotypes to biochemical phenotype and cognitive development in maternal phenylketonuria (PKU).",10429004_1,-1,466,-1,0.3909014
467,PAH,2,3,13,16,METHODOLOGY  PAH gene mutations were examined in 222 hyperphenylalaninemic females enrolled in the Maternal PKU Collaborative Study (MPKUCS).,10429004_2,-1,467,-1,0.32187837
468,phenylalanine,19,20,141,154,RESULTS  The biochemical phenotype predicted from the genotype in functionally hemizygous patients was related significantly to the assigned phenylalanine level.,10429004_8,-1,468,-1,0.34167796
469,xanthomatosis,1,2,7,20,Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.,10430841_0,-1,469,-1,0.298147
470,xanthomatosis,7,8,52,65,Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.,10430841_0,-1,470,-1,0.29419187
471,syndrome,16,17,98,106,"
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX).",10430841_1,-1,471,-1,0.33788416
472,xanthomatosis,27,28,176,189,"
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX).",10430841_1,-1,472,-1,0.2833554
473,CTX,29,30,191,194,"
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX).",10430841_1,-1,473,-1,0.3378885
474,xanthomatosis,4,5,24,37,We conclude that spinal xanthomatosis is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of chronic myelopathy..,10430841_5,-1,474,-1,0.29376438
475,CTX,13,14,88,91,We conclude that spinal xanthomatosis is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of chronic myelopathy..,10430841_5,-1,475,-1,0.3249767
476,myelopathy,24,25,157,167,We conclude that spinal xanthomatosis is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of chronic myelopathy..,10430841_5,-1,476,-1,0.3116871
477,chromosome deletion,6,8,43,62,A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes.,10430930_0,-1,477,-1,0.35310632
478,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) result from the loss of function of imprinted genes in human chromosome 15q11-q13.",10430930_1,-1,478,-1,0.39496747
479,Angelman syndrome,6,8,33,50,"
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) result from the loss of function of imprinted genes in human chromosome 15q11-q13.",10430930_1,-1,479,-1,0.34343916
480,van der Woude syndrome,5,9,28,50,Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait.,10434119_0,-1,480,-1,0.36998463
481,disease,19,20,122,129,Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait.,10434119_0,-1,481,-1,0.38631672
482,van der Woude syndrome,0,4,1,23,"
van der Woude syndrome (vWS, MIM 119300) is a rare autosomal dominant clefting condition with cardinal features of mucous cysts (lower-lip pits) and clefts to the lip and/or palate.",10434119_1,-1,482,-1,0.35106525
483,cysts,22,23,123,128,"
van der Woude syndrome (vWS, MIM 119300) is a rare autosomal dominant clefting condition with cardinal features of mucous cysts (lower-lip pits) and clefts to the lip and/or palate.",10434119_1,-1,483,-1,0.35863748
484,cleft lip,11,13,72,81,"We have investigated 5 novel vWS families through probands attended for cleft lip and/or palate repair at the Department of Maxillofacial Surgery of Hopital Trousseau, Paris, in order to tentatively refine the genetic map of the vWS region in 1q32-q41 and possibly identify unlinked pedigrees.",10434119_3,-1,484,-1,0.3053923
485,map,35,36,218,221,"We have investigated 5 novel vWS families through probands attended for cleft lip and/or palate repair at the Department of Maxillofacial Surgery of Hopital Trousseau, Paris, in order to tentatively refine the genetic map of the vWS region in 1q32-q41 and possibly identify unlinked pedigrees.",10434119_3,-1,485,-1,0.40256864
486,disease,21,22,122,129,Our results support linkage of vWS within a region of tightly linked markers and do not favour locus heterogeneity of the disease trait.,10434119_8,-1,486,-1,0.37847844
487,Wilson disease,7,9,35,49,Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.,10441329_0,-1,487,-1,0.31666496
488,copper,14,15,81,87,Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.,10441329_0,-1,488,-1,0.3472506
489,lead,5,6,28,32,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,489,-1,0.38626784
490,Wilson disease,7,9,36,50,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,490,-1,0.3121213
491,copper toxicity,11,13,54,69,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,491,-1,0.35671833
492,copper,21,22,139,145,"Mutations in the ATP7B gene lead to Wilson disease, a copper toxicity disorder characterized by dramatic build-up of intracellular hepatic copper with subsequent hepatic and neuro-logical abnormalities.",10441329_2,-1,492,-1,0.33656678
493,Wilson disease,27,29,153,167,"Using homologous recombination to disrupt the normal translation of ATP7B, we have generated a strain of mice that are homozygous mutants (null) for the Wilson disease gene.",10441329_3,-1,493,-1,0.33157346
494,copper,10,11,62,68,The ATP7B null mice display a gradual accumulation of hepatic copper that increases to a level 60-fold greater than normal by 5 months of age.,10441329_4,-1,494,-1,0.34456447
495,copper,3,4,15,21,"An increase in copper concentration was also observed in the kidney, brain, placenta and lactating mammary glands of homo-zygous mutants, although milk from the mutant glands was copper deficient.",10441329_5,-1,495,-1,0.34086603
496,copper,30,31,179,185,"An increase in copper concentration was also observed in the kidney, brain, placenta and lactating mammary glands of homo-zygous mutants, although milk from the mutant glands was copper deficient.",10441329_5,-1,496,-1,0.3395298
498,neurological abnormalities,7,9,54,80,Progeny of the homozygous mutant females demonstrated neurological abnormalities and growth retardation characteristic of copper deficiency.,10441329_7,-1,498,-1,0.34040982
499,growth retardation,10,12,85,103,Progeny of the homozygous mutant females demonstrated neurological abnormalities and growth retardation characteristic of copper deficiency.,10441329_7,-1,499,-1,0.32087433
500,copper,14,15,122,128,Progeny of the homozygous mutant females demonstrated neurological abnormalities and growth retardation characteristic of copper deficiency.,10441329_7,-1,500,-1,0.34117264
501,Copper,0,1,0,6,Copper concentration in the livers of the newborn homozygous null mutants was decreased dramatically.,10441329_8,-1,501,-1,0.35361958
502,cirrhotic liver disease,13,16,69,92,"In summary, inactivation of the murine ATP7B gene produces a form of cirrhotic liver disease that resembles Wilson disease in humans and the toxic milk phenotype in the mouse..",10441329_9,-1,502,-1,0.34121165
503,Wilson disease,18,20,108,122,"In summary, inactivation of the murine ATP7B gene produces a form of cirrhotic liver disease that resembles Wilson disease in humans and the toxic milk phenotype in the mouse..",10441329_9,-1,503,-1,0.29079807
504,Machado-Joseph disease,1,3,7,29,French Machado-Joseph disease patients do not exhibit gametic segregation distortion: a sperm typing analysis.,10441343_0,-1,504,-1,0.37792507
505,Machado-Joseph disease,15,17,84,106,"On the basis of a sperm typing study performed in patients of Japanese descent with Machado-Joseph disease (MJD), it was reported that disease alleles are preferentially transmitted during meiosis.",10441343_2,-1,505,-1,0.39302537
506,disease,25,26,135,142,"On the basis of a sperm typing study performed in patients of Japanese descent with Machado-Joseph disease (MJD), it was reported that disease alleles are preferentially transmitted during meiosis.",10441343_2,-1,506,-1,0.36603075
507,disease,10,11,51,58,"Among 910 sperm analyzed, the allele linked to the disease chromosome was detected in 50.",10441343_5,-1,507,-1,0.41327035
508,P,12,13,69,70,The difference in frequency of these two alleles is not significant (P = 0. 8423).,10441343_8,-1,508,-1,0.4062816
509,disease,10,11,65,72,The previous report on the Japanese patients also suggested that disease allele stability may be influenced by a trans effect of an intragenic polymorphism (987 G/C) in the wild-type allele.,10441343_10,-1,509,-1,0.3983167
510,aniridia,23,24,138,146,"
The PAX6 gene is involved in ocular morphogenesis, and PAX6 mutations have been detected in various types of ocular anomalies, including aniridia, Peters anomaly, corneal dystrophy, congenital cataract, and foveal hypoplasia.",10441571_1,-1,510,-1,0.36355385
511,Peters anomaly,25,27,148,162,"
The PAX6 gene is involved in ocular morphogenesis, and PAX6 mutations have been detected in various types of ocular anomalies, including aniridia, Peters anomaly, corneal dystrophy, congenital cataract, and foveal hypoplasia.",10441571_1,-1,511,-1,0.31071287
513,amino acids,10,12,46,57,"The insertion, into the NTS, of 14 additional amino acids encoded by exon 5a abolishes the DNA-binding activity of the NTS and unmasks the DNA-binding ability of the CTS.",10441571_5,-1,513,-1,0.4005405
514,Peters anomaly,10,12,64,78,"We ascertained a novel missense mutation in four pedigrees with Peters anomaly, congenital cataract, Axenfeldt anomaly, and/or foveal hypoplasia, which, to our knowledge, is the first mutation identified in the splice-variant region.",10441571_7,-1,514,-1,0.31817585
516,nucleotide,8,9,33,43,A T-- > A transition at the 20th nucleotide position of exon 5a results in a Val-- > Asp (GTC-- > GAC) substitution at the 7th codon of the alternative splice region.,10441571_8,-1,516,-1,0.40529117
521,n,20,21,114,115,Index cases for the present study were found two different ways  through a series of consecutive ovarian cancers (n = 16) and through our family cancer clinic (n = 14).,10441573_3,-1,521,-1,0.399998
523,n,31,32,160,161,Index cases for the present study were found two different ways  through a series of consecutive ovarian cancers (n = 16) and through our family cancer clinic (n = 14).,10441573_3,-1,523,-1,0.38823953
525,disease,5,6,31,38,The overall findings were that disease started to occur at age 30 years and that by age 50 years 48% of the mutation-carrying women had experienced breast and/or ovarian cancer.,10441573_7,-1,525,-1,0.33589995
531,dermatofibrosarcoma,1,2,4,23,The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.,10446987_0,-1,531,-1,0.3248567
532,Dermatofibrosarcoma,0,1,1,20,"
Dermatofibrosarcoma protuberans (DFSP) displays chromosomal rearrangements involving chromosome 17 and 22, which fuse the collagen type Ialpha1 (COLIA1) gene to the platelet-derived growth factor (PDGF) B-chain (PDGFB) gene.",10446987_1,-1,532,-1,0.31312934
534,c,8,9,65,66,"Finally, COLIA1/PDGFB-expressing cells generated tumors after s. c c. injection into nude mice, and tumor growth was reduced by treatment with CGP57148B.",10446987_7,-1,534,-1,0.42574722
537,Zellweger syndrome,7,9,44,62,Identification of a common PEX1 mutation in Zellweger syndrome.,10447258_0,-1,537,-1,0.33785573
538,disease,4,5,27,34,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,538,-1,0.31982252
539,Zellweger syndrome,7,9,49,67,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,539,-1,0.3154656
540,adrenoleukodystrophy,16,17,120,140,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,540,-1,0.3272966
541,Refsum disease,19,21,155,169,"
The Zellweger spectrum of disease, encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease, is due to a failure to form functional peroxisomes.",10447258_1,-1,541,-1,0.43489212
542,diseases,7,8,60,68,"Cell fusion complementation studies demonstrated that these diseases are genetically heterogeneous, with two-thirds of all patients lying within a single complementation group, CG1.",10447258_2,-1,542,-1,0.3411778
543,Zellweger syndrome,23,25,130,148,"However, previous studies have focused on mildly affected patients and there is still no report of two mutant PEX1 alleles in any Zellweger syndrome patient.",10447258_4,-1,543,-1,0.35561302
544,Zellweger syndrome,13,15,74,92,"Furthermore, mutations in the PMP70 gene have also been identified in two Zellweger syndrome patients from CG1, raising the possibility that CG1 patients may represent a mixture of PEX1-deficient and PMP70-deficient individuals.",10447258_5,-1,544,-1,0.3682134
545,disease,6,7,34,41,"To address the molecular basis of disease in Zellweger syndrome patients from CG1, we examined all 24 PEX1 exons in four patients, including both patients that have mutations in PMP70.",10447258_6,-1,545,-1,0.3395099
546,Zellweger syndrome,8,10,45,63,"To address the molecular basis of disease in Zellweger syndrome patients from CG1, we examined all 24 PEX1 exons in four patients, including both patients that have mutations in PMP70.",10447258_6,-1,546,-1,0.34535715
547,c.,14,15,79,81,"PEX1 mutations were detected in all four patients, including a 1-bp insertion (c. 2097insT) in exon 13 that was present in three of the four patients.",10447258_7,-1,547,-1,0.37781397
548,Zellweger syndrome,18,20,118,136,Subsequent studies demonstrated that this mutation is present in one-half of all CG1 patients and correlates with the Zellweger syndrome phenotype.,10447258_8,-1,548,-1,0.33441395
549,Zellweger syndrome,19,21,101,119,"As this mutation leads to a loss of protein function its frequency makes it the most common cause of Zellweger syndrome, helping to explain the high percentage of patients that belong to CG1.",10447258_9,-1,549,-1,0.33927652
550,Wiskott-Aldrich syndrome,4,6,23,47,"Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.",10447259_0,-1,550,-1,0.38042733
551,Wiskott-Aldrich syndrome,0,2,1,25,"
Wiskott-Aldrich syndrome (WAS) is an X-linked recessive immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections, and caused by mutations in the WAS protein (WASP) gene.",10447259_1,-1,551,-1,0.38151965
552,immunodeficiency,9,10,57,73,"
Wiskott-Aldrich syndrome (WAS) is an X-linked recessive immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections, and caused by mutations in the WAS protein (WASP) gene.",10447259_1,-1,552,-1,0.37448698
554,eczema,14,15,109,115,"
Wiskott-Aldrich syndrome (WAS) is an X-linked recessive immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections, and caused by mutations in the WAS protein (WASP) gene.",10447259_1,-1,554,-1,0.3542642
556,Aminoglycoside,0,1,0,14,Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.,10449429_0,-1,556,-1,0.32732978
557,muscular dystrophy,1,3,10,28,"
Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene, leading to the absence of the dystrophin protein in striated muscle.",10449429_1,-1,557,-1,0.33934245
558,aminoglycoside,7,8,37,51,"On the basis of the observation that aminoglycoside treatment can suppress stop codons in cultured cells, we tested the effect of gentamicin on cultured muscle cells from the mdx mouse - an animal model for DMD that possesses a premature stop codon in the dystrophin gene.",10449429_3,-1,558,-1,0.32752508
559,gentamicin,22,23,130,140,"On the basis of the observation that aminoglycoside treatment can suppress stop codons in cultured cells, we tested the effect of gentamicin on cultured muscle cells from the mdx mouse - an animal model for DMD that possesses a premature stop codon in the dystrophin gene.",10449429_3,-1,559,-1,0.29977
560,gentamicin,5,6,28,38,Exposure of mdx myotubes to gentamicin led to the expression and localization of dystrophin to the cell membrane.,10449429_4,-1,560,-1,0.29271847
561,gentamicin,9,10,54,64,We then evaluated the effects of differing dosages of gentamicin on expression and functional protection of the muscles of mdx mice.,10449429_5,-1,561,-1,0.3324803
562,aminoglycosides,12,13,64,79,"To our knowledge, our results are the first to demonstrate that aminoglycosides can suppress stop codons not only in vitro but also in vivo.",10449429_7,-1,562,-1,0.32111645
563,muscular dystrophy,13,15,82,100,"Furthermore, these results raise the possibility of a novel treatment regimen for muscular dystrophy and other diseases caused by premature stop codon mutations.",10449429_8,-1,563,-1,0.35380512
564,diseases,17,18,111,119,"Furthermore, these results raise the possibility of a novel treatment regimen for muscular dystrophy and other diseases caused by premature stop codon mutations.",10449429_8,-1,564,-1,0.35439664
566,neurodegeneration,21,22,140,157,"
Ataxia-telangiectasia (A-T) is characterized by a markedly increased sensitivity to ionizing radiation, increased incidence of cancer, and neurodegeneration, especially of the cerebellar Purkinje cells.",10449794_1,-1,566,-1,0.34442645
567,tissue damage,6,8,54,67,Ionizing radiation oxidizes macromolecules and causes tissue damage through the generation of reactive oxygen species (ROS).,10449794_2,-1,567,-1,0.36361057
568,reactive oxygen species,12,15,94,117,Ionizing radiation oxidizes macromolecules and causes tissue damage through the generation of reactive oxygen species (ROS).,10449794_2,-1,568,-1,0.33639154
569,diastrophic dysplasia,9,11,53,74,"
We have observed over 25 different mutations in the diastrophic dysplasia sulphate transporter gene (DTDST) in association with the recessive disorders achondrogenesis 1B, atelosteogenesis 2, and diastrophic dysplasia.",10465113_1,-1,569,-1,0.35390842
570,achondrogenesis,23,24,153,168,"
We have observed over 25 different mutations in the diastrophic dysplasia sulphate transporter gene (DTDST) in association with the recessive disorders achondrogenesis 1B, atelosteogenesis 2, and diastrophic dysplasia.",10465113_1,-1,570,-1,0.35855582
571,diastrophic dysplasia,30,32,197,218,"
We have observed over 25 different mutations in the diastrophic dysplasia sulphate transporter gene (DTDST) in association with the recessive disorders achondrogenesis 1B, atelosteogenesis 2, and diastrophic dysplasia.",10465113_1,-1,571,-1,0.32835364
572,cm,29,30,133,135,We had not seen a case of homozygosity for c862t (R279W) until we analysed DNA from a 36 year old male with tall-normal stature (180 cm) who asked for genetic counselling for suspected multiple epiphyseal dysplasia.,10465113_3,-1,572,-1,0.36755824
573,Cleft palate,0,2,0,12,"Cleft palate, swelling of the ear pinna, and hitch hiker thumb were absent.",10465113_6,-1,573,-1,0.39730352
574,swelling,3,4,14,22,"Cleft palate, swelling of the ear pinna, and hitch hiker thumb were absent.",10465113_6,-1,574,-1,0.39731526
575,diastrophic dysplasia,17,19,97,118,Homozygosity for a novel DTDST mutation in a child with a 'broad bone-platyspondylic' variant of diastrophic dysplasia.,10466420_0,-1,575,-1,0.33621147
576,diastrophic dysplasia,9,11,54,75,"We report on a girl with clinical features suggesting diastrophic dysplasia but with unusual radiographic features including severe platyspondyly, wide metaphyses, and fibular overgrowth, which are partially reminiscent of metatropic dysplasia.",10466420_2,-1,576,-1,0.36494976
580,disease,10,11,70,77,"Clues from attenuated polyposis, missense germline variants with mild disease and the somatic mutation cluster region (codons 1, 250-1, 450) indicate, however, that APC mutations might not result in simple loss of protein function.",10470088_4,-1,580,-1,0.35223132
581,colorectal adenomas,32,34,147,166,"We have found that FAP patients with germline APC mutations within a small region (codons 1, 194-1, 392 at most) mainly show allelic loss in their colorectal adenomas, in contrast to other FAP patients, whose second hits tend to occur by truncating mutations in the mutation cluster region.",10470088_5,-1,581,-1,0.2945464
582,contrast,36,37,171,179,"We have found that FAP patients with germline APC mutations within a small region (codons 1, 194-1, 392 at most) mainly show allelic loss in their colorectal adenomas, in contrast to other FAP patients, whose second hits tend to occur by truncating mutations in the mutation cluster region.",10470088_5,-1,582,-1,0.3788132
584,disease,8,9,47,54,"Our findings also indicate a new mechanism for disease severity  if a broader spectrum of mutations is selected in tumors, the somatic mutation rate is effectively higher and more tumors grow..",10470088_10,-1,584,-1,0.35995165
594,Val,12,13,54,57,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,594,-1,0.3927817
595,neurofibrosarcoma,20,21,75,92,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,595,-1,0.34665057
596,CAA,33,34,142,145,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,596,-1,0.36400443
597,Glu,44,45,176,179,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,597,-1,0.373899
598,neurofibrosarcoma,53,54,210,227,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,598,-1,0.3275314
599,amino acid,62,64,252,262,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,599,-1,0.39210403
600,Val,70,71,290,293,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,600,-1,0.3988662
601,Val,79,80,316,319,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,601,-1,0.37758967
602,TTC,84,85,333,336,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,602,-1,0.41099507
603,Phe,88,89,345,348,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,603,-1,0.3358513
604,neurofibrosarcoma,96,97,370,387,"We discovered a missense mutation, GCA to GTA (Ala 54 Val), in exon 2 in a neurofibrosarcoma patient (case 1), two missense mutations, AAA to CAA (Lys 118 Gln) and GAA to GGA (Glu 154 Gly) in exon 5 of another neurofibrosarcoma patient (case 2), and 3 amino acid substitutions, GTG to GCG (Val 179 Ala), GTT to GCT (Val 181 Ala) and TTC to CTC (Phe 186 Leu), in a third neurofibrosarcoma patient (case 3).",10470286_6,-1,604,-1,0.32949412
605,TTC,13,14,72,75,"In case 3, loss of heterozygosity was also demonstrated by informative (TTC) 3/(TTC) 2 polymorphism.",10470286_7,-1,605,-1,0.38742736
606,neurofibrosarcoma,11,12,62,79,Our data demonstrate that mutations occur in the Mxi1 gene in neurofibrosarcoma.,10470286_8,-1,606,-1,0.31565428
607,neurofibrosarcoma,18,19,106,123,Missense mutations in the functional domain of Mxi1 in these cases may be involved in the pathogenesis of neurofibrosarcoma..,10470286_9,-1,607,-1,0.3121515
608,hemochromatosis,9,10,59,74,A population-based study of the clinical expression of the hemochromatosis gene.,10471457_0,-1,608,-1,0.34114456
609,hemochromatosis,5,6,36,51,"
BACKGROUND AND METHODS  Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis (HFE) gene on chromosome 6, elevated serum transferrin saturation, and excess iron deposits throughout the body.",10471457_1,-1,609,-1,0.3053005
610,hemochromatosis,16,17,114,129,"
BACKGROUND AND METHODS  Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis (HFE) gene on chromosome 6, elevated serum transferrin saturation, and excess iron deposits throughout the body.",10471457_1,-1,610,-1,0.3173353
611,iron,32,33,208,212,"
BACKGROUND AND METHODS  Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis (HFE) gene on chromosome 6, elevated serum transferrin saturation, and excess iron deposits throughout the body.",10471457_1,-1,611,-1,0.3140371
612,iron,37,38,224,228,"In 1994, we obtained blood samples for the determination of serum transferrin saturation and ferritin levels and the presence or absence of the C282Y mutation and the H63D mutation (which may contribute to increased hepatic iron levels) in 3011 unrelated white adults.",10471457_3,-1,612,-1,0.32071972
613,ng,12,13,75,77,We recommended liver biopsy for subjects with serum ferritin levels of 300 ng per milliliter or higher.,10471457_5,-1,613,-1,0.32371417
614,hemochromatosis,12,13,73,88,"Four of the homozygous subjects had previously been given a diagnosis of hemochromatosis, and 12 had not.",10471457_9,-1,614,-1,0.32641968
616,alcohol,24,25,123,130,"Eleven of the 16 homozygous subjects underwent liver biopsy; 3 had hepatic fibrosis, and 1, who had a history of excessive alcohol consumption, had cirrhosis and mild microvesicular steatosis.",10471457_12,-1,616,-1,0.33222532
618,steatosis,32,33,182,191,"Eleven of the 16 homozygous subjects underwent liver biopsy; 3 had hepatic fibrosis, and 1, who had a history of excessive alcohol consumption, had cirrhosis and mild microvesicular steatosis.",10471457_12,-1,618,-1,0.3378748
619,hemochromatosis,17,18,111,126,"Eight of the 16 homozygous subjects had clinical findings that were consistent with the presence of hereditary hemochromatosis, such as hepatomegaly, skin pigmentation, and arthritis.",10471457_13,-1,619,-1,0.31987324
622,hemochromatosis,13,14,73,88,"However, only half of those who were homozygous had clinical features of hemochromatosis, and one quarter had serum ferritin levels that remained normal over a four-year period.",10471457_15,-1,622,-1,0.31602845
623,phenylalanine,22,23,122,135,We present a child in whom phenylketonuria was apparently caused by homozygosity for the mutation E390G in exon 11 of the phenylalanine hydroxylase (PAH) gene.,10472529_3,-1,623,-1,0.35980472
624,PAH,25,26,149,152,We present a child in whom phenylketonuria was apparently caused by homozygosity for the mutation E390G in exon 11 of the phenylalanine hydroxylase (PAH) gene.,10472529_3,-1,624,-1,0.36259013
625,disease,7,8,38,45,"However, the clinical severity of the disease was not quite as mild as expected, the mutation was not identified in the father despite confirmed paternity, and the paternal allele showed a highly unusual pattern of polymorphic markers in the PAH gene.",10472529_4,-1,625,-1,0.38341603
626,PAH,42,43,242,245,"However, the clinical severity of the disease was not quite as mild as expected, the mutation was not identified in the father despite confirmed paternity, and the paternal allele showed a highly unusual pattern of polymorphic markers in the PAH gene.",10472529_4,-1,626,-1,0.33298165
627,phenylalanine,14,15,65,78,"Presence of a large deletion involving exons 9, 10 and 11 of the phenylalanine hydroxylase gene was confirmed by long-range PCR.",10472529_5,-1,627,-1,0.35870355
628,X-linked Emery-Dreifuss muscular dystrophy,3,7,15,57,Early onset of X-linked Emery-Dreifuss muscular dystrophy in a boy with emerin gene deletion.,10480214_0,-1,628,-1,0.3495313
629,contractures,3,4,17,29,"
A boy developed contractures of the Achilles tendons at 3 years and of the postcervical muscles at 7 years, although neither contractures of the elbows nor cardiac abnormality were recognized by the age of 9 years.",10480214_1,-1,629,-1,0.37983778
630,contractures,22,23,126,138,"
A boy developed contractures of the Achilles tendons at 3 years and of the postcervical muscles at 7 years, although neither contractures of the elbows nor cardiac abnormality were recognized by the age of 9 years.",10480214_1,-1,630,-1,0.38404018
631,X-linked Emery-Dreifuss muscular dystrophy,6,10,41,83,"These results confirmed the diagnosis of X-linked Emery-Dreifuss muscular dystrophy (EDMD), and reinforce the necessity of molecular genetic diagnosis of the membrane protein emerin in younger patients with possible EDMD before appearance of the typical symptoms, to avoid sudden cardiac death..",10480214_4,-1,631,-1,0.39335427
632,sudden cardiac death,42,45,273,293,"These results confirmed the diagnosis of X-linked Emery-Dreifuss muscular dystrophy (EDMD), and reinforce the necessity of molecular genetic diagnosis of the membrane protein emerin in younger patients with possible EDMD before appearance of the typical symptoms, to avoid sudden cardiac death..",10480214_4,-1,632,-1,0.3749765
633,muscular dystrophy,1,3,16,34,Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations.,10480348_0,-1,633,-1,0.3405738
634,muscular dystrophy,12,14,79,97,"
The dark-adapted electroretinogram (ERG) of patients with Duchenne and Becker muscular dystrophy (DMD/BMD) shows a marked reduction in b-wave amplitude.",10480348_1,-1,634,-1,0.34415755
635,disease,21,22,129,136,"Our results suggest that the most important determinant in the ERG b-wave phenotype is the mutation position, rather than muscle disease severity.",10480348_7,-1,635,-1,0.38710296
636,myotonic dystrophy,6,8,29,47,Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.,10484765_0,-1,636,-1,0.38525334
637,DM,9,10,49,51,Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.,10484765_0,-1,637,-1,0.36341122
638,myotonic dystrophy,3,5,22,40,"
The mutation causing myotonic dystrophy (DM) has been identified as a CTG expansion in the 3-untranslated region (3-UTR) of the DM protein kinase gene (DMPK), but the mechanism (s) of pathogenesis remain unknown.",10484765_1,-1,638,-1,0.38961095
639,DM,6,7,42,44,"
The mutation causing myotonic dystrophy (DM) has been identified as a CTG expansion in the 3-untranslated region (3-UTR) of the DM protein kinase gene (DMPK), but the mechanism (s) of pathogenesis remain unknown.",10484765_1,-1,639,-1,0.38321167
640,DM,24,25,129,131,"
The mutation causing myotonic dystrophy (DM) has been identified as a CTG expansion in the 3-untranslated region (3-UTR) of the DM protein kinase gene (DMPK), but the mechanism (s) of pathogenesis remain unknown.",10484765_1,-1,640,-1,0.3580806
641,DM,2,3,14,16,Studies using DM patient materials have often produced confusing results.,10484765_2,-1,641,-1,0.35822782
642,DM,8,9,39,41,"Therefore, to study the effects of the DM mutation in a controlled environment, we have established a cell culture model system using C2C12 mouse myoblasts.",10484765_3,-1,642,-1,0.37953717
643,DM,28,29,165,167,"By expressing chimeric reporter constructs containing a reporter gene fused to a human DMPK 3-UTR, we identified both cis and trans effects that are mediated by the DM mutation.",10484765_4,-1,643,-1,0.35614324
644,n,12,13,59,60,We determined by deletion analysis that an expanded (CTG) (n) tract alone was sufficient to mediate these cis effects.,10484765_6,-1,644,-1,0.42457137
645,contrast,3,4,16,24,"Furthermore, in contrast to the normal DMPK 3-UTR mRNA, a mutant DMPK 3-UTR mRNA with (CUG) (200) selectively inhibited myogenic differentiation of C2C12 myoblasts.",10484765_7,-1,645,-1,0.38762486
646,n,15,16,91,92,Characterization of spontaneous deletion events mapped the inhibitory effect to the (CTG) (n) expansion and/or the 3 end of the DMPK 3-UTR.,10484765_9,-1,646,-1,0.4466012
647,DM,6,7,40,42,These results provide evidence that the DM mutation acts in cis to reduce protein production (consistent with DMPK haploinsufficiency) and in trans as a riboregulator to inhibit myogenesis..,10484765_10,-1,647,-1,0.36729094
648,disease,2,3,7,14,Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.,10484772_0,-1,648,-1,0.38816112
649,retinal telangiectasis,8,10,41,63,Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.,10484772_0,-1,649,-1,0.31802407
650,disease,1,2,7,14,"
Coats disease is characterized by abnormal retinal vascular development (so-called retinal telangiectasis) which results in massive intraretinal and subretinal lipid accumulation (exudative retinal detachment).",10484772_1,-1,650,-1,0.35364583
651,retinal telangiectasis,11,13,84,106,"
Coats disease is characterized by abnormal retinal vascular development (so-called retinal telangiectasis) which results in massive intraretinal and subretinal lipid accumulation (exudative retinal detachment).",10484772_1,-1,651,-1,0.332261
652,retinal detachment,25,27,191,209,"
Coats disease is characterized by abnormal retinal vascular development (so-called retinal telangiectasis) which results in massive intraretinal and subretinal lipid accumulation (exudative retinal detachment).",10484772_1,-1,652,-1,0.37740812
653,disease,5,6,28,35,"The classical form of Coats disease is almost invariably isolated, unilateral and seen in males.",10484772_2,-1,653,-1,0.37050298
654,disease,8,9,44,51,A female with a unilateral variant of Coats disease gave birth to a son affected by Norrie disease.,10484772_3,-1,654,-1,0.36685032
655,Norrie disease,16,18,84,98,A female with a unilateral variant of Coats disease gave birth to a son affected by Norrie disease.,10484772_3,-1,655,-1,0.33906195
656,disease,13,14,83,90,Subsequently analysis of the retinas of nine enucleated eyes from males with Coats disease demonstrated in one a somatic mutation in the NDP gene which was not present within non-retinal tissue.,10484772_6,-1,656,-1,0.35979885
657,telangiectasis,4,5,22,36,We suggest that Coats telangiectasis is secondary to somatic mutation in the NDP gene which results in a deficiency of norrin (the protein product of the NDP gene) within the developing retina.,10484772_7,-1,657,-1,0.34875458
658,Li-Fraumeni syndrome,12,14,71,91,Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.,10484981_0,-1,658,-1,0.38986635
659,Li-Fraumeni syndrome,0,2,1,21,"
Li-Fraumeni syndrome is an autosomal dominant disorder that is characterized by various types of cancer in childhood and adult cases.",10484981_1,-1,659,-1,0.40211502
662,Li-Fraumeni syndrome,18,20,110,130,"Although hereditary TP53 mutation is very rare in different human cancers, it has been frequently reported in Li-Fraumeni syndrome.",10484981_2,-1,662,-1,0.37952667
664,Li-Fraumeni syndrome,8,10,42,62,"In a Turkish family with the diagnosis of Li-Fraumeni syndrome, we analyzed the mutation pattern of TP53, P57KIP2, P15INK4B, and P16INK4A in the peripheral blood, and loss of heterozygosity (homo/hemizygous deletion) pattern of TP53 and P15INK4B/P16INK4A in two tumor tissues.",10484981_4,-1,664,-1,0.40656838
666,seminoma,4,5,21,29,"The propositus had a seminoma, his daughter a medulloblastoma, and one of his healthy cousins, a TP53 codon 292 missense point mutation (AAA-- > ATA; Lys-- > Ile) in the peripheral blood cells.",10484981_5,-1,666,-1,0.35957405
667,medulloblastoma,9,10,46,61,"The propositus had a seminoma, his daughter a medulloblastoma, and one of his healthy cousins, a TP53 codon 292 missense point mutation (AAA-- > ATA; Lys-- > Ile) in the peripheral blood cells.",10484981_5,-1,667,-1,0.28567216
669,seminoma,8,9,51,59,Tumor tissue obtained from the propositus with the seminoma revealed loss of heterozygosity in the TP53 gene.,10484981_6,-1,669,-1,0.33815253
671,Glu,27,28,137,140,"In the analyses of tumor tissues from the propositus and his daughter, a P16INK4A codon 94 missense point mutation (GCG-- > GAG; Ala-- > Glu) was observed with the hereditary TP53 mutation.",10484981_7,-1,671,-1,0.3424739
672,Li-Fraumeni syndrome,13,15,73,93,P16INK4A codon 94 mutation observed in our family is a novel mutation in Li-Fraumeni syndrome.,10484981_8,-1,672,-1,0.38491926
674,congenital hypothyroidism,11,13,76,101,"
We previously reported nine children with an autosomally recessive form of congenital hypothyroidism due to an iodide transport defect in a large Hutterite family with extensive consanguinity living in central Canada.",10487695_1,-1,674,-1,0.36333296
675,congenital hypothyroidism,8,10,45,70,"Since the original report, we have diagnosed congenital hypothyroidism by newborn TSH screening in 9 additional children from the family.",10487695_2,-1,675,-1,0.37500167
676,congenital hypothyroidism,17,19,97,122,It is now possible to use gene diagnostics of this unique NIS mutation to identify patients with congenital hypothyroidism due to an iodide transport defect in this family and to determine the carrier state of potential parents for genetic counseling and arranging rapid and early diagnosis of their infants.,10487695_9,-1,676,-1,0.35559317
677,diabetes insipidus,5,7,48,66,Molecular analysis in familial neurohypophyseal diabetes insipidus: early diagnosis of an asymptomatic carrier.,10487710_0,-1,677,-1,0.34931576
678,diabetes insipidus,2,4,27,45,"
Familial neurohypophyseal diabetes insipidus (FNDI) is an inherited deficiency of the hormone arginine vasopressin (AVP) and is transmitted as an autosomal dominant trait.",10487710_1,-1,678,-1,0.33643985
679,arginine vasopressin,14,16,95,115,"
Familial neurohypophyseal diabetes insipidus (FNDI) is an inherited deficiency of the hormone arginine vasopressin (AVP) and is transmitted as an autosomal dominant trait.",10487710_1,-1,679,-1,0.32528117
680,AVP,17,18,117,120,"
Familial neurohypophyseal diabetes insipidus (FNDI) is an inherited deficiency of the hormone arginine vasopressin (AVP) and is transmitted as an autosomal dominant trait.",10487710_1,-1,680,-1,0.33956313
681,AVP-NPII,6,7,32,40,The entire coding region of the AVP-NPII gene of all family members was amplified by PCR and sequenced.,10487710_5,-1,681,-1,0.34383807
682,glycine,16,17,83,90,All affected individuals presented a missense mutation (G1757-- > A) that replaces glycine at position 23 with arginine within the NPII domain.,10487710_6,-1,682,-1,0.3812015
683,disease,30,31,156,163,"Additionally, one of the asymptomatic relatives (a girl 8 months old at the time of study) was identified as carrier of the same mutation and developed the disease 3 months later.",10487710_8,-1,683,-1,0.37190253
684,disease,19,20,99,106,"The alteration found in the second exon of the gene in this family seems to be responsible for the disease, as all individuals harboring the mutation had been previously diagnosed or have eventually developed FNDI.",10487710_9,-1,684,-1,0.35313624
685,ATP,5,6,33,36,Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.,10500204_0,-1,685,-1,0.34259486
686,Friedreich ataxia,10,12,65,82,Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.,10500204_0,-1,686,-1,0.32905284
687,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA), the most common of the inherited ataxias, is an autosomal recessive degenerative disorder, characterized clinically by onset before the age of 25 of progressive gait and limb ataxia, absence of deep tendon reflexes, extensor plantar responses, and loss of position and vibration sense in the lower limbs.",10500204_1,-1,687,-1,0.38039902
689,iron,32,33,210,214,Frataxin function is still unknown but the knockout of the yeast frataxin homologue gene (YFH1) showed a severe defect of mitochondrial respiration and loss of mtDNA associated with elevated intramitochondrial iron.,10500204_4,-1,689,-1,0.32996228
690,phosphorus,1,2,6,16,Using phosphorus magnetic resonance spectroscopy we demonstrated a maximum rate of muscle mitochondrial ATP production (V (max)) below the normal range in all 12 FRDA patients and a strong negative correlation between mitochondrial V (max) and the number of GAA repeats in the smaller allele.,10500204_6,-1,690,-1,0.36108458
691,ATP,13,14,104,107,Using phosphorus magnetic resonance spectroscopy we demonstrated a maximum rate of muscle mitochondrial ATP production (V (max)) below the normal range in all 12 FRDA patients and a strong negative correlation between mitochondrial V (max) and the number of GAA repeats in the smaller allele.,10500204_6,-1,691,-1,0.3283197
692,C,11,12,64,65,All patients were found to be homozygous for a newly identified C - > T transition in codon 21 (exon 2) substituting arginine for a premature stop codon (R21X  CGA to TGA) and generating a NlaIII restriction site.,10502833_3,-1,692,-1,0.38198107
693,sterol,3,4,16,22,Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis.,10519880_0,-1,693,-1,0.38733461
694,xanthomatosis,23,24,148,161,Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis.,10519880_0,-1,694,-1,0.29098278
695,xanthomatosis,7,8,53,66,"
OBJECTIVES  A Japanese family with cerebrotendinous xanthomatosis (CTX) was investigated for a sequence alteration in the sterol 27-hydroxylase gene (CYP27).",10519880_1,-1,695,-1,0.28530046
696,CTX,9,10,68,71,"
OBJECTIVES  A Japanese family with cerebrotendinous xanthomatosis (CTX) was investigated for a sequence alteration in the sterol 27-hydroxylase gene (CYP27).",10519880_1,-1,696,-1,0.3564735
697,Wolfram syndrome,7,9,46,62,Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1.,10521293_0,-1,697,-1,0.33987546
698,Wolfram syndrome,0,2,1,17,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,698,-1,0.3548357
699,neurodegenerative,6,7,44,61,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,699,-1,0.3755201
700,diabetes mellitus,11,13,103,120,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,700,-1,0.3260523
701,optic atrophy,15,17,137,150,"
Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy.",10521293_1,-1,701,-1,0.35237145
702,amino acid,25,27,130,140,"mtDNA deletions have been described, and a gene (WFS1) recently has been identified, on chromosome 4p16, encoding a predicted 890 amino acid transmembrane protein.",10521293_2,-1,702,-1,0.3902388
703,Wolfram syndrome,23,25,128,144,Direct DNA sequencing was done to screen the entire coding region of the WFS1 gene in 30 patients from 19 British kindreds with Wolfram syndrome.,10521293_3,-1,703,-1,0.3136731
704,disease,29,30,192,199,"Although some interesting cases were noted, consideration of the small sample size and frequency of each mutation indicated no clear-cut correlations between any of the observed mutations and disease severity.",10521293_10,-1,704,-1,0.37282708
705,Wolfram syndrome,5,7,31,47,"Hence, molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome-carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons..",10521293_12,-1,705,-1,0.2989544
706,psychiatric disorders,18,20,126,147,"Hence, molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome-carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons..",10521293_12,-1,706,-1,0.2993793
707,diabetes mellitus,21,23,151,168,"Hence, molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome-carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons..",10521293_12,-1,707,-1,0.28275675
708,familial Mediterranean fever,1,4,11,39,"Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics.",10528243_0,-1,708,-1,0.33301255
709,familial Mediterranean fever,14,17,93,121,"
To determine the prevalence and characterize demographic, clinical, and genetic features of familial Mediterranean fever (FMF) of late onset, all patients experiencing their first FMF attack at age 40 years or more were identified using the computerized registry of our FMF clinic, and then thoroughly interviewed and examined.",10528243_1,-1,709,-1,0.36287746
710,disease,4,5,20,27,"The severity of the disease in patients and controls was determined using a modified score, developed previously.",10528243_3,-1,710,-1,0.37686187
711,P,11,12,61,62,"These patients were mostly men, of non-North African origin, P < 0.",10528243_6,-1,711,-1,0.41969904
712,disease,14,15,81,88,"All had abdominal attacks and in most these were the only manifestation of their disease, P < 0. 001 001.",10528243_8,-1,712,-1,0.3878392
713,P,16,17,90,91,"All had abdominal attacks and in most these were the only manifestation of their disease, P < 0. 001 001.",10528243_8,-1,713,-1,0.43256778
714,amyloidosis,12,13,66,77,"None had chronic or prolonged manifestations of FMF, for example, amyloidosis, chronic arthritis, or protracted myalgia, P < 0. 001.",10528243_9,-1,714,-1,0.30361855
717,P,21,22,121,122,"None had chronic or prolonged manifestations of FMF, for example, amyloidosis, chronic arthritis, or protracted myalgia, P < 0. 001.",10528243_9,-1,717,-1,0.4387566
718,P,12,13,70,71,"The response to treatment was good despite using low colchicine dose, P < 0. 05.",10528243_10,-1,718,-1,0.43520886
719,disease,7,8,44,51,"The overall severity score indicated a mild disease, P < 0. 001.",10528243_11,-1,719,-1,0.39111894
720,P,9,10,53,54,"The overall severity score indicated a mild disease, P < 0. 001.",10528243_11,-1,720,-1,0.43841124
721,P,8,9,60,61,"Mutational analysis revealed absence of M694V homozygosity, P < 0. 01, compared to our regular FMF population.",10528243_12,-1,721,-1,0.4400828
722,disease,16,17,73,80,"We conclude that the onset of FMF in a late age defines a milder form of disease with typical clinical, demographic, and molecular genetic characteristics",10528243_13,-1,722,-1,0.31620246
723,breast and ovarian cancer syndrome,2,7,16,50,"
The hereditary breast and ovarian cancer syndrome is associated with a high frequency of BRCA1 mutations.",10528853_1,-1,723,-1,0.31179494
724,nucleotide,4,5,22,32,All were confirmed by nucleotide sequencing.,10528853_7,-1,724,-1,0.35944778
725,uniparental disomy,1,3,9,27,Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype.,10528860_0,-1,725,-1,0.34571654
726,uniparental disomy,8,10,36,54,"
We report on a boy with a maternal uniparental disomy for chromosome 14 (UPD (14)).",10528860_1,-1,726,-1,0.36745912
727,Prader-Willi syndrome,17,19,84,105,At 7 years of age he was referred to us by the paediatrician because of symptoms of Prader-Willi syndrome (PWS).,10528860_2,-1,727,-1,0.40577972
728,obesity,5,6,25,32,"He showed short stature, obesity, mild developmental delay, cryptorchidism, and some mild dysmorphic features.",10528860_3,-1,728,-1,0.3642954
729,cryptorchidism,11,12,60,74,"He showed short stature, obesity, mild developmental delay, cryptorchidism, and some mild dysmorphic features.",10528860_3,-1,729,-1,0.3285862
730,intrauterine growth retardation,4,7,30,61,The history further indicated intrauterine growth retardation at the end of the pregnancy.,10528860_4,-1,730,-1,0.3912526
731,hypotonia,4,5,22,31,"After birth he showed hypotonia with poor sucking, for which gavage feeding was needed.",10528860_6,-1,731,-1,0.34870756
734,sleep disturbance,6,8,38,55,There were no behavioural problems or sleep disturbance.,10528860_10,-1,734,-1,0.40504405
735,Prader-Willi syndrome,3,5,17,38,DNA analysis for Prader-Willi syndrome showed no abnormalities.,10528860_12,-1,735,-1,0.42676452
736,Friedreich ataxia,5,7,30,47,Clinical and genetic study of Friedreich ataxia in an Australian population.,10533031_0,-1,736,-1,0.35454383
737,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia is an autosomal recessive disorder caused by mutations in the FRDA gene that encodes a 210-amino acid protein called frataxin.",10533031_1,-1,737,-1,0.38989216
738,scoliosis,24,25,122,131,"We found a correlation between the size of the smaller of the two expanded alleles and age at onset, age into wheelchair, scoliosis, impaired vibration sense, and the presence of foot deformity.",10533031_5,-1,738,-1,0.32421887
740,diabetes mellitus,15,17,96,113,"There was no significant correlation between the size of the smaller allele and cardiomyopathy, diabetes mellitus, loss of proprioception, or bladder symptoms.",10533031_6,-1,740,-1,0.31411663
741,disease,3,4,16,23,"The duration of disease is correlated with wheelchair use and the presence of diabetes, scoliosis, bladder symptoms and impaired proprioception, and vibration sense but no other complications studied..",10533031_8,-1,741,-1,0.36032817
743,scoliosis,15,16,88,97,"The duration of disease is correlated with wheelchair use and the presence of diabetes, scoliosis, bladder symptoms and impaired proprioception, and vibration sense but no other complications studied..",10533031_8,-1,743,-1,0.30861437
744,retinoschisis,5,6,33,46,"Novel mutations in XLRS1 causing retinoschisis, including first evidence of putative leader sequence change.",10533068_0,-1,744,-1,0.30943155
745,retinoschisis,1,2,10,23,"
Juvenile retinoschisis is an X-linked recessive disease caused by mutations in the XLRS1 gene.",10533068_1,-1,745,-1,0.3049111
746,disease,6,7,49,56,"
Juvenile retinoschisis is an X-linked recessive disease caused by mutations in the XLRS1 gene.",10533068_1,-1,746,-1,0.3507247
747,Retinoschisis,23,24,140,153,"We screened 31 new unrelated patients and families for XLRS1 mutations in addition to previously reported mutations for 60 of our families (Retinoschisis Consortium, Hum Mol Genet 1998; 7  1185-1192).",10533068_2,-1,747,-1,0.34942323
748,C,7,8,32,33,"Two novel mutations, c. 38T-- > C (L13P) and c. 667T-- > C (C223R), respectively, present the first genetic evidence for the functional significance of the putative leader peptide sequence and for the functional significance at the carboxyl terminal of the XLRS1 protein beyond the discoidin domain.",10533068_5,-1,748,-1,0.42145672
749,C,15,16,57,58,"Two novel mutations, c. 38T-- > C (L13P) and c. 667T-- > C (C223R), respectively, present the first genetic evidence for the functional significance of the putative leader peptide sequence and for the functional significance at the carboxyl terminal of the XLRS1 protein beyond the discoidin domain.",10533068_5,-1,749,-1,0.41032407
750,Growth hormone,0,2,0,14,"Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome.",10541953_0,-1,750,-1,0.36395758
751,Prader-Willi syndrome,16,18,110,131,"Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome.",10541953_0,-1,751,-1,0.41967767
752,growth hormone,7,9,46,60,"
We studied whether the beneficial effects of growth hormone (GH) treatment on growth and body composition in PWS are accompanied by an improvement in respiratory function.",10541953_1,-1,752,-1,0.3349542
753,P,9,10,60,61,"We measured resting ventilation, airway occlusion pressure (P (0. 1)) and ventilatory response to CO (2) in nine children, aged 7-14 years, before and 6-9 months after the start of GH treatment.",10541953_2,-1,753,-1,0.40383875
754,CO,20,21,98,100,"We measured resting ventilation, airway occlusion pressure (P (0. 1)) and ventilatory response to CO (2) in nine children, aged 7-14 years, before and 6-9 months after the start of GH treatment.",10541953_2,-1,754,-1,0.35600746
755,P,11,12,59,60,"During GH treatment, resting ventilation increased by 26%, P (0. 1) by 72% and the response to CO (2) by 65% (P < 0. 002, < 0. 04 and < 0. 02, respectively).",10541953_3,-1,755,-1,0.41882858
756,CO,24,25,95,97,"During GH treatment, resting ventilation increased by 26%, P (0. 1) by 72% and the response to CO (2) by 65% (P < 0. 002, < 0. 04 and < 0. 02, respectively).",10541953_3,-1,756,-1,0.36365142
757,P,32,33,110,111,"During GH treatment, resting ventilation increased by 26%, P (0. 1) by 72% and the response to CO (2) by 65% (P < 0. 002, < 0. 04 and < 0. 02, respectively).",10541953_3,-1,757,-1,0.44108847
758,Prader-Willi syndrome,6,8,39,60,CONCLUSION  Treatment of children with Prader-Willi syndrome (PWS) seems to have a stimulatory effect on central respiratory structures.,10541953_5,-1,758,-1,0.4124561
759,growth hormone,22,24,148,162,The observed increase in ventilation and inspiratory drive may contribute to the improved activity level reported by parents of PWS children during growth hormone therapy,10541953_6,-1,759,-1,0.32998964
760,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA) is the most common inherited ataxia.",10543403_1,-1,760,-1,0.3647074
762,fragile X syndrome,1,4,6,24,"
Most fragile X syndrome patients have expansion of a (CGG) (n) sequence with > 200 repeats (full mutation) in the FMR1 gene responsible for this condition.",10545613_1,-1,762,-1,0.32653433
763,n,13,14,61,62,"
Most fragile X syndrome patients have expansion of a (CGG) (n) sequence with > 200 repeats (full mutation) in the FMR1 gene responsible for this condition.",10545613_1,-1,763,-1,0.43504414
764,sodium,16,17,96,102,"We observed a consistent, although modest, reactivation of the FMR1 gene with 4-phenylbutyrate, sodium butyrate and trichostatin A, as shown by RT-PCR.",10545613_5,-1,764,-1,0.35124204
765,disease,5,6,25,32,"
von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al., J. Am.",10554035_1,-1,765,-1,0.33756182
766,cancer syndrome,11,13,70,85,"
von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al., J. Am.",10554035_1,-1,766,-1,0.3251558
768,cysts,37,38,250,255,"
von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas, hemangioblastomas of the central nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymphatic sac tumors, and epididymal cystadenomas [W. M. Linehan et al., J. Am.",10554035_1,-1,768,-1,0.36114767
779,neuroectodermal tumors,17,19,118,140,Recurrent hSNF5/INI1 alterations were also observed in choroid plexus carcinomas and in a subset of central primitive neuroectodermal tumors (cPNETs) and medulloblastomas.,10556283_7,-1,779,-1,0.31681025
780,contrast,1,2,3,11,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,-1,780,-1,0.35497466
783,gliomas,16,17,91,98,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,-1,783,-1,0.2873987
784,sarcomas,20,21,113,121,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,-1,784,-1,0.30191177
789,Machado-Joseph disease,4,6,34,56,"
Spinocerebellar ataxia type-3 or Machado-Joseph disease (SCA3/MJD) is a member of the CAG/polyglutamine repeat disease family.",10556285_1,-1,789,-1,0.40780675
790,disease,16,17,112,119,"
Spinocerebellar ataxia type-3 or Machado-Joseph disease (SCA3/MJD) is a member of the CAG/polyglutamine repeat disease family.",10556285_1,-1,790,-1,0.3491355
791,disease,24,25,148,155,"In this family of disorders, a normally polymorphic CAG repeat becomes expanded, resulting in expression of an expanded polyglutamine domain in the disease gene product.",10556285_2,-1,791,-1,0.39035255
792,disease,4,5,37,44,"Experimental models of polyglutamine disease implicate the nucleus in pathogenesis; however, the link between intranuclear expression of expanded polyglutamine and neuronal dysfunction remains unclear.",10556285_3,-1,792,-1,0.36515602
793,disease,7,8,39,46,"Here we demonstrate that ataxin-3, the disease protein in SCA3/MJD, adopts a unique conformation when expressed within the nucleus of transfected cells.",10556285_4,-1,793,-1,0.405697
794,glutamine,26,27,158,167,"The monoclonal antibody 1C2 is known preferentially to bind expanded polyglutamine, but we find that it also binds a fragment of ataxin-3 containing a normal glutamine repeat.",10556285_5,-1,794,-1,0.36332384
795,glutamine,11,12,67,76,"In addition, expression of ataxin-3 within the nucleus exposes the glutamine domain of the full-length non-pathological protein, allowing it to bind the monoclonal antibody 1C2.",10556285_6,-1,795,-1,0.36888593
796,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is a complex neurogenetic disorder.",10556298_1,-1,796,-1,0.4125732
797,syndrome,9,10,48,56,"The phenotype is likely to be a contiguous gene syndrome involving genes which are paternally expressed only, located in the human 15q11-q13 region.",10556298_2,-1,797,-1,0.3507387
798,rhabdomyosarcoma,1,2,10,26,"
Alveolar rhabdomyosarcoma is an aggressive pediatric cancer of striated muscle characterized in 60% of cases by a t (2; 13) (q35; q14).",10557309_1,-1,798,-1,0.3054163
800,rhabdomyosarcoma,26,27,138,154,"Relevance of this model was suggested by verification that three of these genes (IGFBP5, HSIX1, and Slug) were also expressed in alveolar rhabdomyosarcoma cell lines.",10557309_7,-1,800,-1,0.29008603
801,hemochromatosis,1,2,13,28,Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism.,10557317_0,-1,801,-1,0.3324385
802,iron,13,14,82,86,Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism.,10557317_0,-1,802,-1,0.3451389
803,hemochromatosis,5,6,38,53,"
The puzzling linkage between genetic hemochromatosis and histocompatibility loci became even more so when the gene involved, HFE, was identified.",10557317_1,-1,803,-1,0.34012744
804,iron,9,10,45,49,"As yet, our understanding of HFE function in iron homeostasis is only partial; an even more open question is its possible role in the immune system.",10557317_3,-1,804,-1,0.33818346
805,hemochromatosis,3,4,27,42,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,805,-1,0.3516448
806,iron,11,12,86,90,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,806,-1,0.34157145
807,iron,19,20,134,138,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,807,-1,0.3176863
808,iron,32,33,214,218,"Faithfully mimicking human hemochromatosis, mice homozygous for this deletion develop iron overload, characterized by a higher plasma iron content and a raised transferrin saturation as well as an elevated hepatic iron load.",10557317_6,-1,808,-1,0.3194718
809,iron,13,14,69,73,"The primary defect could, indeed, be traced to an augmented duodenal iron absorption.",10557317_7,-1,809,-1,0.34000972
810,iron,8,9,44,48,"In parallel, measurement of the gut mucosal iron content as well as iron regulatory proteins allows a more informed evaluation of various hypotheses regarding the precise role of HFE in iron homeostasis.",10557317_8,-1,810,-1,0.33015656
811,iron,13,14,68,72,"In parallel, measurement of the gut mucosal iron content as well as iron regulatory proteins allows a more informed evaluation of various hypotheses regarding the precise role of HFE in iron homeostasis.",10557317_8,-1,811,-1,0.32477865
812,iron,31,32,186,190,"In parallel, measurement of the gut mucosal iron content as well as iron regulatory proteins allows a more informed evaluation of various hypotheses regarding the precise role of HFE in iron homeostasis.",10557317_8,-1,812,-1,0.32439613
814,leukemia,18,19,115,123,Chromosomes of lymphocytes from one of the patients were studied before and after the onset of chronic lymphocytic leukemia.,1056013_6,-1,814,-1,0.30164078
815,leukemia,1,2,7,15,"Before leukemia was diagnosed, the patient had a lymphocyte clone with a 14q translocation.",1056013_7,-1,815,-1,0.2851002
816,leukemic,9,10,45,53,This clone appears to have given rise to the leukemic cells.,1056013_8,-1,816,-1,0.28205952
818,lymphoma,16,17,103,111,"Increasing evidence, provided by others, for the nonrandom involvement of 14q in African-type Burkitts lymphoma and other lymphoid neoplasms further strengthens this hypothesis..",1056013_10,-1,818,-1,0.30424744
819,neoplasms,20,21,131,140,"Increasing evidence, provided by others, for the nonrandom involvement of 14q in African-type Burkitts lymphoma and other lymphoid neoplasms further strengthens this hypothesis..",1056013_10,-1,819,-1,0.27272546
820,Frasier syndrome,18,20,100,116,"Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.",10571943_0,-1,820,-1,0.3641659
821,Frasier syndrome,28,30,138,154,"
We report new mutations in exon 9 of the WT1 gene that did not alter the ratio of +/- KTS splice isoforms in two unrelated patients with Frasier syndrome (FS).",10571943_1,-1,821,-1,0.36416414
822,syndrome,16,17,105,113,The mutation of intron 9 inducing defective alternative splicing was reported to be responsible for this syndrome.,10571943_2,-1,822,-1,0.3320981
823,Denys-Drash syndrome,18,20,90,110,The mutations found in our cases occurred in the same exon of the WT1 gene as detected in Denys-Drash syndrome (DDS) and could not be explained by the previously proposed mechanism.,10571943_3,-1,823,-1,0.41859958
824,diseases,13,14,69,77,"From a molecular biological point of view, we concluded that the two diseases were not separable, and that FS should be included as an atypical form of DDS..",10571943_5,-1,824,-1,0.33444306
825,deafness,12,13,81,89,Splice-site mutation in the PDS gene may result in intrafamilial variability for deafness in Pendred syndrome.,10571950_0,-1,825,-1,0.293005
826,Pendred syndrome,14,16,93,109,Splice-site mutation in the PDS gene may result in intrafamilial variability for deafness in Pendred syndrome.,10571950_0,-1,826,-1,0.31685865
827,Pendred syndrome,0,2,1,17,"
Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).",10571950_1,-1,827,-1,0.3647637
829,goiter,25,26,174,180,"
Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).",10571950_1,-1,829,-1,0.36626837
830,deafness,13,14,63,71,This disorder may account for up to 10% of cases of hereditary deafness.,10571950_2,-1,830,-1,0.30303666
831,disease,1,2,4,11,"The disease gene (PDS) has been mapped to chromosome 7q22-q31, and encodes a chloride-iodide transport protein.",10571950_3,-1,831,-1,0.40030763
832,deafness,21,22,133,141,We performed mutation analysis of individual exons of the PDS gene in one Spanish family that shows intrafamilial variability of the deafness phenotype (two patients with profound and one with moderate-severe deafness).,10571950_4,-1,832,-1,0.3141006
833,deafness,32,33,209,217,We performed mutation analysis of individual exons of the PDS gene in one Spanish family that shows intrafamilial variability of the deafness phenotype (two patients with profound and one with moderate-severe deafness).,10571950_4,-1,833,-1,0.29838726
834,nucleotide,15,16,80,90,"We identified a new splice-site mutation affecting intron 4 of the PDS gene, at nucleotide position 639 + 7.",10571950_5,-1,834,-1,0.41917574
835,deafness,38,39,210,218,"Since the newly created donor splice site is likely to compete with the normal one, variations of the levels of normal and aberrant transcripts of the PDS gene in the cochlea may explain the variability in the deafness presentation..",10571950_7,-1,835,-1,0.32507348
836,Sjogren-Larsson syndrome,4,6,23,47,The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.,10577908_0,-1,836,-1,0.35754892
837,aldehyde dehydrogenase,12,14,80,102,The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.,10577908_0,-1,837,-1,0.37688556
838,Sjogren-Larsson syndrome,0,2,1,25,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,838,-1,0.33332753
839,ichthyosis,12,13,84,94,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,839,-1,0.34286973
840,mental retardation,14,16,96,114,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,840,-1,0.3257803
841,spasticity,17,18,116,126,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,841,-1,0.36088192
842,aldehyde dehydrogenase,24,26,160,182,"
Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH).",10577908_1,-1,842,-1,0.38634804
843,amino acid,14,16,86,96,"Among these patients, 49 different mutations-including 10 deletions, 2 insertions, 22 amino acid substitutions, 3 nonsense mutations, 9 splice-site defects, and 3 complex mutations-were found.",10577908_3,-1,843,-1,0.36492035
844,C,27,28,163,164,"Nineteen of the missense mutations resulted in a severe reduction of FALDH enzyme catalytic activity when expressed in mammalian cells, but one mutation (798G-- > C [K266N]) seemed to have a greater effect on mRNA stability.",10577908_5,-1,844,-1,0.39033696
845,T,10,11,48,49,"At least four of the common mutations (551C-- > T, 682C-- > T, 733G-- > A, and 798 + 1delG) were associated with multiple SNP haplotypes, suggesting that these mutations originated independently on more than one occasion or were ancient SLS genes that had undergone intragenic recombination.",10577908_9,-1,845,-1,0.4472958
846,SNP,29,30,122,125,"At least four of the common mutations (551C-- > T, 682C-- > T, 733G-- > A, and 798 + 1delG) were associated with multiple SNP haplotypes, suggesting that these mutations originated independently on more than one occasion or were ancient SLS genes that had undergone intragenic recombination.",10577908_9,-1,846,-1,0.39105263
847,C,5,6,44,45,Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis.,10581027_0,-1,847,-1,0.38734028
848,disease,10,11,73,80,Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis.,10581027_0,-1,848,-1,0.38915914
849,syndrome,1,2,18,26,"
Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients.",10581027_1,-1,849,-1,0.31350568
850,keratosis,4,5,31,40,"
Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients.",10581027_1,-1,850,-1,0.35903338
851,periodontitis,30,31,193,206,"
Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients.",10581027_1,-1,851,-1,0.37168014
852,tooth loss,12,14,81,91,"Both the deciduous and permanent dentitions are affected, resulting in premature tooth loss.",10581027_2,-1,852,-1,0.3635106
853,keratosis,1,2,13,22,"Palmoplantar keratosis, varying from mild psoriasiform scaly skin to overt hyperkeratosis, typically develops within the first three years of life.",10581027_3,-1,853,-1,0.29266232
854,Keratosis,0,1,0,9,Keratosis also affects other sites such as elbows and knees.,10581027_4,-1,854,-1,0.34062114
855,periodontitis,5,6,31,44,Most PLS patients display both periodontitis and hyperkeratosis.,10581027_5,-1,855,-1,0.35009545
856,keratosis,5,6,37,46,"Some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset.",10581027_6,-1,856,-1,0.28280157
857,periodontitis,7,8,50,63,"Some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset.",10581027_6,-1,857,-1,0.34604022
858,periodontitis,14,15,93,106,"Some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset.",10581027_6,-1,858,-1,0.3561253
859,C,10,11,58,59,The gene (CTSC) encoding the lysosomal protease cathepsin C (or dipeptidyl aminopeptidase I) lies within this interval.,10581027_10,-1,859,-1,0.3752352
860,C,18,19,101,102,In two of these families we used a functional assay to demonstrate an almost total loss of cathepsin C activity in PLS patients and reduced activity in obligate carriers.,10581027_12,-1,860,-1,0.4046587
861,Van der Woude syndrome,4,8,27,49,Confirmation of linkage of Van der Woude syndrome to chromosome 1q32: evidence of association with STR alleles suggests possible unique origin of the disease mutation.,10589394_0,-1,861,-1,0.36856523
862,STR,16,17,99,102,Confirmation of linkage of Van der Woude syndrome to chromosome 1q32: evidence of association with STR alleles suggests possible unique origin of the disease mutation.,10589394_0,-1,862,-1,0.38645896
863,disease,24,25,150,157,Confirmation of linkage of Van der Woude syndrome to chromosome 1q32: evidence of association with STR alleles suggests possible unique origin of the disease mutation.,10589394_0,-1,863,-1,0.36964414
864,Van der Woude syndrome,0,4,1,23,"
Van der Woude syndrome (VWS) is an autosomal dominant craniofacial disorder with high penetrance and variable expression.",10589394_1,-1,864,-1,0.3555041
865,cleft lip,9,11,58,67,"Its clinical features are variably expressed, but include cleft lip and/or cleft palate, lip pits and hypodontia.",10589394_2,-1,865,-1,0.2994487
866,cleft palate,12,14,75,87,"Its clinical features are variably expressed, but include cleft lip and/or cleft palate, lip pits and hypodontia.",10589394_2,-1,866,-1,0.33763933
867,map,6,7,33,36,"All VWS families studied to date map the disease gene to a < 2 cM region of chromosome 1q32, with no evidence of locus heterogeneity.",10589394_3,-1,867,-1,0.41782758
868,disease,8,9,41,48,"All VWS families studied to date map the disease gene to a < 2 cM region of chromosome 1q32, with no evidence of locus heterogeneity.",10589394_3,-1,868,-1,0.38719952
869,cM,14,15,63,65,"All VWS families studied to date map the disease gene to a < 2 cM region of chromosome 1q32, with no evidence of locus heterogeneity.",10589394_3,-1,869,-1,0.3765409
870,STR,8,9,42,45,"Our assay method for short tandem repeat (STR) markers provided highly accurate size estimation of marker allele fragment sizes, and therefore enabled us to determine the specific alleles segregating with the VWS gene in each of our four families.",10589394_11,-1,870,-1,0.37406206
871,STR,6,7,34,37,We observed a striking pattern of STR allele sharing at several closely linked loci among our four Caucasian VWS families recruited at three different locations in the US.,10589394_12,-1,871,-1,0.3910617
873,Nucleotide,18,19,103,113,"Immunochemical studies demonstrated that the Sit (a) epitopes reside on platelet glycoprotein (GP) Ia. Nucleotide sequence analysis of GPIa cDNA derived from Sit (a) -positive platelets showed C (2531) -- > T (2531) point mutation, resulting in Thr (799) Met dimorphism.",10590055_3,-1,873,-1,0.3771332
874,C,33,34,193,194,"Immunochemical studies demonstrated that the Sit (a) epitopes reside on platelet glycoprotein (GP) Ia. Nucleotide sequence analysis of GPIa cDNA derived from Sit (a) -positive platelets showed C (2531) -- > T (2531) point mutation, resulting in Thr (799) Met dimorphism.",10590055_3,-1,874,-1,0.40724447
875,Glu,23,24,162,165,"Analysis of stable Chinese hamster ovary transfectants expressing allele-specific recombinant forms of GPIa showed that anti-Sit (a) exclusively reacted with the Glu (505) Met (799), but not with the Glu (505) Thr (799) and the Lys (505) Thr (799) isoforms.",10590055_8,-1,875,-1,0.3611635
876,Glu,36,37,200,203,"Analysis of stable Chinese hamster ovary transfectants expressing allele-specific recombinant forms of GPIa showed that anti-Sit (a) exclusively reacted with the Glu (505) Met (799), but not with the Glu (505) Thr (799) and the Lys (505) Thr (799) isoforms.",10590055_8,-1,876,-1,0.3482745
877,contrast,1,2,3,11,"In contrast, anti-Br (a) (HPA-5b) only recognized the Lys (505) Thr (799) form, whereas anti-Br (b) (HPA-5a) reacted with both Glu (505) Thr (799) and Glu (505) Met (799) isoforms.",10590055_9,-1,877,-1,0.3608153
878,Glu,34,35,127,130,"In contrast, anti-Br (a) (HPA-5b) only recognized the Lys (505) Thr (799) form, whereas anti-Br (b) (HPA-5a) reacted with both Glu (505) Thr (799) and Glu (505) Met (799) isoforms.",10590055_9,-1,878,-1,0.3414257
879,Glu,43,44,151,154,"In contrast, anti-Br (a) (HPA-5b) only recognized the Lys (505) Thr (799) form, whereas anti-Br (b) (HPA-5a) reacted with both Glu (505) Thr (799) and Glu (505) Met (799) isoforms.",10590055_9,-1,879,-1,0.33210638
880,amino acid,23,25,126,136,"These results demonstrated that the Met (799) is responsible for formation of the Sit (a) alloantigenic determinants, whereas amino acid 505 (Lys or Glu) specifically controls the expression of Br (a) and Br (b) epitopes, respectively.",10590055_10,-1,880,-1,0.39675397
881,Glu,29,30,149,152,"These results demonstrated that the Met (799) is responsible for formation of the Sit (a) alloantigenic determinants, whereas amino acid 505 (Lys or Glu) specifically controls the expression of Br (a) and Br (b) epitopes, respectively.",10590055_10,-1,881,-1,0.3429114
883,C,4,5,27,28,Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome.,10593994_0,-1,883,-1,0.3780788
884,syndrome,10,11,71,79,Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome.,10593994_0,-1,884,-1,0.31446886
885,syndrome,1,2,18,26,"
Papillon-Lefevre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar hyperkeratosis and severe early onset periodontitis that results in the premature loss of the primary and secondary dentitions.",10593994_1,-1,885,-1,0.30717576
886,periodontitis,18,19,136,149,"
Papillon-Lefevre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar hyperkeratosis and severe early onset periodontitis that results in the premature loss of the primary and secondary dentitions.",10593994_1,-1,886,-1,0.3434303
887,cM,1,2,2,4,8 cM interval on chromosome 11q14.,10593994_3,-1,887,-1,0.37086123
888,C,25,26,159,160,Correlation of physical and genetic maps of this interval indicate it includes at least 40 ESTs and six known genes including the lysosomal protease cathepsin C gene (CTSC).,10593994_4,-1,888,-1,0.39326912
889,amino acid,16,18,78,88,An exon 1 nonsense mutation (856C-- > T) introduces a premature stop codon at amino acid 286.,10593994_9,-1,889,-1,0.36771786
890,nucleotide,10,11,59,69,"Three exon 2 mutations were identified, including a single nucleotide deletion (2692delA) of codon 349 introducing a frameshift and premature termination codon, a 2 bp deletion (2673-2674delCT) that results in introduction of a stop codon at amino acid 343, and a G-- > A substitution in codon 429 (2931G-- > A) introducing a premature termination codon.",10593994_10,-1,890,-1,0.38067743
891,amino acid,44,46,242,252,"Three exon 2 mutations were identified, including a single nucleotide deletion (2692delA) of codon 349 introducing a frameshift and premature termination codon, a 2 bp deletion (2673-2674delCT) that results in introduction of a stop codon at amino acid 343, and a G-- > A substitution in codon 429 (2931G-- > A) introducing a premature termination codon.",10593994_10,-1,891,-1,0.38356966
892,C,7,8,47,48,All PLS patients were homozygous for cathepsin C mutations inherited from a common ancestor.,10593994_11,-1,892,-1,0.3571839
893,C,6,7,44,45,Parents and sibs heterozygous for cathepsin C mutations do not show either the palmoplantar hyperkeratosis or severe early onset periodontitis characteristic of PLS.,10593994_12,-1,893,-1,0.36119306
894,periodontitis,19,20,129,142,Parents and sibs heterozygous for cathepsin C mutations do not show either the palmoplantar hyperkeratosis or severe early onset periodontitis characteristic of PLS.,10593994_12,-1,894,-1,0.35232443
895,C,10,11,72,73,A more complete understanding of the functional physiology of cathepsin C carries significant implications for understanding normal and abnormal skin development and periodontal disease susceptibility,10593994_13,-1,895,-1,0.36691305
896,disease,23,24,178,185,A more complete understanding of the functional physiology of cathepsin C carries significant implications for understanding normal and abnormal skin development and periodontal disease susceptibility,10593994_13,-1,896,-1,0.38041794
897,alkaptonuria,8,9,47,59,Mutational analysis of the HGO gene in Finnish alkaptonuria patients.,10594001_0,-1,897,-1,0.32532635
898,Alkaptonuria,0,1,1,13,"
Alkaptonuria (AKU), the prototypic inborn error of metabolism, has recently been shown to be caused by loss of function mutations in the homogentisate-1, 2-dioxygenase gene (HGO).",10594001_1,-1,898,-1,0.33750817
899,adenomatous polyps,10,12,69,87,"
Inherited mutations of the APC gene predispose carriers to multiple adenomatous polyps of the colon and rectum and to colorectal cancer.",10598803_1,-1,899,-1,0.3225722
900,colorectal cancer,19,21,119,136,"
Inherited mutations of the APC gene predispose carriers to multiple adenomatous polyps of the colon and rectum and to colorectal cancer.",10598803_1,-1,900,-1,0.26055855
901,disease,20,21,99,106,"Mutations located at the extreme 5 end of the APC gene, however, are associated with a less severe disease known as attenuated adenomatous polyposis coli (AAPC).",10598803_2,-1,901,-1,0.3447754
902,adenomatous polyposis coli,24,27,127,153,"Mutations located at the extreme 5 end of the APC gene, however, are associated with a less severe disease known as attenuated adenomatous polyposis coli (AAPC).",10598803_2,-1,902,-1,0.32370144
903,polyps,8,9,61,67,Many individuals with AAPC develop relatively few colorectal polyps but are still at high risk for colorectal cancer.,10598803_3,-1,903,-1,0.31712455
904,colorectal cancer,16,18,99,116,Many individuals with AAPC develop relatively few colorectal polyps but are still at high risk for colorectal cancer.,10598803_3,-1,904,-1,0.2537929
905,Alstrom syndrome,0,2,0,16,Alstrom syndrome: further evidence for linkage to human chromosome 2p13.,10598815_0,-1,905,-1,0.38751096
906,Alstrom syndrome,0,2,1,17,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,906,-1,0.37851855
907,retinal degeneration,10,12,74,94,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,907,-1,0.35488817
909,obesity,18,19,136,143,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,909,-1,0.31768295
910,diabetes mellitus,22,24,171,188,"
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal degeneration, sensorineural hearing loss, early-onset obesity, and non-insulin-dependent diabetes mellitus.",10598815_1,-1,910,-1,0.30919227
911,Alstrom syndrome,3,5,13,29,The gene for Alstrom syndrome (ALMS1) has been previously localized to human chromosome 2p13 by homozygosity mapping in two distinct isolated populations - French Acadian and North African.,10598815_2,-1,911,-1,0.36718297
912,Alstrom syndrome,17,19,109,125,"To confirm these findings, a large linkage study was performed in twelve additional families segregating for Alstrom syndrome.",10598815_5,-1,912,-1,0.35225827
913,map,5,6,35,38,A fine resolution radiation hybrid map of 31 genes and markers has been constructed.,10598815_11,-1,913,-1,0.350499
914,Pendred syndrome,0,2,0,16,Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation.,10602116_0,-1,914,-1,0.38226157
915,Pendred syndrome,0,2,1,17,"
Pendred syndrome comprises congenital sensorineural hearing loss, thyroid goiter, and positive perchlorate discharge test.",10602116_1,-1,915,-1,0.3730199
917,goiter,9,10,75,81,"
Pendred syndrome comprises congenital sensorineural hearing loss, thyroid goiter, and positive perchlorate discharge test.",10602116_1,-1,917,-1,0.3553754
918,deafness,26,27,179,187,"Molecular analysis of the PDS gene was performed in two consanguineous large families from Southern Tunisia comprising a total of 23 individuals affected with profound congenital deafness; the same missense mutation, L445W, was identified in all affected individuals.",10602116_3,-1,918,-1,0.3134013
919,contrast,1,2,3,11,"In contrast, goiter was present in only 11 affected individuals, who interestingly had a normal result of the perchlorate discharge test whenever performed.",10602116_5,-1,919,-1,0.36139354
920,goiter,3,4,13,19,"In contrast, goiter was present in only 11 affected individuals, who interestingly had a normal result of the perchlorate discharge test whenever performed.",10602116_5,-1,920,-1,0.3369243
921,Pendred syndrome,14,16,90,106,The present results question the sensitivity of the perchlorate test for the diagnosis of Pendred syndrome and support the use of a molecular analysis of the PDS gene in the assessment of individuals with severe to profound congenital hearing loss associated with inner ear morphological anomaly even in the absence of a thyroid goiter..,10602116_6,-1,921,-1,0.34492037
922,hearing loss,38,40,235,247,The present results question the sensitivity of the perchlorate test for the diagnosis of Pendred syndrome and support the use of a molecular analysis of the PDS gene in the assessment of individuals with severe to profound congenital hearing loss associated with inner ear morphological anomaly even in the absence of a thyroid goiter..,10602116_6,-1,922,-1,0.35029465
923,goiter,53,54,329,335,The present results question the sensitivity of the perchlorate test for the diagnosis of Pendred syndrome and support the use of a molecular analysis of the PDS gene in the assessment of individuals with severe to profound congenital hearing loss associated with inner ear morphological anomaly even in the absence of a thyroid goiter..,10602116_6,-1,923,-1,0.35074833
924,Knobloch syndrome,0,2,0,17,Knobloch syndrome involving midline scalp defect of the frontal region.,10607954_0,-1,924,-1,0.33761448
925,Knobloch syndrome,7,9,36,53,"
We report on a 4-year-old boy with Knobloch syndrome.",10607954_1,-1,925,-1,0.316821
926,myopia,6,7,40,46,"He has vitreoretinal degeneration, high myopia, cataract, telecanthus, hypertelorism, and a high-arched palate.",10607954_2,-1,926,-1,0.37642795
928,telecanthus,10,11,58,69,"He has vitreoretinal degeneration, high myopia, cataract, telecanthus, hypertelorism, and a high-arched palate.",10607954_2,-1,928,-1,0.35166764
929,hypertelorism,12,13,71,84,"He has vitreoretinal degeneration, high myopia, cataract, telecanthus, hypertelorism, and a high-arched palate.",10607954_2,-1,929,-1,0.3216759
930,syndrome,11,12,56,64,We present a review of the 23 published cases with this syndrome.,10607954_5,-1,930,-1,0.33470762
932,osteolysis,14,15,87,97,"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.",10615125_0,-1,932,-1,0.31654087
933,osteolysis,2,3,20,30,"
Familial expansile osteolysis (FEO, MIM 174810) is a rare, autosomal dominant bone disorder characterized by focal areas of increased bone remodelling.",10615125_1,-1,933,-1,0.31348205
934,cM,17,18,95,97,Our previous linkage studies mapped the gene responsible for FEO to an interval of less than 5 cM between D18S64 and D18S51 on chromosome 18q21.,10615125_3,-1,934,-1,0.37873647
935,disease,22,23,138,145,We identified two heterozygous insertion mutations in exon 1 of TNFRSF11A in affected members of four families with FEO or familial Paget disease of bone (PDB).,10615125_8,-1,935,-1,0.3681256
936,Brugada syndrome,6,8,37,53,Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit.,10618304_0,-1,936,-1,0.40991834
937,Na,10,11,62,64,"
BACKGROUND  Mutations in the gene encoding the human cardiac Na (+) channel alpha-subunit (hH1) are responsible for chromosome 3-linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF).",10618304_1,-1,937,-1,0.38669482
938,syndrome,26,27,156,164,"
BACKGROUND  Mutations in the gene encoding the human cardiac Na (+) channel alpha-subunit (hH1) are responsible for chromosome 3-linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF).",10618304_1,-1,938,-1,0.28552875
939,idiopathic ventricular fibrillation,31,34,176,211,"
BACKGROUND  Mutations in the gene encoding the human cardiac Na (+) channel alpha-subunit (hH1) are responsible for chromosome 3-linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF).",10618304_1,-1,939,-1,0.32861122
940,Na,35,36,227,229,"An auxiliary beta (1) -subunit, widely expressed in excitable tissues, shifts the voltage dependence of steady-state inactivation toward more negative potentials and restores normal gating kinetics of brain and skeletal muscle Na (+) channels expressed in Xenopus oocytes but has little if any functional effect on the cardiac isoform.",10618304_2,-1,940,-1,0.334905
941,contrast,19,20,106,114,"METHODS AND RESULTS  When expressed alone in Xenopus oocytes, T1620M exhibited no persistent currents, in contrast to the LQT3 mutant channels, but the midpoint of steady-state inactivation (V (1/2)) was significantly shifted toward more positive potentials than for wild-type hH1.",10618304_4,-1,941,-1,0.3531282
942,RB1,4,5,32,35,Meiotic segregation analysis of RB1 alleles in retinoblastoma pedigrees by use of single-sperm typing.,10631148_0,-1,942,-1,0.32309973
943,retinoblastoma,7,8,47,61,Meiotic segregation analysis of RB1 alleles in retinoblastoma pedigrees by use of single-sperm typing.,10631148_0,-1,943,-1,0.30879757
944,retinoblastoma,2,3,15,29,"
In hereditary retinoblastoma, different epidemiological studies have indicated a preferential paternal transmission of mutant retinoblastoma alleles to offspring, suggesting the occurrence of a meiotic drive.",10631148_1,-1,944,-1,0.27641854
945,retinoblastoma,15,16,127,141,"
In hereditary retinoblastoma, different epidemiological studies have indicated a preferential paternal transmission of mutant retinoblastoma alleles to offspring, suggesting the occurrence of a meiotic drive.",10631148_1,-1,945,-1,0.29963726
946,retinoblastoma,19,20,132,146,"To investigate this mechanism, we analyzed sperm samples from six individuals from five unrelated families affected with hereditary retinoblastoma.",10631148_2,-1,946,-1,0.28316373
947,retinoblastoma,23,24,145,159,Single-sperm typing techniques were performed for each sample by study of two informative short tandem repeats located either in or close to the retinoblastoma gene (RB1).,10631148_3,-1,947,-1,0.3106267
948,RB1,26,27,166,169,Single-sperm typing techniques were performed for each sample by study of two informative short tandem repeats located either in or close to the retinoblastoma gene (RB1).,10631148_3,-1,948,-1,0.33253732
949,RB1,5,6,38,41,"The segregation probability of mutant RB1 alleles in sperm samples was assessed by use of the SPERMSEG program, which includes experimental parameters, recombination fractions between the markers, and segregation parameters.",10631148_4,-1,949,-1,0.3452811
950,P,13,14,73,74,We detected a significant segregation distortion in the data as a whole (P =. 0099) and a significant heterogeneity in the segregation rate across donors (.,10631148_6,-1,950,-1,0.41540828
951,RB1,6,7,47,50,"The segregation distortion favoring the mutant RB1 allele does not seem to occur during spermatogenesis, and, thus, meiotic drive may result either from various mechanisms, including a fertilization advantage or a better mobility in sperm bearing a mutant RB1 gene, or from the existence of a defectively imprinted gene located on the human X chromosome.",10631148_9,-1,951,-1,0.31932473
952,RB1,42,43,256,259,"The segregation distortion favoring the mutant RB1 allele does not seem to occur during spermatogenesis, and, thus, meiotic drive may result either from various mechanisms, including a fertilization advantage or a better mobility in sperm bearing a mutant RB1 gene, or from the existence of a defectively imprinted gene located on the human X chromosome.",10631148_9,-1,952,-1,0.31308216
953,Friedreich ataxia,0,2,0,17,Friedreich ataxia: an overview.,10633128_0,-1,953,-1,0.38388294
954,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia, an autosomal recessive neurodegenerative disease, is the most common of the inherited ataxias.",10633128_1,-1,954,-1,0.3670587
955,neurodegenerative disease,6,8,43,68,"
Friedreich ataxia, an autosomal recessive neurodegenerative disease, is the most common of the inherited ataxias.",10633128_1,-1,955,-1,0.38556817
956,Friedreich ataxia,27,29,144,161,"The recent discovery of the gene that is mutated in this condition, FRDA, has led to rapid advances in the understanding of the pathogenesis of Friedreich ataxia.",10633128_2,-1,956,-1,0.33242643
957,Friedreich ataxia,7,9,43,60,"There is mounting evidence to suggest that Friedreich ataxia is the result of accumulation of iron in mitochondria leading to excess production of free radicals, which then results in cellular damage and death.",10633128_5,-1,957,-1,0.38179278
958,iron,15,16,94,98,"There is mounting evidence to suggest that Friedreich ataxia is the result of accumulation of iron in mitochondria leading to excess production of free radicals, which then results in cellular damage and death.",10633128_5,-1,958,-1,0.3349978
959,free radicals,23,25,147,160,"There is mounting evidence to suggest that Friedreich ataxia is the result of accumulation of iron in mitochondria leading to excess production of free radicals, which then results in cellular damage and death.",10633128_5,-1,959,-1,0.36412182
961,disease,13,14,76,83,Currently there is no known treatment that alters the natural course of the disease.,10633128_6,-1,961,-1,0.34564462
962,retinoschisis,1,2,9,22,X-linked retinoschisis with point mutations in the XLRS1 gene.,10636421_0,-1,962,-1,0.31011105
963,retinoschisis,3,4,22,35,"
BACKGROUND  X-linked retinoschisis (XLRS) is a relatively rare vitreoretinal dystrophy that causes visual loss in young men.",10636421_1,-1,963,-1,0.3037226
965,disease,7,8,38,45,"Recently, a gene responsible for this disease, designated XLRS1, was identified, and several deleterious gene mutations were reported.",10636421_2,-1,965,-1,0.345174
966,disease,13,14,78,85,"However, the limited data failed to reveal a correlation between mutation and disease phenotype.",10636421_11,-1,966,-1,0.36493808
967,disease,5,6,53,60,"
Ataxia-telangiectasia is a hereditary multisystemic disease resulting from mutations of ataxia telangiectasia, mutated (ATM) and is characterized by neurodegeneration, cancer, immune defects, and hypersensitivity to ionizing radiation.",10639175_1,-1,967,-1,0.3477543
969,neurodegeneration,21,22,150,167,"
Ataxia-telangiectasia is a hereditary multisystemic disease resulting from mutations of ataxia telangiectasia, mutated (ATM) and is characterized by neurodegeneration, cancer, immune defects, and hypersensitivity to ionizing radiation.",10639175_1,-1,969,-1,0.37915194
974,syndrome,1,2,10,18,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,974,-1,0.33389336
975,syndrome,4,5,40,48,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,975,-1,0.32018378
976,syndrome,23,24,164,172,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,976,-1,0.30215988
977,syndrome,29,30,193,201,"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Of the many palmoplantar keratoderma (PPK) conditions, only Papillon-Lefevre syndrome (PLS) and Haim-Munk syndrome (HMS) are associated with premature periodontal destruction.",10662807_0,-1,977,-1,0.3061107
978,periodontitis,13,14,72,85,"Although both PLS and HMS share the cardinal features of PPK and severe periodontitis, a number of additional findings are reported in HMS including arachnodactyly, acro-osteolysis, atrophic changes of the nails, and a radiographic deformity of the fingers.",10662807_1,-1,978,-1,0.34460154
979,arachnodactyly,25,26,149,163,"Although both PLS and HMS share the cardinal features of PPK and severe periodontitis, a number of additional findings are reported in HMS including arachnodactyly, acro-osteolysis, atrophic changes of the nails, and a radiographic deformity of the fingers.",10662807_1,-1,979,-1,0.38724434
980,acro-osteolysis,27,28,165,180,"Although both PLS and HMS share the cardinal features of PPK and severe periodontitis, a number of additional findings are reported in HMS including arachnodactyly, acro-osteolysis, atrophic changes of the nails, and a radiographic deformity of the fingers.",10662807_1,-1,980,-1,0.36339068
981,C,6,7,37,38,"Recently, mutations of the cathepsin C gene have been identified as the underlying genetic defect in PLS.",10662807_5,-1,981,-1,0.38080946
982,C,5,6,28,29,"To determine if a cathepsin C mutation is also responsible for HMS, we sequenced the gene in affected and unaffected subjects from the Cochin isolate in which both the PLS and HMS phenotypes appear.",10662807_6,-1,982,-1,0.39878833
983,C,9,10,57,58,"Here we report identification of a mutation of cathepsin C (exon 6, 2127A-- > G) that changes a highly conserved amino acid in the cathepsin C peptide.",10662807_7,-1,983,-1,0.39783555
984,amino acid,23,25,113,123,"Here we report identification of a mutation of cathepsin C (exon 6, 2127A-- > G) that changes a highly conserved amino acid in the cathepsin C peptide.",10662807_7,-1,984,-1,0.37887248
985,C,28,29,141,142,"Here we report identification of a mutation of cathepsin C (exon 6, 2127A-- > G) that changes a highly conserved amino acid in the cathepsin C peptide.",10662807_7,-1,985,-1,0.3811444
986,C,15,16,97,98,"Additionally, the existence of a shared common haplotype for genetic loci flanking the cathepsin C gene suggests that affected subjects descended from the Cochin isolate are homozygous for a mutation inherited "" identical by descent "" from a common ancestor.",10662807_9,-1,986,-1,0.36012518
987,C,13,14,83,84,These findings provide evidence that PLS and HMS are allelic variants of cathepsin C gene mutations..,10662807_12,-1,987,-1,0.37541217
996,glucose,3,4,19,26,Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history.,10698963_0,-1,996,-1,0.34592837
997,Glucose,0,1,1,8,"
Glucose 6-phosphate dehydrogenase (G6PD) is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions.",10698963_1,-1,997,-1,0.3603308
998,NADPH,22,23,138,143,"
Glucose 6-phosphate dehydrogenase (G6PD) is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions.",10698963_1,-1,998,-1,0.3536426
1001,amino acid,5,7,26,36,"From the alignment of the amino acid (aa) sequence of 52 glucose 6-phosphate dehydrogenase (G6PD) species from 42 different organisms, we found a striking correlation between the aa replacements that cause G6PD deficiency in humans and the sequence conservation of G6PD  two-thirds of such replacements are in highly and moderately conserved (50-99%) aa; relatively few are in fully conserved aa (where they might be lethal) or in poorly conserved aa, where presumably they simply would not cause G6PD deficiency.",10698963_4,-1,1001,-1,0.40569448
1002,glucose,13,14,57,64,"From the alignment of the amino acid (aa) sequence of 52 glucose 6-phosphate dehydrogenase (G6PD) species from 42 different organisms, we found a striking correlation between the aa replacements that cause G6PD deficiency in humans and the sequence conservation of G6PD  two-thirds of such replacements are in highly and moderately conserved (50-99%) aa; relatively few are in fully conserved aa (where they might be lethal) or in poorly conserved aa, where presumably they simply would not cause G6PD deficiency.",10698963_4,-1,1002,-1,0.34963915
1003,amino acid,19,21,133,143,Comparing the distribution of mutations in a human housekeeping gene with evolutionary conservation is a useful tool for pinpointing amino acid residues important for the stability or the function of the corresponding protein.,10698963_6,-1,1003,-1,0.3823142
1004,myotonic dystrophy,9,11,63,81,Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties.,10699184_0,-1,1004,-1,0.35520858
1005,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is the most prevalent inherited neuromuscular disease in adults.",10699184_1,-1,1005,-1,0.35807708
1006,DM,3,4,21,23,"
Myotonic dystrophy (DM) is the most prevalent inherited neuromuscular disease in adults.",10699184_1,-1,1006,-1,0.36377674
1007,neuromuscular disease,10,12,57,78,"
Myotonic dystrophy (DM) is the most prevalent inherited neuromuscular disease in adults.",10699184_1,-1,1007,-1,0.33111912
1008,myotonic dystrophy,15,17,89,107,"The genetic defect is a CTG triplet repeat expansion in the 3-untranslated region of the myotonic dystrophy protein kinase (DMPK) gene, consisting of 15 exons.",10699184_2,-1,1008,-1,0.36634842
1009,contrast,1,2,3,11,"In contrast, the excision of exons 13/14 that causes a frameshift and creates a C-terminally truncated protein is clearly cell type dependent and occurs predominantly in smooth muscle.",10699184_5,-1,1009,-1,0.3609187
1010,n,21,22,127,128,Information on DMPK mRNA and protein isoform expression patterns will be useful for recognizing differential effects of (CTG) (n) expansion in DM manifestation..,10699184_7,-1,1010,-1,0.4027055
1011,DM,25,26,143,145,Information on DMPK mRNA and protein isoform expression patterns will be useful for recognizing differential effects of (CTG) (n) expansion in DM manifestation..,10699184_7,-1,1011,-1,0.3282988
1012,venous thrombosis,9,11,52,69,"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.
Protein S deficiency is a recognized risk factor for venous thrombosis.",10706858_0,-1,1012,-1,0.32757363
1013,Protein S deficiency,19,22,124,144,"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.
Protein S deficiency is a recognized risk factor for venous thrombosis.",10706858_0,-1,1013,-1,0.35551444
1014,venous thrombosis,28,30,177,194,"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.
Protein S deficiency is a recognized risk factor for venous thrombosis.",10706858_0,-1,1014,-1,0.34141925
1015,lead,21,22,134,138,"Of all the inherited thrombophilic conditions, it remains the most difficult to diagnose because of phenotypic variability, which can lead to inconclusive results.",10706858_1,-1,1015,-1,0.4487119
1016,protein S deficiency,4,7,33,53,"Twenty-eight index patients with protein S deficiency and a PROS1 gene defect were studied, together with 109 first-degree relatives.",10706858_3,-1,1016,-1,0.34317437
1021,protein S deficiency,9,12,53,73,We conclude that persons with PROS1 gene defects and protein S deficiency are at increased risk of thrombosis and that free protein S estimation offers the most reliable way of diagnosing the deficiency.,10706858_11,-1,1021,-1,0.3347006
1023,Autoimmune lymphoproliferative syndrome,0,3,0,39,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1023,-1,0.34841204
1024,disease,17,18,111,118,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1024,-1,0.39801
1025,Autoimmune lymphoproliferative syndrome,19,22,120,159,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1025,-1,0.36549294
1026,autoimmune,28,29,187,197,"Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis.",10709732_0,-1,1026,-1,0.3715831
1027,Prader-Willi syndrome,7,9,53,74,Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: further evidence for regional imprinting control.,10712201_0,-1,1027,-1,0.39251295
1028,Angelman syndrome,10,12,79,96,Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: further evidence for regional imprinting control.,10712201_0,-1,1028,-1,0.32728094
1029,Prader-Willi syndrome,15,17,114,135,"
Deletions and other abnormalities of human chromosome 15q11-q13 are associated with two developmental disorders, Prader-Willi syndrome (PWS) and Angelman syndrome (AS).",10712201_1,-1,1029,-1,0.38170362
1030,Angelman syndrome,21,23,146,163,"
Deletions and other abnormalities of human chromosome 15q11-q13 are associated with two developmental disorders, Prader-Willi syndrome (PWS) and Angelman syndrome (AS).",10712201_1,-1,1030,-1,0.30882353
1031,map,29,30,193,196,"To identify additional imprinted genes that could contribute to the PWS phenotype and to understand the regional control of imprinting in 15q11-q13, we have constructed an imprinted transcript map of the PWS-AS deletion interval.",10712201_4,-1,1031,-1,0.35248235
1032,map,36,37,245,248,The imprinting status of 22 expressed sequence tags derived from the radiation-hybrid human transcript maps or physical maps was determined in a reverse transcriptase-PCR assay and correlated with the position of the transcripts on the physical map.,10712201_5,-1,1032,-1,0.3827612
1039,P,2,3,4,5,40 (P =. 01) at D1S212.,10712209_5,-1,1039,-1,0.38267124
1040,disease,12,13,90,97,Further parametric analysis revealed a significant effect of the presence of male-to-male disease transmission within the families.,10712209_10,-1,1040,-1,0.3823166
1041,P,16,17,61,62,"In the subset of 491 such families, the peak HLOD was 2. 56 (P =.",10712209_12,-1,1041,-1,0.39962566
1042,disease,5,6,38,45,"Within the families with male-to-male disease transmission, alpha increased with the early mean age at diagnosis (< 65 years, alpha =.",10712209_16,-1,1042,-1,0.37422913
1043,P,24,25,108,109,"The highest value of alpha was observed for the 48 families that met all three criteria (peak HLOD = 2. 25, P =.",10712209_21,-1,1043,-1,0.40846652
1046,disease,41,42,242,249,"Although HPC1 accounts for only a small proportion of all families affected by hereditary prostate cancer, it appears to play a more prominent role in the subset of families with several members affected at an early age and with male-to-male disease transmission.",10712209_26,-1,1046,-1,0.34214976
1047,Huntington disease,12,14,70,88,A recurrent expansion of a maternal allele with 36 CAG repeats causes Huntington disease in two sisters.,10712225_0,-1,1047,-1,0.3285664
1048,Huntington disease,31,33,161,179,"We describe a recurrent large expansion of a maternal allele with 36 CAG repeats (to 66 and 57 repeats, respectively, in two daughters) associated with onset of Huntington disease (HD) in the second and third decade in a family without history of HD.",10712225_2,-1,1048,-1,0.32809153
1050,disease,19,20,126,133,"
Motor incoordination, immune deficiencies, and an increased risk of cancer are the characteristic features of the hereditary disease ataxia-telangiectasia (A-T), which is caused by mutations in the ATM gene.",10716718_1,-1,1050,-1,0.3760091
1051,contrast,1,2,3,11,"In contrast to other Atm mutant mice, Atm (y/y) mice show a lower incidence of thymic lymphoma and survive beyond a few months of age.",10716718_3,-1,1051,-1,0.37221545
1052,lymphoma,19,20,86,94,"In contrast to other Atm mutant mice, Atm (y/y) mice show a lower incidence of thymic lymphoma and survive beyond a few months of age.",10716718_3,-1,1052,-1,0.31436953
1053,cerebellar dysfunction,12,14,64,86,Atm (y/y) mice exhibit deficits in motor learning indicative of cerebellar dysfunction.,10716718_4,-1,1053,-1,0.34203216
1054,Wilson disease,10,12,60,74,Novel mutations of the ATP7B gene in Japanese patients with Wilson disease.,10721669_0,-1,1054,-1,0.30892333
1055,Wilson disease,0,2,1,15,"
Wilson disease (WD) is an autosomal recessive disorder characterized by copper accumulation in the liver, brain, kidneys, and corneas, and culminating in copper toxication in these organs.",10721669_1,-1,1055,-1,0.34487423
1056,copper,12,13,73,79,"
Wilson disease (WD) is an autosomal recessive disorder characterized by copper accumulation in the liver, brain, kidneys, and corneas, and culminating in copper toxication in these organs.",10721669_1,-1,1056,-1,0.35353553
1057,copper,28,29,155,161,"
Wilson disease (WD) is an autosomal recessive disorder characterized by copper accumulation in the liver, brain, kidneys, and corneas, and culminating in copper toxication in these organs.",10721669_1,-1,1057,-1,0.35351208
1058,contrast,1,2,3,11,"In contrast to these mutations found in patients with hepatic-type of early onset, the mutations A874V, R778L, and 3892delGTC were either missense mutations or in frame 1-amino acid deletion, and occurred in the patients with hepato-neurologic type of late onset.",10721669_5,-1,1058,-1,0.38642746
1059,Wiskott-Aldrich syndrome,6,8,48,72,Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.,10724160_0,-1,1059,-1,0.38280234
1060,Wiskott-Aldrich syndrome,14,16,89,113,"
The Rho-family GTPase, Cdc42, can regulate the actin cytoskeleton through activation of Wiskott-Aldrich syndrome protein (WASP) family members.",10724160_1,-1,1060,-1,0.36125082
1061,C,15,16,113,114,"In the autoinhibited complex, intramolecular interactions with the GTPase-binding domain occlude residues of the C terminus that regulate the Arp2/3 actin-nucleating complex.",10724160_4,-1,1061,-1,0.44258395
1062,C,24,25,154,155,"Binding of Cdc42 to the GTPase-binding domain causes a dramatic conformational change, resulting in disruption of the hydrophobic core and release of the C terminus, enabling its interaction with the actin regulatory machinery.",10724160_5,-1,1062,-1,0.45897952
1063,tumour,9,10,33,39,"
Mutations in the BRCA1 (ref. 1) tumour suppressor gene are found in almost all of the families with inherited breast and ovarian cancers and about half of the families with only breast cancer.",10724175_1,-1,1063,-1,0.33582583
1067,Machado-Joseph disease,0,2,1,23,"
Machado-Joseph disease (MJD) belongs to a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar ataxia.",10732811_1,-1,1067,-1,0.40565684
1068,neurodegenerative disorders,14,16,93,120,"
Machado-Joseph disease (MJD) belongs to a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar ataxia.",10732811_1,-1,1068,-1,0.34981114
1069,cerebellar ataxia,19,21,150,167,"
Machado-Joseph disease (MJD) belongs to a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar ataxia.",10732811_1,-1,1069,-1,0.32854933
1070,n,15,16,92,93,The disease-causing mutation has recently been identified as an unstable and expanded (CAG) n trinucleotide repeat in a novel gene of unknown function.,10732811_2,-1,1070,-1,0.407306
1072,C-terminal,3,4,13,23,"However, the C-terminal end of the putative protein differs strongly from the published human sequence.",10732811_6,-1,1072,-1,0.44121596
1073,n,4,5,10,11,The (CAG) n block in the rat cDNA consists of just three interrupted units suggesting that a long polyglutamine stretch is not essential for the normal function of the ataxin-3 protein in rodents.,10732811_7,-1,1073,-1,0.41247913
1074,muscular dystrophy,7,9,50,68,"Emerin, deficiency of which causes Emery-Dreifuss muscular dystrophy, is localized at the inner nuclear membrane.",10732816_0,-1,1074,-1,0.3573755
1075,muscular dystrophy,3,5,35,53,"
X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle disorder characterized by the clinical triad of progressive wasting of humero-peroneal muscles, early contractures of the elbows, Achilles tendons and postcervical muscles, and cardiac conduction block with a high risk of sudden death.",10732816_1,-1,1075,-1,0.3628441
1076,contractures,26,27,186,198,"
X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle disorder characterized by the clinical triad of progressive wasting of humero-peroneal muscles, early contractures of the elbows, Achilles tendons and postcervical muscles, and cardiac conduction block with a high risk of sudden death.",10732816_1,-1,1076,-1,0.39122197
1077,sudden death,46,48,306,318,"
X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle disorder characterized by the clinical triad of progressive wasting of humero-peroneal muscles, early contractures of the elbows, Achilles tendons and postcervical muscles, and cardiac conduction block with a high risk of sudden death.",10732816_1,-1,1077,-1,0.3576051
1078,gold,6,7,43,47,"We found that the immune-labeled colloidal gold particles were localized on the nucleoplasmic surface of the inner nuclear membrane, but not on the nuclear pore.",10732816_4,-1,1078,-1,0.3340957
1079,calcium,32,33,222,229,"We speculate that emerin contributes to maintain the nuclear structure and stability, as well as nuclear functions, particularly in muscle tissues that have severe stress with rigorous contraction-relaxation movements and calcium flux..",10732816_7,-1,1079,-1,0.33768567
1080,Friedreich ataxia,3,5,23,40,Locus heterogeneity in Friedreich ataxia.,10735274_0,-1,1080,-1,0.34484395
1081,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA) is the most common form of autosomal recessive ataxia.",10735274_1,-1,1081,-1,0.36297244
1083,disease,1,2,4,11,"The disease locus was assigned to chromosome 9 and the disease gene, STM7/X25, has been isolated.",10735274_2,-1,1083,-1,0.3605619
1084,disease,10,11,55,62,"The disease locus was assigned to chromosome 9 and the disease gene, STM7/X25, has been isolated.",10735274_2,-1,1084,-1,0.37786525
1085,impaired glucose tolerance,5,8,27,53,Glycerol as a correlate of impaired glucose tolerance: dissection of a complex system by use of a simple genetic trait.,10736265_0,-1,1085,-1,0.37078878
1086,glucose,12,13,68,75,"
Glycerol kinase (GK) represents the primary entry of glycerol into glucose and triglyceride metabolism.",10736265_1,-1,1086,-1,0.31150576
1087,triglyceride,14,15,80,92,"
Glycerol kinase (GK) represents the primary entry of glycerol into glucose and triglyceride metabolism.",10736265_1,-1,1087,-1,0.31460217
1088,Impaired glucose tolerance,0,3,0,26,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1088,-1,0.36329436
1089,hypertriglyceridemia,7,8,37,57,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1089,-1,0.3387172
1090,diabetes mellitus,15,17,99,116,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1090,-1,0.32419708
1091,cardiovascular disease,18,20,121,143,Impaired glucose tolerance (IGT) and hypertriglyceridemia are associated with an increased risk of diabetes mellitus and cardiovascular disease.,10736265_2,-1,1091,-1,0.32328656
1092,hyperglycerolemia,14,15,88,105,Family screening in the initial cohort identified 18 men from five families with severe hyperglycerolemia (values above 2. 0 mmol/liter) and demonstrated an X-linked pattern of inheritance.,10736265_5,-1,1092,-1,0.31993696
1093,disease,5,6,32,39,-Jean region of Quebec-a common disease haplotype was sought.,10736265_10,-1,1093,-1,0.35702956
1094,cM,1,2,2,4,5 cM was observed in all families.,10736265_12,-1,1094,-1,0.3977946
1095,aspartic acid,36,38,208,221,"Resequencing of the GK gene in family members led to the discovery of a N288D missense mutation in exon 10, which resulted in the substitution of a highly conserved asparagine residue by a negatively charged aspartic acid.",10736265_13,-1,1095,-1,0.37719315
1096,dystonias,6,7,43,52,Clinical and molecular genetics of primary dystonias.,10737119_0,-1,1096,-1,0.32194227
1097,dystonias,1,2,9,18,"
Primary dystonias are movement disorders with dystonia as a major symptom.",10737119_1,-1,1097,-1,0.31786707
1103,dystonia parkinsonism syndrome,4,7,18,48,"1 in the X-linked dystonia parkinsonism syndrome and to Xq22 in X-linked sensorineural deafness, dystonia, and mental retardation.",10737119_9,-1,1103,-1,0.34704062
1104,deafness,13,14,87,95,"1 in the X-linked dystonia parkinsonism syndrome and to Xq22 in X-linked sensorineural deafness, dystonia, and mental retardation.",10737119_9,-1,1104,-1,0.32297117
1106,mental retardation,18,20,111,129,"1 in the X-linked dystonia parkinsonism syndrome and to Xq22 in X-linked sensorineural deafness, dystonia, and mental retardation.",10737119_9,-1,1106,-1,0.32833686
1107,disease,1,2,4,11,The disease genes have been identified in two autosomal dominant forms and in one X-linked recessive form.,10737119_10,-1,1107,-1,0.3635867
1110,deafness,2,3,17,25,"In sensorineural deafness, dystonia, and mental retardation , mutations were found in the gene DDP coding for a polypeptide of unknown function.",10737119_12,-1,1110,-1,0.31702656
1112,mental retardation,7,9,41,59,"In sensorineural deafness, dystonia, and mental retardation , mutations were found in the gene DDP coding for a polypeptide of unknown function.",10737119_12,-1,1112,-1,0.329763
1113,dystonias,10,11,68,77,"This article reviews the clinical and molecular genetics of primary dystonias, critically discusses present findings, and proposes referring to the known forms, most of which can be distinguished by genetic criteria, as dystonias 1-12.",10737119_13,-1,1113,-1,0.30388308
1114,dystonias,36,37,220,229,"This article reviews the clinical and molecular genetics of primary dystonias, critically discusses present findings, and proposes referring to the known forms, most of which can be distinguished by genetic criteria, as dystonias 1-12.",10737119_13,-1,1114,-1,0.3051114
1115,adrenoleukodystrophy,4,5,29,49,"Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described.",10737980_0,-1,1115,-1,0.3473425
1116,Adrenoleukodystrophy,1,2,10,30,"
X-linked Adrenoleukodystrophy (X-ALD) is the most frequent peroxisomal disease.",10737980_1,-1,1116,-1,0.35789406
1117,disease,10,11,72,79,"
X-linked Adrenoleukodystrophy (X-ALD) is the most frequent peroxisomal disease.",10737980_1,-1,1117,-1,0.33785623
1118,fatty acids,10,12,87,98,"The principal biochemical abnormality is the accumulation of saturated very-long-chain fatty acids (VLCFAs  > C22  0, mainly C26  0), which is due to impaired capacity for beta-oxidation in peroxisomes.",10737980_4,-1,1118,-1,0.34412727
1119,disease,13,14,65,72,"Six of the eight patients with the infantile, severe form of the disease presented cardiac involvement, a feature rarely associated with GM1-gangliosidosis.",10737981_3,-1,1119,-1,0.34189153
1120,amino acid,21,23,129,139,"Molecular analysis of the patients RNA and DNA identified two new RNA splicing defects, three new and three previously described amino acid substitutions.",10737981_4,-1,1120,-1,0.3358795
1121,contrast,28,29,137,145,"Interestingly, all patients with cardiac involvement were homozygous for one of these mutations  R59H, Y591C, Y591N, or IVS14-2A > G. In contrast, all other patients were compound heterozygous for one of the following mutations  R201H, R482H, G579D, IVS8 + 2T > C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hbeta-Gal-related protein, also known as the elastin binding protein (EBP).",10737981_5,-1,1121,-1,0.3481364
1122,C.,54,55,262,264,"Interestingly, all patients with cardiac involvement were homozygous for one of these mutations  R59H, Y591C, Y591N, or IVS14-2A > G. In contrast, all other patients were compound heterozygous for one of the following mutations  R201H, R482H, G579D, IVS8 + 2T > C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hbeta-Gal-related protein, also known as the elastin binding protein (EBP).",10737981_5,-1,1122,-1,0.4044626
1123,cardiac abnormalities,64,66,322,343,"Interestingly, all patients with cardiac involvement were homozygous for one of these mutations  R59H, Y591C, Y591N, or IVS14-2A > G. In contrast, all other patients were compound heterozygous for one of the following mutations  R201H, R482H, G579D, IVS8 + 2T > C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hbeta-Gal-related protein, also known as the elastin binding protein (EBP).",10737981_5,-1,1123,-1,0.3450989
1125,obesity,6,7,36,43,In vivo modulation of Hmgic reduces obesity.,10742101_0,-1,1125,-1,0.36336437
1126,tumour,10,11,60,66,"It is disrupted and misexpressed in a number of mesenchymal tumour cell types, including fat-cell tumours (lipomas).",10742101_3,-1,1126,-1,0.29929742
1127,tumours,16,17,98,105,"It is disrupted and misexpressed in a number of mesenchymal tumour cell types, including fat-cell tumours (lipomas).",10742101_3,-1,1127,-1,0.2878343
1128,fat,8,9,47,50,In addition Hmgic-/- mice have a deficiency in fat tissue.,10742101_4,-1,1128,-1,0.33118606
1129,obesity,7,8,38,45,"To study its role in adipogenesis and obesity, we examined Hmgic expression in the adipose tissue of adult, obese mice.",10742101_5,-1,1129,-1,0.36651245
1130,obesity,11,12,74,81,Mice with a partial or complete deficiency of Hmgic resisted diet-induced obesity.,10742101_6,-1,1130,-1,0.35917905
1131,obesity,8,9,46,53,Disruption of Hmgic caused a reduction in the obesity induced by leptin deficiency (Lepob/Lepob) in a gene-dose-dependent manner.,10742101_7,-1,1131,-1,0.38521618
1132,leptin,11,12,65,71,Disruption of Hmgic caused a reduction in the obesity induced by leptin deficiency (Lepob/Lepob) in a gene-dose-dependent manner.,10742101_7,-1,1132,-1,0.3234826
1133,obesity,23,24,140,147,"Our studies implicate a role for HMGIC in fat-cell proliferation, indicating that it may be an adipose-specific target for the treatment of obesity..",10742101_8,-1,1133,-1,0.35743713
1134,factor X deficiency,7,10,61,80,Molecular analysis of the genotype-phenotype relationship in factor X deficiency.,10746568_0,-1,1134,-1,0.32917747
1135,Factor X deficiency,0,3,1,20,"
Factor X deficiency is a rare haemorrhagic condition, normally inherited as an autosomal recessive trait, in which a variable clinical presentation correlates poorly with laboratory phenotype.",10746568_1,-1,1135,-1,0.34240758
1136,factor X deficiency,12,15,58,77,The factor X (F10) genes of 14 unrelated individuals with factor X deficiency (12 familial and two sporadic cases) were sequenced yielding a total of 13 novel mutations.,10746568_2,-1,1136,-1,0.3155756
1137,lead,25,26,183,187,One family manifesting an autosomal dominant pattern of inheritance possessed three clinically affected members who were heterozygous for a splice-site mutation that was predicted to lead to the production of a truncated protein product.,10746568_6,-1,1137,-1,0.38295856
1138,contrast,1,2,3,11,"By contrast, no such relationship could be discerned between laboratory phenotype and polymorphism genotype..",10746568_9,-1,1138,-1,0.3549813
1139,fat,19,20,121,124,"Despite the ubiquitous expression of the truncated HMG I-C protein, the transgenic mice develop a selective abundance of fat tissue early in life, show marked adipose tissue inflammation, and have an abnormally high incidence of lipomas.",10747931_3,-1,1139,-1,0.33587182
1142,diseases,2,3,10,18,"
The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation.",10766245_1,-1,1142,-1,0.3506098
1143,Nijmegen breakage syndrome,17,20,88,114,"
The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation.",10766245_1,-1,1143,-1,0.3674493
1144,chromosomal instability,39,41,211,234,"
The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation.",10766245_1,-1,1144,-1,0.33700824
1145,diseases,21,22,140,148,These observations link ATM and p95/nbs1 in a common signalling pathway and provide an explanation for phenotypic similarities in these two diseases..,10766245_7,-1,1145,-1,0.32950017
1146,fragile X syndrome,5,8,37,55,Understanding the molecular basis of fragile X syndrome.,10767313_0,-1,1146,-1,0.34080112
1147,Fragile X syndrome,0,3,1,19,"
Fragile X syndrome, a common form of inherited mental retardation, is mainly caused by massive expansion of CGG triplet repeats located in the 5-untranslated region of the fragile X mental retardation-1 (FMR1) gene.",10767313_1,-1,1147,-1,0.35352916
1148,mental retardation,9,11,48,66,"
Fragile X syndrome, a common form of inherited mental retardation, is mainly caused by massive expansion of CGG triplet repeats located in the 5-untranslated region of the fragile X mental retardation-1 (FMR1) gene.",10767313_1,-1,1148,-1,0.30791983
1149,fragile X syndrome,3,6,17,35,"In patients with fragile X syndrome, the expanded CGG triplet repeats are hypermethylated and the expression of the FMR1 gene is repressed, which leads to the absence of FMR1 protein (FMRP) and subsequent mental retardation.",10767313_2,-1,1149,-1,0.31750005
1150,mental retardation,37,39,205,223,"In patients with fragile X syndrome, the expanded CGG triplet repeats are hypermethylated and the expression of the FMR1 gene is repressed, which leads to the absence of FMR1 protein (FMRP) and subsequent mental retardation.",10767313_2,-1,1150,-1,0.3202637
1151,diseases,17,18,97,105,These studies will not only help to illuminate the molecular basis of the general class of human diseases with trinucleotide repeat expansion but also provide an avenue to understand aspects of human cognition and intelligence..,10767313_6,-1,1151,-1,0.34649414
1156,Fragile X syndrome,0,3,1,19,"
Fragile X syndrome is a common cause of mental retardation involving loss of expression of the FMR1 gene.",10767339_1,-1,1156,-1,0.35851994
1157,mental retardation,8,10,41,59,"
Fragile X syndrome is a common cause of mental retardation involving loss of expression of the FMR1 gene.",10767339_1,-1,1157,-1,0.31905612
1158,macroorchidism,14,15,81,95,"Fmr1 knockout mice exhibit a phenotype with some similarities to humans, such as macroorchidism and behavioral abnormalities.",10767339_3,-1,1158,-1,0.34318015
1159,behavioral abnormalities,16,18,100,124,"Fmr1 knockout mice exhibit a phenotype with some similarities to humans, such as macroorchidism and behavioral abnormalities.",10767339_3,-1,1159,-1,0.34849298
1160,fragile X syndrome,19,22,121,139,"As a step toward understanding the function of FMR1 and the determination of the potential for therapeutic approaches to fragile X syndrome, yeast artificial chromosome (YAC) transgenic mice were generated in order to determine whether the Fmr1 knockout mouse phenotype could be rescued.",10767339_4,-1,1160,-1,0.34267202
1161,fragile X syndrome,9,12,66,84,These findings have significant implications for gene therapy for fragile X syndrome since overexpression of the gene may harbor its own phenotype..,10767339_11,-1,1161,-1,0.32192189
1162,DM,14,15,98,100,Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability.,10767343_0,-1,1162,-1,0.3918054
1163,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is caused by a CTG repeat expansion in the 3UTR of the DM protein kinase (DMPK) gene.",10767343_1,-1,1163,-1,0.3869625
1164,DM,3,4,21,23,"
Myotonic dystrophy (DM) is caused by a CTG repeat expansion in the 3UTR of the DM protein kinase (DMPK) gene.",10767343_1,-1,1164,-1,0.38652813
1165,DM,17,18,80,82,"
Myotonic dystrophy (DM) is caused by a CTG repeat expansion in the 3UTR of the DM protein kinase (DMPK) gene.",10767343_1,-1,1165,-1,0.37466478
1166,disease,25,26,152,159,A very high level of instability is observed through successive generations and the size of the repeat is generally correlated with the severity of the disease and with age at onset.,10767343_2,-1,1166,-1,0.360947
1167,DM,4,5,26,28,"Furthermore, tissues from DM patients exhibit somatic mosaicism that increases with age.",10767343_3,-1,1167,-1,0.35043928
1168,DM,25,26,138,140,"We generated transgenic mice carrying large human genomic sequences with 20, 55 or > 300 CTG, cloned from patients from the same affected DM family.",10767343_4,-1,1168,-1,0.36894402
1169,DM,22,23,122,124,"Although we did not observe dramatic expansions (or big jumps over several hundred CTG repeats) as in congenital forms of DM, our model carrying > 300 CTG is the first to show instability so close to the human DM situation.",10767343_7,-1,1169,-1,0.32324898
1170,DM,41,42,210,212,"Although we did not observe dramatic expansions (or big jumps over several hundred CTG repeats) as in congenital forms of DM, our model carrying > 300 CTG is the first to show instability so close to the human DM situation.",10767343_7,-1,1170,-1,0.33135864
1171,Friedreich ataxia,3,5,20,37,Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation.,10767347_0,-1,1171,-1,0.36038047
1172,iron,13,14,92,96,Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation.,10767347_0,-1,1172,-1,0.34129602
1173,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is caused in almost all cases by homozygous intronic expansions resulting in the loss of frataxin, a mitochondrial protein conserved through evolution, and involved in mitochondrial iron homeostasis.",10767347_1,-1,1173,-1,0.3685171
1175,iron,41,42,253,257,"
Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is caused in almost all cases by homozygous intronic expansions resulting in the loss of frataxin, a mitochondrial protein conserved through evolution, and involved in mitochondrial iron homeostasis.",10767347_1,-1,1175,-1,0.32724965
1176,iron,28,29,203,207,"Yeast knockout models, and histological and biochemical data from patient heart biopsies or autopsies indicate that the frataxin defect causes a specific iron-sulfur protein deficiency and mitochondrial iron accumulation leading to the pathological changes.",10767347_2,-1,1176,-1,0.33167383
1177,disease,6,7,30,37,"To study the mechanism of the disease, we generated a mouse model by deletion of exon 4 leading to inactivation of the Frda gene product.",10767347_4,-1,1177,-1,0.36334828
1178,iron,9,10,49,53,"Surprisingly, in the frataxin knockout mouse, no iron accumulation was observed during embryonic resorption, suggesting that cell death could be due to a mechanism independent of iron accumulation..",10767347_7,-1,1178,-1,0.31019628
1180,iron,29,30,179,183,"Surprisingly, in the frataxin knockout mouse, no iron accumulation was observed during embryonic resorption, suggesting that cell death could be due to a mechanism independent of iron accumulation..",10767347_7,-1,1180,-1,0.34937912
1181,Gaucher disease,0,2,0,15,Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.,10777718_0,-1,1181,-1,0.38084495
1182,Gaucher disease,2,4,8,23,"
Type 1 Gaucher disease (GD), a non-neuronopathic lysosomal storage disorder, results from the deficient activity of acid beta-glucosidase (GBA).",10777718_1,-1,1182,-1,0.38106284
1183,disease,2,3,7,14,Type 1 disease is panethnic but is more prevalent in individuals of Ashkenazi Jewish (AJ) descent.,10777718_2,-1,1183,-1,0.31959587
1184,STR,17,18,97,100,"To investigate the genetic history of these mutations in the AJ population, short tandem repeat (STR) markers were used to map a 9.",10777718_4,-1,1184,-1,0.36872405
1185,map,23,24,123,126,"To investigate the genetic history of these mutations in the AJ population, short tandem repeat (STR) markers were used to map a 9.",10777718_4,-1,1185,-1,0.35878474
1186,contrast,1,2,3,11,"In contrast, a different conserved haplotype at these markers was identified on the 84GG chromosomes, which was unique to the AJ population.",10777718_8,-1,1186,-1,0.3567225
1187,spondylitis,7,8,39,50,HLA B27 and the genetics of ankylosing spondylitis.,107868_0,-1,1187,-1,0.34767035
1188,spondylitis,9,10,62,73,"
One hundred and twenty-eight of 145 patients with ankylosing spondylitis (AS) were found to be HLA B27 positive.",107868_1,-1,1188,-1,0.33698612
1190,psoriatic arthritis,11,13,89,108,Five patients had evidence of a sero-negative peripheral arthritis resembling peripheral psoriatic arthritis and 3 of these were B27 negative.,107868_2,-1,1190,-1,0.36317125
1191,spondylitis,10,11,63,74,One further B27 negative patients had a sister with ankylosing spondylitis and ulcerative colitis and a mother with ulcerative colitis.,107868_3,-1,1191,-1,0.34999964
1192,ulcerative colitis,12,14,79,97,One further B27 negative patients had a sister with ankylosing spondylitis and ulcerative colitis and a mother with ulcerative colitis.,107868_3,-1,1192,-1,0.3137384
1193,ulcerative colitis,18,20,116,134,One further B27 negative patients had a sister with ankylosing spondylitis and ulcerative colitis and a mother with ulcerative colitis.,107868_3,-1,1193,-1,0.30288053
1194,spondylitis,15,16,109,120,"These findings are interpreted as suggesting some degree of clinical and genetic heterogeneity in ankylosing spondylitis with genes for psoriasis and inflammatory bowel disease being important in some individuals, particularly those who are B27 negative.",107868_5,-1,1194,-1,0.34299523
1196,inflammatory bowel disease,21,24,150,176,"These findings are interpreted as suggesting some degree of clinical and genetic heterogeneity in ankylosing spondylitis with genes for psoriasis and inflammatory bowel disease being important in some individuals, particularly those who are B27 negative.",107868_5,-1,1196,-1,0.37264517
1197,spondylitis,5,6,51,62,Twenty-five first-degree relatives with ankylosing spondylitis were all B27 positive.,107868_6,-1,1197,-1,0.34677237
1198,spondylitis,8,9,47,58,The only instance of disassociation of B27 and spondylitis in a family was where the proband had ulcerative colitis as well as spondylitis.,107868_7,-1,1198,-1,0.35318902
1199,ulcerative colitis,17,19,97,115,The only instance of disassociation of B27 and spondylitis in a family was where the proband had ulcerative colitis as well as spondylitis.,107868_7,-1,1199,-1,0.3597791
1200,spondylitis,22,23,127,138,The only instance of disassociation of B27 and spondylitis in a family was where the proband had ulcerative colitis as well as spondylitis.,107868_7,-1,1200,-1,0.31089845
1201,spondylitis,13,14,78,89,Of 13 B27 positive fathers 3 could be diagnosed as having definite ankylosing spondylitis (23%).,107868_8,-1,1201,-1,0.32901803
1202,spondylitis,15,16,96,107,These findings are thought to provide evidence against the concept that the gene for ankylosing spondylitis is not B27 but a closely linked gene and favour the occurrence of an environmental event affecting approximately one-fifth of B27 positive males to result in disease..,107868_9,-1,1202,-1,0.33441812
1203,disease,42,43,266,273,These findings are thought to provide evidence against the concept that the gene for ankylosing spondylitis is not B27 but a closely linked gene and favour the occurrence of an environmental event affecting approximately one-fifth of B27 positive males to result in disease..,107868_9,-1,1203,-1,0.35039765
1214,cancer syndrome,10,12,63,78,The single family with a BRCA2 mutation had the breast-ovarian cancer syndrome.,10788334_9,-1,1214,-1,0.29606593
1215,fatty acid,15,17,107,117,"
Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency is a life-threatening disorder of mitochondrial fatty acid beta-oxidation.",10790204_1,-1,1215,-1,0.37941146
1216,VLCAD deficiency,8,10,46,62,All patients had the severe childhood form of VLCAD deficiency with early onset and high mortality.,10790204_3,-1,1216,-1,0.36112198
1217,65C,39,40,184,187,"As expected, null mutations were found in patients 2 and 3  patient 2 is homozygous for a frameshift mutation, del 4 bp at 798-801, and patient 3 is homozygous for a nonsense mutation 65C > A (S22X).",10790204_5,-1,1217,-1,0.36947727
1218,C,25,26,131,132,"Patient 1 was homozygous for a complex mutant allele containing two alterations, including a 194C > T transition (P65L) and 739A > C transversion (K247Q); in the case of P65L, the amino acid change does not reduce enzyme activity.",10790204_6,-1,1218,-1,0.40711337
1219,amino acid,38,40,180,190,"Patient 1 was homozygous for a complex mutant allele containing two alterations, including a 194C > T transition (P65L) and 739A > C transversion (K247Q); in the case of P65L, the amino acid change does not reduce enzyme activity.",10790204_6,-1,1219,-1,0.38792738
1220,nucleotide,3,4,13,23,"However, the nucleotide change resulted in exon 3 skipping, whereas the latter K247Q mutation had a drastic effect on enzyme activity.",10790204_7,-1,1220,-1,0.3347271
1221,Prader-Willi syndrome,5,7,40,61,Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting.,10797418_0,-1,1221,-1,0.41894343
1222,Prader-Willi syndrome,1,3,5,26,"
The Prader-Willi syndrome (PWS) critical region on 15q11-q13 is subject to imprinting.",10797418_1,-1,1222,-1,0.41463754
1223,glycine,1,2,6,13,"Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): their structure and expression, and the identification of a large deletion in a family with nonketotic hyperglycinemia.",10798358_0,-1,1223,-1,0.36516804
1224,nonketotic hyperglycinemia,32,34,189,215,"Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): their structure and expression, and the identification of a large deletion in a family with nonketotic hyperglycinemia.",10798358_0,-1,1224,-1,0.3101192
1225,glycine,3,4,18,25,"
Mutations in the glycine decarboxylase gene (GLDC) cause nonketotic hyperglycinemia (NKH), an in-born error of metabolism characterized by severe neurological disturbance.",10798358_1,-1,1225,-1,0.3514632
1226,nonketotic hyperglycinemia,10,12,58,84,"
Mutations in the glycine decarboxylase gene (GLDC) cause nonketotic hyperglycinemia (NKH), an in-born error of metabolism characterized by severe neurological disturbance.",10798358_1,-1,1226,-1,0.31547064
1227,neurological disturbance,24,26,147,171,"
Mutations in the glycine decarboxylase gene (GLDC) cause nonketotic hyperglycinemia (NKH), an in-born error of metabolism characterized by severe neurological disturbance.",10798358_1,-1,1227,-1,0.3313811
1228,GT-AG,9,10,53,58,"All donor and acceptor sites adhere to the canonical GT-AG rule, except for the donor site of intron 21, where a variant form GC is used instead of GT.",10798358_4,-1,1228,-1,0.38336748
1229,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1229,-1,0.4234307
1230,disease,8,9,47,54,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1230,-1,0.36932808
1231,hypotonia,12,13,82,91,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1231,-1,0.34619814
1232,hyperphagia,25,26,179,190,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1232,-1,0.3678434
1233,obesity,30,31,212,219,"
Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity.",10802660_1,-1,1233,-1,0.33507076
1234,map,6,7,43,46,"Five imprinted, paternally expressed genes map to the PWS region, MKRN3 (ref. 3), NDN (ref. 4), NDNL1 (ref. 5), SNRPN (refs 6-8) and IPW (ref. 9), as well as two poorly characterized framents designated PAR-1 and PAR-5 (ref. 10).",10802660_3,-1,1234,-1,0.42179695
1236,myotonic dystrophy,9,11,59,77,Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy.,10802667_0,-1,1236,-1,0.36735722
1237,myotonic dystrophy,22,24,112,130,"
Expansion of a CTG trinucleotide repeat in the 3 UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited disease characterized by skeletal muscle dystrophy and myotonia, cataracts and cardiac conduction defects.",10802667_1,-1,1237,-1,0.36954942
1238,disease,28,29,155,162,"
Expansion of a CTG trinucleotide repeat in the 3 UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited disease characterized by skeletal muscle dystrophy and myotonia, cataracts and cardiac conduction defects.",10802667_1,-1,1238,-1,0.3718241
1239,myotonia,35,36,210,218,"
Expansion of a CTG trinucleotide repeat in the 3 UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited disease characterized by skeletal muscle dystrophy and myotonia, cataracts and cardiac conduction defects.",10802667_1,-1,1239,-1,0.30410072
1242,myotonic dystrophy,28,30,166,184,"Targeted deletion of Dm15, the mouse orthologue of human DMPK, produced mice with a mild myopathy and cardiac conduction abnormalities, but without other features of myotonic dystrophy, such as myotonia and cataracts.",10802667_2,-1,1242,-1,0.32970047
1243,myotonia,33,34,194,202,"Targeted deletion of Dm15, the mouse orthologue of human DMPK, produced mice with a mild myopathy and cardiac conduction abnormalities, but without other features of myotonic dystrophy, such as myotonia and cataracts.",10802667_2,-1,1243,-1,0.3117929
1245,myotonic dystrophy,8,10,56,74,"To determine whether SIX5 deficiency contributes to the myotonic dystrophy phenotype, we disrupted mouse Six5 by replacing the first exon with a beta-galactosidase reporter.",10802667_4,-1,1245,-1,0.36822045
1247,myotonic dystrophy,12,14,82,100,"Our results suggest that SIX5 deficiency contributes to the cataract phenotype in myotonic dystrophy, and that myotonic dystrophy represents a multigenic disorder..",10802667_7,-1,1247,-1,0.3334693
1248,myotonic dystrophy,17,19,111,129,"Our results suggest that SIX5 deficiency contributes to the cataract phenotype in myotonic dystrophy, and that myotonic dystrophy represents a multigenic disorder..",10802667_7,-1,1248,-1,0.33214185
1250,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1250,-1,0.37329453
1251,DM,3,4,21,23,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1251,-1,0.37033743
1252,myotonia,16,17,101,109,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1252,-1,0.32225528
1253,cardiac arrhythmia,18,20,111,129,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1253,-1,0.34529632
1254,mental retardation,23,25,150,168,"
Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts.",10802668_1,-1,1254,-1,0.34568706
1256,DM,4,5,22,24,"The genetic defect in DM is a CTG repeat expansion located in the 3 untranslated region of DMPK and 5 of a homeodomain-encoding gene, SIX5 (formerly DMAHP; refs 2-5).",10802668_2,-1,1256,-1,0.34711903
1257,DM,11,12,64,66,There are three mechanisms by which CTG expansion can result in DM.,10802668_3,-1,1257,-1,0.3522645
1258,DM,21,22,124,126,Previous studies have demonstrated that a dose-dependent loss of Dm15 (the mouse DMPK homologue) in mice produces a partial DM phenotype characterized by decreased development of skeletal muscle force and cardiac conduction disorders.,10802668_7,-1,1258,-1,0.3720284
1259,DM,8,9,33,35,"To test the role of Six5 loss in DM, we have analysed a strain of mice in which Six5 was deleted.",10802668_8,-1,1259,-1,0.34428218
1261,Na,12,13,68,70,Six5 +/- and Six5-/- mice show increased steady-state levels of the Na +/K + -ATPase alpha-1 subunit and decreased Dm15 mRNA levels.,10802668_10,-1,1261,-1,0.37553263
1264,DM,8,9,52,54,"As ocular cataracts are a characteristic feature of DM, these results demonstrate that decreased SIX5 transcription is important in the aetiology of DM.",10802668_12,-1,1264,-1,0.32574606
1265,DM,23,24,149,151,"As ocular cataracts are a characteristic feature of DM, these results demonstrate that decreased SIX5 transcription is important in the aetiology of DM.",10802668_12,-1,1265,-1,0.32426405
1266,DM,6,7,37,39,Our data support the hypothesis that DM is a contiguous gene syndrome associated with the partial loss of both DMPK and SIX5..,10802668_13,-1,1266,-1,0.3342822
1267,syndrome,11,12,61,69,Our data support the hypothesis that DM is a contiguous gene syndrome associated with the partial loss of both DMPK and SIX5..,10802668_13,-1,1267,-1,0.35810074
1268,cerebellar dysfunction,20,22,123,145,"
Mutations in the gene ATM are responsible for the genetic disorder ataxia-telangiectasia (A-T), which is characterized by cerebellar dysfunction, radiosensitivity, chromosomal instability and cancer predisposition.",10802669_1,-1,1268,-1,0.38661444
1269,chromosomal instability,25,27,165,188,"
Mutations in the gene ATM are responsible for the genetic disorder ataxia-telangiectasia (A-T), which is characterized by cerebellar dysfunction, radiosensitivity, chromosomal instability and cancer predisposition.",10802669_1,-1,1269,-1,0.33472243
1271,chromosomal instability,10,12,68,91,"There are strong parallels between the pattern of radiosensitivity, chromosomal instability and cancer predisposition in A-T patients and that in patients with Nijmegen breakage syndrome (NBS).",10802669_3,-1,1271,-1,0.330418
1273,Nijmegen breakage syndrome,23,26,160,186,"There are strong parallels between the pattern of radiosensitivity, chromosomal instability and cancer predisposition in A-T patients and that in patients with Nijmegen breakage syndrome (NBS).",10802669_3,-1,1273,-1,0.3212042
1284,P,38,39,214,215,"RESULTS  Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs BRCA2-linked patients (54 vs 62 years; P =.",10807385_9,-1,1284,-1,0.4178973
1285,recurrence,23,24,153,163,"The hereditary group had a longer disease-free interval following primary chemotherapy in comparison with the nonhereditary group, with a median time to recurrence of 14 months and 7 months, respectively (P <. 001).",10807385_12,-1,1285,-1,0.3674992
1286,P,33,34,205,206,"The hereditary group had a longer disease-free interval following primary chemotherapy in comparison with the nonhereditary group, with a median time to recurrence of 14 months and 7 months, respectively (P <. 001).",10807385_12,-1,1286,-1,0.43036246
1288,P,13,14,91,92,Those with hereditary cancers had improved survival compared with the nonhereditary group (P =. 004).,10807385_13,-1,1288,-1,0.38755748
1290,P,14,15,84,85,"For stage III cancers, BRCA mutation status was an independent prognostic variable (P =. 03).",10807385_14,-1,1290,-1,0.40041402
1296,familial Mediterranean fever,3,6,13,41,"The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.",10807793_0,-1,1296,-1,0.3515119
1297,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever and neutrophil-mediated serosal inflammation.",10807793_1,-1,1297,-1,0.34958616
1300,interferon,9,10,66,76,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1300,-1,0.28019163
1301,IFN,11,12,78,81,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1301,-1,0.3403149
1302,tumor necrosis,15,17,90,104,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1302,-1,0.35899663
1303,lipopolysaccharide,20,21,117,135,"In vitro stimulation of monocytes with the proinflammatory agents interferon (IFN) gamma, tumor necrosis factor, and lipopolysaccharide induced MEFV expression, whereas the antiinflammatory cytokines interleukin (IL) 4, IL-10, and transforming growth factor beta inhibited such expression.",10807793_10,-1,1303,-1,0.32968178
1304,cycloheximide,9,10,61,74,Induction by IFN-gamma occurred rapidly and was resistant to cycloheximide.,10807793_11,-1,1304,-1,0.31573403
1305,N-acetylgalactosamine-6-sulfate,8,9,61,92,Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.,10814710_0,-1,1305,-1,0.39564636
1306,IVA,12,13,133,136,Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.,10814710_0,-1,1306,-1,0.35253137
1307,IVA,1,2,23,26,"
Mucopolysaccharidosis IVA (MPS IVA; OMIM # 253000), a lysosomal storage disorder caused by a deficiency of N -acetylgalactosamine-6-sulfate sulfatase (GALNS), has variable clinical phenotypes.",10814710_1,-1,1307,-1,0.35976094
1308,IVA,4,5,32,35,"
Mucopolysaccharidosis IVA (MPS IVA; OMIM # 253000), a lysosomal storage disorder caused by a deficiency of N -acetylgalactosamine-6-sulfate sulfatase (GALNS), has variable clinical phenotypes.",10814710_1,-1,1308,-1,0.3527964
1309,N,20,21,108,109,"
Mucopolysaccharidosis IVA (MPS IVA; OMIM # 253000), a lysosomal storage disorder caused by a deficiency of N -acetylgalactosamine-6-sulfate sulfatase (GALNS), has variable clinical phenotypes.",10814710_1,-1,1309,-1,0.41824
1310,IVA,14,15,76,79,"To date we have identified 65 missense mutations in the GALNS gene from MPS IVA patients, but the correlation between genotype and phenotype has remained unclear.",10814710_2,-1,1310,-1,0.33529985
1311,N -acetylgalacto-samine-4-sulfatase,17,19,101,136,"Thus, a tertiary structural model of human GALNS was constructed from the X-ray crystal structure of N -acetylgalacto-samine-4-sulfatase and arylsulfatase A, using homology modeling, and 32 missense mutations were investigated.",10814710_9,-1,1311,-1,0.4030042
1312,salt,37,38,189,193,"Consequently, we propose that there are at least three different reasons for the severe phenotype  (i) destruction of the hydrophobic core or modification of the packing; (ii) removal of a salt bridge to destabilize the entire conformation; (iii) modification of the active site.",10814710_10,-1,1312,-1,0.3658094
1313,contrast,1,2,3,11,"In contrast, mild mutations were mostly located on the surface of the GALNS protein.",10814710_11,-1,1313,-1,0.3652544
1314,IVA,11,12,78,81,These studies shed further light on the genotype-phenotype correlation of MPS IVA and structure-function relationship in the sulfatase family.,10814710_12,-1,1314,-1,0.3540886
1315,syndrome,17,18,117,125,"
Mutations at the ataxia-telangiectasia (A-T) locus on chromosome band 11q22 cause a distinctive autosomal recessive syndrome in homozygotes and predispose heterozygotes to cancer, ischemic heart disease, and early mortality.",10817650_1,-1,1315,-1,0.31263322
1317,ischemic heart disease,26,29,181,203,"
Mutations at the ataxia-telangiectasia (A-T) locus on chromosome band 11q22 cause a distinctive autosomal recessive syndrome in homozygotes and predispose heterozygotes to cancer, ischemic heart disease, and early mortality.",10817650_1,-1,1317,-1,0.35441563
1318,amino acid,5,7,29,39,Alterations of the length or amino acid composition of the A-T gene product affect the A-T clinical phenotype in different ways.,10817650_8,-1,1318,-1,0.34368676
1319,familial mediterranean fever,20,23,109,137,"Isolation, genomic organization, and expression analysis of the mouse and rat homologs of MEFV, the gene for familial mediterranean fever.",10818206_0,-1,1319,-1,0.35362837
1320,Familial Mediterranean fever,0,3,1,29,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10818206_1,-1,1320,-1,0.34602875
1322,serositis,16,17,100,109,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10818206_1,-1,1322,-1,0.30656236
1323,synovitis,18,19,113,122,"
Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis.",10818206_1,-1,1323,-1,0.3391121
1325,amino acid,2,4,15,25,A considerable amino acid sequence homology was observed between the mouse and human (47. 6% identity and 65.,10818206_5,-1,1325,-1,0.35384542
1326,zinc,18,19,113,117,"The predicted rodent proteins have several important domains and signals found in human pyrin, including a B-box zinc finger domain, Robbins-Dingwall nuclear localization signal, and coiled-coil domain.",10818206_7,-1,1326,-1,0.35033596
1327,Pelizaeus-Merzbacher disease,8,10,58,86,Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome.,10827108_0,-1,1327,-1,0.36322114
1328,Pelizaeus-Merzbacher disease,9,11,60,88,Mutations and duplications of this gene are associated with Pelizaeus-Merzbacher disease (PMD).,10827108_2,-1,1328,-1,0.37084615
1329,disease,31,32,174,181,"To do this, a collaborative screening study was set up that involved 39 institutions from 19 countries and included 3, 580 unrelated individuals with a family history of the disease and 934 early-onset breast and/or ovarian cancer cases.",10827109_4,-1,1329,-1,0.3768761
1331,disease,5,6,25,32,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1331,-1,0.31731898
1332,tumor syndrome,9,11,49,63,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1332,-1,0.309469
1333,hemangioblastoma,18,19,128,144,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1333,-1,0.3083404
1334,pheochromocytoma,27,28,187,203,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1334,-1,0.34013346
1335,renal cell carcinoma,29,32,205,225,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1335,-1,0.3040191
1336,cysts,34,35,231,236,"
Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome characterized by predisposition for bilateral and multi-centric hemangioblastoma in the retina and central nervous system, pheochromocytoma, renal cell carcinoma, and cysts in the kidney, pancreas, and epididymis.",10830910_1,-1,1336,-1,0.36779732
1337,disease,32,33,190,197,Our results show that (quantitative) Southern blot analysis is a sensitive method for detecting germline deletions of the VHL gene and should be implemented in routine DNA diagnosis for VHL disease.,10830910_6,-1,1337,-1,0.2986507
1338,pheochromocytoma,18,19,115,131,Our data support the previously established observation that families with a germline deletion have a low risk for pheochromocytoma.,10830910_7,-1,1338,-1,0.30108866
1339,disease,7,8,61,68,Further unraveling of genotype-phenotype correlations in VHL disease has revealed that families with a full or partial deletion of the VHL gene exhibit a phenotype with a preponderance of central nervous system hemangioblastoma..,10830910_8,-1,1339,-1,0.3644206
1340,hemangioblastoma,32,33,211,227,Further unraveling of genotype-phenotype correlations in VHL disease has revealed that families with a full or partial deletion of the VHL gene exhibit a phenotype with a preponderance of central nervous system hemangioblastoma..,10830910_8,-1,1340,-1,0.3188488
1341,Friedreich ataxia,10,12,61,78,Age of the intronic GAA triplet repeat expansion mutation in Friedreich ataxia.,10830915_0,-1,1341,-1,0.3421978
1342,Friedreich ataxia,0,2,1,18,"
Friedreich ataxia (FRDA), the most frequently inherited ataxia, is due in the vast majority of cases to a large expansion of an intronic GAA repeat.",10830915_1,-1,1342,-1,0.3653094
1344,Nijmegen breakage syndrome,5,8,50,76,Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.,10839544_0,-1,1344,-1,0.33686242
1345,Nijmegen breakage syndrome,5,8,33,59,"
Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are recessive genetic disorders with susceptibility to cancer and similar cellular phenotypes.",10839544_1,-1,1345,-1,0.34931383
1347,Nijmegen breakage syndrome,9,12,58,84,The NBS1 protein is specifically mutated in patients with Nijmegen breakage syndrome and forms a complex with the DNA repair proteins Rad50 and Mrel1.,10839544_3,-1,1347,-1,0.34081906
1349,diseases,21,22,140,148,"Together, these results demonstrate a biochemical link between cell-cycle checkpoints activated by DNA damage and DNA repair in two genetic diseases with overlapping phenotypes..",10839544_8,-1,1349,-1,0.33890474
1350,microcephaly,6,7,38,50,"Homozygosity mapping in a family with microcephaly, mental retardation, and short stature to a Cohen syndrome region on 8q21.3-8q22.1: redefining a clinical entity.",10842298_0,-1,1350,-1,0.3376544
1351,mental retardation,8,10,52,70,"Homozygosity mapping in a family with microcephaly, mental retardation, and short stature to a Cohen syndrome region on 8q21.3-8q22.1: redefining a clinical entity.",10842298_0,-1,1351,-1,0.3272133
1352,Cohen syndrome,16,18,95,109,"Homozygosity mapping in a family with microcephaly, mental retardation, and short stature to a Cohen syndrome region on 8q21.3-8q22.1: redefining a clinical entity.",10842298_0,-1,1352,-1,0.36723796
1353,syndrome,1,2,3,11,"
A syndrome of microcephaly, progressive postnatal growth deficiency, and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent.",10842298_1,-1,1353,-1,0.3493018
1354,microcephaly,3,4,15,27,"
A syndrome of microcephaly, progressive postnatal growth deficiency, and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent.",10842298_1,-1,1354,-1,0.33735472
1355,mental retardation,11,13,74,92,"
A syndrome of microcephaly, progressive postnatal growth deficiency, and mental retardation was observed in two brothers and their cousin from a multiply consanguineous kindred of Lebanese descent.",10842298_1,-1,1355,-1,0.33073315
1356,Hypotonia,0,1,0,9,"Hypotonia, chorioretinal dystrophy, and myopia were also identified.",10842298_2,-1,1356,-1,0.35203943
1357,myopia,6,7,40,46,"Hypotonia, chorioretinal dystrophy, and myopia were also identified.",10842298_2,-1,1357,-1,0.37854263
1358,mental retardation,12,14,69,87,"Because of absence of a distinctive facial appearance, the degree of mental retardation, and short stature, the initially considered clinical diagnosis of Cohen syndrome was withdrawn and a novel genetic entity was assumed.",10842298_4,-1,1358,-1,0.31399557
1359,Cohen syndrome,25,27,155,169,"Because of absence of a distinctive facial appearance, the degree of mental retardation, and short stature, the initially considered clinical diagnosis of Cohen syndrome was withdrawn and a novel genetic entity was assumed.",10842298_4,-1,1359,-1,0.304957
1360,Cohen syndrome,13,15,85,99,"Intriguingly enough, the identified gene region overlaps the refined gene region for Cohen syndrome (COH1) [Kolehmainen et al., 1997  Euro J Hum Genet 5  206-213].",10842298_10,-1,1360,-1,0.3459093
1361,Cohen syndrome,14,16,91,105,This fact encourages the hypothesis that the described kindred segregates for a variant of Cohen syndrome and suggests a redefinition of its phenotype,10842298_11,-1,1361,-1,0.3018923
1362,spondylitis,9,10,71,82,Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.,10861282_0,-1,1362,-1,0.32622978
1363,spondylitis,1,2,12,23,"
Ankylosing spondylitis (AS) is a common and highly familial rheumatic disorder.",10861282_1,-1,1363,-1,0.32778618
1364,recurrence,2,3,12,22,The sibling recurrence risk ratio for the disease is 63 and heritability assessed in twins > 90%.,10861282_2,-1,1364,-1,0.3731078
1365,disease,7,8,42,49,The sibling recurrence risk ratio for the disease is 63 and heritability assessed in twins > 90%.,10861282_2,-1,1365,-1,0.35039788
1366,disease,19,20,90,97,"Although MHC genes, including HLA-B27, contribute only 20-50% of the genetic risk for the disease, no non-MHC gene has yet been convincingly demonstrated to influence either susceptibility to the disease or its phenotypic expression.",10861282_3,-1,1366,-1,0.35693586
1367,disease,35,36,196,203,"Although MHC genes, including HLA-B27, contribute only 20-50% of the genetic risk for the disease, no non-MHC gene has yet been convincingly demonstrated to influence either susceptibility to the disease or its phenotypic expression.",10861282_3,-1,1367,-1,0.34950483
1368,debrisoquine,29,30,160,172,"Previous linkage and association studies have suggested the presence of a susceptibility gene for AS close to, or within, the cytochrome P450 2D6 gene (CYP2D6, debrisoquine hydroxylase) located at chromosome 22q13.1.",10861282_4,-1,1368,-1,0.40724537
1369,Pendred syndrome,15,17,105,121,Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4).,10861298_0,-1,1369,-1,0.31406385
1370,hearing loss,19,21,140,152,Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4).,10861298_0,-1,1370,-1,0.31463724
1371,chloride,20,21,112,120,"
The PDS gene encodes a transmembrane protein, known as pendrin, which functions as a transporter of iodide and chloride.",10861298_1,-1,1371,-1,0.33720183
1372,Pendred syndrome,7,9,43,59,Mutations in this gene are responsible for Pendred syndrome and autosomal recessive non-syndromic hearing loss at the DFNB4 locus on chromosome 7q31.,10861298_2,-1,1372,-1,0.33664984
1373,hearing loss,13,15,98,110,Mutations in this gene are responsible for Pendred syndrome and autosomal recessive non-syndromic hearing loss at the DFNB4 locus on chromosome 7q31.,10861298_2,-1,1373,-1,0.3384836
1374,hearing loss,11,13,70,82,A screen of 20 individuals from the midwestern USA with non-syndromic hearing loss and dilated vestibular aqueducts identified three people (15%) with PDS mutations.,10861298_3,-1,1374,-1,0.35803774
1375,Pendred syndrome,8,10,55,71,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1375,-1,0.33900812
1376,hearing loss,19,21,145,157,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1376,-1,0.3365968
1377,Pendred syndrome,26,28,184,200,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1377,-1,0.38134995
1378,hearing loss,49,51,316,328,"To determine whether PDS mutations in individuals with Pendred syndrome differ functionally from PDS mutations in individuals with non-syndromic hearing loss, we compared three common Pendred syndrome allele variants (L236P, T416P and E384G), with three PDS mutations reported only in individuals with non-syndromic hearing loss (V480D, V653A and I490L/G497S).",10861298_4,-1,1378,-1,0.3320862
1379,Pendred syndrome,4,6,30,46,"The mutations associated with Pendred syndrome have complete loss of pendrin-induced chloride and iodide transport, while alleles unique to people with DFNB4 are able to transport both iodide and chloride, albeit at a much lower level than wild-type pendrin.",10861298_5,-1,1379,-1,0.35360494
1380,chloride,11,12,85,93,"The mutations associated with Pendred syndrome have complete loss of pendrin-induced chloride and iodide transport, while alleles unique to people with DFNB4 are able to transport both iodide and chloride, albeit at a much lower level than wild-type pendrin.",10861298_5,-1,1380,-1,0.38396737
1381,chloride,30,31,196,204,"The mutations associated with Pendred syndrome have complete loss of pendrin-induced chloride and iodide transport, while alleles unique to people with DFNB4 are able to transport both iodide and chloride, albeit at a much lower level than wild-type pendrin.",10861298_5,-1,1381,-1,0.32004625
1382,goiter,18,19,111,117,We hypothesize that this residual level of anion transport is sufficient to eliminate or postpone the onset of goiter in individuals with DFNB4.,10861298_6,-1,1382,-1,0.3188556
1383,disease,23,24,133,140,"
Germline mutations are the major source of genetic variation that allows a species to evolve over time but at the cost of Mendelian disease and genetic predisposition to multifactorial diseases.",10874302_1,-1,1383,-1,0.36229107
1384,diseases,29,30,186,194,"
Germline mutations are the major source of genetic variation that allows a species to evolve over time but at the cost of Mendelian disease and genetic predisposition to multifactorial diseases.",10874302_1,-1,1384,-1,0.3337413
1385,hemophilia B,13,15,69,81,"Here, we compare the pattern of germline mutation in a population of hemophilia B patients from Mainland China (n = 66) to that in U. S. Caucasians, Blacks, and Mexican Hispanics and stratify by disease severity and ethnicity.",10874302_3,-1,1385,-1,0.3146192
1386,n,20,21,112,113,"Here, we compare the pattern of germline mutation in a population of hemophilia B patients from Mainland China (n = 66) to that in U. S. Caucasians, Blacks, and Mexican Hispanics and stratify by disease severity and ethnicity.",10874302_3,-1,1386,-1,0.3760402
1387,disease,39,40,195,202,"Here, we compare the pattern of germline mutation in a population of hemophilia B patients from Mainland China (n = 66) to that in U. S. Caucasians, Blacks, and Mexican Hispanics and stratify by disease severity and ethnicity.",10874302_3,-1,1387,-1,0.34570786
1389,autoimmune lymphoproliferative syndrome,18,21,142,181,"
Heterozygous mutations encoding abnormal forms of the death receptor Fas dominantly interfere with Fas-induced lymphocyte apoptosis in human autoimmune lymphoproliferative syndrome.",10875918_1,-1,1389,-1,0.33869916
1390,disease,19,20,136,143,These results show that formation of preassociated receptor complexes is necessary for Fas signaling and dominant interference in human disease..,10875918_4,-1,1390,-1,0.3136316
1391,Wiskott-Aldrich syndrome,6,8,40,64,Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells.,10878391_0,-1,1391,-1,0.3555239
1392,Wiskott-Aldrich syndrome,13,15,96,120,Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells.,10878391_0,-1,1392,-1,0.3580292
1393,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS) is caused by defects in the WAS protein (WASP) gene on the X chromosome.",10878391_1,-1,1393,-1,0.36135316
1394,contrast,1,2,3,11,"In contrast, lymphocytes from all the carriers except two lacked the WASPdim population.",10878391_7,-1,1394,-1,0.35620627
1395,retinal degeneration,7,9,60,80,Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy.,10888879_0,-1,1395,-1,0.36879098
1396,retinitis pigmentosa,18,20,117,137,"Mutations in Prph2 have been shown to result in a variety of photoreceptor dystrophies, including autosomal dominant retinitis pigmentosa and macular dystrophy.",10888879_3,-1,1396,-1,0.35462245
1397,diseases,5,6,26,34,"A common feature of these diseases is the loss of photoreceptor function, also seen in the retinal degeneration slow (rds or Prph2 Rd2/Rd2) mouse, which is homozygous for a null mutation in Prph2.",10888879_4,-1,1397,-1,0.34816784
1398,retinal degeneration,17,19,91,111,"A common feature of these diseases is the loss of photoreceptor function, also seen in the retinal degeneration slow (rds or Prph2 Rd2/Rd2) mouse, which is homozygous for a null mutation in Prph2.",10888879_4,-1,1398,-1,0.38019496
1399,afibrinogenemia,14,15,88,103,Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.,10891444_0,-1,1399,-1,0.3415478
1400,afibrinogenemia,1,2,12,27,"
Congenital afibrinogenemia is a rare, autosomal, recessive disorder characterized by the complete absence of detectable fibrinogen.",10891444_1,-1,1400,-1,0.36137813
1401,afibrinogenemia,5,6,21,36,"Consequently, 86% of afibrinogenemia alleles analyzed to date have truncating mutations of FGA, though mutations in all 3 fibrinogen genes, FGG, FGA, and FGB, might be predicted to cause congenital afibrinogenemia..",10891444_9,-1,1401,-1,0.36004096
1402,afibrinogenemia,37,38,198,213,"Consequently, 86% of afibrinogenemia alleles analyzed to date have truncating mutations of FGA, though mutations in all 3 fibrinogen genes, FGG, FGA, and FGB, might be predicted to cause congenital afibrinogenemia..",10891444_9,-1,1402,-1,0.32798
1403,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.,10911990_0,-1,1403,-1,0.3914115
1404,n,7,8,30,31,"
The mechanism by which (CTG) n expansion in the 3 UTR of the DMPK gene causes myotonic dystrophy (DM) is unknown.",10911990_1,-1,1404,-1,0.41840005
1405,myotonic dystrophy,18,20,79,97,"
The mechanism by which (CTG) n expansion in the 3 UTR of the DMPK gene causes myotonic dystrophy (DM) is unknown.",10911990_1,-1,1405,-1,0.38958845
1406,DM,21,22,99,101,"
The mechanism by which (CTG) n expansion in the 3 UTR of the DMPK gene causes myotonic dystrophy (DM) is unknown.",10911990_1,-1,1406,-1,0.38543025
1407,C,8,9,47,48,"We identified four RNA splicing factors--hnRNP C, U2AF (U2 auxiliary factor), PTB (polypyrimidine tract binding protein), and PSF (PTB associated splicing factor) --that bind to two short regions 3 of the (CUG) n, and found a novel 3 DMPK exon resulting in an mRNA lacking the repeats.",10911990_2,-1,1407,-1,0.35222614
1408,n,45,46,211,212,"We identified four RNA splicing factors--hnRNP C, U2AF (U2 auxiliary factor), PTB (polypyrimidine tract binding protein), and PSF (PTB associated splicing factor) --that bind to two short regions 3 of the (CUG) n, and found a novel 3 DMPK exon resulting in an mRNA lacking the repeats.",10911990_2,-1,1408,-1,0.3804117
1409,n,7,8,26,27,We propose that the (CUG) n is an essential cis acting element for this splicing event.,10911990_3,-1,1409,-1,0.38288245
1410,contrast,1,2,3,11,"In contrast to (CUG) n containing mRNAs, the novel isoform is not retained in the nucleus in DM cells, resulting in imbalances in relative levels of cytoplasmic DMPK mRNA isoforms and a new dominant effect of the mutation on DMPK..",10911990_4,-1,1410,-1,0.37945533
1411,n,6,7,21,22,"In contrast to (CUG) n containing mRNAs, the novel isoform is not retained in the nucleus in DM cells, resulting in imbalances in relative levels of cytoplasmic DMPK mRNA isoforms and a new dominant effect of the mutation on DMPK..",10911990_4,-1,1411,-1,0.40956804
1412,DM,20,21,93,95,"In contrast to (CUG) n containing mRNAs, the novel isoform is not retained in the nucleus in DM cells, resulting in imbalances in relative levels of cytoplasmic DMPK mRNA isoforms and a new dominant effect of the mutation on DMPK..",10911990_4,-1,1412,-1,0.3306389
1413,Prader-willi syndrome,9,11,54,75,Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype.,10915770_0,-1,1413,-1,0.3970084
1414,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13.",10915770_1,-1,1414,-1,0.4067702
1415,hypotonia,4,5,38,47,"Affected individuals exhibit neonatal hypotonia, developmental delay and childhood-onset obesity.",10915770_2,-1,1415,-1,0.33627427
1416,obesity,10,11,89,96,"Affected individuals exhibit neonatal hypotonia, developmental delay and childhood-onset obesity.",10915770_2,-1,1416,-1,0.34004724
1417,amino acid,20,22,83,93,"In this study, we have characterized MAGEL2 (also known as NDNL1), a gene with 51% amino acid sequence similarity to necdin and located 41 kb distal to NDN in the PWS deletion region.",10915770_4,-1,1417,-1,0.37311557
1418,retinoschisis,4,5,28,41,"Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells.",10915776_0,-1,1418,-1,0.31450206
1419,retinoschisis,1,2,10,23,"
X-linked retinoschisis is characterized by microcystic-like changes of the macular region and schisis within the inner retinal layers, leading to visual deterioration in males.",10915776_1,-1,1419,-1,0.31823254
1420,amino acid,4,6,18,28,"RS1 encodes a 224 amino acid protein, retinoschisin, which contains a discoidin domain but is of unknown function.",10915776_3,-1,1420,-1,0.39797115
1421,dithiothreitol,29,30,181,195,"We have generated a polyclonal antibody against a peptide from a unique region within retinoschisin, which detects a protein of approximately 28 kDa in retinal samples reduced with dithiothreitol, but multimers sized > 40 kDa under non-reducing conditions.",10915776_4,-1,1421,-1,0.3265587
1422,retinoblastoma,3,4,28,42,"Furthermore, differentiated retinoblastoma cells (Weri-Rb1 cells) were found to express RS1 mRNA and to release retinoschisin.",10915776_8,-1,1422,-1,0.29923755
1423,retinoschisis,3,4,15,28,"Thus, X-linked retinoschisis is caused by abnormalities in a putative secreted photoreceptor protein and is the first example of a secreted photo-receptor protein associated with a retinal dystrophy..",10915776_10,-1,1423,-1,0.31996182
1424,sodium,4,5,27,33,Study of the voltage-gated sodium channel beta 1 subunit gene (SCN1B) in the benign familial infantile convulsions syndrome (BFIC).,10923035_0,-1,1424,-1,0.39581922
1425,convulsions syndrome,18,20,103,123,Study of the voltage-gated sodium channel beta 1 subunit gene (SCN1B) in the benign familial infantile convulsions syndrome (BFIC).,10923035_0,-1,1425,-1,0.32215002
1427,epilepsy syndrome,12,14,75,92,"
Benign familial infantile convulsions (BFIC) is a rare autosomal dominant epilepsy syndrome.",10923035_1,-1,1427,-1,0.32453522
1428,syndrome,1,2,5,13,This syndrome has been recently described in Italian and French pedigrees.,10923035_2,-1,1428,-1,0.34546998
1429,generalized seizures,6,8,36,56,"Patients present with partial, then generalized seizures, with onset at age three months.",10923035_3,-1,1429,-1,0.29994306
1431,sodium,1,2,4,10,"The sodium channel beta1 subunit gene (SCN1B) maps to this candidate region and has been shown to be involved in one Australian pedigree with generalized epilepsy and febrile seizures "" plus "" (GEFS +).",10923035_6,-1,1431,-1,0.3931412
1434,attenuated familial adenomatous polyposis,16,20,111,152,Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.,10924409_0,-1,1434,-1,0.3033954
1435,adenomatous polyposis coli,4,7,27,53,"
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in familial adenomatous polyposis (FAP).",10924409_1,-1,1435,-1,0.3312769
1437,colorectal cancer,14,16,102,119,Patients with FAP typically develop hundreds to thousands of benign colorectal tumors and early-onset colorectal cancer.,10924409_2,-1,1437,-1,0.26643774
1443,Friedreich ataxia,9,11,77,94,Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia.,10930361_0,-1,1443,-1,0.3662309
1444,Friedreich ataxia,7,9,45,62,"
Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiodegenerative and neurodegenerative disease.",10930361_1,-1,1444,-1,0.34464657
1445,neurodegenerative disease,18,20,117,142,"
Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiodegenerative and neurodegenerative disease.",10930361_1,-1,1445,-1,0.32830283
1446,iron,13,14,86,90,Genetic inactivation of the yeast frataxin homologue (Yfh1p) results in mitochondrial iron accumulation and hypersensitivity to oxidative stress.,10930361_3,-1,1446,-1,0.34059858
1448,iron,1,2,10,14,Increased iron deposition and evidence of oxidative damage have also been observed in cardiac tissue and cultured fibroblasts from patients with FRDA.,10930361_4,-1,1448,-1,0.3313892
1449,iron,9,10,69,73,These findings indicate that frataxin is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals.,10930361_5,-1,1449,-1,0.349181
1450,free radicals,17,19,132,145,These findings indicate that frataxin is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals.,10930361_5,-1,1450,-1,0.3573137
1451,Da,10,11,46,48,"Isolated mYfh1p is a soluble monomer (13, 783 Da) that contains no iron and shows no significant tendency to self-associate.",10930361_8,-1,1451,-1,0.37111866
1452,iron,15,16,67,71,"Isolated mYfh1p is a soluble monomer (13, 783 Da) that contains no iron and shows no significant tendency to self-associate.",10930361_8,-1,1452,-1,0.32988653
1453,iron,4,5,28,32,Aerobic addition of ferrous iron to mYfh1p results in assembly of regular spherical multimers with a molecular mass of approximately 1. 1 MDa (megadaltons) and a diameter of 13 +/-2 nm.,10930361_9,-1,1453,-1,0.30962077
1454,MDa,23,24,138,141,Aerobic addition of ferrous iron to mYfh1p results in assembly of regular spherical multimers with a molecular mass of approximately 1. 1 MDa (megadaltons) and a diameter of 13 +/-2 nm.,10930361_9,-1,1454,-1,0.33835602
1455,iron,16,17,88,92,"Each multimer consists of approximately 60 subunits and can sequester > 3, 000 atoms of iron.",10930361_10,-1,1455,-1,0.3327643
1456,iron,5,6,36,40,Titration of mYfh1p with increasing iron concentrations supports a stepwise mechanism of multimer assembly.,10930361_11,-1,1456,-1,0.3116739
1457,iron,4,5,26,30,"Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form.",10930361_12,-1,1457,-1,0.33382547
1458,iron,13,14,85,89,"Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form.",10930361_12,-1,1458,-1,0.33867687
1459,iron,26,27,178,182,"Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form.",10930361_12,-1,1459,-1,0.3250486
1460,Fe,6,7,23,25,"After addition of (55) Fe to the medium, immunoprecipitates of this species contain > 16 atoms of (55) Fe per molecule of mYfh1p.",10930361_14,-1,1460,-1,0.30857387
1461,Fe,23,24,103,105,"After addition of (55) Fe to the medium, immunoprecipitates of this species contain > 16 atoms of (55) Fe per molecule of mYfh1p.",10930361_14,-1,1461,-1,0.3138761
1462,iron,16,17,127,131,We propose that iron-dependent self-assembly of recombinant mYfh1p reflects a physiological role for frataxin in mitochondrial iron sequestration and bioavailability..,10930361_15,-1,1462,-1,0.32439885
1463,faciogenital dysplasia,19,21,93,115,A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).,10930571_0,-1,1463,-1,0.3210665
1464,syndrome,23,24,131,139,A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).,10930571_0,-1,1464,-1,0.29785576
1465,Syndrome,1,2,15,23,"
Aarskog-Scott Syndrome (AAS) is an X-linked disorder characterised by short stature and multiple facial, limb and genital abnormalities.",10930571_1,-1,1465,-1,0.2907801
1466,nucleotide,27,28,138,148,"A gene, FGD1, altered in a patient with AAS phenotype, has been identified and found to encode a protein with homology to Rho/Rac guanine nucleotide exchange factors (Rho/Rac GEF).",10930571_2,-1,1466,-1,0.3970861
1467,nucleotide,9,10,51,61,One patient presented a mutation that results in a nucleotide change in exon 10 of the FGD1 gene (G2559 > A) substituting a Gln for Arg in position 610.,10930571_5,-1,1467,-1,0.36299172
1468,tyrosine,9,10,49,57,The same residue is often mutated in the Brutons tyrosine kinase (Btk) gene in patients with an X-linked agammaglobulinemia.,10930571_8,-1,1468,-1,0.34531456
1469,agammaglobulinemia,20,21,105,123,The same residue is often mutated in the Brutons tyrosine kinase (Btk) gene in patients with an X-linked agammaglobulinemia.,10930571_8,-1,1469,-1,0.29915562
1470,diseases,31,32,177,185,The Arg610Gln mutation represents the first case of a mutation in the PH domain of the FGD1 gene and additional evidence that mutations in PH domains can be associated to human diseases..,10930571_9,-1,1470,-1,0.33188877
1472,Huntington disease,0,2,1,19,"
Huntington disease (HD) is caused by expansion of a glutamine repeat in the amino-terminal region of huntingtin.",10932179_1,-1,1472,-1,0.35757753
1473,glutamine,11,12,53,62,"
Huntington disease (HD) is caused by expansion of a glutamine repeat in the amino-terminal region of huntingtin.",10932179_1,-1,1473,-1,0.38460684
1474,neuronal loss,9,11,71,84,"Despite its widespread expression, mutant huntingtin induces selective neuronal loss in striatal neurons.",10932179_2,-1,1474,-1,0.35270384
1475,glutamate,11,12,80,89,N-terminal mutant huntingtin also binds to synaptic vesicles and inhibits their glutamate uptake in vitro.,10932179_5,-1,1475,-1,0.37360856
1480,adenomatous polyposis coli,1,4,5,31,"
The adenomatous polyposis coli gene (APC) is mutated in familial adenomatous polyposis and in sporadic colorectal tumors.",10947987_1,-1,1480,-1,0.35153076
1482,nucleotide,18,19,105,115,"Here the APC gene product is shown to bind through its armadillo repeat domain to a Rac-specific guanine nucleotide exchange factor (GEF), termed Asef.",10947987_2,-1,1482,-1,0.40886363
1483,Colorectal Cancer,16,18,112,129,"
The axonal chemoattractant netrin-1 guides spinal commissural axons by activating its receptor DCC (Deleted in Colorectal Cancer ).",10958786_1,-1,1483,-1,0.30989692
1484,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.,10976074_0,-1,1484,-1,0.3840195
1485,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM), the most common form of muscular dystrophy in adult humans, results from expansion of a CTG repeat in the 3 untranslated region of the DMPK gene.",10976074_1,-1,1485,-1,0.3747691
1486,DM,3,4,21,23,"
Myotonic dystrophy (DM), the most common form of muscular dystrophy in adult humans, results from expansion of a CTG repeat in the 3 untranslated region of the DMPK gene.",10976074_1,-1,1486,-1,0.39517033
1487,muscular dystrophy,11,13,50,68,"
Myotonic dystrophy (DM), the most common form of muscular dystrophy in adult humans, results from expansion of a CTG repeat in the 3 untranslated region of the DMPK gene.",10976074_1,-1,1487,-1,0.35008308
1488,myotonia,7,8,51,59,"Mice that expressed expanded CUG repeats developed myotonia and myopathy, whereas mice expressing a nonexpanded repeat did not.",10976074_4,-1,1488,-1,0.34311572
1490,DM,12,13,73,75,"Thus, transcripts with expanded CUG repeats are sufficient to generate a DM phenotype.",10976074_5,-1,1490,-1,0.39315617
1491,disease,11,12,56,63,This result supports a role for RNA gain of function in disease pathogenesis..,10976074_6,-1,1491,-1,0.37485838
1492,adenomatous polyposis coli,4,7,27,53,"
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in the hereditary colorectal cancer syndrome familial adenomatous polyposis (FAP).",10982189_1,-1,1492,-1,0.3370376
1493,colorectal cancer syndrome,16,19,107,133,"
Germline mutations of the adenomatous polyposis coli (APC) tumor-suppressor gene result in the hereditary colorectal cancer syndrome familial adenomatous polyposis (FAP).",10982189_1,-1,1493,-1,0.28807586
1494,episodic ataxia,0,2,0,15,"episodic ataxia type 2 (EA-2), familial hemiplegic migraine (FHM) and spinocerebellar ataxia 6 (SCA6).",10987655_2,-1,1494,-1,0.3639727
1495,familial hemiplegic migraine,8,11,31,59,"episodic ataxia type 2 (EA-2), familial hemiplegic migraine (FHM) and spinocerebellar ataxia 6 (SCA6).",10987655_2,-1,1495,-1,0.29767853
1497,amino acid,7,9,39,49,The consequence of this mutation is an amino acid substitution at a highly conserved position within the CACNA1A gene.,10987655_8,-1,1497,-1,0.3698567
1501,serum albumin,8,10,59,72,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1501,-1,0.36111826
1502,arterial hypotension,32,34,205,225,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1502,-1,0.37454173
1503,sodium,47,48,309,315,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1503,-1,0.4061639
1504,chloride,49,50,320,328,"Apparent compensatory mechanisms which come into play when serum albumin is low include prolonged half-life of albumin and transferrin, an increase in serum globulins, beta lipoprotein, and glycoproteins, arterial hypotension with reduced capillary hydrostatic pressure, and the ability to respond with rapid sodium and chloride diuresis in response to small volume changes.",1127526_3,-1,1504,-1,0.37990144
1505,amino acids,3,5,22,33,"Examination of plasma amino acids, an investigation not previously reported, revealed an extremely low plasma tryptophan level, a finding which may be important in view of the role of tryptophan in albumin synthesis..",1127526_4,-1,1505,-1,0.35414848
1506,tryptophan,17,18,110,120,"Examination of plasma amino acids, an investigation not previously reported, revealed an extremely low plasma tryptophan level, a finding which may be important in view of the role of tryptophan in albumin synthesis..",1127526_4,-1,1506,-1,0.3409117
1507,tryptophan,32,33,184,194,"Examination of plasma amino acids, an investigation not previously reported, revealed an extremely low plasma tryptophan level, a finding which may be important in view of the role of tryptophan in albumin synthesis..",1127526_4,-1,1507,-1,0.30598736
1508,Histidinemia,0,1,0,12,Histidinemia.,1146783_0,-1,1508,-1,0.33734494
1509,histidinemia,10,11,39,51,"
Two brothers, 6 and 13 years old, had histidinemia.",1146783_2,-1,1509,-1,0.31221735
1510,disease,21,22,118,125,"On the basis of clinical and biochemical observations, the younger boy was considered to have a classical type of the disease, while the older boy had an atypical form characterized by partial impairment of the skin histidase activity and a moderately prolonged half-life of blood histidine.",1146783_3,-1,1510,-1,0.3488365
1511,pyruvate,3,4,21,29,Carrier detection of pyruvate carboxylase deficiency in fibroblasts and lymphocytes.,116187_0,-1,1511,-1,0.33730915
1512,Pyruvate,0,1,1,9,"
Pyruvate carboxylase (E. C. 6. 4. 1. 1) activity was determined in the circulating peripheral lymphocytes and cultured skin fibroblasts from the family of a patient with hepatic, cerebral, renal cortical, leukocyte, and fibroblast pyruvate carboxylase deficiency (PC Portland deficiency).",116187_1,-1,1512,-1,0.34418666
1513,pyruvate,43,44,232,240,"
Pyruvate carboxylase (E. C. 6. 4. 1. 1) activity was determined in the circulating peripheral lymphocytes and cultured skin fibroblasts from the family of a patient with hepatic, cerebral, renal cortical, leukocyte, and fibroblast pyruvate carboxylase deficiency (PC Portland deficiency).",116187_1,-1,1513,-1,0.33193952
1514,disease,5,6,32,39,These data demonstrate that the disease is inherited in an autosomal recessive manner and that lymphocytes and fibroblasts can be used to detect carriers.,116187_4,-1,1514,-1,0.35114405
1515,pyruvate,1,2,8,16,Neither pyruvate carboxylase nor mitochondrial PEPCK activity in lymphocytes was increased by a 21-hr fast.,116187_5,-1,1515,-1,0.32847092
1518,chromosome breakage,11,13,81,100,Skin fibroblasts of affected individuals showed several orders of magnitude more chromosome breakage than lymphocytes.,1222588_4,-1,1518,-1,0.3305794
1519,Wolman disease,3,5,22,36,Prenatal diagnosis of Wolman disease.,122435_0,-1,1519,-1,0.36813095
1520,Wolman disease,5,7,29,43,"
Two pregnancies at risk for Wolman disease were monitored by assay and electrophoresis of acid lipase in cultured amniotic-fluid cells.",122435_1,-1,1520,-1,0.37176955
1521,Wolman disease,20,22,117,131,"Electrophoresis of cell extracts revealed the absence of the A form of acid lipase, consistent with the diagnosis of Wolman disease.",122435_3,-1,1521,-1,0.3488989
1522,Wolman disease,8,10,51,65,The results suggest that the prenatal diagnosis of Wolman disease be made using the radioassay of acid lipase and/or electrophoresis..,122435_8,-1,1522,-1,0.34060413
1523,neoplasms,1,2,10,19,Malignant neoplasms in the families of patients with ataxia-telangiectasia.,1248000_0,-1,1523,-1,0.32656118
1524,syndrome,8,9,55,63,"
Ataxia-telangiectasia (A-T) is an autosomal recessive syndrome associated with a greatly increased incidence of malignant neoplasms in homozygous affected individuals.",1248000_1,-1,1524,-1,0.32534975
1525,neoplasms,17,18,123,132,"
Ataxia-telangiectasia (A-T) is an autosomal recessive syndrome associated with a greatly increased incidence of malignant neoplasms in homozygous affected individuals.",1248000_1,-1,1525,-1,0.28560838
1528,neoplasms,12,13,67,76,"For this reason, we compared the incidence of death from malignant neoplasms in 2 families of patients with A-T to that expected in a random sample of the general population.",1248000_4,-1,1528,-1,0.2955625
1530,neoplasms,6,7,36,45,"There were 59 deaths from malignant neoplasms in relatives dying before age 75, compared to 42.",1248000_5,-1,1530,-1,0.27868617
1531,p,3,4,12,13,6 expected (p less than 0. 02).,1248000_6,-1,1531,-1,0.3991935
1532,neoplasm,15,16,78,86,"For A-T heterozygotes younger than age 45, the risk of dying from a malignant neoplasm was estimated to be greater than 5 times the risk for the general population.",1248000_7,-1,1532,-1,0.28542197
1534,leukemia,13,14,72,80,"The incidence of ovarian, gastric, and biliary system carcinomas and of leukemia and lymphoma was increased in these A-T families.",1248000_9,-1,1534,-1,0.2935907
1535,lymphoma,15,16,85,93,"The incidence of ovarian, gastric, and biliary system carcinomas and of leukemia and lymphoma was increased in these A-T families.",1248000_9,-1,1535,-1,0.27104792
1536,neoplasms,1,2,6,15,"Other neoplasms that may be associated with this gene in heterozygotes include pancreatic, basal cell, colonic, breast, and cervical carcinomas.",1248000_10,-1,1536,-1,0.3094753
1537,spondylitis,4,5,34,45,"Striking prevalence of ankylosing spondylitis in ""healthy"" w27 positive males and females.",126380_0,-1,1537,-1,0.32978722
1538,spondylitis,1,2,12,23,"
Ankylosing spondylitis is diagnosed once or twice in each 1000 males and one tenth as frequently in females, but the true prevalence is unknown.",126380_1,-1,1538,-1,0.3265454
1539,spondylitis,31,32,213,224,"Evaluation by postal questionnaires, and pelvic radiography of 78 HL-A 27W-positive blood donors selected from a group of apparently healthy subjects revealed 14 who satisfied the criteria for definite ankylosing spondylitis.",126380_3,-1,1539,-1,0.34186748
1540,spondylitis,22,23,105,116,"For a person of either sex with HL-A W27, there appears to be about a 20 per cent chance that ankylosing spondylitis will develop, suggesting a prevalence of 10 to 15 per thousand.",126380_6,-1,1540,-1,0.3280628
1541,atopic dermatitis,12,14,97,114,"
Analbuminemia was fortuitously detected in a nonedematous 12-year-old American Indian girl with atopic dermatitis, mild bronchial asthma, a mild seizure disorder, and hyperlipoproteinemia with a corneal arcus.",1269174_1,-1,1541,-1,0.3346581
1542,bronchial asthma,16,18,121,137,"
Analbuminemia was fortuitously detected in a nonedematous 12-year-old American Indian girl with atopic dermatitis, mild bronchial asthma, a mild seizure disorder, and hyperlipoproteinemia with a corneal arcus.",1269174_1,-1,1542,-1,0.31742674
1543,seizure disorder,21,23,146,162,"
Analbuminemia was fortuitously detected in a nonedematous 12-year-old American Indian girl with atopic dermatitis, mild bronchial asthma, a mild seizure disorder, and hyperlipoproteinemia with a corneal arcus.",1269174_1,-1,1543,-1,0.30753052
1544,serum albumin,13,15,79,92,Immunologic methods revealed trace amounts (17 mg/100 ml) of apparently normal serum albumin.,1269174_2,-1,1544,-1,0.34301776
1545,serum albumin,5,7,38,51,Heterozygotes had subnormal levels of serum albumin.,1269174_5,-1,1545,-1,0.36027515
1546,thalassemia,5,6,27,38,"These findings suggest a "" thalassemia "" -like mutation for this disorder..",1269174_9,-1,1546,-1,0.3626688
1547,piebaldism,11,12,55,65,Deletion of the KIT and PDGFRA genes in a patient with piebaldism.,1279971_0,-1,1547,-1,0.37925476
1548,piebaldism,6,7,37,47,"
We have previously shown that human piebaldism results from mutations of the KIT gene, which encodes the receptor for the mast/stem cell growth factor and is located in chromosome segment 4q12.",1279971_1,-1,1548,-1,0.3539988
1549,piebaldism,6,7,28,38,"Using DNA of a patient with piebaldism, mental retardation, and multiple congenital anomalies associated with a 46, XY, del (4) (q12q21.",1279971_2,-1,1549,-1,0.32861885
1550,mental retardation,8,10,40,58,"Using DNA of a patient with piebaldism, mental retardation, and multiple congenital anomalies associated with a 46, XY, del (4) (q12q21.",1279971_2,-1,1550,-1,0.28883126
1551,congenital anomalies,13,15,73,93,"Using DNA of a patient with piebaldism, mental retardation, and multiple congenital anomalies associated with a 46, XY, del (4) (q12q21.",1279971_2,-1,1551,-1,0.3015451
1552,disease,34,35,267,274,A germ line mutation within the coding sequence for the putative 5-phosphoribosyl-1-pyrophosphate binding site of hypoxanthine-guanine phosphoribosyltransferase (HPRT) in a Lesch-Nyhan patient: missense mutations within a functionally important region probably cause disease.,1282899_0,-1,1552,-1,0.3448812
1553,Lesch-Nyhan syndrome,0,2,1,21,"
Lesch-Nyhan syndrome caused by a complete deficiency of hypoxanthine guanine phosphoribosyltransferase (HPRT) is the result of a heterogeneous group of germ line mutations.",1282899_1,-1,1553,-1,0.42274573
1554,Lesch-Nyhan syndrome,13,15,75,95,We report here a newly identified HPRT mutation in a Japanese patient with Lesch-Nyhan syndrome.,1282899_3,-1,1554,-1,0.40902716
1555,nucleotide,10,11,47,57,"This gene, designated HPRT Tokyo, had a single nucleotide change from G to A, as identified by sequencing cDNA amplified by the polymerase chain reaction.",1282899_4,-1,1555,-1,0.38590652
1556,lead,3,4,20,24,This mutation would lead to an amino acid substitution of Asp for Gly at the amino acid position 140 located within the putative 5-phosphoribosyl-1-pyrophosphate (PRPP) binding region.,1282899_6,-1,1556,-1,0.38793218
1557,amino acid,6,8,31,41,This mutation would lead to an amino acid substitution of Asp for Gly at the amino acid position 140 located within the putative 5-phosphoribosyl-1-pyrophosphate (PRPP) binding region.,1282899_6,-1,1557,-1,0.35009536
1558,amino acid,15,17,77,87,This mutation would lead to an amino acid substitution of Asp for Gly at the amino acid position 140 located within the putative 5-phosphoribosyl-1-pyrophosphate (PRPP) binding region.,1282899_6,-1,1558,-1,0.41050985
1559,disease,39,40,221,228,"However, a comparison of the data suggested that both missense and synonymous mutations can occur at any coding sequence of the human germ line HPRT gene, but that a limited percentage of all the missense mutations cause disease.",1282899_8,-1,1559,-1,0.36718953
1560,disease,7,8,43,50,The probability that a mutation will cause disease tends to be higher when the missense mutation is within a functionally important sequence..,1282899_9,-1,1560,-1,0.37689576
1561,folate,6,7,27,33,It appears to be a typical folate sensitive fragile site.,1301146_1,-1,1561,-1,0.34357613
1562,mental retardation,7,9,40,58,"The fragile site is not associated with mental retardation, it does not give abnormal results when subjected to Southern analysis with probe pfxa3 which detects the unstable DNA sequence characteristic of fragile X syndrome.",1301146_2,-1,1562,-1,0.3391176
1563,fragile X syndrome,32,35,205,223,"The fragile site is not associated with mental retardation, it does not give abnormal results when subjected to Southern analysis with probe pfxa3 which detects the unstable DNA sequence characteristic of fragile X syndrome.",1301146_2,-1,1563,-1,0.32807034
1564,fragile X syndrome,25,28,168,186,"The distinction between the two fragile sites is important clinically since cytogenetic detection of FRAXE, without molecular analysis, could result in misdiagnosis of fragile X syndrome..",1301146_4,-1,1564,-1,0.3273546
1565,Norrie disease,1,3,4,18,The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3.,1301161_0,-1,1565,-1,0.3713941
1566,Norrie disease,0,2,1,15,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1566,-1,0.3590041
1567,blindness,14,15,103,112,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1567,-1,0.3268397
1568,deafness,18,19,129,137,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1568,-1,0.33449918
1569,mental retardation,20,22,142,160,"
Norrie disease is a human X-linked recessive disorder of unknown etiology characterized by congenital blindness, sensory neural deafness and mental retardation.",1301161_1,-1,1569,-1,0.32239664
1570,disease,1,2,5,12,This disease gene was previously linked to the DXS7 (L1. 28) locus and the MAO genes in band Xp11.,1301161_2,-1,1570,-1,0.38663295
1571,MAO,17,18,75,78,This disease gene was previously linked to the DXS7 (L1. 28) locus and the MAO genes in band Xp11.,1301161_2,-1,1571,-1,0.38205397
1572,Norrie disease,12,14,75,89,We report here fine physical mapping of the obligate region containing the Norrie disease gene (NDP) defined by a recombination and by the smallest submicroscopic chromosomal deletion associated with Norrie disease identified to date.,1301161_4,-1,1572,-1,0.3784514
1573,Norrie disease,31,33,200,214,We report here fine physical mapping of the obligate region containing the Norrie disease gene (NDP) defined by a recombination and by the smallest submicroscopic chromosomal deletion associated with Norrie disease identified to date.,1301161_4,-1,1573,-1,0.3573954
1574,n,8,9,37,38,"A recombination event between a (GT) n polymorphism in intron 2 of the MAOB gene and the NDP locus, in a family previously reported to have a recombination between DXS7 and NDP, delineates a flanking marker telomeric to this disease gene.",1301161_6,-1,1574,-1,0.38902178
1575,disease,43,44,225,232,"A recombination event between a (GT) n polymorphism in intron 2 of the MAOB gene and the NDP locus, in a family previously reported to have a recombination between DXS7 and NDP, delineates a flanking marker telomeric to this disease gene.",1301161_6,-1,1575,-1,0.39147097
1576,disease,10,11,51,58,"28, serves as a flanking marker centromeric to the disease gene.",1301161_8,-1,1576,-1,0.3849576
1577,MAO,9,10,46,49,An Alu-PCR fragment from the right arm of the MAO YAC (YMAO.,1301161_9,-1,1577,-1,0.3934816
1578,disease,17,18,96,103,AluR) is not deleted in this patient and also delineates the centromeric extent of the obligate disease region.,1301161_10,-1,1578,-1,0.35294527
1579,phenylalanine,14,15,112,125,Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene.,1301187_0,-1,1579,-1,0.35364607
1580,phenylalanine,4,5,24,37,"
Mutations in the human phenylalanine hydroxylase gene producing phenylketonuria or hyperphenylalaninemia have now been identified in many patients from various ethnic groups.",1301187_1,-1,1580,-1,0.35569197
1581,PAH,17,18,130,133,These mutations all exhibit a high degree of association with specific restriction fragment-length polymorphism haplotypes at the PAH locus.,1301187_2,-1,1581,-1,0.32567847
1582,amino acid,7,9,37,47,One splicing mutation results in a 3 amino acid in-frame insertion.,1301187_4,-1,1582,-1,0.39088008
1583,PAH,24,25,154,157,"About half of all missense mutations have been examined by in vitro expression analysis, and a significant correlation has been observed between residual PAH activity and disease phenotype.",1301187_8,-1,1583,-1,0.3756021
1584,disease,27,28,171,178,"About half of all missense mutations have been examined by in vitro expression analysis, and a significant correlation has been observed between residual PAH activity and disease phenotype.",1301187_8,-1,1584,-1,0.37539163
1585,aspartate,5,6,16,25,A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.,1301189_0,-1,1585,-1,0.41262951
1586,Tay-Sachs disease,15,17,102,119,A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.,1301189_0,-1,1586,-1,0.43103924
1587,Tay-Sachs disease,4,6,31,48,"
The mutation causing juvenile Tay-Sachs disease (TSD) in two sibs of Lebanese-Maronite origin is described.",1301189_1,-1,1587,-1,0.438346
1588,Lebanese-Maronite,13,14,70,87,"
The mutation causing juvenile Tay-Sachs disease (TSD) in two sibs of Lebanese-Maronite origin is described.",1301189_1,-1,1588,-1,0.32121086
1589,Tay-Sachs disease,16,18,102,119,The predicted protein environment in which the mutation occurs is compared to that of the adult-onset Tay-Sachs disease mutation caused by a Gly269-- > Ser substitution in exon 7.,1301189_9,-1,1589,-1,0.4517148
1590,Tay-Sachs disease,1,3,6,23,Novel Tay-Sachs disease mutations from China.,1301190_0,-1,1590,-1,0.4321854
1591,Tay-Sachs disease,8,10,60,77,"
We describe three HEXA mutations associated with infantile Tay-Sachs disease (TSD) in three unrelated nonconsanguineous Chinese families.",1301190_1,-1,1591,-1,0.44468543
1592,C,16,17,111,112,Single strand conformational polymorphism analysis and direct sequencing of amplified exon 13 revealed a T-- > C transition at nt 1453 with the corresponding amino acid substitution W485R in the second family.,1301190_7,-1,1592,-1,0.39192122
1593,amino acid,24,26,158,168,Single strand conformational polymorphism analysis and direct sequencing of amplified exon 13 revealed a T-- > C transition at nt 1453 with the corresponding amino acid substitution W485R in the second family.,1301190_7,-1,1593,-1,0.35447896
1594,C,10,11,65,66,When the site-specific mutagenized alpha cDNA carrying the T-- > C transition at nt 1453 was expressed in COS 1 cells hexosaminidase S activity was not detectable above background.,1301190_10,-1,1594,-1,0.38444713
1595,K,16,17,67,68,A G-- > A transition at nt 1444 (exon 13) corresponding to the E482K substitution was found in the third family.,1301190_11,-1,1595,-1,0.32681647
1596,phenylalanine,20,21,121,134,"
The genetic defects responsible for most phenylketonuria (PKU) and hyperphenylalaninemia (HPA) cases are located in the phenylalanine hydroxylase (PAH) gene.",1301200_1,-1,1596,-1,0.3578913
1597,PAH,23,24,148,151,"
The genetic defects responsible for most phenylketonuria (PKU) and hyperphenylalaninemia (HPA) cases are located in the phenylalanine hydroxylase (PAH) gene.",1301200_1,-1,1597,-1,0.3701331
1598,PAH,17,18,107,110,"Most mutations are linked to specific haplotypes, as defined by eight polymorphic restriction sites in the PAH gene.",1301200_3,-1,1598,-1,0.32297295
1599,glycine,19,20,113,120,"Sequence analysis revealed a C-to-G transversion at the second base of codon 322, resulting in a substitution of glycine for alanine, in four mutant haplotype 12 genes, and a G-to-A transition at the second base of codon 408, resulting in a substitution of glutamine for arginine, in another three mutant haplotype 12 genes.",1301200_5,-1,1599,-1,0.36632594
1600,alanine,21,22,125,132,"Sequence analysis revealed a C-to-G transversion at the second base of codon 322, resulting in a substitution of glycine for alanine, in four mutant haplotype 12 genes, and a G-to-A transition at the second base of codon 408, resulting in a substitution of glutamine for arginine, in another three mutant haplotype 12 genes.",1301200_5,-1,1600,-1,0.33793822
1601,glutamine,47,48,257,266,"Sequence analysis revealed a C-to-G transversion at the second base of codon 322, resulting in a substitution of glycine for alanine, in four mutant haplotype 12 genes, and a G-to-A transition at the second base of codon 408, resulting in a substitution of glutamine for arginine, in another three mutant haplotype 12 genes.",1301200_5,-1,1601,-1,0.33062565
1602,PAH,16,17,108,111,"Both mutations were tested in a eukaryotic expression system in which enzyme activities of different mutant PAH enzymes reflect the relative severities of the mutations, although these in vitro activities cannot be translated directly into in vivo hepatic activities.",1301200_7,-1,1602,-1,0.3640832
1603,PAH,4,5,17,20,The A322G mutant PAH had about 75% and the R408Q mutant PAH about 55% of the wild-type PAH enzyme activity.,1301200_8,-1,1603,-1,0.32986495
1604,PAH,13,14,56,59,The A322G mutant PAH had about 75% and the R408Q mutant PAH about 55% of the wild-type PAH enzyme activity.,1301200_8,-1,1604,-1,0.35318476
1605,PAH,20,21,87,90,The A322G mutant PAH had about 75% and the R408Q mutant PAH about 55% of the wild-type PAH enzyme activity.,1301200_8,-1,1605,-1,0.29266414
1606,PAH,10,11,62,65,These in vitro activities are the highest reported for mutant PAH enzymes produced in the same expression system.,1301200_9,-1,1606,-1,0.35788783
1607,phenylalanine,14,15,68,81,In vitro and in vivo correlations for I65T and M1V mutations at the phenylalanine hydroxylase locus.,1301201_0,-1,1607,-1,0.3409194
1608,phenylalanine,3,4,18,31,"
Mutations at the phenylalanine hydroxylase (PAH) locus are the major cause of hyperphenylalaninemia.",1301201_1,-1,1608,-1,0.35107303
1609,PAH,6,7,45,48,"
Mutations at the phenylalanine hydroxylase (PAH) locus are the major cause of hyperphenylalaninemia.",1301201_1,-1,1609,-1,0.35201952
1610,PAH,18,19,85,88,"We have previously described four mutations (M1V, IVS12nt1, R408W, and S349P) at the PAH locus in French Canadians with ancestry in eastern Quebec.",1301201_2,-1,1610,-1,0.3564462
1611,PAH,80,81,401,404,"Here we report (1) identification of another mutation, on a haplotype 9 chromosome, which converts codon 65 from isoleucine (ATT) to threonine (ACT), (2) expression analysis of the I65T mutation in COS cells demonstrating 75% loss of both immunoreactive protein and enzyme activity, and (3) expression analysis of the most prevalent PKU allele (M1V) in eastern Quebec, showing nondetectable levels of PAH protein and activity, a finding compatible with a mutation in the translation initiation codon.",1301201_3,-1,1611,-1,0.32902578
1612,Tay-Sachs disease,7,9,41,58,"
Following the birth of two infants with Tay-Sachs disease (TSD), a non-Jewish, Pennsylvania Dutch kindred was screened for TSD carriers using the biochemical assay.",1301937_1,-1,1612,-1,0.44048053
1613,nucleotide,9,10,36,46,"The second, a C-- > T transition at nucleotide 739 (Arg247Trp), has been shown by Triggs-Raine et al. (1992) to be a clinically benign "" pseudodeficient "" allele associated with reduced enzyme activity against artificial substrate.",1301937_6,-1,1613,-1,0.35461956
1614,Tay-Sachs disease,5,7,32,49,A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.,1301938_0,-1,1614,-1,0.41323552
1615,Tay-Sachs disease,0,2,1,18,"
Tay-Sachs disease (TSD) is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A (Hex A).",1301938_1,-1,1615,-1,0.44845486
1616,disease,35,36,137,144,"We have discovered that a Tay-Sachs mutation, IVS-9 + 1 G-- > A, first detected by Akli et al. (Genomics 11  124-134, 1991), is a common disease allele in non-Jewish Caucasians (10/58 alleles examined).",1301938_2,-1,1616,-1,0.35705382
1617,choroideremia,11,12,60,73,Aberrant splicing of the CHM gene is a significant cause of choroideremia.,1302003_0,-1,1617,-1,0.32367638
1618,Choroideremia,0,1,1,14,"
Choroideremia (CHM) is an X-linked progressive degeneration of the choroid and retina.",1302003_1,-1,1618,-1,0.31945565
1619,nucleotide,6,7,29,39,In one large family a single nucleotide (T) insertion into the donor splice site of exon C leads to two aberrantly spliced mRNAs both producing a premature stop codon.,1302003_6,-1,1619,-1,0.37163538
1620,C,18,19,89,90,In one large family a single nucleotide (T) insertion into the donor splice site of exon C leads to two aberrantly spliced mRNAs both producing a premature stop codon.,1302003_6,-1,1620,-1,0.34342715
1621,tumour,9,10,53,59,Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.,1302008_0,-1,1621,-1,0.31490472
1622,Denys-Drash syndrome,0,2,1,21,"
Denys-Drash syndrome is a rare human developmental disorder affecting the urogenital system and leading to renal failure, intersex disorders and Wilms tumour.",1302008_1,-1,1622,-1,0.38997257
1623,renal failure,15,17,108,121,"
Denys-Drash syndrome is a rare human developmental disorder affecting the urogenital system and leading to renal failure, intersex disorders and Wilms tumour.",1302008_1,-1,1623,-1,0.3253317
1624,tumour,22,23,152,158,"
Denys-Drash syndrome is a rare human developmental disorder affecting the urogenital system and leading to renal failure, intersex disorders and Wilms tumour.",1302008_1,-1,1624,-1,0.31723702
1625,syndrome,8,9,43,51,"In this report, four individuals with this syndrome are described carrying germline point mutations in the Wilms tumour suppressor gene, WT1.",1302008_2,-1,1625,-1,0.32209638
1626,tumour,18,19,113,119,"In this report, four individuals with this syndrome are described carrying germline point mutations in the Wilms tumour suppressor gene, WT1.",1302008_2,-1,1626,-1,0.29593572
1627,zinc,7,8,37,41,Three of these mutations were in the zinc finger domains of WT1.,1302008_3,-1,1627,-1,0.36591995
1628,myotonic dystrophy,3,5,24,42,Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs.,1302022_0,-1,1628,-1,0.3760973
1629,myotonic dystrophy,3,5,25,43,"
The mutation underlying myotonic dystrophy (DM) has been identified as an expansion of a polymorphic CTG-repeat in a gene encoding protein kinase activity.",1302022_1,-1,1629,-1,0.38435468
1630,DM,6,7,45,47,"
The mutation underlying myotonic dystrophy (DM) has been identified as an expansion of a polymorphic CTG-repeat in a gene encoding protein kinase activity.",1302022_1,-1,1630,-1,0.3753849
1631,DM,3,4,24,26,Characterization of the DM region of both species reveals another active gene (DMR-N9) in close proximity to the kinase gene.,1302022_4,-1,1631,-1,0.3899859
1632,DM,3,4,26,28,Clinical manifestation of DM may be caused by the expanded CTG-repeat compromising the (alternative) expression of DM-kinase or DMR-N9 proteins..,1302022_6,-1,1632,-1,0.35270157
1633,Fragile X syndrome,0,3,0,18,Fragile X syndrome without CCG amplification has an FMR1 deletion.,1302032_0,-1,1633,-1,0.32549486
1634,fragile X syndrome,10,13,61,79,"
We describe a patient with typical clinical features of the fragile X syndrome, but without cytogenetic expression of the fragile X or an amplified CCG trinucleotide repeat fragment.",1302032_1,-1,1634,-1,0.3019135
1635,fragile X syndrome,27,30,155,173,"This finding confirms that the fragile X phenotype can exist, without amplification of the CCG repeat or cytogenetic expression of the fragile X, and that fragile X syndrome is a genetically homogeneous disorder involving FMR1.",1302032_3,-1,1635,-1,0.3288649
1636,Huntington disease,3,5,15,33,Cloning of the Huntington disease region in yeast artificial chromosomes.,1303170_0,-1,1636,-1,0.34739485
1637,Huntington disease,4,6,26,44,"
The gene responsible for Huntington disease has been localized to a 2. 5 million base pair (Mb) region between the loci D4S10 and D4S168 on the short arm of chromosome 4.",1303170_1,-1,1637,-1,0.35663217
1638,Mb,18,19,93,95,"
The gene responsible for Huntington disease has been localized to a 2. 5 million base pair (Mb) region between the loci D4S10 and D4S168 on the short arm of chromosome 4.",1303170_1,-1,1638,-1,0.39535362
1639,Mb,1,2,2,4,"2 Mb of the HD region in YACs, including one continuous segment of 2.",1303170_7,-1,1639,-1,0.3778122
1640,Mb,1,2,2,4,0 Mb covering the region that most likely contains the HD gene.,1303170_8,-1,1640,-1,0.39353758
1641,Mb,16,17,76,78,Ten of the twenty eight YAC clones comprise a minimal set spanning the 2. 2 Mb.,1303170_9,-1,1641,-1,0.3589702
1642,Norrie disease,10,12,56,70,Characterization of a YAC containing part or all of the Norrie disease locus.,1303171_0,-1,1642,-1,0.39595816
1643,monoamine oxidase,13,15,73,90,"
It has been shown from pulsed-field gel electrophoresis (PFGE) that the monoamine oxidase genes A and B (MAOA & MAOB) and DXS7 loci are physically very close.",1303171_1,-1,1643,-1,0.37865418
1644,map,1,2,4,7,The map derived from the YL1.,1303171_5,-1,1644,-1,0.361905
1645,map,6,7,35,38,28-YAC is compatible both with the map from an independently derived YAC carrying MAOA and B genes and with the long range genomic map for the region.,1303171_6,-1,1645,-1,0.39278096
1646,map,23,24,131,134,28-YAC is compatible both with the map from an independently derived YAC carrying MAOA and B genes and with the long range genomic map for the region.,1303171_6,-1,1646,-1,0.3619968
1647,Norrie disease,34,36,175,189,A series of subclones prepared from a phage library (lambda DASH II) of the YAC have been characterised and have been employed to determine the end point of the deletion of a Norrie disease (NDP) patient who has been shown to lack both DXS7 and MAO coding sequences.,1303171_7,-1,1647,-1,0.3613161
1648,MAO,49,50,245,248,A series of subclones prepared from a phage library (lambda DASH II) of the YAC have been characterised and have been employed to determine the end point of the deletion of a Norrie disease (NDP) patient who has been shown to lack both DXS7 and MAO coding sequences.,1303171_7,-1,1648,-1,0.36286405
1649,glucose,4,5,24,31,"
The high prevalence of glucose 6-phosphate dehydrogenase (G6PD) deficiency in African populations is due almost entirely to the enzyme variant A-, which differs from the wild-type G6PD B by two amino acid replacements, 68 Val-- > Met and 126 Asn-- > Asp.",1303173_1,-1,1649,-1,0.35281202
1650,amino acid,33,35,195,205,"
The high prevalence of glucose 6-phosphate dehydrogenase (G6PD) deficiency in African populations is due almost entirely to the enzyme variant A-, which differs from the wild-type G6PD B by two amino acid replacements, 68 Val-- > Met and 126 Asn-- > Asp.",1303173_1,-1,1650,-1,0.3687466
1651,Glu,10,11,66,69,Comparable results were produced when the replacement 119 Gln-- > Glu was studied instead of 126 Asn-- > Asp.,1303173_8,-1,1651,-1,0.37727323
1652,N,4,5,44,45,"Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region.",1303277_0,-1,1652,-1,0.35944837
1653,Prader-Willi syndrome,14,16,80,101,"Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region.",1303277_0,-1,1653,-1,0.4047805
1654,Prader-Willi syndrome,0,2,1,22,"
Prader-Willi syndrome (PWS) is associated with paternally derived chromosomal deletions in region 15q11-13 or with maternal disomy for chromosome 15.",1303277_1,-1,1654,-1,0.4053459
1655,Tay-Sachs disease,6,8,40,57,The presence of two different infantile Tay-Sachs disease mutations in a Cajun population.,1307230_0,-1,1655,-1,0.43027738
1656,Tay-Sachs disease,13,15,73,90,"
A study was undertaken to characterize the mutation (s) responsible for Tay-Sachs disease (TSD) in a Cajun population in southwest Louisiana and to identify the origins of these mutations.",1307230_1,-1,1656,-1,0.47425023
1657,contrast,1,2,3,11,"In contrast, the intron 9 mutation apparently was introduced within the last century and probably is limited to a few Louisiana families..",1307230_7,-1,1657,-1,0.3268166
1658,Norrie disease,6,8,36,50,Mutations in the candidate gene for Norrie disease.,1307245_0,-1,1658,-1,0.36332515
1659,X,11,12,60,61,"
Recently, we and others have isolated a candidate gene for X linked Norrie disease (ND) which was found to be deleted or disrupted in several patients.",1307245_1,-1,1659,-1,0.39519164
1660,Norrie disease,13,15,69,83,"
Recently, we and others have isolated a candidate gene for X linked Norrie disease (ND) which was found to be deleted or disrupted in several patients.",1307245_1,-1,1660,-1,0.36606437
1661,Norrie disease,24,26,143,157,"These findings, and the absence of functionally relevant base changes in healthy controls, emphasize the causal role of this candidate gene in Norrie disease and pave the way for reliable diagnosis and carrier detection..",1307245_6,-1,1661,-1,0.37352413
1662,muscular dystrophy,11,13,69,87,Co-amplification of 11 exons from genomic DNA of Duchenne and Becker muscular dystrophy (DMD/BMD) patients with no deletion or duplication was performed and the samples subjected to multiple SSCP analysis.,1307253_2,-1,1662,-1,0.37125567
1663,nucleoside,4,5,45,55,Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase.,1311721_0,-1,1663,-1,0.31802073
1664,nucleoside,12,13,64,74,"
High level expression of the nm23-H1 gene, which encodes for a nucleoside diphosphate kinase, has been found to correlate with diminished metastasis in some tumors but not in others.",1311721_1,-1,1664,-1,0.32500046
1665,metastasis,23,24,139,149,"
High level expression of the nm23-H1 gene, which encodes for a nucleoside diphosphate kinase, has been found to correlate with diminished metastasis in some tumors but not in others.",1311721_1,-1,1665,-1,0.3083227
1667,neuroblastoma,1,2,3,16,"In neuroblastoma, higher levels of p19/nm23, which are associated with amplification of the N-myc oncogene, large tumor mass, and metastasis, were observed in advanced stage tumors compared with limited stage disease.",1311721_3,-1,1667,-1,0.31459457
1669,metastasis,23,24,130,140,"In neuroblastoma, higher levels of p19/nm23, which are associated with amplification of the N-myc oncogene, large tumor mass, and metastasis, were observed in advanced stage tumors compared with limited stage disease.",1311721_3,-1,1669,-1,0.30456653
1671,disease,35,36,209,216,"In neuroblastoma, higher levels of p19/nm23, which are associated with amplification of the N-myc oncogene, large tumor mass, and metastasis, were observed in advanced stage tumors compared with limited stage disease.",1311721_3,-1,1671,-1,0.3192615
1673,leukemia,16,17,105,113,The levels of p19/nm23 were compared between resting and mitotically stimulated normal human PBLs and in leukemia cells.,1311721_5,-1,1673,-1,0.27847672
1674,leukemia,1,2,3,11,"In leukemia cells obtained from patients with different subtypes of acute leukemia, p19/nm23 levels were also increased relative to resting normal lymphocytes.",1311721_7,-1,1674,-1,0.2709742
1675,leukemia,11,12,74,82,"In leukemia cells obtained from patients with different subtypes of acute leukemia, p19/nm23 levels were also increased relative to resting normal lymphocytes.",1311721_7,-1,1675,-1,0.25926575
1676,cyclosporin,6,7,53,64,"Treatment of mitotically stimulated lymphocytes with cyclosporin, which inhibits proliferation, blocked the increase in p19/nm23; treatment of the leukemia cell line HL-60 with dimethylsulfoxide, which induces terminal differentiation, resulted in diminished levels of p19/nm23.",1311721_8,-1,1676,-1,0.29832736
1677,leukemia,21,22,147,155,"Treatment of mitotically stimulated lymphocytes with cyclosporin, which inhibits proliferation, blocked the increase in p19/nm23; treatment of the leukemia cell line HL-60 with dimethylsulfoxide, which induces terminal differentiation, resulted in diminished levels of p19/nm23.",1311721_8,-1,1677,-1,0.29695082
1678,adenomatous polyposis coli,8,11,65,91,An intrachromosomal insertion causing 5q22 deletion and familial adenomatous polyposis coli in two generations.,1313112_0,-1,1678,-1,0.30186108
1679,adenomatous polyposis coli,3,6,20,46,"
We report familial adenomatous polyposis coli (FAPC) with epidermoid cysts, osteomata, and areas of congenital hypertrophy of the retinal pigment epithelium (CHRPEs) in a male patient and his maternal aunt, both of whom suffered a mild to moderate degree of mental handicap.",1313112_1,-1,1679,-1,0.32436904
1680,cysts,11,12,70,75,"
We report familial adenomatous polyposis coli (FAPC) with epidermoid cysts, osteomata, and areas of congenital hypertrophy of the retinal pigment epithelium (CHRPEs) in a male patient and his maternal aunt, both of whom suffered a mild to moderate degree of mental handicap.",1313112_1,-1,1680,-1,0.31724337
1682,cGMP,6,7,44,48,Chromosome mapping of the rod photoreceptor cGMP phosphodiesterase beta-subunit gene in mouse and human: tight linkage to the Huntington disease region (4p16.3).,1315306_0,-1,1682,-1,0.35202718
1683,Huntington disease,19,21,126,144,Chromosome mapping of the rod photoreceptor cGMP phosphodiesterase beta-subunit gene in mouse and human: tight linkage to the Huntington disease region (4p16.3).,1315306_0,-1,1683,-1,0.38839227
1684,retinal degeneration,1,3,5,25,"
The retinal degeneration mouse (gene symbol, rd) is an animal model for certain forms of human hereditary retinopathies.",1315306_1,-1,1684,-1,0.39770815
1685,rd,8,9,46,48,"
The retinal degeneration mouse (gene symbol, rd) is an animal model for certain forms of human hereditary retinopathies.",1315306_1,-1,1685,-1,0.38660342
1686,rd,8,9,46,48,Recent findings of a nonsense mutation in the rd mouse PDE beta-subunit gene (Pdeb) prompted us to investigate the chromosome locations of the mouse and human genes.,1315306_2,-1,1686,-1,0.39573625
1687,cM,6,7,11,13,1 +/- 2. 3 cM distal of Mgsa on mouse chromosome 5.,1315306_4,-1,1687,-1,0.38732618
1688,Huntington disease,6,8,21,39,"3, very close to the Huntington disease (HD) region.",1315306_6,-1,1688,-1,0.36808014
1689,map,4,5,28,31,Analysis of the comparative map for mice and humans shows that the mouse homologue of the HD gene will reside on chromosome 5.,1315306_7,-1,1689,-1,0.3939008
1690,sarcoma,2,3,18,25,Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome.,1316718_0,-1,1690,-1,0.30698943
1691,lymphoma,5,6,37,45,Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome.,1316718_0,-1,1691,-1,0.29572582
1692,Wiskott-Aldrich syndrome,11,13,68,92,Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome.,1316718_0,-1,1692,-1,0.37198895
1693,eczema,9,10,38,44,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,-1,1693,-1,0.35192552
1696,Wiskott-Aldrich syndrome,20,22,114,138,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,-1,1696,-1,0.39857376
1698,splenomegaly,34,35,209,221,"
A 24 year old male with a history of eczema, recurrent mild infections, and thrombocytopenia consistent with the Wiskott-Aldrich syndrome (WAS) presented with a mediastinal mass, generalized lymphadenopathy, splenomegaly, and severe thrombocytopenia.",1316718_1,-1,1698,-1,0.36739835
1700,sarcoma,9,10,67,74,An initial inguinal lymph node biopsy surprisingly revealed Kaposi sarcoma.,1316718_5,-1,1700,-1,0.27866474
1701,lymphoma,19,20,121,129,"However, following splenectomy to increase the platelet count, biopsy of the mediastinal mass revealed T-cell large cell lymphoma.",1316718_6,-1,1701,-1,0.3093462
1702,human immunodeficiency virus,32,35,192,220,"Studies of biopsied tissue for the presence of Epstein-Barr virus and cytomegalovirus were negative, as were studies of blood, including the polymerase chain reaction, for the presence of the human immunodeficiency virus (HIV).",1316718_7,-1,1702,-1,0.34790596
1703,sarcoma,7,8,35,42,This is the first report of Kaposi sarcoma arising in a patient with a congenital immunodeficiency syndrome.,1316718_8,-1,1703,-1,0.28877252
1704,immunodeficiency syndrome,15,17,82,107,This is the first report of Kaposi sarcoma arising in a patient with a congenital immunodeficiency syndrome.,1316718_8,-1,1704,-1,0.34352803
1705,sarcoma,2,3,16,23,"Although Kaposi sarcoma can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with HIV, we postulate that longevity in the face of mild immunosuppression was the major factor in the development of Kaposi sarcoma in this patient..",1316718_9,-1,1705,-1,0.2873183
1706,sarcoma,42,43,268,275,"Although Kaposi sarcoma can arise in the face of the severe immunosuppression that follows allograft transplantation and in patients infected with HIV, we postulate that longevity in the face of mild immunosuppression was the major factor in the development of Kaposi sarcoma in this patient..",1316718_9,-1,1706,-1,0.26580244
1707,gastric cancer,14,16,82,96,"The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer.",1317264_0,-1,1707,-1,0.2917986
1708,gastric cancer,1,3,10,24,"
Although gastric cancer is the most common cancer in the world, genetic changes during its carcinogenesis are not well understood.",1317264_1,-1,1708,-1,0.29120687
1712,metaplasia,11,12,75,85,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1712,-1,0.3631554
1713,adenomatous polyposis coli,18,21,109,135,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1713,-1,0.36105394
1714,adenomatous polyps,31,33,177,195,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1714,-1,0.3346851
1716,gastric cancer,42,44,247,261,"Since some gastric cancers are considered to originate from the intestinal metaplasia, it is likely that the adenomatous polyposis coli (APC) gene, the mutation of which causes adenomatous polyps in the colon, is associated with carcinogenesis of gastric cancer.",1317264_2,-1,1716,-1,0.25759676
1722,muscular dystrophy,10,12,59,77,A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues.,1319059_0,-1,1722,-1,0.36907586
1723,muscular dystrophy,3,5,20,38,"
The known Duchenne muscular dystrophy (DMD) gene products, the muscle- and brain-type dystrophin isoforms, are 427-kDa proteins translated from 14-kilobase (kb) mRNAs.",1319059_1,-1,1723,-1,0.35397938
1724,amino acids,13,15,89,100,"It contains the C-terminal and the cysteine-rich domains of dystrophin, seven additional amino acids at the N terminus, and some modifications formed by alternative splicing in the C-terminal domain.",1319059_5,-1,1724,-1,0.38142422
1725,N,17,18,108,109,"It contains the C-terminal and the cysteine-rich domains of dystrophin, seven additional amino acids at the N terminus, and some modifications formed by alternative splicing in the C-terminal domain.",1319059_5,-1,1725,-1,0.46923092
1726,polyps,16,17,101,107,Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients.,1319838_0,-1,1726,-1,0.31889468
1727,adenomatous polyposis coli,5,8,31,57,"
Recently we have isolated the adenomatous polyposis coli (APC) gene which causes familial adenomatous polyposis (FAP), and its germ-line mutations in a substantial number of FAP patients have been identified.",1319838_1,-1,1727,-1,0.34650582
1728,polyps,36,37,196,202,"On the basis of this information, we compared the location of germ-line mutations in the APC gene in 22 unrelated patients (12 of whom have been reported previously) with the number of colorectal polyps developed in FAP patients; 17 were sparse types and five were profuse types.",1319838_2,-1,1728,-1,0.32653105
1729,polyps,23,24,142,148,"The location of the germ-line mutations seems to correlate with the two clinical types; germ-line mutations in five FAP patients with profuse polyps were observed between codon 1250 and codon 1464, whereas mutations in 17 FAP patients with fewer polyps were observed in the other regions of the APC gene.",1319838_4,-1,1729,-1,0.3091141
1730,polyps,41,42,246,252,"The location of the germ-line mutations seems to correlate with the two clinical types; germ-line mutations in five FAP patients with profuse polyps were observed between codon 1250 and codon 1464, whereas mutations in 17 FAP patients with fewer polyps were observed in the other regions of the APC gene.",1319838_4,-1,1730,-1,0.3089116
1731,polyps,8,9,50,56,The result suggests that the number of colorectal polyps in FAP patients may be associated with a difference in the stability or biological function of the truncated APC protein..,1319838_5,-1,1731,-1,0.3085382
1732,Tay-Sachs disease,1,3,11,28,"
Infantile Tay-Sachs disease (TSD) is caused by mutations in the HEXA gene that result in the complete absence of beta-hexosaminidase A activity.",1322637_1,-1,1732,-1,0.42532074
1733,phenylalanine,12,13,70,83,Elsewhere we reported an in-frame deletion of one of the two adjacent phenylalanine codons at position 304 or 305 (delta F304/305) in one HEXA allele of a Moroccan Jewish TSD patient and in three obligate carriers from six unrelated Moroccan Jewish families.,1322637_4,-1,1733,-1,0.36298215
1734,Tay-Sachs disease,12,14,57,74,This mutation is at a CpG site in a Japanese infant with Tay-Sachs disease and was described elsewhere.,1322637_8,-1,1734,-1,0.43046734
1735,nucleotide,17,18,61,71,"The results show that 50% (47 of 94) were G to T mutation at nucleotide (nt) 1376, 21. 3% (20 of 94) were G to A mutation at nt 1388, 7.",1323345_4,-1,1735,-1,0.34838298
1736,C,26,27,65,66,"4% (7 of 94) were A to G mutation at nt 95, 4. 2% (4 of 94) were C to T mutation at nt 1024, 1. 1% (1 of 94) was G to T mutation at nt 392, and 1.",1323345_6,-1,1736,-1,0.4164565
1737,colorectal cancer,13,15,90,107,"
Familial adenomatous polyposis (FAP) is a dominantly inherited condition predisposing to colorectal cancer.",1324223_1,-1,1737,-1,0.27810374
1738,adenomatous polyposis coli,8,11,46,72,The recent isolation of the responsible gene (adenomatous polyposis coli or APC) has facilitated the search for germ line mutations in affected individuals.,1324223_2,-1,1738,-1,0.33766767
1739,colorectal carcinoma,12,14,55,75,1 megabase pairs of DNA around the MCC (for mutated in colorectal carcinoma) and APC (for adenomatous polyposis coli) genes at 5q21 have been isolated and characterized.,1325652_2,-1,1739,-1,0.30266538
1740,adenomatous polyposis coli,19,22,90,116,1 megabase pairs of DNA around the MCC (for mutated in colorectal carcinoma) and APC (for adenomatous polyposis coli) genes at 5q21 have been isolated and characterized.,1325652_2,-1,1740,-1,0.32137707
1741,Denys-Drash syndrome,4,6,26,46,Inherited WT1 mutation in Denys-Drash syndrome.,1327525_0,-1,1741,-1,0.381065
1742,Denys-Drash syndrome,3,5,19,39,"
Patients with the Denys-Drash syndrome (Wilms tumor, genital anomalies, and nephropathy) have been demonstrated to carry de novo constitutional mutations in WT1, the Wilms tumor gene at chromosome 11p13.",1327525_1,-1,1742,-1,0.3751512
1743,Wilms tumor,6,8,41,52,"
Patients with the Denys-Drash syndrome (Wilms tumor, genital anomalies, and nephropathy) have been demonstrated to carry de novo constitutional mutations in WT1, the Wilms tumor gene at chromosome 11p13.",1327525_1,-1,1743,-1,0.30823752
1745,Wilms tumor,28,30,167,178,"
Patients with the Denys-Drash syndrome (Wilms tumor, genital anomalies, and nephropathy) have been demonstrated to carry de novo constitutional mutations in WT1, the Wilms tumor gene at chromosome 11p13.",1327525_1,-1,1745,-1,0.3084864
1746,Denys-Drash syndrome,20,22,128,148,This observation indicates that the WT1 exon 9 mutation affecting 394Arg demonstrated in over one-half of the patients with the Denys-Drash syndrome may exhibit incomplete penetrance.,1327525_4,-1,1746,-1,0.3969951
1747,syndrome,9,10,60,68,"Consequently, familial studies in patients affected by this syndrome are recommended..",1327525_5,-1,1747,-1,0.3210551
1748,Wilms tumor,26,28,154,165,"
Fluorescence in situ hybridization (FISH) with biotin-labeled probes mapping to 11p13 has been used for the molecular analysis of deletions of the WAGR (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation) locus.",1334370_1,-1,1748,-1,0.3416515
1749,aniridia,29,30,167,175,"
Fluorescence in situ hybridization (FISH) with biotin-labeled probes mapping to 11p13 has been used for the molecular analysis of deletions of the WAGR (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation) locus.",1334370_1,-1,1749,-1,0.35356748
1750,mental retardation,35,37,210,228,"
Fluorescence in situ hybridization (FISH) with biotin-labeled probes mapping to 11p13 has been used for the molecular analysis of deletions of the WAGR (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation) locus.",1334370_1,-1,1750,-1,0.34006986
1751,aniridia,12,13,75,83,"We have detected a submicroscopic 11p13 deletion in a child with inherited aniridia who subsequently presented with Wilms tumor in a horseshoe kidney, only revealed at surgery.",1334370_2,-1,1751,-1,0.36564934
1752,Wilms tumor,17,19,116,127,"We have detected a submicroscopic 11p13 deletion in a child with inherited aniridia who subsequently presented with Wilms tumor in a horseshoe kidney, only revealed at surgery.",1334370_2,-1,1752,-1,0.3203273
1753,aniridia,5,6,20,28,"The mother, who has aniridia, was also found to carry a deletion including both the aniridia candidate gene (AN2) and the Wilms tumor predisposition gene (WT1).",1334370_3,-1,1753,-1,0.37450668
1754,aniridia,17,18,84,92,"The mother, who has aniridia, was also found to carry a deletion including both the aniridia candidate gene (AN2) and the Wilms tumor predisposition gene (WT1).",1334370_3,-1,1754,-1,0.38293222
1755,Wilms tumor,25,27,122,133,"The mother, who has aniridia, was also found to carry a deletion including both the aniridia candidate gene (AN2) and the Wilms tumor predisposition gene (WT1).",1334370_3,-1,1755,-1,0.30748862
1756,Wilms tumor,0,2,0,11,Wilms tumor has so far only been associated with sporadic de novo aniridia cases.,1334370_5,-1,1756,-1,0.31838906
1757,aniridia,12,13,66,74,Wilms tumor has so far only been associated with sporadic de novo aniridia cases.,1334370_5,-1,1757,-1,0.35354134
1758,aniridia,10,11,50,58,"We have shown that a cosmid probe for a candidate aniridia gene, homologous to the mouse Pax-6 gene, is deleted in cell lines from aniridia patients with previously characterized deletions at 11p13, while another cosmid marker mapping between two aniridia-associated translocation breakpoints (and hence a second candidate marker) is present on both chromosomes.",1334370_6,-1,1758,-1,0.39962003
1759,aniridia,26,27,131,139,"We have shown that a cosmid probe for a candidate aniridia gene, homologous to the mouse Pax-6 gene, is deleted in cell lines from aniridia patients with previously characterized deletions at 11p13, while another cosmid marker mapping between two aniridia-associated translocation breakpoints (and hence a second candidate marker) is present on both chromosomes.",1334370_6,-1,1759,-1,0.3940444
1760,disease,15,16,109,116,We present here a pedigree of a 31-year-old C2-deficient individual with clinical manifestations of Hodgkins disease.,133535_3,-1,1760,-1,0.34988788
1761,adenomatous polyposis coli,13,16,73,99,"
We report here the result of a screening for germ-line mutations in the adenomatous polyposis coli (APC) gene in 61 new familial adenomatous polyposis (FAP) patients as well as a summary of the results of 150 patients.",1338764_1,-1,1761,-1,0.33459327
1762,cytosine,81,82,444,452,"Our findings revealed the following characteristics of the germ-line mutations of APC  1) the great majority of the mutations were found to truncate the APC product; 2) almost all of the mutations were located within the first half of the coding region; 3) no correlation was observed between the locations of germ-line mutations and extracolonic manifestations in FAP patients; 4) more than 80% of base substitutions in the APC gene were from cytosine to other nucleotides, nearly one-third of which occurred at the GpG site.",1338764_3,-1,1762,-1,0.38811824
1764,adenomatous polyposis coli,6,9,38,64,"
We examined somatic mutations of the adenomatous polyposis coli (APC) gene in 63 colorectal tumors (16 adenomas and 47 carcinomas) developed in familial adenomatous polyposis (FAP) and non-FAP patients.",1338904_1,-1,1764,-1,0.35888192
1766,adenomas,19,20,104,112,"
We examined somatic mutations of the adenomatous polyposis coli (APC) gene in 63 colorectal tumors (16 adenomas and 47 carcinomas) developed in familial adenomatous polyposis (FAP) and non-FAP patients.",1338904_1,-1,1766,-1,0.32373667
1771,adenomas,17,18,73,81,"Combining these data and the results of LOH, more than 80% of tumors (14 adenomas and 39 carcinomas) had at least one mutation in the APC gene, of which more than 60% (9 adenomas and 23 carcinomas) had two mutations.",1338904_8,-1,1771,-1,0.31212214
1772,adenomas,40,41,170,178,"Combining these data and the results of LOH, more than 80% of tumors (14 adenomas and 39 carcinomas) had at least one mutation in the APC gene, of which more than 60% (9 adenomas and 23 carcinomas) had two mutations.",1338904_8,-1,1772,-1,0.30356818
1774,Denys-Drash syndrome,9,11,58,78,Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.,1338906_0,-1,1774,-1,0.3872129
1775,Denys-Drash syndrome,1,3,5,25,"
The Denys-Drash syndrome is characterised by a typical nephropathy, genital abnormalities and also predisposes to the development of Wilms tumor.",1338906_1,-1,1775,-1,0.40027112
1777,Wilms tumor,19,21,134,145,"
The Denys-Drash syndrome is characterised by a typical nephropathy, genital abnormalities and also predisposes to the development of Wilms tumor.",1338906_1,-1,1777,-1,0.28956318
1778,Wilms tumor,2,4,12,23,"A candidate Wilms tumor gene, WT1, from the 11p13 chromosome region has recently been cloned.",1338906_3,-1,1778,-1,0.3155243
1779,nucleotide,3,4,14,24,Three were at nucleotide position 1180 resulting in an arg > trp amino acid change.,1338906_6,-1,1779,-1,0.38746646
1780,trp amino acid,11,14,61,75,Three were at nucleotide position 1180 resulting in an arg > trp amino acid change.,1338906_6,-1,1780,-1,0.34210083
1781,nucleotide,6,7,32,42,A single base pair insertion at nucleotide position 821 in exon 6 resulted in the generation of a premature stop codon in the last patient.,1338906_9,-1,1781,-1,0.3898169
1782,diastrophic dysplasia,8,10,64,85,Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland.,1345170_0,-1,1782,-1,0.38489833
1783,disease,15,16,116,123,"
Linkage disequilibrium mapping in isolated populations provides a powerful tool for fine structure localization of disease genes.",1345170_1,-1,1783,-1,0.35922074
1784,disease,33,34,202,209,"Here, Luria and Delbrucks classical methods for analysing bacterial cultures are adapted to the study of human isolated founder populations in order to estimate (i) the recombination fraction between a disease locus and a marker; (ii) the expected degree of allelic homogeneity in a population; and (iii) the mutation rate of marker loci.",1345170_2,-1,1784,-1,0.42368612
1785,diastrophic dysplasia,10,12,67,88,"Using these methods, we report striking linkage disequilibrium for diastrophic dysplasia (DTD) in Finland indicating that the DTD gene should lie within 0.",1345170_3,-1,1785,-1,0.38916916
1786,Wiskott-Aldrich syndrome,1,3,4,28,"The Wiskott-Aldrich syndrome: refinement of the localization on Xp and identification of another closely linked marker locus, OATL1.",1346773_0,-1,1786,-1,0.37342352
1787,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS) has previously been mapped to the proximal short arm of the X chromosome between the DXS14 and DXS7 loci.",1346773_1,-1,1787,-1,0.379793
1788,myotonic dystrophy,11,13,70,88,Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.,1346924_0,-1,1788,-1,0.3488859
1789,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is the most common form of adult muscular dystrophy, with a prevalence of 2-14 per 100, 000 individuals.",1346924_1,-1,1789,-1,0.35829383
1790,DM,3,4,21,23,"
Myotonic dystrophy (DM) is the most common form of adult muscular dystrophy, with a prevalence of 2-14 per 100, 000 individuals.",1346924_1,-1,1790,-1,0.36408597
1791,muscular dystrophy,12,14,58,76,"
Myotonic dystrophy (DM) is the most common form of adult muscular dystrophy, with a prevalence of 2-14 per 100, 000 individuals.",1346924_1,-1,1791,-1,0.32428876
1792,disease,1,2,4,11,"The disease is characterized by progressive muscle weakness and sustained muscle contraction, often with a wide range of accompanying symptoms.",1346924_2,-1,1792,-1,0.34912446
1793,muscle weakness,6,8,44,59,"The disease is characterized by progressive muscle weakness and sustained muscle contraction, often with a wide range of accompanying symptoms.",1346924_2,-1,1793,-1,0.35998648
1794,disease,8,9,37,44,"The age at onset and severity of the disease show extreme variation, both within and between families.",1346924_3,-1,1794,-1,0.36866984
1795,DM,18,19,107,109,It is flanked by the tightly linked genetic markers ERCC1 proximally and D19S51 distally; these define the DM critical region.,1346924_6,-1,1795,-1,0.41096446
1796,disease,23,24,146,153,"The size of this fragment varies between affected siblings, and increases in size through generations in parallel with increasing severity of the disease.",1346924_8,-1,1796,-1,0.36113605
1797,DM,13,14,85,87,We postulate that this unstable DNA sequence is the molecular feature that underlies DM.,1346924_9,-1,1797,-1,0.33659208
1798,muscular dystrophy,43,45,211,229,"To learn about causative mechanisms, we have cloned and sequenced the breakpoints of a cytologically balanced constitutional reciprocal translocation, t (X; 4) (p21. 2; q31. 22), present in a girl with Duchenne muscular dystrophy (DMD).",1347968_2,-1,1798,-1,0.3432256
1799,DiGeorge syndrome,4,6,23,40,A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.,1349199_0,-1,1799,-1,0.37966853
1800,DiGeorge syndrome,0,2,1,18,"
DiGeorge syndrome (DGS), a developmental field defect of the third and fourth pharyngeal pouches, is characterized by aplasia or hypoplasia of the thymus and parathyroid glands and by conotruncal cardiac malformations.",1349199_1,-1,1800,-1,0.3877298
1801,cardiac malformations,33,35,197,218,"
DiGeorge syndrome (DGS), a developmental field defect of the third and fourth pharyngeal pouches, is characterized by aplasia or hypoplasia of the thymus and parathyroid glands and by conotruncal cardiac malformations.",1349199_1,-1,1801,-1,0.32085124
1802,contrast,1,2,3,11,"In contrast, molecular analysis detected DNA deletions in all 14 probands.",1349199_6,-1,1802,-1,0.36265123
1803,adrenocortical carcinoma,10,12,44,68,Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis.,1351034_0,-1,1803,-1,0.31228435
1804,neoplasms,1,2,11,20,"
Endocrine neoplasms have been reported occasionally in patients with familial adenomatous polyposis (FAP).",1351034_1,-1,1804,-1,0.32506078
1806,adenomatous polyposis coli,12,15,56,82,"Loss of heterozygosity (LOH) in the region close to the adenomatous polyposis coli (APC) gene was detected in this carcinoma, and evidence was obtained that there was a loss of the normal allele of the APC gene.",1351034_3,-1,1806,-1,0.31971368
1812,RB1,8,9,44,47,Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.,1352883_0,-1,1812,-1,0.3062447
1813,retinoblastoma,20,21,122,136,Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.,1352883_0,-1,1813,-1,0.3011816
1814,RB1,4,5,41,44,"
The retinoblastoma-predisposition gene, RB1, segregates as an autosomal dominant trait with high (90%) penetrance.",1352883_1,-1,1814,-1,0.3162229
1816,RB1,7,8,35,38,Mutations were found in exon 20 of RB1 in both cases.,1352883_4,-1,1816,-1,0.3137584
1817,tryptophan,17,18,79,89,In one family a C----T transition in codon 661 converts an arginine (CGG) to a tryptophan (TGG) codon.,1352883_5,-1,1817,-1,0.30224147
1818,amino acid,21,23,142,152,"In this family, incomplete penetrance and mild phenotypic expression were observed in virtually all patients, possibly indicating that single amino acid changes may modify protein structure/function such that tumorigenesis is not inevitable.",1352883_6,-1,1818,-1,0.37517777
1819,glutamine,16,17,88,97,In the second family the mutation in codon 675 is a G----T transversion that converts a glutamine (GAA) to a stop (TAA) codon.,1352883_7,-1,1819,-1,0.324598
1820,TAA,24,25,115,118,In the second family the mutation in codon 675 is a G----T transversion that converts a glutamine (GAA) to a stop (TAA) codon.,1352883_7,-1,1820,-1,0.41376126
1821,glutamine,20,21,111,120,"In that allele arginine84, a residue that is highly conserved in the arylsulfatase gene family, is replaced by glutamine.",1353340_2,-1,1821,-1,0.32941312
1822,contrast,1,2,3,11,"In contrast to alleles that cause early-onset MLD, the arginine84 to glutamine substitution is associated with some residual ARSA activity.",1353340_3,-1,1822,-1,0.39392543
1823,glutamine,12,13,69,78,"In contrast to alleles that cause early-onset MLD, the arginine84 to glutamine substitution is associated with some residual ARSA activity.",1353340_3,-1,1823,-1,0.3765286
1824,Trisomy,0,1,0,7,Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy.,1357962_0,-1,1824,-1,0.35668695
1825,Prader-Willi syndrome,12,14,54,75,Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy.,1357962_0,-1,1825,-1,0.39818516
1826,Uniparental disomy,0,2,1,19,"
Uniparental disomy has recently been recognized to cause human disorders, including Prader-Willi syndrome (PWS).",1357962_1,-1,1826,-1,0.4060273
1827,Prader-Willi syndrome,12,14,85,106,"
Uniparental disomy has recently been recognized to cause human disorders, including Prader-Willi syndrome (PWS).",1357962_1,-1,1827,-1,0.40292537
1828,uniparental disomy,14,16,110,128,We describe a particularly instructive case which raises important issues concerning the mechanisms producing uniparental disomy and whose evaluation provides evidence that trisomy may precede uniparental disomy in a fetus.,1357962_2,-1,1828,-1,0.35920426
1829,trisomy,22,23,173,180,We describe a particularly instructive case which raises important issues concerning the mechanisms producing uniparental disomy and whose evaluation provides evidence that trisomy may precede uniparental disomy in a fetus.,1357962_2,-1,1829,-1,0.3598567
1830,uniparental disomy,25,27,193,211,We describe a particularly instructive case which raises important issues concerning the mechanisms producing uniparental disomy and whose evaluation provides evidence that trisomy may precede uniparental disomy in a fetus.,1357962_2,-1,1830,-1,0.34085312
1831,trisomy,9,10,71,78,"Chorionic villus sampling performed for advanced maternal age revealed trisomy 15 in all direct and cultured cells, though the fetus appeared normal.",1357962_3,-1,1831,-1,0.3568485
1832,uniparental disomy,30,32,170,188,"Maternal nondisjunction with fertilization of a disomic egg by a normal sperm, followed by loss of the paternal 15, is a likely cause of confined placental mosaicism and uniparental disomy in this case of PWS, and advanced maternal age may be a predisposing factor..",1357962_8,-1,1832,-1,0.34562472
1833,amelogenesis imperfecta,4,6,34,57,Genetic heterogeneity in X-linked amelogenesis imperfecta.,1358807_0,-1,1833,-1,0.33370736
1834,amelogenesis imperfecta,21,23,138,161,3 encodes for the enamel protein amelogenin and has been implicated as the gene responsible for the inherited dental abnormality X-linked amelogenesis imperfecta (XAI).,1358807_3,-1,1834,-1,0.3300505
1835,disease,15,16,75,82,"This supports the involvement of AMELX, located close to DXS16, in the XAI disease process (AIH1) in those families.",1358807_7,-1,1835,-1,0.36406562
1836,cM,8,9,31,33,30 for a location of AIH1 at 2 cM distal to DXS16.,1358807_9,-1,1836,-1,0.39832962
1837,cM,9,10,59,61,"The support interval around this location extended about 8 cM proximal to DXS92, and the AIH1 location could not be precisely defined by multipoint mapping.",1358807_10,-1,1837,-1,0.36163902
1838,cM,5,6,32,34,The support interval extended 9 cM proximal to DXS144E and 14 cM distal to F9.,1358807_17,-1,1838,-1,0.37085435
1839,cM,11,12,62,64,The support interval extended 9 cM proximal to DXS144E and 14 cM distal to F9.,1358807_17,-1,1839,-1,0.36682448
1840,amino acid,8,10,38,48,"
Phenylketonuria (PKU), a disorder of amino acid metabolism prevalent among Caucasians and other ethnic groups, is caused primarily by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",1361100_1,-1,1840,-1,0.36606267
1841,phenylalanine,29,30,170,183,"
Phenylketonuria (PKU), a disorder of amino acid metabolism prevalent among Caucasians and other ethnic groups, is caused primarily by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",1361100_1,-1,1841,-1,0.3643347
1842,PAH,32,33,197,200,"
Phenylketonuria (PKU), a disorder of amino acid metabolism prevalent among Caucasians and other ethnic groups, is caused primarily by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",1361100_1,-1,1842,-1,0.35722873
1843,PAH,16,17,94,97,"PKU is a highly heterogeneous disorder, with more than 60 molecular lesions identified in the PAH gene.",1361100_2,-1,1843,-1,0.33369648
1844,PAH,12,13,86,89,"The haplotype associations, relative frequencies, and distributions of five prevalent PAH mutations (R158Q, R261Q, IVS10nt546, R408W, and IVS12n1) were established in a comprehensive European sample population and subsequently were examined to determine the potential roles of several genetic mechanisms in explaining the present distribution of the major PKU alleles.",1361100_3,-1,1844,-1,0.34941068
1845,PAH,26,27,148,151,Each of these five mutations was strongly associated with only one of the more than 70 chromosomal haplotypes defined by eight RFLPs in or near the PAH gene.,1361100_4,-1,1845,-1,0.3164061
1846,diseases,11,12,86,94,"
Inherited complement deficiencies are associated with a variety of connective tissue diseases.",1361318_1,-1,1846,-1,0.3348331
1848,sicca syndrome,27,29,169,183,A family with inherited deficiency of complement factor 2 (C2) is described in which two family members with homozygous C2 deficiency developed cutaneous vasculitis and sicca syndrome.,1361318_2,-1,1848,-1,0.34242126
1850,Pelizaeus-Merzbacher disease,17,19,77,105,New variant in exon 3 of the proteolipid protein (PLP) gene in a family with Pelizaeus-Merzbacher disease.,1376553_0,-1,1850,-1,0.36324218
1851,C,1,2,3,4,"
A C--greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with Pelizaeus-merzbacher disease (PMD).",1376553_1,-1,1851,-1,0.42476898
1852,Pelizaeus-merzbacher disease,28,30,135,163,"
A C--greater than G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with Pelizaeus-merzbacher disease (PMD).",1376553_1,-1,1852,-1,0.38213864
1853,amino acid,7,9,41,51,The transversion should not result in an amino acid change in the protein but it does result in the loss of a HaeIII restriction endonuclease cleavage site.,1376553_2,-1,1853,-1,0.33722788
1854,disease,5,6,26,33,It is concordant with the disease in this family.,1376553_3,-1,1854,-1,0.35700774
1855,disease,3,4,13,20,"The cause of disease in this family remains unknown, but the association between this rare mutation and PMD is intriguing.",1376553_6,-1,1855,-1,0.33760723
1857,Pelizaeus-Merzbacher disease,20,22,128,156,"Mutations of the X-chromosome-linked PLP gene are lethal, identified first in the jimpy mouse and subsequently in patients with Pelizaeus-Merzbacher disease.",1380672_3,-1,1857,-1,0.34333017
1859,Pelizaeus-Merzbacher disease,34,36,188,216,"We suggest that PLP has a vital function in glial cell development, distinct from its later role in myelin assembly, and that this dichotomy of action may explain the clinical spectrum of Pelizaeus-Merzbacher disease..",1380672_8,-1,1859,-1,0.32977265
1860,Tay-Sachs disease,12,14,75,92,"
Deficiency of beta-hexosaminidase A (Hex A) activity typically results in Tay-Sachs disease.",1384323_1,-1,1860,-1,0.42215633
1861,Tay-Sachs disease,27,29,171,188,We analyzed the HEXA gene of one pseudodeficient subject and identified both a C739-to-T substitution that changes Arg247----Trp on one allele and a previously identified Tay-Sachs disease mutation on the second allele.,1384323_3,-1,1861,-1,0.46946028
1862,Tay-Sachs disease,12,14,67,84,This allele accounted for 32% (20/62) of non-Jewish enzyme-defined Tay-Sachs disease carriers but for none of 36 Jewish enzyme-defined carriers who did not have one of three known mutations common to this group.,1384323_5,-1,1862,-1,0.4456103
1863,Tay-Sachs disease,10,12,47,64,"The C739-to-T allele, together with a "" true "" Tay-Sachs disease allele, causes Hex A pseudodeficiency.",1384323_6,-1,1863,-1,0.45675445
1864,Tay-Sachs disease,26,28,187,204,"Given both the large proportion of non-Jewish carriers with this allele and that standard biochemical screening cannot differentiate between heterozygotes for the C739-to-T mutations and Tay-Sachs disease carriers, DNA testing for this mutation in at-risk couples is essential.",1384323_7,-1,1864,-1,0.44934982
1865,Pelizaeus-Merzbacher disease,0,2,0,28,"Pelizaeus-Merzbacher disease: detection of mutations Thr181----Pro and Leu223----Pro in the proteolipid protein gene, and prenatal diagnosis.",1384324_0,-1,1865,-1,0.36813766
1866,Pelizaeus-Merzbacher disease,8,10,47,75,"
A family with an apparent history of X-linked Pelizaeus-Merzbacher disease presented for genetic counseling, requesting carrier detection and prenatal diagnosis.",1384324_1,-1,1866,-1,0.35703576
1867,nucleotide,21,22,133,143,"Sequencing of the exon from the CVS, the predicted-carrier mother, and the obligate-carrier grandmother revealed an A-to-C change at nucleotide 541 in the two women but not in the fetus.",1384324_5,-1,1867,-1,0.34388855
1868,amino acid,9,11,49,59,"As this change results in a Thr-to-Pro change at amino acid 181 in a region of the gene predicted to be part of a transmembrane segment, it was concluded that this was the mutation causing the disease in this family.",1384324_6,-1,1868,-1,0.39191982
1869,disease,37,38,193,200,"As this change results in a Thr-to-Pro change at amino acid 181 in a region of the gene predicted to be part of a transmembrane segment, it was concluded that this was the mutation causing the disease in this family.",1384324_6,-1,1869,-1,0.3713588
1870,nucleotide,29,30,137,147,"In addition, in a second family, an exon 5 variant band pattern on SSCP analysis was shown by sequencing to be due to a T-to-C change at nucleotide 668.",1384324_7,-1,1870,-1,0.3460125
1871,Pelizaeus-Merzbacher disease,11,13,70,98,These results provide further examples of mutations in PLP that cause Pelizaeus-Merzbacher disease and illustrate the value of SSCP in genetic analysis..,1384324_9,-1,1871,-1,0.3564067
1872,disease,2,3,15,22,von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.,1409710_0,-1,1872,-1,0.33004686
1873,disease,27,28,146,153,"A missense mutation, Gly-561-- > Ser, was identified within the proposed glycoprotein Ib binding domain of vWF in the proband with von Willebrand disease type B, a unique variant characterized by no ristocetin-induced, but normal botrocetin-induced, binding to glycoprotein Ib.",1409710_3,-1,1873,-1,0.32779473
1874,disease,33,34,205,212,"The corresponding mutant recombinant protein, rvWF (G561S), formed normal multimers and exhibited the same functional defect as the patients plasma vWF, confirming that this mutation causes von Willebrand disease type B. These data show that botrocetin and ristocetin cofactor activities of vWF can be dissociated by a point mutation and confirm that these mediators promote vWF binding to platelets by different mechanisms.",1409710_4,-1,1874,-1,0.329191
1875,disease,22,23,149,156,The normal botrocetin-induced binding and the defective ristocetin-induced binding of rvWF (G561S) suggest that the primary defect in von Willebrand disease type B may be a failure of normal allosteric regulation of the glycoprotein Ib binding function of vWF..,1409710_5,-1,1875,-1,0.29368126
1876,syndrome,5,6,28,36,Typical and partial cat eye syndrome: identification of the marker chromosome by FISH.,1424237_0,-1,1876,-1,0.3151592
1877,syndrome,8,9,50,58,"
Three children are reported with typical cat eye syndrome (CES) and three more children with partial CES because of absence of coloboma, in which the supernumerary marker chromosome was studied by FISH.",1424237_1,-1,1877,-1,0.31223455
1878,tetrasomy,18,19,98,107,"Using a genomic library, and also a centromeric and particularly a cosmid probe of 22q11, partial tetrasomy was shown in all cases..",1424237_2,-1,1878,-1,0.39412883
1879,malaria,17,18,113,120,"Carriers of G6PD deficiency are residents of 11 villages located in Alasani-Aphtalan valley, highly endemic with malaria in the past; nearly all marriages are endogamic.",144081_2,-1,1879,-1,0.3329965
1880,Craniofrontonasal dysplasia,0,2,0,27,Craniofrontonasal dysplasia.,1468459_0,-1,1880,-1,0.34527484
1881,craniofrontonasal dysplasia,6,8,33,60,"
We report on nine patients with craniofrontonasal dysplasia (CFND).",1468459_1,-1,1881,-1,0.34085417
1882,frontonasal dysplasia,8,10,56,77,Seven classical cases had facial features suggestive of frontonasal dysplasia and coronal craniosynostosis.,1468459_2,-1,1882,-1,0.33896208
1883,syndactyly,11,12,88,98,Extracranial abnormalities such as brittle nails with prominent longitudinal grooves or syndactyly of fingers and toes were observed in individual patients.,1468459_3,-1,1883,-1,0.33927414
1884,Hypotonia,0,1,0,9,Hypotonia and laxity of joints are common and may necessitate supportive measures.,1468459_6,-1,1884,-1,0.35018492
1885,contrast,1,2,3,11,"In contrast to previous reports of this condition, one of our severely affected cases is a male..",1468459_9,-1,1885,-1,0.35413474
1886,Tay-Sachs disease,10,12,52,69,The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.,1483696_0,-1,1886,-1,0.4623527
1887,Tay-Sachs disease,11,13,59,76,"
Mutations at the hexosaminidase A (HEXA) gene which cause Tay-Sachs disease (TSD) have elevated frequency in the Ashkenazi Jewish and French-Canadian populations.",1483696_1,-1,1887,-1,0.46909928
1888,disease,17,18,105,112,We report a novel TSD allele in the French-Canadian population associated with the infantile form of the disease.,1483696_2,-1,1888,-1,0.33875927
1889,Aspartylglucosaminuria,0,1,1,23,"
Aspartylglucosaminuria (AGU) is a recessive autosomally inherited lysosomal storage disorder due to deficiency of the enzyme aspartylglucosaminidase (AGA).",1505217_1,-1,1889,-1,0.3316424
1890,aniridia,8,9,50,58,"Resolution of the two loci for autosomal dominant aniridia, AN1 and AN2, to a single locus on chromosome 11p13.",1505982_0,-1,1890,-1,0.3746404
1891,aniridia,7,8,42,50,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1891,-1,0.3992896
1892,aniridia,13,14,79,87,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1892,-1,0.37732908
1893,aniridia,21,22,121,129,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1893,-1,0.39281878
1894,syndrome,27,28,158,166,"
Two distinct loci have been proposed for aniridia; AN1 for autosomal dominant aniridia on chromosome 2p and AN2 for the aniridia in the WAGR contiguous gene syndrome on chromosome 11p13.",1505982_1,-1,1894,-1,0.3247133
1895,aniridia,10,11,63,71,"In this report, the kindred segregating for autosomal dominant aniridia, which suggested linkage to acid phosphatase-1 (ACP1) and led to the assignment of the AN1 locus on chromosome 2p, has been updated and expanded.",1505982_2,-1,1895,-1,0.37373078
1896,aniridia,4,5,29,37,"Linkage analysis between the aniridia phenotype and ACP1 does not support the original linkage results, excluding linkage up to theta = 0.",1505982_3,-1,1896,-1,0.4014413
1897,aniridia,13,14,54,62,"APOB, D2S71, D2S5, and D2S1, also excluded linkage to aniridia.",1505982_6,-1,1897,-1,0.36667767
1898,aniridia,15,16,92,100,Markers that have been isolated from the chromosome 11p13 region were then analyzed in this aniridia family.,1505982_7,-1,1898,-1,0.403408
1899,aniridia,7,8,36,44,These data suggest that a locus for aniridia (AN1) on chromosome 2p has been misassigned and that this autosomal dominant aniridia family is segregating for an aniridia mutation linked to markers in the 11p13 region.,1505982_17,-1,1899,-1,0.39372888
1900,aniridia,22,23,122,130,These data suggest that a locus for aniridia (AN1) on chromosome 2p has been misassigned and that this autosomal dominant aniridia family is segregating for an aniridia mutation linked to markers in the 11p13 region.,1505982_17,-1,1900,-1,0.3870949
1901,an aniridia,27,29,157,168,These data suggest that a locus for aniridia (AN1) on chromosome 2p has been misassigned and that this autosomal dominant aniridia family is segregating for an aniridia mutation linked to markers in the 11p13 region.,1505982_17,-1,1901,-1,0.34867033
1902,pyoderma gangrenosum,1,3,6,26,Fatal pyoderma gangrenosum in association with C7 deficiency.,1517503_0,-1,1902,-1,0.3608625
1903,pyoderma gangrenosum,1,3,10,30,"
Although pyoderma gangrenosum (PG) is often associated with systemic diseases, it has not been reported in association with congenital complement deficiencies.",1517503_1,-1,1903,-1,0.36759037
1904,PG,4,5,32,34,"
Although pyoderma gangrenosum (PG) is often associated with systemic diseases, it has not been reported in association with congenital complement deficiencies.",1517503_1,-1,1904,-1,0.34656367
1905,diseases,11,12,70,78,"
Although pyoderma gangrenosum (PG) is often associated with systemic diseases, it has not been reported in association with congenital complement deficiencies.",1517503_1,-1,1905,-1,0.34270823
1906,PG,9,10,55,57,We describe an aggressive and ultimately fatal case of PG in a patient with a congenital C7 deficiency.,1517503_2,-1,1906,-1,0.34212136
1907,PG,25,26,175,177,"Deficiencies of C7 can be associated with decreased neutrophil chemotaxis, phagocytosis, and opsonization, similar to the immunologic abnormalities described in patients with PG.",1517503_3,-1,1907,-1,0.32646793
1908,PG,14,15,87,89,"Our patients decreased complement level, if not directly related to the development of PG, may have contributed to the aggressive nature of her disease..",1517503_4,-1,1908,-1,0.32571608
1909,disease,25,26,144,151,"Our patients decreased complement level, if not directly related to the development of PG, may have contributed to the aggressive nature of her disease..",1517503_4,-1,1909,-1,0.33620638
1910,nucleotide,22,23,97,107,"The first type of mutation (487 G----A) was found in an affected Chinese with a G to A change at nucleotide 487, which results in a (163) Gly to Ser substitution.",1562739_7,-1,1910,-1,0.35632417
1911,nucleotide,9,10,41,51,"This mutation causes an A to G change at nucleotide position 493, producing an (165) Asn to Asp substitution.",1562739_9,-1,1911,-1,0.3833648
1912,nucleotide,9,10,40,50,This mutation causes a G to T change at nucleotide position 1376 that results in an (459) Arg to Leu substitution.,1562739_12,-1,1912,-1,0.39389157
1913,nucleotide,9,10,40,50,This mutation causes a G to A change at nucleotide 1388 that produces an (463) Arg to His substitution.,1562739_15,-1,1913,-1,0.3468218
1914,muscular dystrophy,9,11,59,77,"An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy.",1577476_0,-1,1914,-1,0.34479797
1915,muscular dystrophy,17,19,111,129,"An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy.",1577476_0,-1,1915,-1,0.33315897
1916,muscular dystrophy,2,4,18,36,"
Golden retriever muscular dystrophy (GRMD) is a spontaneous, X-linked, progressively fatal disease of dogs and is also a homologue of Duchenne muscular dystrophy (DMD).",1577476_1,-1,1916,-1,0.33399707
1917,disease,15,16,92,99,"
Golden retriever muscular dystrophy (GRMD) is a spontaneous, X-linked, progressively fatal disease of dogs and is also a homologue of Duchenne muscular dystrophy (DMD).",1577476_1,-1,1917,-1,0.36800405
1918,muscular dystrophy,25,27,144,162,"
Golden retriever muscular dystrophy (GRMD) is a spontaneous, X-linked, progressively fatal disease of dogs and is also a homologue of Duchenne muscular dystrophy (DMD).",1577476_1,-1,1918,-1,0.3380759
1919,contrast,4,5,21,29,"The polymorphism, in contrast, has near normal activity.",1610789_3,-1,1919,-1,0.35716838
1921,Denys-Drash syndrome,16,18,110,130,Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.,1655284_0,-1,1921,-1,0.3629733
1922,Denys-Drash syndrome,0,2,1,21,"
Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms tumor (nephroblastoma).",1655284_1,-1,1922,-1,0.3883637
1923,renal failure,14,16,97,110,"
Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms tumor (nephroblastoma).",1655284_1,-1,1923,-1,0.33918104
1924,Wilms tumor,20,22,139,150,"
Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms tumor (nephroblastoma).",1655284_1,-1,1924,-1,0.29848447
1925,Wilms tumor,14,16,75,86,"To investigate its possible role, we have analyzed the coding exons of the Wilms tumor suppressor gene (WT1) for germline mutations.",1655284_2,-1,1925,-1,0.3113306
1926,Denys-Drash syndrome,5,7,28,48,"In ten independent cases of Denys-Drash syndrome, point mutations in the zinc finger domains of one WT1 gene copy were found.",1655284_3,-1,1926,-1,0.38784322
1927,zinc,12,13,73,77,"In ten independent cases of Denys-Drash syndrome, point mutations in the zinc finger domains of one WT1 gene copy were found.",1655284_3,-1,1927,-1,0.35271487
1928,zinc,10,11,49,53,Nine of these mutations are found within exon 9 (zinc finger III); the remaining mutation is in exon 8 (zinc finger II).,1655284_4,-1,1928,-1,0.36452067
1929,zinc,23,24,104,108,Nine of these mutations are found within exon 9 (zinc finger III); the remaining mutation is in exon 8 (zinc finger II).,1655284_4,-1,1929,-1,0.34860364
1931,granulosa,8,9,53,62,Wilms tumors from three individuals and one juvenile granulosa cell tumor demonstrate reduction to homozygosity for the mutated WT1 allele.,1655284_7,-1,1931,-1,0.33750525
1933,Denys-Drash syndrome,11,13,57,77,Our results provide evidence of a direct role for WT1 in Denys-Drash syndrome and thus urogenital system development..,1655284_8,-1,1933,-1,0.38502425
1934,adrenoleukodystrophy,4,5,29,49,Linkage analysis in X-linked adrenoleukodystrophy and application in post- and prenatal diagnosis.,1671851_0,-1,1934,-1,0.34561822
1935,factor VIII,13,15,80,91,"
We have performed linkage analysis with the DNA markers DXS52 and the clotting factor VIII gene (F8C), in several large families with X-linked adrenoleukodystrophy (ALD).",1671851_1,-1,1935,-1,0.32261664
1936,adrenoleukodystrophy,26,27,144,164,"
We have performed linkage analysis with the DNA markers DXS52 and the clotting factor VIII gene (F8C), in several large families with X-linked adrenoleukodystrophy (ALD).",1671851_1,-1,1936,-1,0.3421927
1937,vision blindness,26,28,145,161,"In four patients with ALD, no major structural rearrangement in the Xqter region was observed; in particular, there were no abnormalities in the vision blindness genes.",1671851_6,-1,1937,-1,0.39205098
1938,disease,6,7,53,60,"
Classical phenylketonuria is an autosomal recessive disease caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",1671881_1,-1,1938,-1,0.35634026
1939,phenylalanine,13,14,95,108,"
Classical phenylketonuria is an autosomal recessive disease caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",1671881_1,-1,1939,-1,0.3581526
1940,PAH,16,17,122,125,"
Classical phenylketonuria is an autosomal recessive disease caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",1671881_1,-1,1940,-1,0.3522284
1941,PAH,14,15,79,82,"The abolition of an invariant BamHI site located in the coding sequence of the PAH gene (exon 7) led to the recognition of two new point mutations at codon 272 and 273 (272gly----stop and 273ser----phe, respectively).",1671881_2,-1,1941,-1,0.32297763
1942,PAH,24,25,149,152,The present study supports the view that the clinical heterogeneity in PKU is accounted for by the large variety of mutant genotypes associated with PAH deficiencies..,1671881_4,-1,1942,-1,0.3116468
1943,map,3,4,22,25,A detailed multipoint map of human chromosome 4 provides evidence for linkage heterogeneity and position-specific recombination rates.,1673289_0,-1,1943,-1,0.37630203
1944,map,19,20,121,124,"
Utilizing the CEPH reference panel and genotypic data for 53 markers, we have constructed a 20-locus multipoint genetic map of human chromosome 4.",1673289_1,-1,1944,-1,0.3784378
1945,map,1,2,4,7,The map integrates a high-resolution genetic map of 4p16 into a continuous map extending to 4q31 and an unlinked cluster of three loci at 4q35.,1673289_3,-1,1945,-1,0.36930647
1946,map,6,7,45,48,The map integrates a high-resolution genetic map of 4p16 into a continuous map extending to 4q31 and an unlinked cluster of three loci at 4q35.,1673289_3,-1,1946,-1,0.3610658
1947,map,12,13,75,78,The map integrates a high-resolution genetic map of 4p16 into a continuous map extending to 4q31 and an unlinked cluster of three loci at 4q35.,1673289_3,-1,1947,-1,0.33672062
1948,cM,11,12,61,63,The 20 linked markers form a continuous linkage group of 152 cM in males and 202 cM in females.,1673289_4,-1,1948,-1,0.3792135
1949,cM,16,17,81,83,The 20 linked markers form a continuous linkage group of 152 cM in males and 202 cM in females.,1673289_4,-1,1949,-1,0.37228352
1950,map,1,2,4,7,The map was constructed employing the LINKAGE and CRIMAP computational methodologies to build the multipoint map via a stepwise algorithm.,1673289_6,-1,1950,-1,0.33778027
1951,map,15,16,109,112,The map was constructed employing the LINKAGE and CRIMAP computational methodologies to build the multipoint map via a stepwise algorithm.,1673289_6,-1,1951,-1,0.33186403
1952,map,3,4,20,23,A detailed 10-point map of the 4p16 region constructed from the CEPH panel provides evidence for heterogeneity in the linkage maps constructed from families segregating for Huntington disease (HD).,1673289_7,-1,1952,-1,0.3508543
1953,Huntington disease,26,28,173,191,A detailed 10-point map of the 4p16 region constructed from the CEPH panel provides evidence for heterogeneity in the linkage maps constructed from families segregating for Huntington disease (HD).,1673289_7,-1,1953,-1,0.33504266
1954,Pelizaeus-Merzbacher disease,6,8,44,72,Carrier detection and prenatal diagnosis of Pelizaeus-Merzbacher disease using a combination of anonymous DNA polymorphisms and the proteolipid protein (PLP) gene cDNA.,1676565_0,-1,1954,-1,0.35387218
1955,Pelizaeus-Merzbacher disease,16,18,111,139,"
We report carrier identification and a prenatal diagnosis using DNA polymorphisms in 2 families with X-linked Pelizaeus-Merzbacher disease (PMD).",1676565_1,-1,1955,-1,0.3764465
1956,adenomatous polyposis coli,20,23,106,132,"
Small (100-260 kb), nested deletions were characterized in DNA from two unrelated patients with familial adenomatous polyposis coli (APC).",1678319_1,-1,1956,-1,0.29709563
1957,familial Mediterranean fever,4,7,29,57,Exclusion of linkage between familial Mediterranean fever and the human serum amyloid A (SAA) gene cluster.,1679035_0,-1,1957,-1,0.35524285
1958,familial Mediterranean fever,9,12,67,95,"
We studied the relationship between the autosomal recessive trait familial Mediterranean fever (FMF) and the serum amyloid A (SAA) genes by comparing alleles of a highly polymorphic dinucleotide repeat and a conventional restriction fragment length polymorphism (RFLP) in the SAA gene cluster in Israeli FMF kindreds.",1679035_1,-1,1958,-1,0.37131318
1959,cM,1,2,2,4,4 cM including and surrounding the SAA gene cluster as the site of the FMF mutation although SAA proteins are prominent physiologic markers of the acute attacks.,1679035_4,-1,1959,-1,0.39772457
1960,lymphoma,12,13,72,80,"PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.",1682919_0,-1,1960,-1,0.31521747
1961,lymphoma,6,7,35,43,"
Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms.",1682919_1,-1,1961,-1,0.32829466
1962,lymphoma,20,21,125,133,"
Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms.",1682919_1,-1,1962,-1,0.29557598
1963,neoplasms,29,30,181,190,"
Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms.",1682919_1,-1,1963,-1,0.23832507
1964,parathyroid hormone,18,20,118,137,"PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification.",1682919_3,-1,1964,-1,0.3243718
1965,adenomas,26,27,170,178,"PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification.",1682919_3,-1,1965,-1,0.3002554
1966,neoplasms,55,56,334,343,"PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification.",1682919_3,-1,1966,-1,0.2671037
1967,lymphomas,10,11,65,74,"PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas.",1682919_5,-1,1967,-1,0.26919615
1968,contrast,17,18,101,109,"PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas.",1682919_5,-1,1968,-1,0.3926215
1969,lymphomas,24,25,151,160,"PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas.",1682919_5,-1,1969,-1,0.2706967
1970,lymphomas,5,6,31,40,Three of the seven centrocytic lymphomas had detectable BCL1 DNA rearrangement.,1682919_6,-1,1970,-1,0.28620544
1971,contrast,14,15,79,87,"Also, two unusual cases of CLL with BCL1 rearrangement overexpressed PRAD1, in contrast to five CLL controls.",1682919_7,-1,1971,-1,0.3902909
1972,neoplasms,27,28,149,158,"Thus, PRAD1 is an excellent candidate "" BCL1 oncogene. "" Its overexpression may be a key consequence of rearrangement of the BCL1 vicinity in B-cell neoplasms and a unifying pathogenetic feature in centrocytic lymphoma.",1682919_8,-1,1972,-1,0.28022414
1973,lymphoma,35,36,210,218,"Thus, PRAD1 is an excellent candidate "" BCL1 oncogene. "" Its overexpression may be a key consequence of rearrangement of the BCL1 vicinity in B-cell neoplasms and a unifying pathogenetic feature in centrocytic lymphoma.",1682919_8,-1,1973,-1,0.28697902
1974,disease,30,31,181,188,"However, combinations with other MLD mutations suggest that the point mutation in exon 3 does result in some residual enzyme activity and is associated with late-onset forms of the disease.",1684088_14,-1,1974,-1,0.33237103
1975,Wiskott-Aldrich syndrome,9,11,72,96,Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.,1684569_0,-1,1975,-1,0.37259147
1976,Wiskott-Aldrich syndrome,12,14,73,97,"
We report on a thrombocytopenic female belonging to a pedigree with the Wiskott-Aldrich syndrome (WAS).",1684569_1,-1,1976,-1,0.37540916
1978,Pelizaeus-Merzbacher disease,16,18,77,105,A new mutation in the proteolipid protein (PLP) gene in a German family with Pelizaeus-Merzbacher disease.,1707231_0,-1,1978,-1,0.34579325
1979,Pelizaeus-Merzbacher disease,25,27,127,155,"
A C-to-T transition in exon 4 of the PLP gene was found in 2 affected males and two obligate carriers in a German family with Pelizaeus-Merzbacher disease.",1707231_1,-1,1979,-1,0.35565636
1980,amino acid,12,14,60,70,"The mutation, which causes loss of an HphI site and changes amino acid 155 from threonine to isoleucine, was absent from 108 normal chromosomes.",1707231_2,-1,1980,-1,0.4056992
1981,phenylalanine,7,8,39,52,A 3-base pair in-frame deletion of the phenylalanine hydroxylase gene results in a kinetic variant of phenylketonuria.,1709636_0,-1,1981,-1,0.34863907
1982,disease,8,9,49,56,"
Phenylketonuria (PKU) is an autosomal recessive disease due to deficiency of a hepatic enzyme, phenylalanine hydroxylase (PAH).",1709636_1,-1,1982,-1,0.36770886
1983,phenylalanine,17,18,96,109,"
Phenylketonuria (PKU) is an autosomal recessive disease due to deficiency of a hepatic enzyme, phenylalanine hydroxylase (PAH).",1709636_1,-1,1983,-1,0.3733386
1984,PAH,20,21,123,126,"
Phenylketonuria (PKU) is an autosomal recessive disease due to deficiency of a hepatic enzyme, phenylalanine hydroxylase (PAH).",1709636_1,-1,1984,-1,0.35023087
1985,PAH,3,4,15,18,The absence of PAH activity results in typical PKU while persistence of a residual enzyme activity gives rise to variant forms of the disease.,1709636_2,-1,1985,-1,0.31256443
1986,disease,23,24,134,141,The absence of PAH activity results in typical PKU while persistence of a residual enzyme activity gives rise to variant forms of the disease.,1709636_2,-1,1986,-1,0.31816378
1987,PAH,10,11,54,57,"We report here a 3-base pair in-frame deletion of the PAH gene (delta 194) in a mild variant, with markedly reduced affinity of the enzyme for phenylalanine (Km = 160 nM), and we provide functional evidence for responsibility of the deletion in the mutant phenotype.",1709636_3,-1,1987,-1,0.3414577
1988,phenylalanine,29,30,143,156,"We report here a 3-base pair in-frame deletion of the PAH gene (delta 194) in a mild variant, with markedly reduced affinity of the enzyme for phenylalanine (Km = 160 nM), and we provide functional evidence for responsibility of the deletion in the mutant phenotype.",1709636_3,-1,1988,-1,0.31504512
1989,phenylalanine,35,36,186,199,"Since the deletion was located in the third exon of the gene, which presents no homology with other hydroxylases, we suggest that exon 3 is involved in the specificity of the enzyme for phenylalanine.",1709636_4,-1,1989,-1,0.34227535
1990,piebaldism,14,15,83,93,Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.,1717985_0,-1,1990,-1,0.36447564
1991,Piebaldism,0,1,1,11,"
Piebaldism is an autosomal dominant genetic disorder characterized by cogenital patches of skin and hair from which melanocytes are completely absent.",1717985_1,-1,1991,-1,0.34708926
1992,piebaldism,13,14,79,89,We identified a KIT gene mutation in a proband with classic autosomal dominant piebaldism.,1717985_3,-1,1992,-1,0.34567875
1993,tyrosine,13,14,76,84,"This mutation results in a Gly----Arg substitution at codon 664, within the tyrosine kinase domain.",1717985_4,-1,1993,-1,0.3380299
1994,Piebaldism,0,1,0,10,Piebaldism in this family thus appears to be the human homologue to dominant white spotting (W) of the mouse..,1717985_6,-1,1994,-1,0.36081412
1995,abetalipoproteinemia,8,9,64,84,Genetic analysis of a Japanese family with normotriglyceridemic abetalipoproteinemia indicates a lack of linkage to the apolipoprotein B gene.,1731805_0,-1,1995,-1,0.32165244
1996,abetalipoproteinemia,1,2,22,42,"
Normotriglyceridemic abetalipoproteinemia is a rare familial disorder characterized by an isolated deficiency of apoB-100.",1731805_1,-1,1996,-1,0.32109794
1997,disease,8,9,48,55,"We have previously reported a patient with this disease, who had normal apoB-48 but no apoB-100.",1731805_2,-1,1997,-1,0.32937714
1998,contrast,1,2,3,11,"By contrast, an American case had a point substitution in the apoB gene generating an in-frame stop codon.",1731805_5,-1,1998,-1,0.3465192
1999,Norrie disease,5,7,29,43,Localisation of the gene for Norrie disease to between DXS7 and DXS426 on Xp.,1733838_0,-1,1999,-1,0.37009704
2000,Norrie disease,17,19,84,98,"4-Xp11 4-Xp11. 23, has been used to refine further the localisation of the gene for Norrie disease (NDP).",1733838_2,-1,2000,-1,0.3658964
2001,phenylalanine,3,4,21,34,Aberrant splicing of phenylalanine hydroxylase mRNA: the major cause for phenylketonuria in parts of southern Europe.,1769645_0,-1,2001,-1,0.35141912
2002,phenylalanine,6,7,33,46,"
We report a mutation within the phenylalanine hydroxylase (PAH) gene that causes aberrant splicing of the mRNA and that is in tight association with chromosomal haplotypes 6, 10, and 36.",1769645_1,-1,2002,-1,0.37419978
2003,PAH,9,10,60,63,"
We report a mutation within the phenylalanine hydroxylase (PAH) gene that causes aberrant splicing of the mRNA and that is in tight association with chromosomal haplotypes 6, 10, and 36.",1769645_1,-1,2003,-1,0.3710017
2004,PAH,29,30,150,153,"Because of the high frequency of these particular haplotypes in Bulgaria, Italy, and Turkey, it appears to be one of the more frequent defects in the PAH gene causing classical phenylketonuria in this part of Europe.",1769645_2,-1,2004,-1,0.33923125
2005,PAH,16,17,72,75,"The mutation is a G to A transition at position 546 in intron 10 of the PAH gene, 11 bp upstream from the intron 10/exon 11 boundary.",1769645_3,-1,2005,-1,0.34048235
2006,PAH,4,5,24,27,"Normal amounts of liver PAH protein are present in homozygous patients, but no catalytic activity can be detected.",1769645_5,-1,2006,-1,0.2961094
2007,amino acids,18,20,123,134,This loss of enzyme activity is probably caused by conformational changes resulting from the insertion of three additional amino acids (Gly-Leu-Gln) between the normal sequences encoded by exon 10 and exon 11..,1769645_6,-1,2007,-1,0.3895614
2008,Gardner syndrome,0,2,0,16,Gardner syndrome in a boy with interstitial deletion of the long arm of chromosome 5.,1776638_0,-1,2008,-1,0.35418224
2009,Gardner syndrome,6,8,37,53,"
We described a 15-year-old boy with Gardner syndrome (GS), mental retardation, and craniofacial abnormalities.",1776638_1,-1,2009,-1,0.30750754
2010,mental retardation,12,14,60,78,"
We described a 15-year-old boy with Gardner syndrome (GS), mental retardation, and craniofacial abnormalities.",1776638_1,-1,2010,-1,0.32676125
2011,craniofacial abnormalities,16,18,84,110,"
We described a 15-year-old boy with Gardner syndrome (GS), mental retardation, and craniofacial abnormalities.",1776638_1,-1,2011,-1,0.31016573
2012,adenomatous polyposis coli,14,17,83,109,"The breakpoints in the present case and in 3 previously reported 5q- patients with adenomatous polyposis coli suggest that the gene responsible for GS/or familial polyposis coli (FPC) is in the 5q22 region, a result consistent with the findings of linkage studies",1776638_4,-1,2012,-1,0.31712657
2013,Huntington disease,0,2,0,18,Huntington disease and childhood-onset Tourette syndrome.,1831007_0,-1,2013,-1,0.34214675
2014,Tourette syndrome,4,6,39,56,Huntington disease and childhood-onset Tourette syndrome.,1831007_0,-1,2014,-1,0.3510747
2015,Tourette syndrome,5,7,40,57,"
A 40-year-old man with childhood-onset Tourette syndrome (TS) developed Huntington disease (HD).",1831007_1,-1,2015,-1,0.36522475
2016,TS,8,9,59,61,"
A 40-year-old man with childhood-onset Tourette syndrome (TS) developed Huntington disease (HD).",1831007_1,-1,2016,-1,0.36865523
2017,Huntington disease,11,13,73,91,"
A 40-year-old man with childhood-onset Tourette syndrome (TS) developed Huntington disease (HD).",1831007_1,-1,2017,-1,0.3239769
2018,TS,11,12,65,67,We believe this to be the first reported case of childhood-onset TS with adult onset HD.,1831007_2,-1,2018,-1,0.35560352
2019,Tay-Sachs disease,16,18,88,105,"Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.",1833974_0,-1,2019,-1,0.44362226
2020,Tay-Sachs disease,6,8,47,64,"
The rapid identification of mutations causing Tay-Sachs disease requires the capacity to readily screen the regions of the HEXA gene most likely to be affected by mutation.",1833974_1,-1,2020,-1,0.42979223
2021,Tay-Sachs disease,4,6,26,43,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2021,-1,0.4544045
2022,TG,22,23,122,124,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2022,-1,0.37286454
2023,amino acid,49,51,218,228,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2023,-1,0.3800084
2024,C,60,61,274,275,"Five novel mutations from Tay-Sachs disease patients were detected  a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing.",1833974_4,-1,2024,-1,0.38095537
2025,galactose,8,9,58,67,"
Galactosemia is an autosomal recessive disorder of human galactose metabolism caused by deficiency of the enzyme galactose-1-phosphate uridyl transferase (GALT).",1897530_1,-1,2025,-1,0.35081005
2026,nucleotide,5,6,24,34,"First, we identified at nucleotide 591 a transition which substitutes glutamine 188 by arginine.",1897530_4,-1,2026,-1,0.36461923
2027,glutamine,11,12,70,79,"First, we identified at nucleotide 591 a transition which substitutes glutamine 188 by arginine.",1897530_4,-1,2027,-1,0.37779137
2028,glutamine,2,3,12,21,"The mutated glutamine is not only highly conserved in evolution (conserved also in Escherichia coli and Saccharomyces cerevisiae), but is also two amino acid residues downstream from the active site histidine-proline-histidine triad and results in about 10% of normal enzymatic activity.",1897530_5,-1,2028,-1,0.36027122
2029,amino acid,25,27,147,157,"The mutated glutamine is not only highly conserved in evolution (conserved also in Escherichia coli and Saccharomyces cerevisiae), but is also two amino acid residues downstream from the active site histidine-proline-histidine triad and results in about 10% of normal enzymatic activity.",1897530_5,-1,2029,-1,0.424371
2030,tryptophan,10,11,54,64,"Second, we report the substitution of arginine 333 by tryptophan, caused by a transition at nucleotide 1025.",1897530_8,-1,2030,-1,0.3192561
2031,nucleotide,17,18,92,102,"Second, we report the substitution of arginine 333 by tryptophan, caused by a transition at nucleotide 1025.",1897530_8,-1,2031,-1,0.35398608
2032,Lesch-Nyhan syndrome,1,3,5,25,"
The Lesch-Nyhan syndrome is a severe X chromosome-linked human disease caused by a virtual absence of hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity.",1937471_1,-1,2032,-1,0.443218
2033,disease,9,10,64,71,"
The Lesch-Nyhan syndrome is a severe X chromosome-linked human disease caused by a virtual absence of hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity.",1937471_1,-1,2033,-1,0.3328511
2034,gouty arthritis,12,14,66,81,A partial deficiency in the activity of this enzyme can result in gouty arthritis.,1937471_2,-1,2034,-1,0.36899036
2035,Lesch-Nyhan syndrome,30,32,165,185,"To determine the genetic basis for reduction or loss of enzyme activity, we have amplified and sequenced the coding region of HPRT cDNA from four patients  one with Lesch-Nyhan syndrome (HPRTPerth) and three with partial deficiencies of HPRT activity, which have been designated HPRTUrangan, HPRTSwan and HPRTToowong.",1937471_3,-1,2035,-1,0.43920094
2036,amino acid,31,33,157,167,"In all four patients, the only mutation identified was a single base substitution in exons 2 or 3 of the coding region, which in each case predicts a single amino acid substitution in the translated protein.",1937471_4,-1,2036,-1,0.36179414
2037,abetalipoproteinemia,9,10,78,98,Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.,1939657_0,-1,2037,-1,0.33092692
2038,abetalipoproteinemia,8,9,63,83,"
We have previously described a disorder, normotriglyceridemic abetalipoproteinemia, that is characterized by the virtual absence of plasma low density lipoproteins and complete absence of apoB-100, but with apparently normal secretion of triglyceride-rich lipoproteins containing apoB-48.",1939657_1,-1,2038,-1,0.31921867
2039,nucleotide,12,13,67,77,"We have found this individual to be homozygous for a single C-to-T nucleotide substitution at apoB codon 2252, which produces a premature in-frame stop codon.",1939657_3,-1,2039,-1,0.3605265
2040,disease,7,8,38,45,"
Phenylketonuria (PKU) is a metabolic disease caused by recessive mutations of the gene encoding the hepatic enzyme phenylalanine hydroxylase (PAH).",1968617_1,-1,2040,-1,0.36069813
2041,phenylalanine,19,20,116,129,"
Phenylketonuria (PKU) is a metabolic disease caused by recessive mutations of the gene encoding the hepatic enzyme phenylalanine hydroxylase (PAH).",1968617_1,-1,2041,-1,0.37488762
2042,PAH,22,23,143,146,"
Phenylketonuria (PKU) is a metabolic disease caused by recessive mutations of the gene encoding the hepatic enzyme phenylalanine hydroxylase (PAH).",1968617_1,-1,2042,-1,0.34660518
2043,PAH,17,18,89,92,Here we report that a single molecular defect--a deletion spanning the third exon of the PAH gene--is responsible for all the PKU cases among the Yemenite Jews.,1968617_4,-1,2043,-1,0.31831613
2044,PAH,3,4,21,24,"Although the deleted PAH gene was traced to 25 different locations throughout Yemen, family histories and official documents of the Yemenite Jewish community showed that the common ancestor of all the carriers of this genetic defect lived in Sana, the capital of Yemen, before the eighteenth century..",1968617_6,-1,2044,-1,0.33841586
2045,aspartylglucosaminuria,2,3,11,33,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2045,-1,0.33138984
2046,AGU,4,5,35,38,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2046,-1,0.35900003
2047,Aspartylglucosaminuria,17,18,88,110,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2047,-1,0.3322116
2048,aspartylglucosaminidase,29,30,163,186,"Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
Aspartylglucosaminuria (AGU) is caused by deficient activity of the enzyme aspartylglucosaminidase (AGA).",1973404_0,-1,2048,-1,0.3346205
2049,map,4,5,20,23,We have studied the map position of the AGU locus in relation to other marker loci on the long arm of chromosome 4 using linkage analyses.,1973404_2,-1,2049,-1,0.41127935
2050,AGU,8,9,40,43,We have studied the map position of the AGU locus in relation to other marker loci on the long arm of chromosome 4 using linkage analyses.,1973404_2,-1,2050,-1,0.39131024
2051,AGU,35,36,184,187,"Restriction fragment length polymorphism alleles for the ADH2, ADH3, EGF, FG alpha and FG beta loci and blood group antigens for the MNS locus were determined in a panel of 12 Finnish AGU families.",1973404_3,-1,2051,-1,0.35264608
2052,AGU,4,5,21,24,"Loose linkage of the AGU locus to the FG and MNS loci was observed (z = 1. 16, z = 1. 39, respectively).",1973404_6,-1,2052,-1,0.38215047
2053,map,5,6,33,36,Multipoint analysis to the fixed map [ADH- (0. 03) -EGF- (0. 35) -FG- (0. 11) -MNS] suggests that the location of the AGU locus is 0. 05-0. 30 recombination units distal to MNS (z = 3. 03).,1973404_7,-1,2053,-1,0.36854735
2054,AGU,33,34,118,121,Multipoint analysis to the fixed map [ADH- (0. 03) -EGF- (0. 35) -FG- (0. 11) -MNS] suggests that the location of the AGU locus is 0. 05-0. 30 recombination units distal to MNS (z = 3. 03).,1973404_7,-1,2054,-1,0.3997556
2055,myotonic dystrophy,16,18,90,108,Linkage relationships of the apolipoprotein C1 gene and a cytochrome P450 gene (CYP2A) to myotonic dystrophy.,1975560_0,-1,2055,-1,0.35837263
2056,myotonic dystrophy,32,34,152,170,"
We have studied the genetic linkage of two markers, the apolipoprotein C1 (APOC1) gene and a cytochrome P450 (CYP2A) gene, in relation to the gene for myotonic dystrophy (DM).",1975560_1,-1,2056,-1,0.35993588
2057,DM,35,36,172,174,"
We have studied the genetic linkage of two markers, the apolipoprotein C1 (APOC1) gene and a cytochrome P450 (CYP2A) gene, in relation to the gene for myotonic dystrophy (DM).",1975560_1,-1,2057,-1,0.36988464
2058,cM,3,4,8,10,"29 at 2 cM was observed for APOC1-DM, with a lod score of 8.",1975560_3,-1,2058,-1,0.40504977
2059,cM,3,4,8,10,55 at 4 cM for CYP2A-DM.,1975560_4,-1,2059,-1,0.38647208
2060,map,13,14,83,86,"From examination of the genotypes of the recombinant individuals, CYP2A appears to map proximal to DM because in one recombinant individual CYP2A, APOC2 and CKMM had all recombined with DM.",1975560_6,-1,2060,-1,0.3869908
2061,DM,16,17,99,101,"From examination of the genotypes of the recombinant individuals, CYP2A appears to map proximal to DM because in one recombinant individual CYP2A, APOC2 and CKMM had all recombined with DM.",1975560_6,-1,2061,-1,0.35595348
2062,DM,31,32,186,188,"From examination of the genotypes of the recombinant individuals, CYP2A appears to map proximal to DM because in one recombinant individual CYP2A, APOC2 and CKMM had all recombined with DM.",1975560_6,-1,2062,-1,0.3254441
2063,DM,17,18,94,96,Localisation of CYP2A on a panel of somatic cell hybrids also suggests that it is proximal to DM and APOC2/C1/E gene cluster.,1975560_8,-1,2063,-1,0.3465611
2064,map,2,3,16,19,Genetic linkage map of six polymorphic DNA markers around the gene for familial adenomatous polyposis on chromosome 5.,1978564_0,-1,2064,-1,0.378387
2065,map,3,4,19,22,"
A genetic linkage map of six polymorphic DNA markers close to the gene (APC) for familial adenomatous polyposis (FAP) on chromosome 5q is reported.",1978564_1,-1,2065,-1,0.38716853
2066,map,25,26,151,154,"A number of crucial recombination events have been identified which are informative at three or more loci, allowing confident ordering of parts of the map.",1978564_3,-1,2066,-1,0.3742988
2067,e,1,2,11,12,"48-telomer e, although EF5. 44 could lie in the interval L5.",1978564_7,-1,2067,-1,0.37793127
2068,cM,23,24,116,118,"48, but published deletion mapping in colorectal carcinomas and linkage analysis in FAP suggest that YN5. 48 is 1-3 cM from APC.",1978564_12,-1,2068,-1,0.38167065
2069,map,19,20,118,121,These data not only allow use of flanking markers for presymptomatic diagnosis of FAP but also provide a high-density map of the region for isolation of the APC gene itself and for further assessment of the role of chromosome 5 deletions in the biology of sporadic colorectal cancer.,1978564_16,-1,2069,-1,0.35473174
2070,colorectal cancer,46,48,265,282,These data not only allow use of flanking markers for presymptomatic diagnosis of FAP but also provide a high-density map of the region for isolation of the APC gene itself and for further assessment of the role of chromosome 5 deletions in the biology of sporadic colorectal cancer.,1978564_16,-1,2070,-1,0.2592342
2071,P,4,5,20,21,Serum amyloid A and P protein genes in familial Mediterranean fever.,1981994_0,-1,2071,-1,0.37016022
2072,familial Mediterranean fever,8,11,39,67,Serum amyloid A and P protein genes in familial Mediterranean fever.,1981994_0,-1,2072,-1,0.32850346
2073,P,15,16,80,81,"
Two recent studies have suggested the involvement of serum amyloid A (SAA) and P (APCS) genes in familial Mediterranean fever (MEF).",1981994_1,-1,2073,-1,0.3621276
2074,familial Mediterranean fever,21,24,98,126,"
Two recent studies have suggested the involvement of serum amyloid A (SAA) and P (APCS) genes in familial Mediterranean fever (MEF).",1981994_1,-1,2074,-1,0.3568036
2075,amyloidosis,31,32,157,168,"To test the role of SAA and APCS in MEF and MEF-amyloidosis, we studied 17 informative families (15 Armenians, 2 non-Ashkenazi Jews) and 8 MEF patients with amyloidosis using a candidate gene approach.",1981994_2,-1,2075,-1,0.28356016
2076,nucleotide,25,26,149,159,"All three of these variants, believed on the basis of biochemical characterization and population origin to be unique, have the G----A transition at nucleotide 202 and the A----G transition at nucleotide 376, mutations that we now recognize to be characteristic of G6PD A-.",1999339_3,-1,2076,-1,0.3256181
2077,nucleotide,32,33,193,203,"All three of these variants, believed on the basis of biochemical characterization and population origin to be unique, have the G----A transition at nucleotide 202 and the A----G transition at nucleotide 376, mutations that we now recognize to be characteristic of G6PD A-.",1999339_3,-1,2077,-1,0.31877947
2078,lupus erythematosus,8,10,56,75,Hereditary deficiency of C5 in association with discoid lupus erythematosus.,1999552_0,-1,2078,-1,0.33549696
2079,lupus erythematosus,5,7,34,53,"
A 29-year-old woman with discoid lupus erythematosus had undetectable classic pathway complement activity.",1999552_1,-1,2079,-1,0.31294996
2080,lupus erythematosus,14,16,85,104,To our knowledge this is the first documented case of an association between discoid lupus erythematosus and C5 deficiency..,1999552_4,-1,2080,-1,0.3427807
2081,phenylalanine,9,10,54,67,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2081,-1,0.36871374
2082,PAH,12,13,81,84,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2082,-1,0.3701644
2083,phenylalanine,14,15,86,99,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2083,-1,0.36250907
2084,oxygen,21,22,155,161,"
A missense mutation has been identified in the human phenylalanine hydroxylase [PAH; phenylalanine 4-monooxygenase; L-phenylalanine, tetrahydrobiopterin  oxygen oxidoreductase (4-hydroxylating), EC 1. 14. 16. 1] gene in a Chinese patient with classic phenylketonuria (PKU).",2006152_1,-1,2084,-1,0.32243147
2085,PAH,25,26,170,173,"Population genetic studies reveal that this mutation is tightly linked to restriction fragment length polymorphism haplotype 4, which is the predominant haplotype of the PAH locus in the Oriental population.",2006152_4,-1,2085,-1,0.34004706
2086,Na+/glucose,8,9,58,69,Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter.,2008213_0,-1,2086,-1,0.38017112
2087,disease,9,10,65,72,"
Glucose/galactose malabsorption (GGM) is an autosomal recessive disease manifesting within the first weeks of life and characterized by a selective failure to absorb dietary glucose and galactose from the intestine.",2008213_1,-1,2087,-1,0.35662374
2088,glucose,26,27,175,182,"
Glucose/galactose malabsorption (GGM) is an autosomal recessive disease manifesting within the first weeks of life and characterized by a selective failure to absorb dietary glucose and galactose from the intestine.",2008213_1,-1,2088,-1,0.2993411
2089,galactose,28,29,187,196,"
Glucose/galactose malabsorption (GGM) is an autosomal recessive disease manifesting within the first weeks of life and characterized by a selective failure to absorb dietary glucose and galactose from the intestine.",2008213_1,-1,2089,-1,0.30411628
2090,diarrhoea,3,4,22,31,The consequent severe diarrhoea and dehydration are usually fatal unless these sugars are eliminated from the diet.,2008213_2,-1,2090,-1,0.38284895
2092,Na,11,12,71,73,Intestinal biopsies of GGM patients have revealed a specific defect in Na (+) -dependent absorption of glucose in the brush border.,2008213_3,-1,2092,-1,0.37535775
2093,glucose,18,19,103,110,Intestinal biopsies of GGM patients have revealed a specific defect in Na (+) -dependent absorption of glucose in the brush border.,2008213_3,-1,2093,-1,0.29088822
2094,glucose,1,2,7,14,Normal glucose absorption is mediated by the Na +/glucose cotransporter in the brush border membrane of the intestinal epithelium.,2008213_4,-1,2094,-1,0.32762036
2095,Na,7,8,45,47,Normal glucose absorption is mediated by the Na +/glucose cotransporter in the brush border membrane of the intestinal epithelium.,2008213_4,-1,2095,-1,0.39369148
2096,Na,7,8,47,49,Cellular influx is driven by the transmembrane Na + electrochemical potential gradient; thereafter the sugar moves to the blood across the basolateral membrane via the facilitated glucose carrier.,2008213_5,-1,2096,-1,0.38100296
2097,glucose,27,28,180,187,Cellular influx is driven by the transmembrane Na + electrochemical potential gradient; thereafter the sugar moves to the blood across the basolateral membrane via the facilitated glucose carrier.,2008213_5,-1,2097,-1,0.33031958
2098,Na,7,8,42,44,"We have previously cloned and sequenced a Na +/glucose cotransporter from normal human ileum and shown that this gene, SGLT1, resides on the distal q arm of chromosome 22.",2008213_6,-1,2098,-1,0.38439915
2099,Na,27,28,169,171,Sequence analysis of the amplified products has revealed a single missense mutation in SGLT1 which cosegregates with the GGM phenotype and results in a complete loss of Na (+) -dependent glucose transport in Xenopus oocytes injected with this complementary RNA..,2008213_8,-1,2099,-1,0.3716173
2100,glucose,32,33,187,194,Sequence analysis of the amplified products has revealed a single missense mutation in SGLT1 which cosegregates with the GGM phenotype and results in a complete loss of Na (+) -dependent glucose transport in Xenopus oocytes injected with this complementary RNA..,2008213_8,-1,2100,-1,0.31589717
2101,Prader-Willi syndrome,13,15,86,107,A de novo unbalanced reciprocal translocation identified as paternal in origin in the Prader-Willi syndrome.,2016095_0,-1,2101,-1,0.40841675
2102,Prader-Willi syndrome,18,20,130,151,"
Interstitial cytogenetic deletions involving the paternally derived chromosome 15q11-13 have been described in patients with the Prader-Willi syndrome (PWS).",2016095_1,-1,2102,-1,0.39630333
2103,myotonic dystrophy,3,5,20,38,Localisation of the myotonic dystrophy locus to 19q13.2-19q13.3 and its relationship to twelve polymorphic loci on 19q.,2037285_0,-1,2103,-1,0.38401106
2104,myotonic dystrophy,8,10,47,65,We report here the linkage relationship of the myotonic dystrophy (DM) locus to twelve of these markers as studied in 45 families with DM.,2037285_2,-1,2104,-1,0.40080023
2105,DM,11,12,67,69,We report here the linkage relationship of the myotonic dystrophy (DM) locus to twelve of these markers as studied in 45 families with DM.,2037285_2,-1,2105,-1,0.39886802
2106,DM,25,26,135,137,We report here the linkage relationship of the myotonic dystrophy (DM) locus to twelve of these markers as studied in 45 families with DM.,2037285_2,-1,2106,-1,0.342559
2107,map,3,4,22,25,The resulting genetic map is supported by the localisation of the DNA markers in a panel of somatic cell hybrids.,2037285_3,-1,2107,-1,0.3653223
2108,DM,13,14,64,66,"Ten of the twelve markers have been shown to be proximal to the DM gene and two, PRKCG and D19S22, distal but at distances of approximately 25 cM and 15 cM, respectively.",2037285_4,-1,2108,-1,0.3873933
2109,cM,29,30,143,145,"Ten of the twelve markers have been shown to be proximal to the DM gene and two, PRKCG and D19S22, distal but at distances of approximately 25 cM and 15 cM, respectively.",2037285_4,-1,2109,-1,0.4006701
2110,cM,32,33,153,155,"Ten of the twelve markers have been shown to be proximal to the DM gene and two, PRKCG and D19S22, distal but at distances of approximately 25 cM and 15 cM, respectively.",2037285_4,-1,2110,-1,0.38691354
2111,creatine kinase,13,15,70,85,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2111,-1,0.29382864
2112,cM,20,21,111,113,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2112,-1,0.39005286
2113,cM,23,24,120,122,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2113,-1,0.38636076
2114,DM,26,27,132,134,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2114,-1,0.34447575
2115,APOC2-CKM-DM,33,34,167,179,"The closest proximal markers are APOC2 (apolipoprotein C-II) and CKM (creatine kinase, muscle) approximately 3 cM and 2 cM from the DM gene respectively, in the order APOC2-CKM-DM.",2037285_5,-1,2115,-1,0.34348416
2116,DM,7,8,36,38,"The distance between APOC2, CKM and DM (of the order of 2 million base pairs) and their known orientation should permit directional chromosome walking and jumping.",2037285_6,-1,2116,-1,0.3226961
2117,DM,23,24,136,138,The data presented here should enable us to determine whether or not new markers are distal to APOC2/CKM and thus potentially flank the DM gene..,2037285_7,-1,2117,-1,0.3722871
2118,HAL,9,10,56,59,"
The human gene for histidase (histidine ammonia-lyase; HAL), the enzyme deficient in histidinemia, was assigned to human chromosome 12 by Southern blot analysis of human X mouse somatic cell hybrid DNA.",2055114_1,-1,2118,-1,0.33054715
2119,histidinemia,16,17,86,98,"
The human gene for histidase (histidine ammonia-lyase; HAL), the enzyme deficient in histidinemia, was assigned to human chromosome 12 by Southern blot analysis of human X mouse somatic cell hybrid DNA.",2055114_1,-1,2119,-1,0.28007796
2120,Hal,7,8,35,38,"The homologous locus in the mouse (Hal) was mapped to region 10C2----D1 by in situ hybridization, using a cell line from a mouse homozygous for a 1. 10 Robertsonian translocation.",2055114_4,-1,2120,-1,0.31318074
2121,phenylalanine,20,21,135,148,"These assignments extend the conserved syntenic region between human chromosome 12 and mouse chromosome 10 that includes the genes for phenylalanine hydroxylase, gamma interferon, peptidase, and citrate synthase.",2055114_5,-1,2121,-1,0.3843822
2122,interferon,24,25,168,178,"These assignments extend the conserved syntenic region between human chromosome 12 and mouse chromosome 10 that includes the genes for phenylalanine hydroxylase, gamma interferon, peptidase, and citrate synthase.",2055114_5,-1,2122,-1,0.29621843
2123,citrate,29,30,195,202,"These assignments extend the conserved syntenic region between human chromosome 12 and mouse chromosome 10 that includes the genes for phenylalanine hydroxylase, gamma interferon, peptidase, and citrate synthase.",2055114_5,-1,2123,-1,0.37414798
2124,histidinemia,19,20,112,124,"The localization of histidase to mouse chromosome 10 suggests that the histidase regulatory locus (Hsd) and the histidinemia mutation (his), which are both known to be on chromosome 10, may be alleles of the histidase structural gene locus.",2055114_6,-1,2124,-1,0.31621212
2125,Lesch-Nyhan syndrome,7,9,51,71,Determination of the mutations responsible for the Lesch-Nyhan syndrome in 17 subjects.,2071157_0,-1,2125,-1,0.44072667
2126,purine,9,10,61,67,"
Hypoxanthine--guanine phosphoribosyltransferase (HPRT) is a purine salvage enzyme that catalyzes the conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate.",2071157_1,-1,2126,-1,0.28643888
2127,guanosine,24,25,169,178,"
Hypoxanthine--guanine phosphoribosyltransferase (HPRT) is a purine salvage enzyme that catalyzes the conversion of hypoxanthine to inosine monophosphate and guanine to guanosine monophosphate.",2071157_1,-1,2127,-1,0.30845547
2128,Lesch-Nyhan syndrome,32,34,237,257,The direct sequencing of the polymerase chain reaction-amplified product of reverse-transcribed HPRT mRNA enabled the rapid identification of the mutations found in 17 previously uncharacterized cell lines derived from patients with the Lesch-Nyhan syndrome..,2071157_4,-1,2128,-1,0.38329926
2129,adrenoleukodystrophy,10,11,64,84,"
We present a large kindred that contained patients with either adrenoleukodystrophy (ALD) or adrenomyeloneuropathy (AMN).",2161209_1,-1,2129,-1,0.32647502
2130,MZ,6,7,34,36,Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy.,2180286_0,-1,2130,-1,0.36437485
2131,muscular dystrophy,11,13,62,80,Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy.,2180286_0,-1,2131,-1,0.33552516
2132,MZ,3,4,15,17,"
One of female MZ twins presented with muscular dystrophy.",2180286_1,-1,2132,-1,0.3801058
2133,muscular dystrophy,7,9,39,57,"
One of female MZ twins presented with muscular dystrophy.",2180286_1,-1,2133,-1,0.3272089
2134,creatine,3,4,22,30,"Physical examination, creatine phosphokinase levels, and muscle biopsy were consistent with Duchenne muscular dystrophy (DMD).",2180286_2,-1,2134,-1,0.33200917
2135,muscular dystrophy,14,16,101,119,"Physical examination, creatine phosphokinase levels, and muscle biopsy were consistent with Duchenne muscular dystrophy (DMD).",2180286_2,-1,2135,-1,0.32703197
2136,muscular dystrophy,12,14,68,86,"However, because of her sex she was diagnosed as having limb-girdle muscular dystrophy.",2180286_3,-1,2136,-1,0.32865286
2138,uniparental disomy,21,23,139,157,"Both linkage analysis and DNA fingerprint analysis revealed that each twin has two different X chromosomes, eliminating the possibility of uniparental disomy as a mechanism for DMD expression.",2180286_11,-1,2138,-1,0.41264284
2139,MZ,15,16,92,94,"On the basis of methylation differences of the paternal and maternal X chromosomes in these MZ twins, we propose uneven lyonization (X chromosome inactivation) as the underlying mechanism for disease expression in the affected female..",2180286_12,-1,2139,-1,0.34380102
2140,disease,32,33,192,199,"On the basis of methylation differences of the paternal and maternal X chromosomes in these MZ twins, we propose uneven lyonization (X chromosome inactivation) as the underlying mechanism for disease expression in the affected female..",2180286_12,-1,2140,-1,0.34785962
2141,adrenal insufficiency,6,8,71,92,Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred.,218453_0,-1,2141,-1,0.32353333
2142,adrenoleukodystrophy,3,4,15,35,"
Four cases of adrenoleukodystrophy (ALD) and one case of adrenomyeloneuropathy (AMN) have developed in a kindred over three generations demonstrating that AMN is a clinical variant of ALD.",218453_1,-1,2142,-1,0.34278643
2143,adrenoleukodystrophy,3,4,15,35,"
Four cases of adrenoleukodystrophy (ALD) and one case of adrenomyeloneuropathy (AMN) have developed in a kindred over three generations demonstrating that AMN is a clinical variant of ALD.",218453_1,-1,2143,-1,0.34278643
2144,ACTH,8,9,59,63,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2144,-1,0.323326
2145,adrenal insufficiency,33,35,182,203,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2145,-1,0.3219696
2146,cortisol,39,40,228,236,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2146,-1,0.3037425
2147,ACTH,47,48,284,288,"However, basal morning plasma adrenocorticotropic hormone (ACTH) levels were markedly elevated in the two males with ALD and AMN, despite the fact that they had no clinical signs of adrenal insufficiency and that morning plasma cortisol levels and their response to maximal exogenous ACTH stimulation appeared to be normal.",218453_4,-1,2147,-1,0.31260142
2148,Friedreich ataxia,4,6,29,46,Regional localisation of the Friedreich ataxia locus to human chromosome 9q13----q21.1.,2209091_0,-1,2148,-1,0.37149656
2149,Friedreich ataxia,5,7,33,50,"
We have previously assigned the Friedreich ataxia locus (FRDA) to chromosome 9; the current maximal lod score between FRDA and MCT112 (D9S15) is greater than 50 at a recombination fraction of theta = 0.",2209091_1,-1,2149,-1,0.36343288
2150,disease,37,38,190,197,"We have used in situ hybridisation with MCT112, a corresponding cosmid MJ1, and DR47 (D9S5), coupled with mapping studies on hybrid cell panels, to define more precisely the location of the disease locus.",2209091_3,-1,2150,-1,0.38125837
2151,cholesteryl esters,12,14,79,97,The plasma cholesteryl-ester transfer protein (CETP) catalyzes the transfer of cholesteryl esters from high-density lipoprotein (HDL) to other lipoproteins.,2215607_2,-1,2151,-1,0.32956308
2152,n,7,8,47,48,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2152,-1,0.45821846
2154,cholesterol,17,18,101,112,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2154,-1,0.33260614
2155,SD,22,23,124,126,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2155,-1,0.41422084
2156,cholesterol,43,44,195,206,"Family members homozygous for CETP deficiency (n = 10) had moderate hypercholesterolemia (mean total cholesterol level [+/- SD], 7. 01 +/- 0. 83 mmol per liter), markedly increased levels of HDL cholesterol (4. 24 +/- 1.",2215607_8,-1,2156,-1,0.3211548
2157,cholesterol,15,16,91,102,"01 mmol per liter) and apolipoprotein A-I, and decreased levels of low-density lipoprotein cholesterol (1. 99 +/- 0. 80 mmol per liter) and apolipoprotein B. Members heterozygous for the deficiency (n = 20), whose CETP levels were in the lower part of the normal range, had moderately increased levels of HDL cholesterol and apolipoprotein A-I and an increased ratio of HDL subclass 2 to HDL subclass 3, as compared with unaffected family members (1. 5 +/- 0. 8 vs. 0. 7 +/- 0. 4).",2215607_9,-1,2157,-1,0.27870744
2158,n,38,39,199,200,"01 mmol per liter) and apolipoprotein A-I, and decreased levels of low-density lipoprotein cholesterol (1. 99 +/- 0. 80 mmol per liter) and apolipoprotein B. Members heterozygous for the deficiency (n = 20), whose CETP levels were in the lower part of the normal range, had moderately increased levels of HDL cholesterol and apolipoprotein A-I and an increased ratio of HDL subclass 2 to HDL subclass 3, as compared with unaffected family members (1. 5 +/- 0. 8 vs. 0. 7 +/- 0. 4).",2215607_9,-1,2158,-1,0.42239186
2159,cholesterol,62,63,309,320,"01 mmol per liter) and apolipoprotein A-I, and decreased levels of low-density lipoprotein cholesterol (1. 99 +/- 0. 80 mmol per liter) and apolipoprotein B. Members heterozygous for the deficiency (n = 20), whose CETP levels were in the lower part of the normal range, had moderately increased levels of HDL cholesterol and apolipoprotein A-I and an increased ratio of HDL subclass 2 to HDL subclass 3, as compared with unaffected family members (1. 5 +/- 0. 8 vs. 0. 7 +/- 0. 4).",2215607_9,-1,2159,-1,0.28782642
2160,cholesterol,12,13,74,85,CETP deficiency was not found in six unrelated subjects with elevated HDL cholesterol levels who were from different parts of the United States.,2215607_10,-1,2160,-1,0.31718054
2161,premature atherosclerosis,5,7,25,50,There was no evidence of premature atherosclerosis in the families with CETP deficiency.,2215607_14,-1,2161,-1,0.34020245
2162,cM,22,23,121,123,The present paper describes further mapping of the AT locus by means of a panel of 10 markers that span approximately 60 cM in the 11q22-23 region centered around S144 and THY1.,2220826_4,-1,2162,-1,0.38180795
2164,C9 deficiency,3,5,14,27,First case of C9 deficiency in Europe.,2241452_1,-1,2164,-1,0.3524476
2165,C9 deficiency,11,13,51,64,"
We describe the first cases, to our knowledge, of C9 deficiency in Europe that were detected in a Swiss family, of which two members--one with a complete deficiency and the other with approximately half-normal C9 levels--experienced bacterial meningitis.",2241452_2,-1,2165,-1,0.35551316
2169,hemolytic,21,22,132,141,"Complement assays showed a complete deficiency of the C9 component, while the other individual component levels were normal and the hemolytic activity (measured using the CH50 assay) was only slightly reduced.",2241452_5,-1,2169,-1,0.34304076
2170,C9 deficiency,5,7,33,46,"A family study revealed complete C9 deficiency in the patients healthy brother and half-normal C9 concentrations in his sister, his son (who also had experienced an episode of bacterial meningitis), and his niece, consistent with an inherited C9 deficiency.",2241452_6,-1,2170,-1,0.36237085
2172,C9 deficiency,42,44,243,256,"A family study revealed complete C9 deficiency in the patients healthy brother and half-normal C9 concentrations in his sister, his son (who also had experienced an episode of bacterial meningitis), and his niece, consistent with an inherited C9 deficiency.",2241452_6,-1,2172,-1,0.35397124
2174,C9 deficiency,12,14,73,86,"This first case of recurrent meningitis in a white patient with complete C9 deficiency suggests that this complement defect may also be a risk factor for bacterial, especially neisserial, infections..",2241452_7,-1,2174,-1,0.36171457
2176,muscular dystrophy,26,28,150,168,"When used in conjunction with an existing primer set, these two multiplex reactions detect about 98% of deletions in patients with Duchenne or Becker muscular dystrophy (DMD, BMD).",2253937_2,-1,2176,-1,0.35317206
2177,protein deficiency,50,52,256,274,These data demonstrate that  1) there is an identical 2-base pair deletion in an exon of the C5 gene in several different C5-deficient mouse strains; 2) the mRNA transcribed from the C5D gene retains this deletion; and 3) this mutation should result in C5 protein deficiency.,2303408_15,-1,2177,-1,0.35716823
2178,phenylalanine,17,18,100,113,Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene.,2309142_0,-1,2178,-1,0.35845792
2179,phenylalanine,14,15,82,95,"
Phenylketonuria (PKU) is a genetic disorder secondary to a deficiency of hepatic phenylalanine hydroxylase (PAH).",2309142_1,-1,2179,-1,0.3621297
2180,PAH,17,18,109,112,"
Phenylketonuria (PKU) is a genetic disorder secondary to a deficiency of hepatic phenylalanine hydroxylase (PAH).",2309142_1,-1,2180,-1,0.3452918
2181,PAH,4,5,25,28,"Several mutations in the PAH gene have recently been reported, and linkage disequilibrium was observed between RFLP haplotypes and specific mutations.",2309142_2,-1,2181,-1,0.32004052
2182,PAH,12,13,60,63,A new molecular lesion has been identified in exon 7 of the PAH gene in a Hungarian PKU patient by direct sequencing of PCR-amplified DNA.,2309142_3,-1,2182,-1,0.3208908
2183,PAH,24,25,140,143,"The C-to-T transition causes the substitution of Arg243 to a termination codon, and the mutant allele is associated with haplotype 4 of the PAH gene.",2309142_4,-1,2183,-1,0.3339523
2184,adrenoleukodystrophy,7,8,44,64,The red-green visual pigment gene region in adrenoleukodystrophy.,2309698_0,-1,2184,-1,0.3296092
2185,adrenoleukodystrophy,15,16,117,137,"
Although recent data established that a specific very-long-chain fatty acyl-CoA synthetase is defective in X-linked adrenoleukodystrophy (ALD), the ALD gene is still unidentified.",2309698_1,-1,2185,-1,0.334749
2186,color vision defects,42,45,243,263,"The previous report of such rearrangements was based on small numbers and lack of knowledge that the frequency of "" abnormal "" color vision arrays on molecular analysis was twice as high as expected on the basis of the frequency of phenotypic color vision defects.",2309698_7,-1,2186,-1,0.34239694
2187,disease,24,25,140,147,"It is possible, however, that phenotypic color vision anomalies in AMN may be phenocopies secondary to retinal or neural involvement by the disease.",2309698_13,-1,2187,-1,0.34468907
2188,diseases,15,16,91,99,The single case of blue cone monochromacy may therefore be a fortuitous coincidence of two diseases..,2309698_14,-1,2188,-1,0.38094193
2189,haemolysis,7,8,41,51,"Surprisingly, she has suffered only mild haemolysis and has never experienced massive spontaneous haemolysis.",2310692_4,-1,2189,-1,0.3219621
2190,haemolysis,14,15,98,108,"Surprisingly, she has suffered only mild haemolysis and has never experienced massive spontaneous haemolysis.",2310692_4,-1,2190,-1,0.29707327
2192,haemolysis,17,18,93,103,Both the Ham test and the sugar water test using normal human serum or plasma yielded marked haemolysis of the patients erythrocytes.,2310692_7,-1,2192,-1,0.3485815
2193,haemolysis,10,11,59,69,Addition of purified human C9 to her plasma fully restored haemolysis.,2310692_9,-1,2193,-1,0.31745422
2194,haemolysis,20,21,129,139,These observations indicated that C9 may play a critical role in haemolytic attacks in patients with PNH and that characteristic haemolysis in PNH may be tempered by coexisting C9 deficiency..,2310692_10,-1,2194,-1,0.3175921
2195,C9 deficiency,28,30,177,190,These observations indicated that C9 may play a critical role in haemolytic attacks in patients with PNH and that characteristic haemolysis in PNH may be tempered by coexisting C9 deficiency..,2310692_10,-1,2195,-1,0.34721208
2196,muscular dystrophy,5,7,39,57,"Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation.",2316519_0,-1,2196,-1,0.3623918
2197,muscular dystrophy,12,14,74,92,"
Partial gene deletion is the major cause of mutation leading to Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2316519_1,-1,2197,-1,0.33104137
2198,muscular dystrophy,19,21,110,128,"
Partial gene deletion is the major cause of mutation leading to Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2316519_1,-1,2198,-1,0.32339868
2199,map,15,16,116,119,"The extent of these duplications has been characterized according to the published exon-containing HindIII fragment map, and in six of the 10 duplications a novel restriction fragment that spanned the duplication junction was detected.",2316519_5,-1,2199,-1,0.3497886
2200,Glucose,0,1,0,7,Glucose 6-phosphate dehydrogenase variants: Gd (+) Alexandra associated with neonatal jaundice and Gd (-) Camperdown in a young man with lamellar cataracts.,23402_0,-1,2200,-1,0.33474544
2207,von Hippel-Lindau disease,9,12,56,81,"Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.",2352258_0,-1,2207,-1,0.3243557
2208,renal cell carcinoma,19,22,132,152,"Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.",2352258_0,-1,2208,-1,0.28605187
2209,retinoblastoma,10,11,67,81,"
Analysis of the age incidence curves for unilateral and bilateral retinoblastoma led Knudson to propose that hereditary tumours may arise by a single event and sporadic tumours by a two stage mutation process.",2352258_1,-1,2209,-1,0.29969278
2210,tumours,17,18,121,128,"
Analysis of the age incidence curves for unilateral and bilateral retinoblastoma led Knudson to propose that hereditary tumours may arise by a single event and sporadic tumours by a two stage mutation process.",2352258_1,-1,2210,-1,0.31495163
2211,tumours,26,27,170,177,"
Analysis of the age incidence curves for unilateral and bilateral retinoblastoma led Knudson to propose that hereditary tumours may arise by a single event and sporadic tumours by a two stage mutation process.",2352258_1,-1,2211,-1,0.3150387
2212,renal cell carcinoma,7,10,45,65,It has been suggested recently that sporadic renal cell carcinoma may arise from a two stage mutation process.,2352258_2,-1,2212,-1,0.29353938
2213,renal cell carcinoma,8,11,53,73,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2213,-1,0.31633034
2214,n,12,13,75,76,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2214,-1,0.43298298
2215,n,20,21,117,118,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2215,-1,0.42413285
2216,disease,33,34,170,177,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2216,-1,0.30426514
2217,renal cell carcinoma,43,46,227,247,"We analysed the age incidence curves for symptomatic renal cell carcinoma (n = 26) and cerebellar haemangioblastoma (n = 68) in 109 patients with von Hippel-Lindau (VHL) disease, and compared them to 104 patients with sporadic renal cell carcinoma and 43 patients with sporadic cerebellar haemangioblastoma.",2352258_3,-1,2217,-1,0.3170125
2218,renal cell carcinoma,5,8,29,49,"The age incidence curves for renal cell carcinoma and cerebellar haemangioblastoma in VHL disease were compatible with a single mutation model, whereas the age incidence curves for sporadic renal cell carcinoma and cerebellar haemangioblastoma suggested a two stage mutation process.",2352258_4,-1,2218,-1,0.31180328
2219,disease,13,14,90,97,"The age incidence curves for renal cell carcinoma and cerebellar haemangioblastoma in VHL disease were compatible with a single mutation model, whereas the age incidence curves for sporadic renal cell carcinoma and cerebellar haemangioblastoma suggested a two stage mutation process.",2352258_4,-1,2219,-1,0.3075148
2220,renal cell carcinoma,29,32,190,210,"The age incidence curves for renal cell carcinoma and cerebellar haemangioblastoma in VHL disease were compatible with a single mutation model, whereas the age incidence curves for sporadic renal cell carcinoma and cerebellar haemangioblastoma suggested a two stage mutation process.",2352258_4,-1,2220,-1,0.2978528
2221,tumour,12,13,71,77,These data are compatible with the VHL gene functioning as a recessive tumour suppressor gene.,2352258_5,-1,2221,-1,0.29953483
2222,renal cell carcinoma,5,8,47,67,Sporadic cerebellar haemangioblastoma and some renal cell carcinoma may arise from somatic mutations inactivating both alleles at the VHL locus..,2352258_6,-1,2222,-1,0.28451395
2223,Tay-Sachs disease,4,6,26,43,Screening for carriers of Tay-Sachs disease among Ashkenazi Jews.,2355960_0,-1,2223,-1,0.4059686
2224,Tay-Sachs disease,3,5,18,35,"The prevention of Tay-Sachs disease (GM2 gangliosidosis, type 1) depends on the identification of carriers of the gene for this autosomal recessive disorder.",2355960_3,-1,2224,-1,0.42963284
2225,Tay-Sachs disease,10,12,63,80,We compared the enzyme-based test widely used in screening for Tay-Sachs disease with a test based on analysis of DNA.,2355960_4,-1,2225,-1,0.42924073
2226,Tay-Sachs disease,25,27,151,168,"We developed methods to detect the three mutations in the HEXA gene that occur with high frequency among Ashkenazi Jews  two mutations cause infantile Tay-Sachs disease, and the third causes the adult-onset form of the disease.",2355960_5,-1,2226,-1,0.42575884
2227,disease,37,38,219,226,"We developed methods to detect the three mutations in the HEXA gene that occur with high frequency among Ashkenazi Jews  two mutations cause infantile Tay-Sachs disease, and the third causes the adult-onset form of the disease.",2355960_5,-1,2227,-1,0.33972347
2228,Tay-Sachs disease,6,8,40,57,"Among 62 Ashkenazi obligate carriers of Tay-Sachs disease, the three specific mutations accounted for all but one of the mutant alleles (98 percent).",2355960_8,-1,2228,-1,0.44270906
2229,disease,35,36,192,199,"Of the 177, 79 percent had the exon 11 insertion mutation, 18 percent had the intron 12 splice-junction mutation, and 3 percent had the less severe exon 7 mutation associated with adult-onset disease.",2355960_10,-1,2229,-1,0.3294376
2230,e,25,26,127,128,"In addition, of 152 persons defined as noncarriers by the enzyme-based test, 1 was identified as a carrier by DNA analysis (i. e e., a false negative enzyme-test result).",2355960_12,-1,2230,-1,0.47576576
2231,Tay-Sachs disease,26,28,159,176,The increased specificity and predictive value of the DNA-based test make it a useful adjunct to the diagnostic tests currently used to screen for carriers of Tay-Sachs disease.,2355960_14,-1,2231,-1,0.41574126
2232,cholesteryl ester,4,6,27,44,Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect.,2390095_0,-1,2232,-1,0.3285411
2233,cholesteryl ester,4,6,24,41,"
The molecular basis of cholesteryl ester transfer protein (CETP) deficiency was investigated in 4 unrelated CETP-deficient families.",2390095_1,-1,2233,-1,0.3641155
2234,C----T,1,2,2,8,"A C----T mutation at nucleotide 563 of G6PD Mediterranean has been identified by Vulliamy et al., and the same mutation has been found by De Vita et al. in G6PD Mediterranean, G6PD Sassari, and G6PD Cagliari.",2393028_4,-1,2234,-1,0.4188259
2235,nucleotide,4,5,21,31,"A C----T mutation at nucleotide 563 of G6PD Mediterranean has been identified by Vulliamy et al., and the same mutation has been found by De Vita et al. in G6PD Mediterranean, G6PD Sassari, and G6PD Cagliari.",2393028_4,-1,2235,-1,0.35282773
2236,nucleotide,9,10,51,61,"The latter subjects had an additional mutation, at nucleotide 1311, that did not produce a coding change.",2393028_5,-1,2236,-1,0.35133818
2237,nucleotide,6,7,29,39,All had both the mutation at nucleotide 563 and that at nucleotide 1311.,2393028_7,-1,2237,-1,0.34436134
2238,nucleotide,11,12,56,66,All had both the mutation at nucleotide 563 and that at nucleotide 1311.,2393028_7,-1,2238,-1,0.3362901
2239,nucleotide,33,34,205,215,"A sixth sample, resembling G6PD Mediterranean kinetically but with a slightly rapid electrophoretic mobility, was designated G6PD Andalus and was found to have a different mutation, a G----A transition at nucleotide 1361, producing an arginine-to-histidine substitution.",2393028_8,-1,2239,-1,0.32275912
2240,muscular dystrophy,24,26,138,156,"
We describe two brothers with identical inherited deletions of one single exon within the middle of the DMD gene; one brother has Becker muscular dystrophy diagnosed at 11 years of age, whereas the older brother is normal at 18.",2404853_1,-1,2240,-1,0.3408288
2241,muscular dystrophy,14,16,103,121,These results have implications for genetic counselling and prenatal diagnosis in families with Becker muscular dystrophy..,2404853_2,-1,2241,-1,0.33847755
2242,muscular dystrophy,1,3,9,27,Duchenne muscular dystrophy gene expression in normal and diseased human muscle.,2450401_0,-1,2242,-1,0.36164415
2243,muscular dystrophy,9,11,39,57,"
A probe for the 5 end of the Duchenne muscular dystrophy (DMD) gene was used to study expression of the gene in normal human muscle, myogenic cell cultures, and muscle from patients with DMD.",2450401_1,-1,2243,-1,0.3734384
2244,muscular dystrophy,15,17,109,127,Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene.,2491010_0,-1,2244,-1,0.35066095
2245,muscular dystrophy,5,7,44,62,"
Eighty unrelated individuals with Duchenne muscular dystrophy (DMD)or Becker muscular dystrophy (BMD) were found to have deletions in the major deletion-rich region of the DMD locus.",2491010_1,-1,2245,-1,0.33659324
2246,muscular dystrophy,9,11,78,96,"
Eighty unrelated individuals with Duchenne muscular dystrophy (DMD)or Becker muscular dystrophy (BMD) were found to have deletions in the major deletion-rich region of the DMD locus.",2491010_1,-1,2246,-1,0.33849078
2247,contrast,18,19,89,97,"This is in agreement with recent findings by Baumbach et al. and Koenig et al. but is in contrast to findings, by Malhotra et al. at the 5 ' end of the gene.",2491010_9,-1,2247,-1,0.3903124
2248,aniridia,9,10,78,86,"
Chromosome translocations involving 11p13 have been associated with familial aniridia in two kindreds highlighting the chromosomal localization of the AN2 locus.",2544995_1,-1,2248,-1,0.37285048
2249,Wilms tumor,10,12,45,56,"This locus is also part of the WAGR complex (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation).",2544995_2,-1,2249,-1,0.33813286
2250,aniridia,13,14,58,66,"This locus is also part of the WAGR complex (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation).",2544995_2,-1,2250,-1,0.36604732
2251,mental retardation,19,21,101,119,"This locus is also part of the WAGR complex (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation).",2544995_2,-1,2251,-1,0.33902013
2252,myotonic dystrophy,8,10,51,69,Linkage analysis of the apolipoprotein C2 gene and myotonic dystrophy on human chromosome 19 reveals linkage disequilibrium in a French-Canadian population.,2562820_0,-1,2252,-1,0.371014
2253,muscular dystrophy,33,35,163,181,"
The gene for human apolipoprotein C2 (APOC2), situated on the proximal long arm of chromosome 19, is closely linked to the gene for the most common form of adult muscular dystrophy, myotonic dystrophy (DM).",2562820_1,-1,2253,-1,0.31438527
2254,myotonic dystrophy,36,38,183,201,"
The gene for human apolipoprotein C2 (APOC2), situated on the proximal long arm of chromosome 19, is closely linked to the gene for the most common form of adult muscular dystrophy, myotonic dystrophy (DM).",2562820_1,-1,2254,-1,0.34120405
2255,DM,39,40,203,205,"
The gene for human apolipoprotein C2 (APOC2), situated on the proximal long arm of chromosome 19, is closely linked to the gene for the most common form of adult muscular dystrophy, myotonic dystrophy (DM).",2562820_1,-1,2255,-1,0.34492356
2256,DM,5,6,34,36,We have conducted a comprehensive DM linkage study utilizing all six RFLPs and involving 50 families and 372 individuals.,2562820_3,-1,2256,-1,0.37419313
2257,DM,6,7,51,53,We also demonstrate linkage disequilibrium between DM and APOC2 in our French-Canadian population (standardized disequilibrium constant phi =.,2562820_9,-1,2257,-1,0.32818434
2258,P,13,14,27,28,"22, chi 2 = 5. 12, df = 1, P less than 0. 04).",2562820_10,-1,2258,-1,0.4135128
2259,DM,12,13,83,85,This represents the first evidence of linkage disequilibrium between APOC2 and the DM locus.,2562820_11,-1,2259,-1,0.3783178
2260,Phenylalanine,0,1,0,13,Phenylalanine hydroxylase gene haplotypes in Polynesians: evolutionary origins and absence of alleles associated with severe phenylketonuria.,2563633_0,-1,2260,-1,0.35194206
2261,phenylalanine,7,8,35,48,"
A total of 630 haplotypes for the phenylalanine hydroxylase (PAH) gene locus were established in five groups of Polynesians comprising Samoans, Tongans, Cook Islanders, Maori, and Niueans.",2563633_1,-1,2261,-1,0.3659061
2262,PAH,10,11,62,65,"
A total of 630 haplotypes for the phenylalanine hydroxylase (PAH) gene locus were established in five groups of Polynesians comprising Samoans, Tongans, Cook Islanders, Maori, and Niueans.",2563633_1,-1,2262,-1,0.36937916
2263,PAH,20,21,116,119,"The absence of severe phenylketonuria (PKU) in both Polynesians and Southeast Asians is consistent with the lack of PAH haplotypes 2 and 3, on which the severe PKU mutants have arisen among Caucasians..",2563633_5,-1,2263,-1,0.37444958
2264,retinoblastoma,8,9,57,71,Preferential germline mutation of the paternal allele in retinoblastoma.,2568588_0,-1,2264,-1,0.30625746
2265,retinoblastoma tumours,9,11,56,78,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2265,-1,0.28378564
2266,retinoblastoma,22,23,146,160,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2266,-1,0.31083602
2267,RB1,25,26,167,170,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2267,-1,0.3167816
2268,RB1,34,35,210,213,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2268,-1,0.28919896
2269,tumour,39,40,236,242,"
The event triggering malignant proliferation in 70% of retinoblastoma tumours is loss of heterozygosity for chromosome 13q14, whereby the normal retinoblastoma gene (RB1) allele is lost and an already mutated RB1 allele remains in the tumour.",2568588_1,-1,2269,-1,0.28760627
2270,retinoblastoma,8,9,50,64,"Most bilateral patients have no family history of retinoblastoma and are presumed to have new germline mutations which arose in the egg, sperm or early embryo.",2568588_3,-1,2270,-1,0.27751905
2271,retinoblastoma tumours,12,14,70,92,We have determined the parental origin of the retained allele in nine retinoblastoma tumours from eight unrelated non-familial cases by using RB1-linked genetic markers.,2568588_4,-1,2271,-1,0.28261796
2272,tumours,1,2,4,11,Six tumours retained the paternal allele and three retained the maternal allele.,2568588_5,-1,2272,-1,0.36666104
2273,tumours,4,5,24,31,"Of the three unilateral tumours, only one retained the paternal RB1 allele.",2568588_6,-1,2273,-1,0.28724465
2274,RB1,11,12,64,67,"Of the three unilateral tumours, only one retained the paternal RB1 allele.",2568588_6,-1,2274,-1,0.33278874
2275,RB1,9,10,45,48,"Thus, there is no evidence that the paternal RB1 allele is preferentially retained in retinoblastoma, as has been suggested to be the case in osteosarcoma.",2568588_7,-1,2275,-1,0.32644838
2276,retinoblastoma,15,16,86,100,"Thus, there is no evidence that the paternal RB1 allele is preferentially retained in retinoblastoma, as has been suggested to be the case in osteosarcoma.",2568588_7,-1,2276,-1,0.2731069
2277,osteosarcoma,26,27,142,154,"Thus, there is no evidence that the paternal RB1 allele is preferentially retained in retinoblastoma, as has been suggested to be the case in osteosarcoma.",2568588_7,-1,2277,-1,0.28000417
2278,contrast,1,2,3,11,"By contrast, tumours from four of the five bilateral patients retained the paternal RB1 allele.",2568588_8,-1,2278,-1,0.3801844
2279,tumours,3,4,13,20,"By contrast, tumours from four of the five bilateral patients retained the paternal RB1 allele.",2568588_8,-1,2279,-1,0.3383167
2280,RB1,14,15,84,87,"By contrast, tumours from four of the five bilateral patients retained the paternal RB1 allele.",2568588_8,-1,2280,-1,0.34729916
2281,RB1,6,7,39,42,"This suggests either that new germline RB1 mutations arise more frequently during spermatogenesis than during oogenesis, or that imprinting in the early embryo affects chromosomal susceptibility to mutation..",2568588_9,-1,2281,-1,0.32120645
2282,phenylalanine,4,5,26,39,Haplotype analysis of the phenylalanine hydroxylase gene in Turkish phenylketonuria families.,2569949_0,-1,2282,-1,0.34355873
2283,phenylalanine,10,11,67,80,"
We have estimated the haplotype distribution of mutant and normal phenylalanine hydroxylase (PAH) alleles for 17 Turkish phenylketonuria (PKU) families  20 normal and 27 mutated PAH alleles could be identified.",2569949_1,-1,2283,-1,0.35707662
2284,PAH,13,14,94,97,"
We have estimated the haplotype distribution of mutant and normal phenylalanine hydroxylase (PAH) alleles for 17 Turkish phenylketonuria (PKU) families  20 normal and 27 mutated PAH alleles could be identified.",2569949_1,-1,2284,-1,0.37286764
2285,PAH,30,31,179,182,"
We have estimated the haplotype distribution of mutant and normal phenylalanine hydroxylase (PAH) alleles for 17 Turkish phenylketonuria (PKU) families  20 normal and 27 mutated PAH alleles could be identified.",2569949_1,-1,2285,-1,0.32131696
2286,Huntington disease,0,2,0,18,Huntington disease: no evidence for locus heterogeneity.,2571579_0,-1,2286,-1,0.3533345
2287,Huntington disease,6,8,29,47,"
A total of 63 families with Huntington disease (HD) were examined for linkage between HD and G8 (D4S10).",2571579_1,-1,2287,-1,0.34281704
2288,choroideremia,7,8,53,66,Haplotype and multipoint linkage analysis in Finnish choroideremia families.,2575071_0,-1,2288,-1,0.34848836
2289,choroideremia,4,5,32,45,"
Multipoint linkage analysis of choroideremia (TCD) and seven X chromosomal restriction fragment length polymorphisms (RFLPs) was carried out in 18 Finnish TCD families.",2575071_1,-1,2289,-1,0.36219782
2290,choroideremia,11,12,82,95,"This supports the previously described hypothesis that the large Northern Finnish choroideremia pedigrees, comprising a total of over 80 living patients representing more than a fifth of all TCD patients described worldwide, carry the same mutation.",2575071_8,-1,2290,-1,0.33962762
2291,aniridia,2,3,19,27,Autosomal dominant aniridia linked to the chromosome 11p13 markers catalase and D11S151 in a large Dutch family.,2575483_0,-1,2291,-1,0.36998382
2292,aniridia,7,8,45,53,"
In a large pedigree with autosomal dominant aniridia, we found close linkage between the aniridia locus AN2 and the markers catalase (CAT) (zeta = 7.",2575483_1,-1,2292,-1,0.38304448
2293,aniridia,15,16,90,98,"
In a large pedigree with autosomal dominant aniridia, we found close linkage between the aniridia locus AN2 and the markers catalase (CAT) (zeta = 7.",2575483_1,-1,2293,-1,0.42051247
2294,aniridia,6,7,40,48,We conclude that the autosomal dominant aniridia in this family is due to a mutation at the AN2 locus on 11p13.,2575483_5,-1,2294,-1,0.3837421
2295,aniridia,19,20,82,90,We have excluded linkage (zeta less than -2 at theta less than 0. 18) between the aniridia and the chromosome 2p25 marker D2S1 (linked to ACP1).,2575483_6,-1,2295,-1,0.4052267
2296,myotonic dystrophy,4,6,33,51,Recombination events that locate myotonic dystrophy distal to APOC2 on 19q.,2591962_0,-1,2296,-1,0.36522132
2297,myotonic dystrophy,9,11,62,80,"
We previously reported a recombination in an individual with myotonic dystrophy (DM) which placed the markers D19S19 and APOC2 on the same side of the DM locus.",2591962_1,-1,2297,-1,0.36857903
2298,DM,12,13,82,84,"
We previously reported a recombination in an individual with myotonic dystrophy (DM) which placed the markers D19S19 and APOC2 on the same side of the DM locus.",2591962_1,-1,2298,-1,0.37070197
2299,DM,27,28,152,154,"
We previously reported a recombination in an individual with myotonic dystrophy (DM) which placed the markers D19S19 and APOC2 on the same side of the DM locus.",2591962_1,-1,2299,-1,0.36330104
2300,DM,15,16,102,104,Haplotyping of this family with more recently characterized probes which are either tightly linked to DM or distal to the linkage group at q13.,2591962_2,-1,2300,-1,0.3704145
2301,DM,4,5,17,19,2 shows that the DM locus is distal to APOC2.,2591962_3,-1,2301,-1,0.3906991
2302,DM,7,8,46,48,This is confirmed by other recombinants where DM segregates with distal probes.,2591962_4,-1,2302,-1,0.38082874
2303,DM,18,19,127,129,"Additional marker to marker recombinations in unaffected individuals are reported and support the order and orientation of the DM linkage group as pter- (INSR, LDLR, S9) - (S19, BCL3, APOC2) - (CKMM, DM) - (S22, + + + PRKCG) -qter.",2591962_5,-1,2303,-1,0.35835105
2304,DM,42,43,200,202,"Additional marker to marker recombinations in unaffected individuals are reported and support the order and orientation of the DM linkage group as pter- (INSR, LDLR, S9) - (S19, BCL3, APOC2) - (CKMM, DM) - (S22, + + + PRKCG) -qter.",2591962_5,-1,2304,-1,0.34260505
2305,DM,8,9,49,51,The data presented here cannot determine whether DM is proximal or distal to CKMM.,2591962_6,-1,2305,-1,0.35685903
2306,DM,21,22,129,131,The consequences of this probe order for antenatal diagnosis and future research aiming to isolate the gene which is affected in DM are discussed.,2591962_7,-1,2306,-1,0.33752355
2307,RB1,3,4,17,20,Mutations in the RB1 gene and their effects on transcription.,2601691_0,-1,2307,-1,0.32504174
2308,RB1,6,7,37,40,"
Inactivation of both alleles of the RB1 gene during normal retinal development initiates the formation of a retinoblastoma (RB) tumor.",2601691_1,-1,2308,-1,0.3099357
2309,retinoblastoma,17,18,109,123,"
Inactivation of both alleles of the RB1 gene during normal retinal development initiates the formation of a retinoblastoma (RB) tumor.",2601691_1,-1,2309,-1,0.27742308
2311,RB1,6,7,43,46,"To identify the mutations which inactivate RB1, 21 RB tumors isolated from 19 patients were analyzed with the polymerase chain reaction or an RNase protection assay or both.",2601691_2,-1,2311,-1,0.31031513
2315,nucleotide,18,19,84,94,"Mutations were identified in 13 of 21 RB tumors; in 8 tumors, the precise errors in nucleotide sequence were characterized.",2601691_3,-1,2315,-1,0.33421266
2316,RB1,32,33,192,195,"Each of four germ line mutations involved a small deletion or duplication, while three somatic mutations were point mutations leading to splice alterations and loss of an exon from the mature RB1 mRNA.",2601691_4,-1,2316,-1,0.3096187
2318,RB1,44,45,264,267,"We were unable to detect expression of the mutant allele in lymphoblasts of three bilaterally affected patients, although the mutation was present in the genomic DNA and transcripts containing the mutations were obvious in the RB tumors in the absence of a normal RB1 allele.",2601691_5,-1,2318,-1,0.3017071
2319,RB1,13,14,88,91,The variations in the level of expression of mutant transcripts suggest deregulation of RB1 transcription in the absence of a functional RB1 gene product..,2601691_6,-1,2319,-1,0.31164542
2320,RB1,21,22,137,140,The variations in the level of expression of mutant transcripts suggest deregulation of RB1 transcription in the absence of a functional RB1 gene product..,2601691_6,-1,2320,-1,0.29997236
2321,Langer-Giedion syndrome,4,6,28,51,Partial deletion 8q without Langer-Giedion syndrome: a recognisable syndrome.,2651669_0,-1,2321,-1,0.36256436
2322,syndrome,9,10,68,76,Partial deletion 8q without Langer-Giedion syndrome: a recognisable syndrome.,2651669_0,-1,2322,-1,0.33691466
2323,Langer-Giedion syndrome,12,14,73,96,The clinical features were similar and there were no obvious stigmata of Langer-Giedion syndrome (LGS).,2651669_3,-1,2323,-1,0.35878044
2324,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM).,2703233_0,-1,2324,-1,0.35750705
2325,creatine kinase,10,12,65,80,Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM).,2703233_0,-1,2325,-1,0.2832668
2326,creatine,9,10,54,62,"
We have studied genetic linkage between the gene for creatine kinase muscle type (CKMM) and the gene for myotonic dystrophy (DM).",2703233_1,-1,2326,-1,0.2918121
2327,myotonic dystrophy,20,22,106,124,"
We have studied genetic linkage between the gene for creatine kinase muscle type (CKMM) and the gene for myotonic dystrophy (DM).",2703233_1,-1,2327,-1,0.3640388
2328,DM,23,24,126,128,"
We have studied genetic linkage between the gene for creatine kinase muscle type (CKMM) and the gene for myotonic dystrophy (DM).",2703233_1,-1,2328,-1,0.34854504
2329,myotonic dystrophy,5,7,17,35,"In a panel of 65 myotonic dystrophy families from Canada and the Netherlands, a maximum lod score (Zmax) of 22.",2703233_2,-1,2329,-1,0.36750573
2330,Color vision defects,0,3,0,20,Color vision defects in adrenomyeloneuropathy.,2729274_0,-1,2330,-1,0.3858854
2331,adrenoleukodystrophy,34,35,191,211,"These observations confirm our earlier impression that the frequency of abnormal color vision is increased in these kindreds, and it supports our contentions that (1) AMN (and its companion, adrenoleukodystrophy) are very closely linked to the visual pigment loci at Xq28 and (2) this proximity might provide the opportunity to observe contiguous gene defects..",2729274_4,-1,2331,-1,0.3358661
2332,Lesch-Nyhan,12,13,78,89,"
We report the identification of a female patient with the X-linked recessive Lesch-Nyhan syndrome (hypoxanthine phosphoribosyltransferase [HPRT] deficiency).",2760209_1,-1,2332,-1,0.40183124
2333,syndrome,13,14,90,98,"
We report the identification of a female patient with the X-linked recessive Lesch-Nyhan syndrome (hypoxanthine phosphoribosyltransferase [HPRT] deficiency).",2760209_1,-1,2333,-1,0.3111035
2334,disease,34,35,200,207,"Comparison of this patients DNA with the DNA of her parents revealed that a microdeletion, which occurred within a maternal gamete and involved the entire HPRT gene, was partially responsible for the disease in this patient.",2760209_3,-1,2334,-1,0.36144993
2335,Pelizaeus-Merzbacher disease,0,2,0,28,Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein.,2773936_0,-1,2335,-1,0.36702734
2336,Pelizaeus-Merzbacher disease,2,4,14,42,"Historically, Pelizaeus-Merzbacher disease has encompassed a host of neurologic disorders that present with a deficit of myelin, the membrane elaborated by glial cells that encircles and successively enwraps axons.",2773936_2,-1,2336,-1,0.37156907
2337,Pelizaeus-Merzbacher disease,4,6,28,56,"To discriminate variants of Pelizaeus-Merzbacher disease, a set of oligonucleotide primers was constructed to polymerase-chain-reaction (PCR) amplify and sequence the gene encoding proteolipid protein (PLP), a structural protein that comprises half of the protein of the myelin sheath.",2773936_4,-1,2337,-1,0.34775552
2338,Pelizaeus-Merzbacher disease,7,9,47,75,"Our results delineate the clinical features of Pelizaeus-Merzbacher disease, define the possible molecular pathology of this dysmyelinating disorder, and address the molecular classification of inborn errors of myelin metabolism.",2773936_6,-1,2338,-1,0.34519696
2339,Pelizaeus-Merzbacher disease,18,20,94,122,"Patients with the classical form (type I) and the more severely affected, connatal variant of Pelizaeus-Merzbacher disease (type II) would be predicted to display mutation at the PLP locus.",2773936_7,-1,2339,-1,0.3682838
2340,Pelizaeus-Merzbacher disease,14,16,76,104,"The other variants (types III-VI), which have sometimes been categorized as Pelizaeus-Merzbacher disease, may represent mutations in genes encoding other structural myelin proteins or proteins critical to myelination..",2773936_8,-1,2340,-1,0.3518575
2341,disease,6,7,40,47,Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.,2786201_0,-1,2341,-1,0.30742225
2342,disease,2,3,16,23,"
von Willebrand disease (vWD), the most common inherited bleeding disorder in humans, can result from either a quantitative or a qualitative defect in the adhesive glycoprotein, von Willebrand factor (vWF).",2786201_1,-1,2342,-1,0.2736847
2346,aniridia,7,8,67,75,Translocation t(5;11)(q13.1;p13) associated with familial isolated aniridia.,2817003_0,-1,2346,-1,0.3620009
2347,aniridia,6,7,37,45,"
A father and daughter with isolated aniridia were observed to have an apparently balanced, reciprocal translocation involving chromosomes 5 and 11 [t (5; 11) (q13. 1; p13)].",2817003_1,-1,2347,-1,0.36563247
2348,aniridia,15,16,82,90,"This finding, in association with 3 other instances of single breaks at 11p13 and aniridia, supports the assignment of AN2 to 11p13.",2817003_3,-1,2348,-1,0.37918788
2349,disease,4,5,38,45,Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.,2828430_0,-1,2349,-1,0.38052073
2350,abetalipoproproteinemia,7,8,60,83,Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.,2828430_0,-1,2350,-1,0.33217937
2351,abetalipoproteinemia,9,10,58,78,"These results are distinct from those previously noted in abetalipoproteinemia, which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein..",2828430_7,-1,2351,-1,0.32893014
2352,Lesch-Nyhan syndrome,8,10,51,71,"
Molecular analysis of an unusual patient with the Lesch-Nyhan syndrome has suggested that the mutation is due to a partial HPRT gene duplication.",2835825_1,-1,2352,-1,0.4089216
2353,Lesch-Nyhan syndrome,9,11,53,73,This may explain the relatively mild symptoms of the Lesch-Nyhan syndrome exhibited by this patient..,2835825_8,-1,2353,-1,0.42830408
2354,glycerol kinase deficiency,1,4,8,34,"Complex glycerol kinase deficiency: molecular-genetic, cytogenetic, and clinical studies of five Japanese patients.",2852474_0,-1,2354,-1,0.34743187
2355,glycerol kinase deficiency,6,9,42,68,"
Five male Japanese patients with complex glycerol kinase deficiency (CGKD) and their relatives were studied clinically, cytogenetically, and molecular-genetically.",2852474_1,-1,2355,-1,0.33457768
2356,muscular dystrophy,3,5,17,35,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2356,-1,0.3638136
2357,muscle weakness,6,8,39,54,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2357,-1,0.35270175
2358,mental retardation,9,11,56,74,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2358,-1,0.33743244
2359,glycerol kinase deficiency,17,20,111,137,"All patients had muscular dystrophy or muscle weakness, mental retardation, congenital adrenal hypoplasia, and glycerol kinase deficiency.",2852474_2,-1,2359,-1,0.336046
2360,muscular dystrophy,16,18,103,121,A comparison of the clinical manifestations of the present five patients and reported CGKD or Duchenne muscular dystrophy (DMD) patients with DNA deletion suggests the existence of a certain gene responsible for gonadotropin deficiency (GTD).,2852474_7,-1,2360,-1,0.3520203
2361,ornithine,15,16,87,96,"The result of the present study and results of previous studies suggest that genes for ornithine transcarbamylase (OTC), DMD, and GK and putative genes responsible for congenital adrenal hypoplasia (AHC) and GTD are arranged from telomere to centromere as pter--GTD--AHC--GK--DMD--OTC--cen",2852474_8,-1,2361,-1,0.36764097
2362,chronic active hepatitis,10,13,67,91,Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis.,2862466_0,-1,2362,-1,0.38565645
2363,chronic active hepatitis,5,8,32,56,"
Of 26 patients with autoimmune chronic active hepatitis (CAH) starting in childhood 18 (69%) had low C4 and 5 (19%) had low C3 serum levels.",2862466_1,-1,2363,-1,0.39516106
2364,phenylalanine,17,18,106,119,"
Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH, phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",2884570_1,-1,2364,-1,0.37122414
2365,PAH,20,21,133,136,"
Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH, phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",2884570_1,-1,2365,-1,0.3821206
2366,phenylalanine,22,23,138,151,"
Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH, phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",2884570_1,-1,2366,-1,0.37612015
2367,PAH,20,21,128,131,"To define the molecular basis of PKU, we characterized twelve restriction fragment-length polymorphism (RFLP) haplotypes of the PAH locus in the northern European population and observed that 90% of the PKU alleles in this population are confined to four common RFLP haplotypes.",2884570_3,-1,2367,-1,0.331034
2368,PAH,9,10,53,56,We have recently reported a splicing mutation in the PAH gene that is associated with RFLP haplotype 3 which is present at about 40% of mutant alleles.,2884570_4,-1,2368,-1,0.31582665
2369,Trp,19,20,104,107,This defect is caused by a C-to-T transition in exon 12 resulting in an amino-acid substitution (Arg to Trp) at residue 408 of PAH.,2884570_6,-1,2369,-1,0.3321865
2370,PAH,25,26,127,130,This defect is caused by a C-to-T transition in exon 12 resulting in an amino-acid substitution (Arg to Trp) at residue 408 of PAH.,2884570_6,-1,2370,-1,0.35047626
2371,PAH,34,35,220,223,Direct hybridization analysis of the point mutation using a specific oligonucleotide probe demonstrated that this mutation is also in linkage disequilibrium with RFLP haplotype 2 alleles that make up about 20% of mutant PAH genes,2884570_7,-1,2371,-1,0.31808972
2372,Choroideremia,0,1,0,13,Choroideremia: close linkage to DXYS1 and DXYS12 demonstrated by segregation analysis and historical-genealogical evidence.,2886237_0,-1,2372,-1,0.34476787
2373,choroideremia,14,15,106,119,"
Linkage studies using restriction fragment length polymorphisms were conducted in the X-linked disorder, choroideremia, designated TCD for Progressive Tapeto-Choroidal Dystrophy.",2886237_1,-1,2373,-1,0.34045708
2374,disease,1,2,4,11,The disease mainly occurs in three large kindreds in remote Northern Finland.,2886237_6,-1,2374,-1,0.34825656
2375,Von Hippel-Lindau disease,0,3,0,25,Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.,2894613_0,-1,2375,-1,0.356344
2376,renal cell carcinoma,12,15,77,97,Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.,2894613_0,-1,2376,-1,0.29057845
2377,Von Hippel-Lindau disease,0,3,1,26,"
Von Hippel-Lindau disease (VHL) is an autosomal dominant disorder with inherited susceptibility to various forms of cancer, including hemangioblastomas of the central nervous system, phaeochromocytomas, pancreatic malignancies, and renal cell carcinomas.",2894613_1,-1,2377,-1,0.3563624
2381,tumours,19,20,128,135,"Renal cell carcinomas constitute a particularly frequent cause of death in this disorder, occurring as bilateral and multifocal tumours, and presenting at an earlier age than in sporadic, non-familial cases of this tumour type.",2894613_2,-1,2381,-1,0.2806741
2382,tumour,35,36,215,221,"Renal cell carcinomas constitute a particularly frequent cause of death in this disorder, occurring as bilateral and multifocal tumours, and presenting at an earlier age than in sporadic, non-familial cases of this tumour type.",2894613_2,-1,2382,-1,0.29025868
2383,tumour,9,10,56,62,An alternative or prior event to oncogene activation in tumour formation may be the inactivation of a putative tumour suppressor which can be associated with both the inherited and sporadic forms of the cancer.,2894613_6,-1,2383,-1,0.3087047
2384,tumour,18,19,111,117,An alternative or prior event to oncogene activation in tumour formation may be the inactivation of a putative tumour suppressor which can be associated with both the inherited and sporadic forms of the cancer.,2894613_6,-1,2384,-1,0.31577685
2386,renal cell carcinoma,7,10,51,71,"Consequently, sporadic and VHL-associated forms of renal cell carcinoma might both result from alterations causing loss of function of the same tumour suppressor gene on this chromosome..",2894613_8,-1,2386,-1,0.2797805
2387,tumour,22,23,144,150,"Consequently, sporadic and VHL-associated forms of renal cell carcinoma might both result from alterations causing loss of function of the same tumour suppressor gene on this chromosome..",2894613_8,-1,2387,-1,0.3017267
2388,oculocerebrorenal syndrome,7,9,45,71,"Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment.",2895982_0,-1,2388,-1,0.36018637
2389,oculocerebrorenal syndrome,2,4,10,36,"
The Lowe oculocerebrorenal syndrome (OCRL) is characterized by congenital cataract, mental retardation, and defective renal tubular function.",2895982_1,-1,2389,-1,0.35589838
2391,mental retardation,13,15,85,103,"
The Lowe oculocerebrorenal syndrome (OCRL) is characterized by congenital cataract, mental retardation, and defective renal tubular function.",2895982_1,-1,2391,-1,0.31870887
2392,map,1,2,2,5,"A map assignment of OCRL to Xq24-q26 has been made previously by linkage analysis with DXS42 at Xq24-q26 (theta = 0, z = 5. 09) and with DXS10 at Xq26 (theta = 0, z = 6. 45).",2895982_2,-1,2392,-1,0.40241754
2393,syndrome,13,14,69,77,Evidence for placing OCRL at Xq25 also comes from a female with Lowe syndrome and an X; 3 translocation.,2895982_6,-1,2393,-1,0.3170786
2394,nucleotide,4,5,27,37,Identification of a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale) responsible for Lesch-Nyhan syndrome.,2910902_0,-1,2394,-1,0.34006307
2395,Lesch-Nyhan syndrome,16,18,131,151,Identification of a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale) responsible for Lesch-Nyhan syndrome.,2910902_0,-1,2395,-1,0.42891562
2396,Lesch-Nyhan syndrome,10,12,89,109,"
Complete deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) causes the Lesch-Nyhan syndrome.",2910902_1,-1,2396,-1,0.3962501
2397,Lesch-Nyhan syndrome,16,18,86,106,"Previous characterization of a mutant form of HPRT, HPRTYale, from a subject with the Lesch-Nyhan syndrome revealed normal mRNA and protein concentrations, no residual catalytic activity, and cathodal migration upon PAGE.",2910902_2,-1,2397,-1,0.40680945
2398,nucleotide,1,2,4,14,The nucleotide sequence of full-length HPRTYale cDNA revealed a single nucleotide substitution compared with normal HPRT cDNA  G----C at nucleotide position 211.,2910902_4,-1,2398,-1,0.4002522
2399,nucleotide,10,11,71,81,The nucleotide sequence of full-length HPRTYale cDNA revealed a single nucleotide substitution compared with normal HPRT cDNA  G----C at nucleotide position 211.,2910902_4,-1,2399,-1,0.38922462
2400,nucleotide,20,21,137,147,The nucleotide sequence of full-length HPRTYale cDNA revealed a single nucleotide substitution compared with normal HPRT cDNA  G----C at nucleotide position 211.,2910902_4,-1,2400,-1,0.41575825
2401,glycine,7,8,56,63,"This transversion predicts substitution of arginine for glycine at amino acid position 71, explaining the cathodal migration of HPRTYale.",2910902_5,-1,2401,-1,0.33820602
2402,amino acid,9,11,67,77,"This transversion predicts substitution of arginine for glycine at amino acid position 71, explaining the cathodal migration of HPRTYale.",2910902_5,-1,2402,-1,0.38843343
2403,glycine,10,11,55,62,Inclusion of the bulky arginine side chain in place of glycine probably disrupts protein folding as well.,2910902_7,-1,2403,-1,0.34892246
2404,glucose,5,6,34,41,"
The human X-linked gene encoding glucose 6-phosphate dehydrogenase (G6PD) is highly polymorphic; more than 300 G6PD variants have been identified.",2912069_1,-1,2404,-1,0.346046
2406,glucose,8,9,52,59,Chronic nonspherocytic hemolytic anemia (CNSHA) and glucose 6 phosphate dehydrogenase (G6PD) deficiency in a patient with familial amyloidotic polyneuropathy (FAP).,2912886_0,-1,2406,-1,0.34180894
2412,C,22,23,116,117,"Heat stability was found to be markedly decreased (8% of residual activity after 20 min of incubation at 46 degrees C) and a particular characteristic of this enzyme was a biphasic pH curve with a greatly increased activity at low pH. Although molecular characteristics of this variant closely resemble those of G6PD Bangkok and G6PD Duarte, it can be distinguished from these and all other previously reported variants by virtue of its unusual pH curve.",2912886_7,-1,2412,-1,0.38465884
2413,retinoblastoma,9,10,76,90,Molecular detection of chromosomal translocations that disrupt the putative retinoblastoma susceptibility locus.,2927388_0,-1,2413,-1,0.31600466
2414,retinoblastoma,12,13,72,86,"
A candidate DNA sequence with many of the properties predicted for the retinoblastoma susceptibility (RB1) locus has been cloned (S. H. Friend, R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja, Nature [London] 323  643-645, 1986).",2927388_1,-1,2414,-1,0.3158924
2415,RB1,15,16,103,106,"
A candidate DNA sequence with many of the properties predicted for the retinoblastoma susceptibility (RB1) locus has been cloned (S. H. Friend, R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja, Nature [London] 323  643-645, 1986).",2927388_1,-1,2415,-1,0.31837264
2416,ca,7,8,29,31,The large size of this gene (ca.,2927388_2,-1,2416,-1,0.39639828
2417,map,14,15,83,86,"Here we used field inversion gel electrophoresis (FIGE) to construct a restriction map of approximately 1, 000 kb of DNA surrounding the RB1 locus and to detect the translocation breakpoints in three retinoblastoma patients.",2927388_4,-1,2417,-1,0.37445897
2418,RB1,25,26,137,140,"Here we used field inversion gel electrophoresis (FIGE) to construct a restriction map of approximately 1, 000 kb of DNA surrounding the RB1 locus and to detect the translocation breakpoints in three retinoblastoma patients.",2927388_4,-1,2418,-1,0.29579863
2419,retinoblastoma,35,36,200,214,"Here we used field inversion gel electrophoresis (FIGE) to construct a restriction map of approximately 1, 000 kb of DNA surrounding the RB1 locus and to detect the translocation breakpoints in three retinoblastoma patients.",2927388_4,-1,2419,-1,0.279227
2420,RB1,26,27,159,162,"Both probes identified an additional hybridizing fragment in the DNA from each patient, permitting the breakpoints in all three to be mapped within the cloned RB1 gene.",2927388_6,-1,2420,-1,0.31253508
2421,RB1,11,12,70,73,Analysis of the breakpoint in one translocation cell line allowed the RB1 gene to be oriented with its 5 end toward the centromere.,2927388_7,-1,2421,-1,0.31563768
2422,retinoblastoma,11,12,72,86,The detection and mapping of the translocation breakpoints of all three retinoblastoma patients to within the putative RB1 gene substantiated the authenticity of this candidate sequence and demonstrated the utility of FIGE in detecting chromosomal rearrangements affecting this locus.,2927388_9,-1,2422,-1,0.2781253
2423,RB1,17,18,119,122,The detection and mapping of the translocation breakpoints of all three retinoblastoma patients to within the putative RB1 gene substantiated the authenticity of this candidate sequence and demonstrated the utility of FIGE in detecting chromosomal rearrangements affecting this locus.,2927388_9,-1,2423,-1,0.33174714
2426,bacterial infections,15,17,104,124,"
A 10-year-old Laotian boy had homozygous deficiency of the third component of complement and recurrent bacterial infections beginning at age 5 months.",2963536_1,-1,2426,-1,0.2739755
2427,hemolytic,2,3,26,35,"Serum complement-mediated hemolytic, chemotactic, and opsonic activities were deficient.",2963536_3,-1,2427,-1,0.35991457
2428,hemolytic,10,11,59,68,"In vitro addition of purified C3 to patient serum restored hemolytic complement to normal levels, and plasma infusion during each of four episodes of pneumonia significantly enhanced serum opsonic activity for as long as 36 hours.",2963536_4,-1,2428,-1,0.37308523
2429,pneumonia,25,26,150,159,"In vitro addition of purified C3 to patient serum restored hemolytic complement to normal levels, and plasma infusion during each of four episodes of pneumonia significantly enhanced serum opsonic activity for as long as 36 hours.",2963536_4,-1,2429,-1,0.34177944
2431,disease,11,12,84,91,These findings further support the association of C3 deficiency with immune-complex disease and suggest that plasma infusion may be an adjunct to antibiotic therapy in the management of severe pyogenic infections in patients with C3 deficiency..,2963536_6,-1,2431,-1,0.34018597
2433,emphysema,36,37,174,183,"A deficiency of AAT in individuals homozygous for the PI Z allele occurs in about 1 in 2, 000-8, 000 caucasians and is associated with an increased risk of early adult onset emphysema and liver disease in childhood.",2989709_2,-1,2433,-1,0.3595692
2434,disease,39,40,194,201,"A deficiency of AAT in individuals homozygous for the PI Z allele occurs in about 1 in 2, 000-8, 000 caucasians and is associated with an increased risk of early adult onset emphysema and liver disease in childhood.",2989709_2,-1,2434,-1,0.37025315
2435,muscular dystrophy,11,13,80,98,Segregation analysis of a marker localised Xp21.2-Xp21.3 in Duchenne and Becker muscular dystrophy families.,2995231_0,-1,2435,-1,0.35323206
2436,muscular dystrophy,10,12,57,75,"3, has been studied in kindreds segregating for Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2995231_3,-1,2436,-1,0.3349922
2437,muscular dystrophy,17,19,93,111,"3, has been studied in kindreds segregating for Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD).",2995231_3,-1,2437,-1,0.33429065
2438,Prader-Willi syndrome,12,14,83,104,Isolation of molecular probes associated with the chromosome 15 instability in the Prader-Willi syndrome.,3012567_0,-1,2438,-1,0.4020687
2439,Prader-Willi syndrome,18,20,113,134,"
Flow cytometry and recombinant DNA techniques have been used to obtain reagents for a molecular analysis of the Prader-Willi syndrome (PWS).",3012567_1,-1,2439,-1,0.4028787
2440,diseases,20,21,117,125,2 may elucidate the molecular basis for the instability of this chromosomal region in patients with the PWS or other diseases associated with chromosomal abnormalities in the proximal long arm of human chromosome 15,3012567_10,-1,2440,-1,0.3220901
2441,muscular dystrophy,11,13,68,86,Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy.,3014348_0,-1,2441,-1,0.32677123
2442,muscular dystrophy,1,3,10,28,"
Duchenne muscular dystrophy (DMD) is an X-linked recessive genetic disorder for which the biochemical defect is as yet unknown.",3014348_1,-1,2442,-1,0.3397669
2443,muscular dystrophy,33,35,198,216,Here we describe the combined results of more than 20 research laboratories with respect to the occurrence of deletions at the DXS164 locus in DNA samples isolated from patients with DMD and Becker muscular dystrophy (BMD).,3014348_5,-1,2443,-1,0.32726732
2444,Lesch-Nyhan syndrome,5,7,29,49,A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.,3029599_0,-1,2444,-1,0.43293333
2445,Lesch-Nyhan syndrome,2,4,11,31,"
The human Lesch-Nyhan syndrome is a rare neurological and behavioural disorder, affecting only males, which is caused by an inherited deficiency in the level of activity of the purine salvage enzyme hypoxanthine-guanosine phosphoribosyl transferase (HPRT).",3029599_1,-1,2445,-1,0.4523496
2446,purine,30,31,178,184,"
The human Lesch-Nyhan syndrome is a rare neurological and behavioural disorder, affecting only males, which is caused by an inherited deficiency in the level of activity of the purine salvage enzyme hypoxanthine-guanosine phosphoribosyl transferase (HPRT).",3029599_1,-1,2446,-1,0.3064119
2447,purine,5,6,33,39,How the resulting alterations in purine metabolism lead to the severe symptoms characteristic of Lesch-Nyhan patients is still not understood.,3029599_2,-1,2447,-1,0.3212323
2448,lead,7,8,51,55,How the resulting alterations in purine metabolism lead to the severe symptoms characteristic of Lesch-Nyhan patients is still not understood.,3029599_2,-1,2448,-1,0.38650903
2449,Lesch-Nyhan syndrome,7,9,34,54,"To derive an animal model for the Lesch-Nyhan syndrome, we have used cultured mouse embryonic stem cells, mutagenized by retroviral insertion and selected for loss of HPRT activity, to construct chimaeric mice.",3029599_4,-1,2449,-1,0.4245872
2450,retinoblastoma,12,13,75,89,Re-evaluation of the sublocalization of esterase D and its relation to the retinoblastoma locus by in situ hybridization.,3032521_0,-1,2450,-1,0.29764187
2451,retinoblastoma,6,7,33,47,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2451,-1,0.30003342
2452,retinoblastoma,16,17,100,114,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2452,-1,0.31839165
2453,RB1,18,19,116,119,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2453,-1,0.2994769
2454,RB1,26,27,151,154,"A deletion in an individual with retinoblastoma was reported to separate the closely linked ESD and retinoblastoma (RB1) loci, placing ESD proximal to RB1.",3032521_6,-1,2454,-1,0.31607512
2455,RB1,26,27,149,152,"From these findings, we conclude that the deletion in this individual cannot be used to determine the orientation nor the sublocalization of ESD and RB1 within the 13q14 region.",3032521_9,-1,2455,-1,0.2895565
2456,common variable immunodeficiency,5,8,41,73,Hereditary C2 deficiency associated with common variable immunodeficiency.,313733_0,-1,2456,-1,0.34317714
2457,immunodeficiency,11,12,76,92,"
Homozygous C2 deficiency in a 19-year-old boy was associated with variable immunodeficiency manifested by marked hypoimmunoglobulinemia and impaired antibody responses, normal circulating B lymphocytes, and subnormal T-cell functions.",313733_1,-1,2457,-1,0.3336625
2458,muscular dystrophy,3,5,16,34,Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome.,3162536_0,-1,2458,-1,0.32060042
2459,muscular dystrophy,11,13,70,88,"
We have analysed over 300 patients suffering from Duchenne or Becker muscular dystrophy (DMD or BMD).",3162536_1,-1,2459,-1,0.342243
2460,muscular dystrophy,8,10,50,68,Patterns of exon deletions in Duchenne and Becker muscular dystrophy.,3169738_0,-1,2460,-1,0.33650228
2461,muscular dystrophy,8,10,46,64,"
A panel of patients with Duchenne and Becker muscular dystrophy (DMD and BMD) has been screened with the cDNA probes Cf56a and Cf23a, which detect exons in the central part of the DMD gene.",3169738_1,-1,2461,-1,0.34997442
2463,skin rash,14,16,82,91,"Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.",318684_0,-1,2463,-1,0.3371975
2464,arthralgias,18,19,97,108,"Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.",318684_0,-1,2464,-1,0.31818876
2466,skin rash,9,11,60,69,"
A previously well 34-month-old male presenting with fever, skin rash, and arthralgias was found to lack C3 by immunochemical (undetectable) and hemolytic (1% normal) assays.",318684_1,-1,2466,-1,0.3550862
2467,arthralgias,13,14,75,86,"
A previously well 34-month-old male presenting with fever, skin rash, and arthralgias was found to lack C3 by immunochemical (undetectable) and hemolytic (1% normal) assays.",318684_1,-1,2467,-1,0.328665
2468,hemolytic,25,26,145,154,"
A previously well 34-month-old male presenting with fever, skin rash, and arthralgias was found to lack C3 by immunochemical (undetectable) and hemolytic (1% normal) assays.",318684_1,-1,2468,-1,0.34953186
2469,hemolytic,9,10,35,44,"C4, C5, properdin, and C3b-INA and hemolytic activities of complement components C1 to C9 except C3 were normal or elevated; total hemolytic complement activity was 13% of normal and was reconstituted by purified C3.",318684_4,-1,2469,-1,0.30500185
2470,hemolytic,25,26,131,140,"C4, C5, properdin, and C3b-INA and hemolytic activities of complement components C1 to C9 except C3 were normal or elevated; total hemolytic complement activity was 13% of normal and was reconstituted by purified C3.",318684_4,-1,2470,-1,0.33863357
2471,skin rash,49,51,263,272,A transfusion of 320 ml 1-hour-old normal whole blood on the fifty-second day resulted in transitory elevation of the C3 level to 25 mg/dl with a fall-off (approximately 2 1/2% per hour) to undetectable levels by 69 hours; it was followed by disappearance of the skin rash and arthralgias and return to normal of the previously elevated temperature and CRP levels.,318684_7,-1,2471,-1,0.37277135
2472,arthralgias,52,53,277,288,A transfusion of 320 ml 1-hour-old normal whole blood on the fifty-second day resulted in transitory elevation of the C3 level to 25 mg/dl with a fall-off (approximately 2 1/2% per hour) to undetectable levels by 69 hours; it was followed by disappearance of the skin rash and arthralgias and return to normal of the previously elevated temperature and CRP levels.,318684_7,-1,2472,-1,0.34526113
2475,skin rash,24,26,142,151,"Thus, this child is a unique individual with inherited C3 deficiency presenting with absence of repeated infections, whose symptoms of fever, skin rash, and arthralgia were abated by whole blood transfusion..",318684_9,-1,2475,-1,0.36978942
2476,arthralgia,28,29,157,167,"Thus, this child is a unique individual with inherited C3 deficiency presenting with absence of repeated infections, whose symptoms of fever, skin rash, and arthralgia were abated by whole blood transfusion..",318684_9,-1,2476,-1,0.3489483
2477,disease,18,19,122,129,Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.,3258663_0,-1,2477,-1,0.31083545
2478,disease,3,4,23,30,"
Severe von Willebrand disease is characterized by undetectable or trace quantities of von Willebrand factor in plasma and tissue stores.",3258663_1,-1,2478,-1,0.3053089
2479,P,22,23,148,149,Gene dosage analysis was consistent with heterozygous deletions in both of the asymptomatic parents and four asymptomatic siblings of this kindred (P less than 0. 01).,3258663_5,-1,2479,-1,0.41504544
2480,disease,12,13,86,93,These techniques should prove useful in identifying carriers of severe von Willebrand disease and also in defining patients predictably at risk of developing alloantibodies to vWF.,3258663_10,-1,2480,-1,0.32175854
2481,Sjogren-Larsson syndrome,0,2,0,24,Sjogren-Larsson syndrome.,3343337_0,-1,2481,-1,0.37158152
2482,alcohol,2,3,15,22,Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.,3343337_1,-1,2482,-1,0.3262007
2483,alcohol,11,12,80,87,Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.,3343337_1,-1,2483,-1,0.33295706
2484,Sjogren-Larsson syndrome,15,17,102,126,"
Lipid metabolism was studied in cultured skin fibroblasts from patients with the inherited disorder, Sjogren-Larsson syndrome (SLS).",3343337_2,-1,2484,-1,0.30085573
2485,alcohol,8,9,56,63,Hexadecanol accumulation was not due to increased fatty alcohol synthesis nor its deficient utilization for glycerol ether synthesis.,3343337_5,-1,2485,-1,0.3851371
2486,ether,16,17,117,122,Hexadecanol accumulation was not due to increased fatty alcohol synthesis nor its deficient utilization for glycerol ether synthesis.,3343337_5,-1,2486,-1,0.348221
2487,fatty acid,36,38,203,213,"The half-life of intracellular hexadecanol loaded into SLS fibroblasts was increased (70 min) compared with normal (15 min), and intact SLS fibroblasts showed impaired oxidation of [14C] -hexadecanol to fatty acid.",3343337_6,-1,2487,-1,0.3536124
2488,alcohol  NAD,1,4,6,18,"Fatty alcohol  NAD + oxidoreductase, the enzyme catalyzing this reaction, was deficient in SLS fibroblasts.",3343337_7,-1,2488,-1,0.37548804
2489,n,7,8,40,41,Mean total activity in SLS fibroblasts (n = 5),3343337_8,-1,2489,-1,0.4614683
2490,alcohol  NAD,13,16,76,88,These results suggest that the primary defect in SLS is deficiency of fatty alcohol  NAD + oxidoreductase.,3343337_11,-1,2490,-1,0.37186718
2491,alcohol,15,16,100,107,SLS represents the first inherited disorder in man associated with an isolated abnormality in fatty alcohol metabolism..,3343337_12,-1,2491,-1,0.32544723
2492,muscular dystrophy,4,6,31,49,Germinal mosaicism in Duchenne muscular dystrophy.,3346017_0,-1,2492,-1,0.3279659
2493,muscular dystrophy,5,7,31,49,"
We have identified a Duchenne muscular dystrophy (DMD) pedigree where the disease is associated with a molecular deletion within the DMD locus.",3346017_1,-1,2493,-1,0.3536279
2494,disease,13,14,75,82,"
We have identified a Duchenne muscular dystrophy (DMD) pedigree where the disease is associated with a molecular deletion within the DMD locus.",3346017_1,-1,2494,-1,0.36041373
2495,muscular dystrophy,13,15,75,93,"
The presence of nebulin in a muscle specimen from a patient with Duchenne muscular dystrophy (DMD) due to a large deletion precludes the possibility that this protein is the DMD gene product..",3346018_1,-1,2495,-1,0.31862763
2496,muscular dystrophy,5,7,34,52,Expression of the murine Duchenne muscular dystrophy gene in muscle and brain.,3347839_0,-1,2496,-1,0.3532557
2497,muscular dystrophy,6,8,35,53,5 kilobases of the murine Duchenne muscular dystrophy (Dmd) messenger RNA (mRNA).,3347839_2,-1,2497,-1,0.33915526
2498,muscular dystrophy,16,18,100,118,The identification of Dmd mRNA in brain raises the possibility of a relation between human Duchenne muscular dystrophy (DMD) gene expression and the mental retardation found in some DMD males.,3347839_5,-1,2498,-1,0.3506823
2499,mental retardation,25,27,149,167,The identification of Dmd mRNA in brain raises the possibility of a relation between human Duchenne muscular dystrophy (DMD) gene expression and the mental retardation found in some DMD males.,3347839_5,-1,2499,-1,0.33657932
2500,Glucose,0,1,0,7,Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.,3348216_0,-1,2500,-1,0.33740452
2502,glucose,10,11,68,75,"
We have evaluated the hypothesis of a negative association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and cancer in a cohort of 481 Sardinian males with hematological malignancies.",3348216_1,-1,2502,-1,0.3543767
2504,hematological malignancies,27,29,171,197,"
We have evaluated the hypothesis of a negative association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and cancer in a cohort of 481 Sardinian males with hematological malignancies.",3348216_1,-1,2504,-1,0.26235363
2505,disease,24,25,149,156,The same conclusion resulted from the comparison of the frequency of expression of the GdB gene in 23 heterozygous women having a clonal hematologic disease and a control group of 37 healthy heterozygotes.,3348216_3,-1,2505,-1,0.32857746
2506,hematologic neoplasms,17,19,110,131,Therefore at present there is no evidence that G6PD deficiency has a protective effect against development of hematologic neoplasms..,3348216_4,-1,2506,-1,0.29434127
2507,Hepatoblastoma,0,1,0,14,"Hepatoblastoma, pigmented ocular fundus lesions and jaw lesions in Gardner syndrome.",3354603_0,-1,2507,-1,0.32403252
2508,Gardner syndrome,10,12,67,83,"Hepatoblastoma, pigmented ocular fundus lesions and jaw lesions in Gardner syndrome.",3354603_0,-1,2508,-1,0.31107903
2509,Hepatoblastoma,0,1,1,15,"
Hepatoblastoma is a rare neoplasm of infants and children only recently documented in association with hereditary adenomatous polyposis of the colon [Kingston et al., 1983].",3354603_1,-1,2509,-1,0.32843277
2510,neoplasm,4,5,26,34,"
Hepatoblastoma is a rare neoplasm of infants and children only recently documented in association with hereditary adenomatous polyposis of the colon [Kingston et al., 1983].",3354603_1,-1,2510,-1,0.3110176
2511,hepatoblastoma,5,6,29,43,We report four children with hepatoblastoma from four unrelated families with Gardner syndrome (GS).,3354603_2,-1,2511,-1,0.32092357
2512,Gardner syndrome,11,13,78,94,We report four children with hepatoblastoma from four unrelated families with Gardner syndrome (GS).,3354603_2,-1,2512,-1,0.31396365
2513,hepatoblastoma,14,15,61,75,"One child, now 19 years old, survived after a resection of a hepatoblastoma in infancy and recently was found to have GS.",3354603_3,-1,2513,-1,0.33704442
2514,odontoma,4,5,21,29,"He has an associated odontoma and pigmented ocular fundus lesions, both of which have been shown to be clinical markers of GS.",3354603_4,-1,2514,-1,0.3436044
2515,colonic polyps,3,5,13,27,A search for colonic polyps should be made in families of infants and children with hepatoblastoma.,3354603_6,-1,2515,-1,0.32041618
2516,hepatoblastoma,15,16,84,98,A search for colonic polyps should be made in families of infants and children with hepatoblastoma.,3354603_6,-1,2516,-1,0.30763862
2517,colonic polyps,16,18,81,95,"If the child survives, he or she should be monitored for the later appearance of colonic polyps.",3354603_7,-1,2517,-1,0.31729153
2518,Tay-Sachs disease,8,10,54,71,Identification of an altered splice site in Ashkenazi Tay-Sachs disease.,3362213_0,-1,2518,-1,0.40081295
2519,Tay-Sachs disease,0,2,1,18,"
Tay-Sachs disease is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A (ref. 1).",3362213_1,-1,2519,-1,0.4491194
2520,disease,17,18,82,89,"A relatively high frequency of carriers (1/27) of a lethal, infantile form of the disease is found in the Ashkenazi Jewish population, but it is not yet evident whether this has resulted from a founder effect and random genetic drift or from a selective advantage of heterozygotes.",3362213_2,-1,2520,-1,0.34926355
2521,C,7,8,35,36,"This change, the substitution of a C for G in the first nucleotide of intron 12 is expected to result in defective splicing of the messenger RNA.",3362213_4,-1,2521,-1,0.36025506
2522,nucleotide,13,14,56,66,"This change, the substitution of a C for G in the first nucleotide of intron 12 is expected to result in defective splicing of the messenger RNA.",3362213_4,-1,2522,-1,0.37833047
2523,Tay-Sachs disease,42,44,237,254,"A test for the mutant allele based on amplification of DNA by the polymerase chain rection and cleavage of a DdeI restriction site generated by the mutation revealed that this case and two other cases of the Ashkenazi, infantile form of Tay-Sachs disease are heterozygous for two different mutations.",3362213_5,-1,2523,-1,0.4217346
2524,X-linked,0,1,0,8,X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus.,3377761_0,-1,2524,-1,0.37128797
2526,favism,13,14,70,76,"In one of the commonest, G6PD Mediterranean, which is associated with favism among other clinical manifestations, a single amino acid replacement was found (serine----phenylalanine)  it must be responsible for the decreased stability and the reduced catalytic efficiency of this enzyme.",3393536_7,-1,2526,-1,0.33547562
2527,amino acid,21,23,123,133,"In one of the commonest, G6PD Mediterranean, which is associated with favism among other clinical manifestations, a single amino acid replacement was found (serine----phenylalanine)  it must be responsible for the decreased stability and the reduced catalytic efficiency of this enzyme.",3393536_7,-1,2527,-1,0.3906779
2530,myotonic dystrophy,3,5,22,40,Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides.,3417303_0,-1,2530,-1,0.37816817
2531,E,7,8,60,61,Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides.,3417303_0,-1,2531,-1,0.4173475
2532,myotonic dystrophy,4,6,21,39,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2532,-1,0.3677132
2533,DM,7,8,41,43,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2533,-1,0.36206585
2534,E,29,30,190,191,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2534,-1,0.42944795
2535,DM,35,36,208,210,"
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific oligonucleotides has been employed to study the linkage relationship between the apolipoprotein E (APOE) gene and DM.",3417303_1,-1,2535,-1,0.3248637
2536,DM,1,2,4,6,"For DM and APOE, a maximum lod score (zmax of 7. 47 was obtained at a recombination frequency (theta) of 0.",3417303_4,-1,2536,-1,0.3587403
2537,DM,17,18,93,95,"These results suggest that, in addition to APOC2, APOE is a useful marker for presymptomatic DM diagnosis.",3417303_9,-1,2537,-1,0.32542658
2538,choroideremia,19,20,123,136,Regional localization of polymorphic DNA loci on the proximal long arm of the X chromosome using deletions associated with choroideremia.,3422216_0,-1,2538,-1,0.34150735
2539,choroideremia,12,13,71,84,"
In two unrelated families, males have been identified who suffer from choroideremia and at the same time have an interstitial deletion on the proximal long arm of the X chromosome.",3422216_1,-1,2539,-1,0.34025943
2540,choroideremia,21,22,125,138,By Southern blot analysis we have mapped ten different polymorphic DNA loci relative to the position of the deletion and the choroideremia locus TCD.,3422216_7,-1,2540,-1,0.35608277
2541,phenylalanine,5,6,43,56,Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells.,3455778_0,-1,2541,-1,0.3504213
2542,hepatoma,11,12,86,94,Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells.,3455778_0,-1,2542,-1,0.33094838
2543,phenylalanine,12,13,69,82,"
Phenylketonuria (PKU) is caused by deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",3455778_1,-1,2543,-1,0.36598554
2544,PAH,15,16,96,99,"
Phenylketonuria (PKU) is caused by deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH).",3455778_1,-1,2544,-1,0.34159487
2545,PAH,3,4,20,23,"A full-length human PAH cDNA sequence has been inserted into pzip-neoSV (X), which is a retroviral vector containing the bacterial neo gene.",3455778_2,-1,2545,-1,0.32905778
2546,PAH,22,23,128,131,"Recombinant virus was detected in the culture medium of the transfected psi 2 cells, which is capable of transmitting the human PAH gene into mouse NIH 3T3 cells by infection leading to stable incorporation of the recombinant provirus.",3455778_4,-1,2546,-1,0.35113835
2548,PAH,3,4,23,26,"Infected cells express PAH mRNA, immunoreactive PAH protein, and exhibit pterin-dependent phenylalanine hydroxylase activity.",3455778_5,-1,2548,-1,0.2999926
2549,PAH,7,8,48,51,"Infected cells express PAH mRNA, immunoreactive PAH protein, and exhibit pterin-dependent phenylalanine hydroxylase activity.",3455778_5,-1,2549,-1,0.30782673
2550,phenylalanine,13,14,90,103,"Infected cells express PAH mRNA, immunoreactive PAH protein, and exhibit pterin-dependent phenylalanine hydroxylase activity.",3455778_5,-1,2550,-1,0.33566236
2551,hepatoma,10,11,59,67,The recombinant virus is also capable of infecting a mouse hepatoma cell line that does not normally synthesize PAH.,3455778_6,-1,2551,-1,0.34982955
2552,PAH,18,19,112,115,The recombinant virus is also capable of infecting a mouse hepatoma cell line that does not normally synthesize PAH.,3455778_6,-1,2552,-1,0.35807937
2553,PAH,0,1,0,3,PAH activity is present in the cellular extracts and the entire hydroxylation system is reconstituted in the hepatoma cells infected with the recombinant viruses.,3455778_7,-1,2553,-1,0.31677562
2554,hepatoma,17,18,109,117,PAH activity is present in the cellular extracts and the entire hydroxylation system is reconstituted in the hepatoma cells infected with the recombinant viruses.,3455778_7,-1,2554,-1,0.34037927
2555,PAH,6,7,43,46,"Thus, recombinant viruses containing human PAH cDNA provide a means for introducing functional PAH into mammalian cells of hepatic origin and can potentially be introduced into whole animals as a model for somatic gene therapy for PKU..",3455778_8,-1,2555,-1,0.3109034
2556,PAH,14,15,95,98,"Thus, recombinant viruses containing human PAH cDNA provide a means for introducing functional PAH into mammalian cells of hepatic origin and can potentially be introduced into whole animals as a model for somatic gene therapy for PKU..",3455778_8,-1,2556,-1,0.31980345
2557,muscular dystrophy,19,21,122,140,Estimation of the male to female ratio of mutation rates from the segregation of X-chromosomal DNA haplotypes in Duchenne muscular dystrophy families.,3464560_0,-1,2557,-1,0.35371402
2558,muscular dystrophy,17,19,100,118,"
A novel procedure is presented to estimate the ratio of male to female mutation rates for Duchenne muscular dystrophy (DMD).",3464560_1,-1,2558,-1,0.3276073
2559,contrast,1,2,3,11,"In contrast to classical methods, the proposed procedure is not restricted to sporadic or familiar cases nor is any information on the carrier status of female relatives required..",3464560_4,-1,2559,-1,0.38335976
2561,Retinoblastoma,0,1,1,15,"
Retinoblastoma is a childhood tumor that can arise because of mutant alleles acquired as somatic or germinal mutations.",3480530_1,-1,2561,-1,0.30035955
2563,RB1,23,24,144,147,The mutations creating these alleles act by inactivating copies of a recessive oncogene located within band q14 of chromosome 13 and termed the RB1 locus.,3480530_3,-1,2563,-1,0.3220136
2564,retinoblastoma,19,20,125,139,We have reported isolation of a cDNA fragment that recognizes chromosomal sequences possessing many of the attributes of the retinoblastoma gene associated with the RB1 locus.,3480530_4,-1,2564,-1,0.3017442
2565,RB1,24,25,165,168,We have reported isolation of a cDNA fragment that recognizes chromosomal sequences possessing many of the attributes of the retinoblastoma gene associated with the RB1 locus.,3480530_4,-1,2565,-1,0.30968645
2567,retinoblastoma,23,24,154,168,We now report that this segment is additionally the target of somatic mutations in mesenchymal tumors among patients having no apparent predisposition to retinoblastoma and no previous evidence of retinoblastoma.,3480530_5,-1,2567,-1,0.25927436
2568,retinoblastoma,29,30,197,211,We now report that this segment is additionally the target of somatic mutations in mesenchymal tumors among patients having no apparent predisposition to retinoblastoma and no previous evidence of retinoblastoma.,3480530_5,-1,2568,-1,0.2538068
2570,muscular dystrophy,3,5,22,40,Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.,3524231_0,-1,2570,-1,0.33465597
2571,growth hormone,6,8,46,60,Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.,3524231_0,-1,2571,-1,0.32730937
2572,mazindol,9,10,60,68,"
A controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was performed in a pair of 7 1/2 year-old monozygotic twins, with Duchenne muscular dystrophy (DMD).",3524231_1,-1,2572,-1,0.34226087
2573,muscular dystrophy,30,32,173,191,"
A controlled, double-blind therapeutic trial with the drug mazindol, a growth hormone inhibitor, was performed in a pair of 7 1/2 year-old monozygotic twins, with Duchenne muscular dystrophy (DMD).",3524231_1,-1,2573,-1,0.32467085
2574,growth hormone,19,21,111,125,"The rationale for this trial was based on a patient (reported previously) affected simultaneously with DMD and growth hormone (GH) deficiency, who is showing a benign course of the dystrophic process and is still walking at 18 years.",3524231_2,-1,2574,-1,0.36488974
2575,mg,6,7,28,30,"One of the twins received 2 mg of mazindol daily, while the other received a placebo.",3524231_3,-1,2575,-1,0.34969756
2576,mazindol,8,9,34,42,"One of the twins received 2 mg of mazindol daily, while the other received a placebo.",3524231_3,-1,2576,-1,0.3336602
2577,disease,5,6,33,40,"
Many mutations leading to human disease are the result of single DNA base pair changes that cannot be identified by Southern analysis.",3563511_1,-1,2577,-1,0.3375213
2578,Lesch-Nyhan syndrome,36,38,253,273,"The recently described ribonuclease A cleavage procedure, with a polyuridylic acid-paper affinity chromatography step, has been used to identify the mutational lesions in the hypoxanthine phosphoribosyltransferase (HPRT) messenger RNAs of patients with Lesch-Nyhan syndrome.",3563511_3,-1,2578,-1,0.39818156
2579,Lesch-Nyhan syndrome,14,16,79,99,This approach now allows HPRT mutation detection in 50 percent of the cases of Lesch-Nyhan syndrome.,3563511_5,-1,2579,-1,0.41474855
2582,syndrome,26,27,166,174,"Since sporadic variants of G6PD causing HNSHA show no special racial predilection, the diagnosis of G6PD deficiency should always be considered in patients with this syndrome..",3565372_5,-1,2582,-1,0.32056776
2583,Wiskott-Aldrich syndrome,8,10,58,82,"Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.",3572301_0,-1,2583,-1,0.37758747
2584,immunodeficiency Wiskott-Aldrich syndrome,30,33,200,241,"
The mAb L10 was used to determine the distribution and the function of sialophorin, the heavily glycosylated surface molecule that is deficient/defective in lymphocytes of patients with the X-linked immunodeficiency Wiskott-Aldrich syndrome.",3572301_1,-1,2584,-1,0.35541406
2585,thymidine,22,23,143,152,Functional studies demonstrated that L10 mAb stimulates the proliferation of peripheral blood T lymphocytes as measured by stimulation of [3H] thymidine incorporation.,3572301_3,-1,2585,-1,0.30758306
2586,thymidine,10,11,48,57,The time course and magnitude of increased [3H] thymidine incorporation by T lymphocytes in response to L10 mAb paralleled that induced by anti-CD3 mAb.,3572301_4,-1,2586,-1,0.2987573
2587,Hypopigmentation,0,1,0,16,Hypopigmentation in the Prader-Willi syndrome.,3578281_0,-1,2587,-1,0.3836501
2588,Prader-Willi syndrome,3,5,24,45,Hypopigmentation in the Prader-Willi syndrome.,3578281_0,-1,2588,-1,0.41593695
2589,Prader-Willi syndrome,11,13,77,98,"
Cutaneous and ocular pigmentation were evaluated in 29 individuals with the Prader-Willi syndrome (PWS).",3578281_1,-1,2589,-1,0.40425196
2590,hypopigmentation,2,3,13,29,"Criteria for hypopigmentation included the presence of type I or II skin, the lightest skin type in the family by history, and iris translucency on globe transillumination.",3578281_2,-1,2590,-1,0.39724904
2591,hypopigmentation,3,4,16,32,"The presence of hypopigmentation correlated with a small interstitial deletion on the proximal long arm of chromosome 15; however, this deletion was also found in individuals who did not meet the full criteria for hypopigmentation.",3578281_4,-1,2591,-1,0.4041527
2592,hypopigmentation,36,37,214,230,"The presence of hypopigmentation correlated with a small interstitial deletion on the proximal long arm of chromosome 15; however, this deletion was also found in individuals who did not meet the full criteria for hypopigmentation.",3578281_4,-1,2592,-1,0.35833538
2593,glutathione,4,5,33,44,"Hairbulb tyrosinase activity and glutathione content, as well as urine cysteinyldopa excretion, were low in PWS individuals with and without hypopigmentation and did not separate these two groups.",3578281_5,-1,2593,-1,0.30436254
2594,hypopigmentation,22,23,141,157,"Hairbulb tyrosinase activity and glutathione content, as well as urine cysteinyldopa excretion, were low in PWS individuals with and without hypopigmentation and did not separate these two groups.",3578281_5,-1,2594,-1,0.37315276
2595,hypopigmentation,3,4,17,33,We conclude that hypopigmentation is found in a significant proportion of individuals with PWS and that the hypopigmentation may be associated with a deletion of the long arm of chromosome 15.,3578281_6,-1,2595,-1,0.40328637
2596,hypopigmentation,17,18,108,124,We conclude that hypopigmentation is found in a significant proportion of individuals with PWS and that the hypopigmentation may be associated with a deletion of the long arm of chromosome 15.,3578281_6,-1,2596,-1,0.39323607
2597,hypopigmentation,4,5,22,38,The mechanism for the hypopigmentation is unknown..,3578281_7,-1,2597,-1,0.40724006
2598,adrenoleukodystrophy,10,11,81,101,Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.,3591825_0,-1,2598,-1,0.3082351
2599,adrenoleukodystrophy,14,15,83,103,"
We report on two clinically, neurologically normal relatives of a boy affected by adrenoleukodystrophy (ALD); they were found repeatedly to have the biochemical defect of an ALD hemizygote.",3591825_1,-1,2599,-1,0.33813328
2600,fatty acids,8,10,60,71,The assay consisted in the determination of very-long-chain fatty acids in lyophilized and reconstituted plasma.,3591825_2,-1,2600,-1,0.35915986
2601,disease,5,6,32,39,"While no evidence of neurologic disease (leukodystrophy or myeloneuropathy) was present in these hemizygotes, adrenocortical insufficiency provoking compensatory high ACTH release was found in both.",3591825_3,-1,2601,-1,0.39851573
2602,ACTH,22,23,167,171,"While no evidence of neurologic disease (leukodystrophy or myeloneuropathy) was present in these hemizygotes, adrenocortical insufficiency provoking compensatory high ACTH release was found in both.",3591825_3,-1,2602,-1,0.32313472
2603,muscular dystrophy,10,12,55,73,The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome.,3600793_0,-1,2603,-1,0.3637998
2604,muscular dystrophy,11,13,63,81,"
The recent discovery of sequences at the site of the Duchenne muscular dystrophy (DMD) gene in humans has opened up the possibility of a detailed molecular analysis of the genes in humans and in related mammalian species.",3600793_1,-1,2604,-1,0.36514106
2605,disease,13,14,76,83,"Until relatively recently, there was no obvious mouse model of this genetic disease for the development of therapeutic strategies.",3600793_2,-1,2605,-1,0.35287607
2606,muscular dystrophy,8,10,54,72,"The identification of a mouse X-linked mutant showing muscular dystrophy, mdx, has provided a candidate mouse genetic homologue to the DMD locus; the relatively mild pathological features of mdx suggest it may have more in common with mutations of the Becker muscular dystrophy type at the same human locus, however. But the close genetic linkage of mdx to G6PD and Hprt on the mouse X chromosome, coupled with its comparatively mild pathology, have suggested that the mdx mutation may instead correspond to Emery Dreifuss muscular dystrophy which itself is closely linked to DNA markers at Xq28-qter in the region of G6PD on the human X chromosome.",3600793_3,-1,2606,-1,0.354317
2607,muscular dystrophy,44,46,259,277,"The identification of a mouse X-linked mutant showing muscular dystrophy, mdx, has provided a candidate mouse genetic homologue to the DMD locus; the relatively mild pathological features of mdx suggest it may have more in common with mutations of the Becker muscular dystrophy type at the same human locus, however. But the close genetic linkage of mdx to G6PD and Hprt on the mouse X chromosome, coupled with its comparatively mild pathology, have suggested that the mdx mutation may instead correspond to Emery Dreifuss muscular dystrophy which itself is closely linked to DNA markers at Xq28-qter in the region of G6PD on the human X chromosome.",3600793_3,-1,2607,-1,0.3692884
2608,muscular dystrophy,91,93,523,541,"The identification of a mouse X-linked mutant showing muscular dystrophy, mdx, has provided a candidate mouse genetic homologue to the DMD locus; the relatively mild pathological features of mdx suggest it may have more in common with mutations of the Becker muscular dystrophy type at the same human locus, however. But the close genetic linkage of mdx to G6PD and Hprt on the mouse X chromosome, coupled with its comparatively mild pathology, have suggested that the mdx mutation may instead correspond to Emery Dreifuss muscular dystrophy which itself is closely linked to DNA markers at Xq28-qter in the region of G6PD on the human X chromosome.",3600793_3,-1,2608,-1,0.3826383
2609,map,2,3,16,19,"These sequences map provocatively close to the mdx mutation and unexpectedly distant from sparse fur, spf, the mouse homologue of OTC (ornithine transcarbamylase) which is closely linked to DMD on the human X chromosome..",3600793_5,-1,2609,-1,0.3930262
2610,ornithine,24,25,135,144,"These sequences map provocatively close to the mdx mutation and unexpectedly distant from sparse fur, spf, the mouse homologue of OTC (ornithine transcarbamylase) which is closely linked to DMD on the human X chromosome..",3600793_5,-1,2610,-1,0.3676205
2611,muscular dystrophy,8,10,54,72,Localization of the region homologous to the Duchenne muscular dystrophy locus on the mouse X chromosome.,3600794_0,-1,2611,-1,0.3615491
2612,muscular dystrophies,16,18,92,112,"
Recent progress has resulted in part of the gene mutated in Duchenne and the milder Becker muscular dystrophies being cloned and has suggested that the gene itself extends over 1, 000 to 2, 000 kilobases (kb).",3600794_1,-1,2612,-1,0.31373274
2613,disease,27,28,146,153,"To study how mutations in this gene affect muscle development and integrity, it would be of interest to have available a mouse model of the human disease.",3600794_2,-1,2613,-1,0.34433547
2614,syndrome,11,12,68,76,"The mouse mdx mutation affects muscle and confers a mild dystrophic syndrome, but it is not clear whether this mutation is equivalent to Duchenne/Becker muscular dystrophy in man.",3600794_3,-1,2614,-1,0.3066096
2615,muscular dystrophy,25,27,153,171,"The mouse mdx mutation affects muscle and confers a mild dystrophic syndrome, but it is not clear whether this mutation is equivalent to Duchenne/Becker muscular dystrophy in man.",3600794_3,-1,2615,-1,0.3497009
2616,muscular dystrophy,12,14,66,84,Here we describe the use of two sequences from the human Duchenne muscular dystrophy (DMD) gene that cross-hybridize to mouse X-linked sequences to localize the gene homologous to DMD in the mouse.,3600794_4,-1,2616,-1,0.36495325
2617,map,2,3,15,18,"Both sequences map to the region of 10 centimorgan lying between the Tabby (Ta) and St14-1 (DxPas8) loci, close to the phosphorylase b kinase locus (Phk).",3600794_5,-1,2617,-1,0.42462295
2618,muscular dystrophy,35,37,194,212,"By analogy with the human X-chromosome, we conclude that the region in the mouse around the G6pd and St14-1 loci may contain two genes corresponding to distinct human myopathies  Emery Dreifuss muscular dystrophy which is known to be closely linked to St14-1 in man and the DMD homologue described here..",3600794_6,-1,2618,-1,0.3284095
2619,phenylalanine,18,19,116,129,"
Classical Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",3615198_1,-1,2619,-1,0.36591938
2620,PAH,21,22,143,146,"
Classical Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",3615198_1,-1,2620,-1,0.35477024
2621,PAH,4,5,27,30,"We isolated several mutant PAH cDNA clones from a PKU carrier individual and showed that they contained an internal 116 base pair deletion, corresponding precisely to exon 12 of the human chromosomal PAH gene.",3615198_2,-1,2621,-1,0.3070798
2622,PAH,33,34,200,203,"We isolated several mutant PAH cDNA clones from a PKU carrier individual and showed that they contained an internal 116 base pair deletion, corresponding precisely to exon 12 of the human chromosomal PAH gene.",3615198_2,-1,2622,-1,0.28644067
2623,amino acids,13,15,83,94,The deletion causes the synthesis of a truncated protein lacking the C-terminal 52 amino acids.,3615198_3,-1,2623,-1,0.38548073
2624,PAH,8,9,54,57,Gene transfer and expression studies using the mutant PAH cDNA indicated that the deletion abolishes PAH activity in the cell as a result of protein instability.,3615198_4,-1,2624,-1,0.3164817
2625,PAH,15,16,101,104,Gene transfer and expression studies using the mutant PAH cDNA indicated that the deletion abolishes PAH activity in the cell as a result of protein instability.,3615198_4,-1,2625,-1,0.30778056
2626,PAH,12,13,73,76,"To determine the molecular basis of the deletion, the mutant chromosomal PAH gene was isolated from this individual and shown to contain a GT-- greater than AT substitution at the 5 splice donor site of intron 12.",3615198_5,-1,2626,-1,0.3258904
2627,muscular dystrophy,4,6,29,47,Conservation of the Duchenne muscular dystrophy gene in mice and humans.,3659917_0,-1,2627,-1,0.35887867
2628,muscular dystrophy,5,7,27,45,"
A portion of the Duchenne muscular dystrophy (DMD) gene transcript from human fetal skeletal muscle and mouse adult heart was sequenced, representing approximately 25 percent of the total, 14-kb DMD transcript.",3659917_1,-1,2628,-1,0.3620434
2629,amino acid,5,7,31,41,The nucleic acid and predicted amino acid sequences from the two species are nearly 90 percent homologous.,3659917_2,-1,2629,-1,0.33339405
2630,amino acid,1,3,4,14,"The amino acid sequence that is predicted from this portion of the DMD gene indicates that the protein product might serve a structural role in muscle, but the abundance and tissue distribution of the messenger RNA suggests that the DMD protein is not nebulin..",3659917_3,-1,2630,-1,0.36221898
2631,Prader-Willi syndrome,1,3,9,30,Familial Prader-Willi syndrome with apparently normal chromosomes.,3674116_0,-1,2631,-1,0.40453073
2632,Prader-Willi syndrome,12,14,35,56,"
We report on 4 sibs (2F, 2M) with Prader-Willi syndrome (PWS).",3674116_1,-1,2632,-1,0.41496238
2633,muscular dystrophy,6,8,41,59,Nebulin and titin expression in Duchenne muscular dystrophy appears normal.,3678494_0,-1,2633,-1,0.3249966
2634,muscular dystrophy,24,26,171,189,"
Monoclonal antibodies which recognize different epitopes on either titin or nebulin show normal staining patterns on frozen sections of three muscle biopsies of Duchenne muscular dystrophy (DMD).",3678494_1,-1,2634,-1,0.34234598
2636,myasthenia gravis,7,9,55,72,"Heterozygous C2 deficiency associated with angioedema, myasthenia gravis, and systemic lupus erythematosus.",3718019_0,-1,2636,-1,0.34572193
2637,systemic lupus erythematosus,11,14,78,106,"Heterozygous C2 deficiency associated with angioedema, myasthenia gravis, and systemic lupus erythematosus.",3718019_0,-1,2637,-1,0.30832988
2638,myasthenia gravis,5,7,28,45,"
We describe a patient with myasthenia gravis, systemic lupus erythematosus, and angioedema associated with heterozygous complement factor 2 (C2) deficiency.",3718019_1,-1,2638,-1,0.35954997
2639,systemic lupus erythematosus,8,11,47,75,"
We describe a patient with myasthenia gravis, systemic lupus erythematosus, and angioedema associated with heterozygous complement factor 2 (C2) deficiency.",3718019_1,-1,2639,-1,0.32775944
2641,phenylalanine,6,7,38,51,Gene transfer and expression of human phenylalanine hydroxylase.,3856322_0,-1,2641,-1,0.3447549
2642,phenylalanine,13,14,71,84,"
Phenylketonuria (PKU) is caused by a genetic deficiency of the enzyme phenylalanine hydroxylase (PAH).",3856322_1,-1,2642,-1,0.36511183
2643,PAH,16,17,98,101,"
Phenylketonuria (PKU) is caused by a genetic deficiency of the enzyme phenylalanine hydroxylase (PAH).",3856322_1,-1,2643,-1,0.34567314
2644,PAH,7,8,47,50,A full-length complementary DNA clone of human PAH was inserted into a eukaryotic expression vector and transferred into mouse NIH3T3 cells which do not normally express PAH.,3856322_2,-1,2644,-1,0.2966098
2645,PAH,26,27,170,173,A full-length complementary DNA clone of human PAH was inserted into a eukaryotic expression vector and transferred into mouse NIH3T3 cells which do not normally express PAH.,3856322_2,-1,2645,-1,0.3029243
2646,PAH,5,6,38,41,"The transformed mouse cells expressed PAH messenger RNA, immunoreactive protein, and enzymatic activity that are characteristic of the normal human liver products, demonstrating that a single gene contains all of the necessary genetic information to code for functional PAH.",3856322_3,-1,2646,-1,0.30012786
2647,PAH,41,42,270,273,"The transformed mouse cells expressed PAH messenger RNA, immunoreactive protein, and enzymatic activity that are characteristic of the normal human liver products, demonstrating that a single gene contains all of the necessary genetic information to code for functional PAH.",3856322_3,-1,2647,-1,0.3153727
2648,PAH,8,9,43,46,"These results support the use of the human PAH probe in prenatal diagnosis and detection of carriers, to provide new opportunities for the biochemical characterization of normal and mutant enzymes, and in the investigation of alternative genetic therapies for PKU..",3856322_4,-1,2648,-1,0.32315978
2649,phenylalanine,4,5,24,37,Regional mapping of the phenylalanine hydroxylase gene and the phenylketonuria locus in the human genome.,3862128_0,-1,2649,-1,0.3496102
2650,amino acid metabolism,10,13,61,82,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2650,-1,0.32657233
2651,phenylalanine,21,22,128,141,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2651,-1,0.37070143
2652,PAH,24,25,155,158,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2652,-1,0.37997535
2653,phenylalanine,26,27,160,173,"
Phenylketonuria (PKU) is an autosomal recessive disorder of amino acid metabolism caused by a deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH; phenylalanine 4-monooxygenase, EC 1. 14. 16. 1).",3862128_1,-1,2653,-1,0.37491408
2654,PAH,5,6,23,26,A cDNA clone for human PAH has previously been used to assign the corresponding gene to human chromosome 12.,3862128_2,-1,2654,-1,0.3116892
2655,map,4,5,23,26,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2655,-1,0.39409935
2656,disease,8,9,43,50,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2656,-1,0.36902192
2657,PAH,12,13,65,68,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2657,-1,0.32538906
2658,PAH,45,46,265,268,"To define the regional map position of the disease locus and the PAH gene on human chromosome 12, DNA was isolated from human-hamster somatic cell hybrids with various deletions of human chromosome 12 and was analyzed by Southern blot analysis using the human cDNA PAH clone as a hybridization probe.",3862128_3,-1,2658,-1,0.32128295
2659,PAH,24,25,158,161,"From these results, together with detailed biochemical and cytogenetic characterization of the hybrid cells, the region on chromosome 12 containing the human PAH gene has been defined as 12q14.",3862128_4,-1,2659,-1,0.3126545
2660,PAH map,1,3,4,11,The PAH map position on chromosome 12 was further localized by in situ hybridization of 125I-labeled human PAH cDNA to chromosomes prepared from a human lymphoblastoid cell line.,3862128_6,-1,2660,-1,0.3502145
2661,PAH,17,18,107,110,The PAH map position on chromosome 12 was further localized by in situ hybridization of 125I-labeled human PAH cDNA to chromosomes prepared from a human lymphoblastoid cell line.,3862128_6,-1,2661,-1,0.30492547
2662,PAH,13,14,90,93,Results of these experiments demonstrated that the region on chromosome 12 containing the PAH gene and the PKU locus in man is 12q22----12q24. 1.,3862128_7,-1,2662,-1,0.32972616
2663,map,7,8,46,49,These results not only provide a regionalized map position for a major human disease locus but also can serve as a reference point for linkage analysis with other DNA markers on human chromosome 12,3862128_8,-1,2663,-1,0.380935
2664,disease,13,14,77,84,These results not only provide a regionalized map position for a major human disease locus but also can serve as a reference point for linkage analysis with other DNA markers on human chromosome 12,3862128_8,-1,2664,-1,0.35153902
2665,disease,6,7,39,46,Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.,3876122_0,-1,2665,-1,0.29788402
2666,disease,4,5,23,30,"
Type I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF  Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS) -agarose gel electrophoresis.",3876122_1,-1,2666,-1,0.26751342
2667,Ag,23,24,130,132,"
Type I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF  Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS) -agarose gel electrophoresis.",3876122_1,-1,2667,-1,0.30512327
2668,sodium,40,41,210,216,"
Type I von Willebrand disease (vWD) is characterized by equally low plasma concentrations of von Willebrand factor antigen (vWF  Ag) and ristocetin cofactor (RiCof) and by the presence of all vWF multimers in sodium dodecyl sulfate (SDS) -agarose gel electrophoresis.",3876122_1,-1,2668,-1,0.4353125
2669,Ag,21,22,107,109,"For 17 patients (13 kindreds) diagnosed with these criteria, we have studied the platelet contents of vWF  Ag and RiCof and the changes of these in plasma after DDAVP infusion.",3876122_2,-1,2669,-1,0.28569135
2670,DDAVP,32,33,161,166,"For 17 patients (13 kindreds) diagnosed with these criteria, we have studied the platelet contents of vWF  Ag and RiCof and the changes of these in plasma after DDAVP infusion.",3876122_2,-1,2670,-1,0.3154104
2671,Ag,3,4,14,16,"Platelet vWF  Ag and RiCof were normal in four kindreds (called "" platelet normal "" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF  Ag, RiCof and the bleeding time (BT) became normal.",3876122_3,-1,2671,-1,0.31421006
2672,vasopressin,22,23,128,139,"Platelet vWF  Ag and RiCof were normal in four kindreds (called "" platelet normal "" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF  Ag, RiCof and the bleeding time (BT) became normal.",3876122_3,-1,2672,-1,0.34075466
2673,Ag,27,28,153,155,"Platelet vWF  Ag and RiCof were normal in four kindreds (called "" platelet normal "" subgroup); following 1-deamino-8-D-arginine vasopressin; plasma vWF  Ag, RiCof and the bleeding time (BT) became normal.",3876122_3,-1,2673,-1,0.29328153
2675,Ag,7,8,31,33,"In six kindreds, platelet vWF  Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF  Ag and RiCof remained low, and the BT was prolonged.",3876122_4,-1,2675,-1,0.30675617
2676,DDAVP,19,20,83,88,"In six kindreds, platelet vWF  Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF  Ag and RiCof remained low, and the BT was prolonged.",3876122_4,-1,2676,-1,0.3249592
2677,Ag,24,25,102,104,"In six kindreds, platelet vWF  Ag and RiCof were equally low (platelet low); after DDAVP, plasma vWF  Ag and RiCof remained low, and the BT was prolonged.",3876122_4,-1,2677,-1,0.29056716
2678,Ag,12,13,80,82,"In three additional kindreds, platelets contained normal concentrations of vWF  Ag, but RiCof was very low (platelet discordant); even though a complete set of multimers was found in plasma and platelets, there was a relatively small amount of large multimers.",3876122_5,-1,2678,-1,0.2882218
2679,DDAVP,1,2,6,11,"After DDAVP, plasma vWF  Ag became normal, but RiCof remained low and the BT was very prolonged.",3876122_6,-1,2679,-1,0.3177645
2680,Ag,6,7,25,27,"After DDAVP, plasma vWF  Ag became normal, but RiCof remained low and the BT was very prolonged.",3876122_6,-1,2680,-1,0.30768624
2681,Ag,16,17,84,86,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2681,-1,0.2968431
2682,DDAVP,56,57,279,284,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2682,-1,0.32002655
2683,DDAVP,61,62,304,309,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2683,-1,0.3414938
2684,Ag,77,78,392,394,"These findings demonstrated that there can be an abnormal vWF (RiCof less than vWF  Ag) even in type I vWD, coexisting with a complete set of vWF multimers (platelet discordant); that the abnormal vWF can be shown more clearly in platelets than in plasma or else in plasma after DDAVP infusion; and that DDAVP normalizes the BT only in those patients with normal platelet levels of both vWF  Ag and RiCof (platelet normal)..",3876122_7,-1,2684,-1,0.29174396
2685,van der Woude syndrome,5,9,34,56,Genetic analysis in families with van der Woude syndrome.,4019732_0,-1,2685,-1,0.36072737
2686,van der Woude syndrome,37,41,224,246,"
We have brought together information on 864 affected individuals in 164 families (including three new pedigrees) reported in the 137 year period since 1845 when Demarquay first described a family with what was later called van der Woude syndrome (VWS).",4019732_1,-1,2686,-1,0.37115914
2687,cleft palate,6,8,26,38,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2687,-1,0.32960874
2688,CP,9,10,40,42,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2688,-1,0.36395222
2689,cleft lip,12,14,48,57,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2689,-1,0.29744616
2690,CP,17,18,74,76,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2690,-1,0.32770595
2691,K,44,45,220,221,"Both types of oral cleft, cleft palate (CP) and cleft lip with or without CP (CLP), segregate in these families together with lower lip pits or fistulae in an autosomal dominant mode with high penetrance estimated to be K =.",4019732_2,-1,2691,-1,0.37754714
2692,CP,5,6,21,23,"Cleft types (CLP and CP) occur in VWS in the same proportions as in the general non-VWS population, ie, about twice as many cleft-bearing individuals have CLP as have CP.",4019732_5,-1,2692,-1,0.312033
2693,ie,21,22,100,102,"Cleft types (CLP and CP) occur in VWS in the same proportions as in the general non-VWS population, ie, about twice as many cleft-bearing individuals have CLP as have CP.",4019732_5,-1,2693,-1,0.420089
2694,CP,33,34,167,169,"Cleft types (CLP and CP) occur in VWS in the same proportions as in the general non-VWS population, ie, about twice as many cleft-bearing individuals have CLP as have CP.",4019732_5,-1,2694,-1,0.2945873
2695,CP,16,17,78,80,"On the other hand, we do not find the usually observed excess of females with CP and excess of males with CLP; in VWS the sex ratios are more nearly equal.",4019732_6,-1,2695,-1,0.3371518
2696,spondylitis,14,15,93,104,"
The serum of a 44-yr-old woman of French-Canadian descent having a B-27 positive ankylosing spondylitis was deficient in the seventh component of complement (C7) as determined by hemolytic and immunochemical methods.",409732_2,-1,2696,-1,0.33864823
2697,hemolytic,29,30,180,189,"
The serum of a 44-yr-old woman of French-Canadian descent having a B-27 positive ankylosing spondylitis was deficient in the seventh component of complement (C7) as determined by hemolytic and immunochemical methods.",409732_2,-1,2697,-1,0.36652595
2698,CM,20,21,111,113,Studies of the HLA antigens in all the 22 subjects and in three spouses indicated no close linkage between the CM deficienty and the HLA system.,409732_8,-1,2698,-1,0.37091592
2704,hemolytic,15,16,83,92,"The proband, who has had nine episodes of disseminated gonococcal infection, has a hemolytic C5 level of approximately 0.",495634_3,-1,2704,-1,0.33938563
2705,hemolytic,14,15,77,86,"The probands twin as well as another sister also had extremely low levels of hemolytic C5 (approximately 0. 5 per cent normal), but both these subjects have been healthy.",495634_6,-1,2705,-1,0.33462402
2706,Hemolytic,0,1,0,9,Hemolytic complement and bacteriolytic activity could be restored by the addition of purified C5.,495634_7,-1,2706,-1,0.36110747
2708,hemolytic,12,13,81,90,Twenty-two of 32 other family members from three generations had depressed whole hemolytic complement levels.,495634_10,-1,2708,-1,0.3345548
2709,hemolytic,9,10,38,47,"In 19 of 30 family members, levels of hemolytic C5 ranged from 13 to 64 per cent of normal.",495634_11,-1,2709,-1,0.33892444
2710,NADPH,15,16,66,71,"These three variants had normal levels of Km G6P, Km NADP, and Ki NADPH, normal utilizations of both 2-deoxy-G6P and deamino-NAPD, normal heat stability, and a normal pH curve.",511159_8,-1,2710,-1,0.29742873
2711,Lesch-Nyhan syndrome,17,19,104,124,"Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome.",523196_0,-1,2711,-1,0.41277093
2712,hyperuricemia,8,9,38,51,"B., was among the first reported with hyperuricemia and central nervous system symptoms.",523196_2,-1,2712,-1,0.33724317
2713,Lesch-Nyhan syndrome,10,12,57,77,8) distinct from the enzyme present in patients with the Lesch-Nyhan syndrome.,523196_5,-1,2713,-1,0.4201374
2714,spasticity,5,6,33,43,"The patient had chroeoathetosis, spasticity, dysarthric speech, and hyperuricemia.",523196_6,-1,2714,-1,0.3637656
2715,hyperuricemia,11,12,68,81,"The patient had chroeoathetosis, spasticity, dysarthric speech, and hyperuricemia.",523196_6,-1,2715,-1,0.33366904
2716,purine,9,10,48,54,"Using a newly developed method for the study of purine metabolism in intact cultured cells, this patient was found to metabolize some 9% of 8-14C-hypoxanthine, and 90% of the isotope utilized was converted to adenine and guanine nucleotides.",523196_9,-1,2716,-1,0.31202492
2717,contrast,1,2,3,11,"In contrast, cells from patients with the Lesch-Nyhan syndrome were virtually completely unable to convert hypoxanthine to nucleotides.",523196_10,-1,2717,-1,0.34849837
2718,Lesch-Nyhan syndrome,8,10,42,62,"In contrast, cells from patients with the Lesch-Nyhan syndrome were virtually completely unable to convert hypoxanthine to nucleotides.",523196_10,-1,2718,-1,0.4240515
2719,thymidine,16,17,117,126,"The growth of the cultured fibroblasts of this patient was intermediate in media containing hypoxanthine aminopterin thymidine (HAT), whereas the growth of Lesch-Nyhan cells was inhibited and normal cells grew normally.",523196_12,-1,2719,-1,0.343658
2720,8-azaguanine,2,3,13,25,"Similarly in 8-azaguanine, 6-thioguanine, and 8-azahypoxanthine, the growth of the patients cells was intermediate between normal and Lesch-Nyhan cells.",523196_13,-1,2720,-1,0.30964237
2721,8-azaguanine,2,3,13,25,"Similarly in 8-azaguanine, 6-thioguanine, and 8-azahypoxanthine, the growth of the patients cells was intermediate between normal and Lesch-Nyhan cells.",523196_13,-1,2721,-1,0.30964237
2722,6-thioguanine,4,5,27,40,"Similarly in 8-azaguanine, 6-thioguanine, and 8-azahypoxanthine, the growth of the patients cells was intermediate between normal and Lesch-Nyhan cells.",523196_13,-1,2722,-1,0.34595138
2723,purine,13,14,103,109,These observations provide further evidence for genetic heterogeneity among patients with disorders in purine metabolism involving the HPRT gene.,523196_14,-1,2723,-1,0.3223
2724,muscular dystrophy,4,6,27,45,Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences.,6086495_0,-1,2724,-1,0.36241946
2725,muscular dystrophy,6,8,30,48,"
A linkage study in 30 Becker muscular dystrophy (BMD) kindreds using three cloned DNA sequences from the X chromosome which demonstrate restriction fragment length polymorphisms (RFLPs), suggests that the BMD gene is located on the short arm of the X chromosome, in the p21 region.",6086495_1,-1,2725,-1,0.36995903
2726,gouty arthritis,6,8,46,61,"Partial HPRT deficiencies are associated with gouty arthritis, while absence of activity results in Lesch-Nyhan syndrome (L-N).",6087154_3,-1,2726,-1,0.3725707
2727,Lesch-Nyhan syndrome,15,17,100,120,"Partial HPRT deficiencies are associated with gouty arthritis, while absence of activity results in Lesch-Nyhan syndrome (L-N).",6087154_3,-1,2727,-1,0.44064996
2728,syndrome,19,20,110,118,"Thus, Haldanes principle predicts that new mutations at the hprt locus must occur frequently in order for L-N syndrome to be maintained in the population.",6087154_5,-1,2728,-1,0.33229664
2729,Wiskott-Aldrich syndrome,12,14,93,117,Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier.,6101415_0,-1,2729,-1,0.38576218
2730,Wiskott-Aldrich syndrome,5,7,28,52,"
An obligate carrier of the Wiskott-Aldrich syndrome (WAS) who was also heterozygous for the A and B types of X-linked glucose-6-phosphate dehydrogenase was found.",6101415_1,-1,2730,-1,0.37267077
2731,Wiskott-Aldrich syndrome,35,37,223,247,These findings suggest that selection against the WAS gene occurs in platelets and thymus-derived T lymphocytes and that the defects associated with WAS expressed in these cell-types may be implicated in the genesis of the Wiskott-Aldrich syndrome..,6101415_5,-1,2731,-1,0.3585857
2732,nephritis,3,4,26,35,Complement deficiency and nephritis.,6103091_0,-1,2732,-1,0.3366482
2735,haematuria,16,17,135,145,One child with heterozygous C3 deficiency was found to have membranoproliferative glomerulonephritis; proteinuria and/or microscopical haematuria was present in all three homozygous C3-deficient children.,6103091_3,-1,2735,-1,0.35456678
2738,renal disease,17,19,94,107,The only child of the family with normal complement had no increased risk of infection and no renal disease.,6103091_5,-1,2738,-1,0.31045613
2739,nephritis,14,15,94,103,This family study provides further support for the proposal that C3 deficiency predisposes to nephritis..,6103091_6,-1,2739,-1,0.31237096
2740,thalassemia,20,21,131,142,"In Sardinians with the beta 0-thalassemia trait, parasite growth was normal except when G6PD deficiency occurred together with the thalassemia trait.",6337374_3,-1,2740,-1,0.35093376
2741,malaria,30,31,186,193,"The data support the hypothesis that G6PD deficiency may confer a selective advantage in a malarious area; the female heterozygote may be at a particular advantage because resistance to malaria equals that of male hemizygotes, but the risk of fatal hemolysis may be less.",6337374_4,-1,2741,-1,0.32836375
2743,adrenoleukodystrophy,4,5,26,46,Bone marrow transplant in adrenoleukodystrophy.,6387532_0,-1,2743,-1,0.32581744
2744,adrenoleukodystrophy,24,25,146,166,"
An allogeneic bone marrow transplant (BMT) from a normal HLA identical sibling donor was performed in a 13-year-old boy with rapidly progressive adrenoleukodystrophy (ALD).",6387532_1,-1,2744,-1,0.33530733
2745,neurologic deterioration,11,13,75,99,"Engraftment and complete hematologic recovery occurred within 4 weeks, but neurologic deterioration continued.",6387532_2,-1,2745,-1,0.35582057
2746,adenovirus infection,5,7,23,43,The patient died of an adenovirus infection 141 days after BMT.,6387532_3,-1,2746,-1,0.33892047
2747,fatty acids,12,14,73,84,ALD is characterized by abnormally high plasma levels of very long chain fatty acids (VLCFA) as a result of impaired capacity to degrade them.,6387532_4,-1,2747,-1,0.3203095
2748,IV,14,15,79,81,Among 7 samples of G6PD with normal and increased activity two new variants of IV class -- Nukha and Bash-Kungut -- were found..,6453040_6,-1,2748,-1,0.30733863
2749,Adrenoleukodystrophy,0,1,0,20,"Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.",6524872_0,-1,2749,-1,0.3481903
2750,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD) is a genetically determined disorder associated with progressive central demyelination and adrenal cortical insufficiency.",6524872_1,-1,2750,-1,0.36210716
2751,fatty acids,10,12,83,94,"All affected persons show increased levels of saturated unbranched very-long-chain fatty acids, particularly hexacosanoate (C26  0), because of impaired capacity to degrade these acids.",6524872_2,-1,2751,-1,0.34454924
2752,syndrome,20,21,141,149,"This degradation normally takes place in a subcellular organelle called the peroxisome, and ALD, together with Zellwegers cerebrohepatorenal syndrome, is now considered to belong to the newly formed category of peroxisomal disorders.",6524872_3,-1,2752,-1,0.31355575
2753,peroxisomal disorders,33,35,211,232,"This degradation normally takes place in a subcellular organelle called the peroxisome, and ALD, together with Zellwegers cerebrohepatorenal syndrome, is now considered to belong to the newly formed category of peroxisomal disorders.",6524872_3,-1,2753,-1,0.29511678
2754,syndrome,16,17,109,117,"Neonatal ALD, a distinct entity with autosomal recessive inheritance and points of resemblance to Zellwegers syndrome, accounted for 7% of the cases.",6524872_8,-1,2754,-1,0.2831551
2755,muscular dystrophy,11,13,60,78,Clinical use of DNA markers linked to the gene for Duchenne muscular dystrophy.,6585184_0,-1,2755,-1,0.3464019
2756,muscular dystrophy,4,6,32,50,"
Seventy families with Duchenne muscular dystrophy (DMD) known to the Institute of Child Health fall into three categories with respect to potential linkage analysis with the X chromosome DNA markers RC8 and L1.",6585184_1,-1,2756,-1,0.3400292
2757,n,12,13,72,73,Families in which there is at least one obligatory female heterozygote (n = 13).,6585184_3,-1,2757,-1,0.4348186
2758,n,19,20,93,94,"Families in which there is a single affected boy, who also has one or more healthy brothers (n = 26).",6585184_5,-1,2758,-1,0.41669676
2759,n,10,11,53,54,Families with a single affected boy with no brother (n = 30).,6585184_7,-1,2759,-1,0.42382872
2760,syndrome,5,6,30,38,"Family studies in Bechterew's syndrome (ankylosing spondylitis) III. Genetics.
The results of segregation analyses in 75 families where the proband had ankylosing spondylitis, are presented.",6604602_0,-1,2760,-1,0.32020882
2761,spondylitis,8,9,51,62,"Family studies in Bechterew's syndrome (ankylosing spondylitis) III. Genetics.
The results of segregation analyses in 75 families where the proband had ankylosing spondylitis, are presented.",6604602_0,-1,2761,-1,0.32210994
2762,spondylitis,27,28,163,174,"Family studies in Bechterew's syndrome (ankylosing spondylitis) III. Genetics.
The results of segregation analyses in 75 families where the proband had ankylosing spondylitis, are presented.",6604602_0,-1,2762,-1,0.32998434
2763,spondylitis,10,11,66,77,The results were in agreement with our hypothesis that ankylosing spondylitis is part of a syndrome where different genetic factors interact.,6604602_3,-1,2763,-1,0.3343012
2764,syndrome,15,16,91,99,The results were in agreement with our hypothesis that ankylosing spondylitis is part of a syndrome where different genetic factors interact.,6604602_3,-1,2764,-1,0.3195642
2765,disease,7,8,42,49,"Such known factors are HLA B27 associated disease susceptibility, susceptibility to psoriatic arthropathy and susceptibility to entero-arthropathy.",6604602_4,-1,2765,-1,0.43310133
2766,psoriatic,12,13,84,93,"Such known factors are HLA B27 associated disease susceptibility, susceptibility to psoriatic arthropathy and susceptibility to entero-arthropathy.",6604602_4,-1,2766,-1,0.36402935
2769,disease,11,12,69,76,"Environmental factors (intestinal bacteria) are known to trigger the disease at least in some persons, and we have postulated that all or most of them have the predisposition to develop disease.",6604602_6,-1,2769,-1,0.38160226
2770,disease,33,34,186,193,"Environmental factors (intestinal bacteria) are known to trigger the disease at least in some persons, and we have postulated that all or most of them have the predisposition to develop disease.",6604602_6,-1,2770,-1,0.380677
2771,syndrome,3,4,10,18,"Thus, the syndrome has a multifactorial etiology.",6604602_7,-1,2771,-1,0.32090566
2773,uveitis,17,18,127,134,"The phenotypic expressions of the different genetic predispositions involved, include sacro-iliitis, psoriasis, acute anterior uveitis, peripheral arthropathy and inflammatory bowel disease.",6604602_8,-1,2773,-1,0.34113383
2774,inflammatory bowel disease,22,25,163,189,"The phenotypic expressions of the different genetic predispositions involved, include sacro-iliitis, psoriasis, acute anterior uveitis, peripheral arthropathy and inflammatory bowel disease.",6604602_8,-1,2774,-1,0.3732709
2776,syndrome,14,15,94,102,We suggest the descriptive name HEREDITARY MULTIFOCAL RELAPSING INFLAMMATION (HEMRI) for this syndrome.,6604602_9,-1,2776,-1,0.32833955
2777,spondylitis,1,2,11,22,"Ankylosing spondylitis, psoriatic arthropathy and entero-arthropathy may be regarded as clinical sub-types of the syndrome..",6604602_10,-1,2777,-1,0.34353134
2778,psoriatic,3,4,24,33,"Ankylosing spondylitis, psoriatic arthropathy and entero-arthropathy may be regarded as clinical sub-types of the syndrome..",6604602_10,-1,2778,-1,0.35973203
2779,syndrome,15,16,114,122,"Ankylosing spondylitis, psoriatic arthropathy and entero-arthropathy may be regarded as clinical sub-types of the syndrome..",6604602_10,-1,2779,-1,0.32152155
2780,Prader-Willi syndrome,0,2,0,21,Prader-Willi syndrome and chromosome 15.,6618488_0,-1,2780,-1,0.43843508
2781,Prader-Willi syndrome,20,22,107,128,"
A chromosome 15 anomaly was observed in 12 of 20 patients, 17 of whom were clinically suspected of having Prader-Willi syndrome (PWS).",6618488_2,-1,2781,-1,0.3961744
2782,Tay-Sachs disease,1,3,4,21,The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.,6650504_0,-1,2782,-1,0.47427595
2783,Tay-Sachs disease,7,9,41,58,"
From data collected in a North American Tay-Sachs disease (TSD) heterozygote screening program, the TSD carrier frequency among 46, 304 Jewish individuals was found to be.",6650504_1,-1,2783,-1,0.44024095
2784,P,32,33,176,177,"Relative to Jews of Polish and Russian origins, there was at least a twofold increase in the TSD carrier frequency in Jews of Austrian, Hungarian, and Czechoslovakian origins (P less than. 005).",6650504_7,-1,2784,-1,0.42364678
2787,hemolytic,2,3,17,26,Serum complement hemolytic and bactericidal activities were lacking and could be restored to normal by addition of appropriate amounts of purified C6.,6783144_3,-1,2787,-1,0.3583957
2794,lupus erythematosus,2,4,17,36,Familial discoid lupus erythematosus associated with heterozygote C2 deficiency.,6902670_0,-1,2794,-1,0.34120765
2795,lupus erythematosus,5,7,35,54,"
Two siblings with chronic discoid lupus erythematosus and several family members were found with heterozygous C2 deficiency.",6902670_1,-1,2795,-1,0.32458058
2800,C,11,12,65,66,"0 with otherwise normal properties (heat stability at 46 degrees C, apparent affinity for substrates, optimum pH, and utilization of substrate analogues).",7055648_4,-1,2800,-1,0.40115348
2801,favism,22,23,151,157,"Heterogeneity of ""Mediterranean type"" glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain and description of two new variants associated with favism.",7106752_0,-1,2801,-1,0.335522
2803,Favism,3,4,4,10,"(3) Favism has been observed associated with all kinds of variants described here. (4) G6PD Betica, which is the most frequent variant found in subjects of Southern Spanish origin, has been observed associated with favism in all cases except one.",7106752_11,-1,2803,-1,0.32284647
2804,favism,41,42,215,221,"(3) Favism has been observed associated with all kinds of variants described here. (4) G6PD Betica, which is the most frequent variant found in subjects of Southern Spanish origin, has been observed associated with favism in all cases except one.",7106752_11,-1,2804,-1,0.2931395
2808,hemolytic,4,5,19,28,He had episodes of hemolytic crisis several times after upper respiratory infection.,7166314_3,-1,2808,-1,0.34099567
2810,NADPH,30,31,167,172,"The enzymatic characteristics were examined when he was 5 years old, and his G6PD showed faster-than-normal electrophoretic mobility, low Km G6P, high Km NADP, low Ki NADPH, normal utilization of substrate analogues, heat instability, and a normal pH optimum curve.",7166314_6,-1,2810,-1,0.28324622
2813,myasthenia gravis,3,5,31,48,Heterozygous C2-deficiency and myasthenia gravis.,7191069_0,-1,2813,-1,0.3606454
2814,myasthenia gravis,4,6,33,50,"
Complement deficiency states in myasthenia gravis (MG) have not been reported previously.",7191069_1,-1,2814,-1,0.36554486
2815,MG,7,8,52,54,"
Complement deficiency states in myasthenia gravis (MG) have not been reported previously.",7191069_1,-1,2815,-1,0.35706827
2816,MG,7,8,45,47,"We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family..",7191069_2,-1,2816,-1,0.33163548
2817,Adrenoleukodystrophy,0,1,0,20,Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.,7202134_0,-1,2817,-1,0.36450428
2818,fatty acids,10,12,76,87,Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.,7202134_0,-1,2818,-1,0.3497371
2819,fatty acids,11,13,61,72,"
With a new method we measured the saturated very long chain fatty acids in the plasma of adrenoleukodystrophy (ALD) hemizygotes, ALD heterozygotes, and controls.",7202134_1,-1,2819,-1,0.3476837
2820,adrenoleukodystrophy,17,18,90,110,"
With a new method we measured the saturated very long chain fatty acids in the plasma of adrenoleukodystrophy (ALD) hemizygotes, ALD heterozygotes, and controls.",7202134_1,-1,2820,-1,0.350349
2821,fatty acid,9,11,62,72,ALD hemizygotes showed increased levels of hexacosanoate (C26 fatty acid) which represented 0.,7202134_2,-1,2821,-1,0.3843825
2822,fatty acids,12,14,32,43,"081 +/- 0. 0066% (SEM) of total fatty acids, compared to 0. 015 +/- 0. 0032% in the controls.",7202134_3,-1,2822,-1,0.34335676
2823,fatty acids,6,8,18,29,"C25, C24, and C23 fatty acids were also increased, but the C22 and C20 fatty acids were normal.",7202134_4,-1,2823,-1,0.37000597
2824,fatty acids,17,19,71,82,"C25, C24, and C23 fatty acids were also increased, but the C22 and C20 fatty acids were normal.",7202134_4,-1,2824,-1,0.3693244
2825,fatty acids,9,11,26,37,057 +/- 0. 0063% of total fatty acids.,7202134_6,-1,2825,-1,0.34974602
2826,xanthomatosis,6,7,55,68,Abnormal high density lipoproteins in cerebrotendinous xanthomatosis.,7298854_0,-1,2826,-1,0.30366495
2827,disease,18,19,117,124,"
The plasma lipoprotein profiles and high density lipoproteins (HDL) were characterized in patients with the genetic disease cerebrotendinous xanthomatosis (CTX).",7298854_1,-1,2827,-1,0.3705845
2828,xanthomatosis,20,21,142,155,"
The plasma lipoprotein profiles and high density lipoproteins (HDL) were characterized in patients with the genetic disease cerebrotendinous xanthomatosis (CTX).",7298854_1,-1,2828,-1,0.29912913
2829,CTX,22,23,157,160,"
The plasma lipoprotein profiles and high density lipoproteins (HDL) were characterized in patients with the genetic disease cerebrotendinous xanthomatosis (CTX).",7298854_1,-1,2829,-1,0.33735326
2830,cholesterol,26,27,176,187,Abnormalities in the HDL may contribute to their increased atherogenesis and excessive deposits of tissue sterols in the presence of low or low-normal concentrations of plasma cholesterol (165 +/- 25 mg/dl) and low density lipoproteins (LDL).,7298854_2,-1,2830,-1,0.33764747
2831,CTX,6,7,46,49,"The mean HDL-cholesterol concentration in the CTX plasmas was 14. 5 +/- 3. 2 mg/dl, about one-third the normal value.",7298854_3,-1,2831,-1,0.3633286
2832,cholesteryl esters,6,8,28,46,"Relative to normal HDL, the cholesteryl esters are low, free cholesterol and phospholipids essentially normal, and triglycerides increased.",7298854_5,-1,2832,-1,0.3461211
2833,cholesterol,12,13,61,72,"Relative to normal HDL, the cholesteryl esters are low, free cholesterol and phospholipids essentially normal, and triglycerides increased.",7298854_5,-1,2833,-1,0.34940583
2834,triglycerides,19,20,115,128,"Relative to normal HDL, the cholesteryl esters are low, free cholesterol and phospholipids essentially normal, and triglycerides increased.",7298854_5,-1,2834,-1,0.32122943
2835,cholesterol,9,10,39,50,The ratio of apoprotein (apo) to total cholesterol in the HDL of CTX was two to three times greater than normal.,7298854_6,-1,2835,-1,0.30358046
2836,CTX,14,15,65,68,The ratio of apoprotein (apo) to total cholesterol in the HDL of CTX was two to three times greater than normal.,7298854_6,-1,2836,-1,0.3430252
2837,CTX,2,3,7,10,"In the CTX HDL, the ratio of apoAI to apoAII was high, the proportion of apoC low, and a normally minor form of apoAI increased relative to other forms.",7298854_7,-1,2837,-1,0.37714666
2838,bile acid,29,31,185,194,The abnormalities in lipoprotein distribution profile and composition of the plasma HDL result from metabolic defects that are not understood but may be linked to the genetic defect in bile acid synthesis in CTX.,7298854_9,-1,2838,-1,0.3433435
2839,CTX,33,34,208,211,The abnormalities in lipoprotein distribution profile and composition of the plasma HDL result from metabolic defects that are not understood but may be linked to the genetic defect in bile acid synthesis in CTX.,7298854_9,-1,2839,-1,0.31794474
2840,cholesterol,26,27,153,164,"As a consequence, it is probable that the normal functions of the HDL, possibly including modulation of LDL-cholesterol uptake and the removal of excess cholesterol from peripheral tissues, are perturbed significantly in this disease.",7298854_10,-1,2840,-1,0.3465651
2841,disease,36,37,226,233,"As a consequence, it is probable that the normal functions of the HDL, possibly including modulation of LDL-cholesterol uptake and the removal of excess cholesterol from peripheral tissues, are perturbed significantly in this disease.",7298854_10,-1,2841,-1,0.33815658
2842,xanthomatosis,3,4,29,42,Genetics of cerebrotendinous xanthomatosis (CTX): an autosomal recessive trait with high gene frequency in Sephardim of Moroccan origin.,7315872_0,-1,2842,-1,0.3003541
2843,CTX,5,6,44,47,Genetics of cerebrotendinous xanthomatosis (CTX): an autosomal recessive trait with high gene frequency in Sephardim of Moroccan origin.,7315872_0,-1,2843,-1,0.35624596
2844,xanthomatosis,12,13,74,87,"
We described 6 patients (from 3 families) affected with cerebrotendinous xanthomatosis (CTX).",7315872_1,-1,2844,-1,0.30504
2845,CTX,14,15,89,92,"
We described 6 patients (from 3 families) affected with cerebrotendinous xanthomatosis (CTX).",7315872_1,-1,2845,-1,0.3537417
2846,CTX,7,8,31,34,"In view of the small number of CTX patients diagnosed in the world (a total of 50 including our 6 patients), we are probably dealing with an ethnic subgroup with a high CTX gene frequency, which we have estimated to be 1/108.",7315872_3,-1,2846,-1,0.33851767
2847,CTX,35,36,169,172,"In view of the small number of CTX patients diagnosed in the world (a total of 50 including our 6 patients), we are probably dealing with an ethnic subgroup with a high CTX gene frequency, which we have estimated to be 1/108.",7315872_3,-1,2847,-1,0.33993506
2848,disease,8,9,50,57,"Since there are differences in expression in this disease, we recommend cholestanol study in cases of undiagnosed cataract or tendinous xanthomas in childhood or early adolescence.",7315872_4,-1,2848,-1,0.32838035
2850,CTX,3,4,17,20,"The diagnosis in CTX is important not only for genetic counseling, but also in veiw of possible treatment..",7315872_5,-1,2850,-1,0.32720953
2851,glucose,4,5,24,31,New genetic variants of glucose 6-phosphate dehydrogenase (G6PD) in Italy.,7316485_0,-1,2851,-1,0.33790636
2852,haemolysis,22,23,115,125,"All of them were found in Italian males and all were associated with enzyme deficiency, but only two with signs of haemolysis.",7316485_2,-1,2852,-1,0.31743953
2853,map,21,22,111,114,"These and other variants reported in the literature, which must thus far be regarded as sporadic, are found to map in parts of Italy where common types of G6PD deficiency are also prevalent..",7316485_3,-1,2853,-1,0.43721744
2855,Wiskott-Aldrich syndrome,3,5,19,43,Nephropathy in the Wiskott-Aldrich syndrome.,7422429_0,-1,2855,-1,0.37642917
2857,Wiskott-Aldrich syndrome,10,12,58,82,"
Nephropathy was detected in five of 32 patients with the Wiskott-Aldrich syndrome who were participating in a study of transfer factor (TF) therapy.",7422429_1,-1,2857,-1,0.38230994
2859,renal,8,9,51,56,An additional patient was identified who died with renal failure without having received TF.,7422429_6,-1,2859,-1,0.34054023
2860,renal failure,4,6,25,38,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2860,-1,0.3833218
2861,Wiskott-Aldrich syndrome,9,11,53,77,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2861,-1,0.38301978
2862,disease,27,28,190,197,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2862,-1,0.3873739
2863,syndrome,32,33,220,228,The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome..,7422429_7,-1,2863,-1,0.3332043
2864,Wiskott-Aldrich syndrome,0,2,0,24,Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection.,7437512_0,-1,2864,-1,0.40830675
2865,Wiskott-Aldrich syndrome,10,12,56,80,"
A family in which two male siblings were affected with Wiskott-Aldrich syndrome (WAS) was studied using G-6-PD isoenzymes as an X-linked marker in order to investigate the nature of cellular abnormalities.",7437512_1,-1,2865,-1,0.38603413
2866,adrenoleukodystrophy,5,6,20,40,A new CT pattern in adrenoleukodystrophy.,7444053_0,-1,2866,-1,0.33187217
2867,adrenoleukodystrophy,10,11,50,70,"
A new CT pattern was observed in 2 patients with adrenoleukodystrophy (ALD).",7444053_1,-1,2867,-1,0.3263546
2868,contrast,30,31,186,194,"This pattern, which the authors call Type II, is characterized by the absence of posterior periventricular areas of decreased attenuation around the trigone on non-contrast scans  after contrast infusion, however, there is striking enhancement of various white-matter structures (tracts or fiber systems) such as the internal capsules, corpus callosum, corona radiata, forceps major, and cerebral peduncles.",7444053_2,-1,2868,-1,0.34103844
2873,riboflavin,17,18,99,109,"Moreover, G6PD deficiency should be added to other conditions, such as the galactosemic states and riboflavin deficiency, where cataracts represent a sensitive indicator of metabolic abnormalities of the RBC..",7458742_5,-1,2873,-1,0.33654857
2875,metabolic abnormalities,27,29,173,196,"Moreover, G6PD deficiency should be added to other conditions, such as the galactosemic states and riboflavin deficiency, where cataracts represent a sensitive indicator of metabolic abnormalities of the RBC..",7458742_5,-1,2875,-1,0.2859123
2877,sudden death,12,14,116,128,Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood.,7479827_0,-1,2877,-1,0.3532922
2878,fatty acids,3,5,30,41,"
beta-Oxidation of long-chain fatty acids provides the major source of energy in the heart.",7479827_1,-1,2878,-1,0.36953452
2881,liver failure,19,21,127,140,"Defects in enzymes of the beta-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy.",7479827_2,-1,2881,-1,0.38363144
2884,nucleotide,13,14,75,85,We have isolated the human VLCAD cDNA and gene and determined the complete nucleotide sequences.,7479827_4,-1,2884,-1,0.36942288
2885,VLCAD deficiency,18,20,123,139,Polymerase chain reaction amplification of VLCAD mRNA and genomic exons defined the molecular defects in two patients with VLCAD deficiency who presented with unexplained cardiac arrest and cardiomyopathy.,7479827_5,-1,2885,-1,0.35548377
2888,tryptophan,26,27,127,137,"The second patient was a compound heterozygote, with a missense mutation, C1837-- > T, changing the arginine at residue 613 to tryptophan on one allele and a single base deletion at the intron-exon 6 boundary as the second mutation.",7479827_7,-1,2888,-1,0.32223988
2889,VLCAD deficiency,10,12,67,83,This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid beta-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.,7479827_8,-1,2889,-1,0.3678237
2890,fatty acid,14,16,103,113,This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid beta-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.,7479827_8,-1,2890,-1,0.382238
2892,sudden death,26,28,193,205,This initial delineation of human mutations in VLCAD suggests that VLCAD deficiency reduces myocardial fatty acid beta-oxidation and energy production and is associated with cardiomyopathy and sudden death in childhood.,7479827_8,-1,2892,-1,0.32808664
2898,Wilson disease,7,9,38,52,Mapping of the mouse homologue of the Wilson disease gene to mouse chromosome 8.,7490097_0,-1,2898,-1,0.34807596
2899,Wilson disease,6,8,28,42,"
ATP7B, the gene altered in Wilson disease (WD) patients, lies in a block of homology shared between human chromosome 13q14 and the central region of mouse chromosome 14.",7490097_1,-1,2899,-1,0.329867
2900,map,15,16,87,90,ATP4B lies in 13q34 and is separated from ATP7B by several loci whose mouse homologues map to mouse chromosome 14.,7490097_4,-1,2900,-1,0.37215164
2912,lead,16,17,91,95,"An in-frame stop codon is found 17 codons downstream from the intron boundary, which would lead to a truncated polypeptide 13.",7535801_7,-1,2912,-1,0.40269086
2913,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation.,7543316_0,-1,2913,-1,0.3945876
2914,myotonic dystrophy,5,7,46,64,"
The trinucleotide expansion mutation causing myotonic dystrophy is in the 3 untranslated region of a protein kinase gene.",7543316_1,-1,2914,-1,0.3548128
2915,disease,14,15,103,110,"The molecular mechanisms by which the expanded repeat causes the clinically variable and multisystemic disease, myotonic dystrophy, are not understood.",7543316_2,-1,2915,-1,0.3724973
2916,myotonic dystrophy,16,18,112,130,"The molecular mechanisms by which the expanded repeat causes the clinically variable and multisystemic disease, myotonic dystrophy, are not understood.",7543316_2,-1,2916,-1,0.35078883
2917,myotonic dystrophy,8,10,55,73,"Here we use muscle biopsies from classical adult-onset myotonic dystrophy patients to study the accumulation of transcripts from both the normal and expanded DM kinase genes in patient muscle, and compare the results to normal and myopathic controls.",7543316_4,-1,2917,-1,0.35313073
2918,DM,23,24,158,160,"Here we use muscle biopsies from classical adult-onset myotonic dystrophy patients to study the accumulation of transcripts from both the normal and expanded DM kinase genes in patient muscle, and compare the results to normal and myopathic controls.",7543316_4,-1,2918,-1,0.38007092
2919,myopathic,37,38,231,240,"Here we use muscle biopsies from classical adult-onset myotonic dystrophy patients to study the accumulation of transcripts from both the normal and expanded DM kinase genes in patient muscle, and compare the results to normal and myopathic controls.",7543316_4,-1,2919,-1,0.39942816
2920,DM,6,7,39,41,"We found relatively small decreases of DM kinase RNA in the total RNA pool from muscle; however, these reductions were not disease specific.",7543316_5,-1,2920,-1,0.3467345
2921,disease,23,24,123,130,"We found relatively small decreases of DM kinase RNA in the total RNA pool from muscle; however, these reductions were not disease specific.",7543316_5,-1,2921,-1,0.41197044
2922,DM,17,18,83,85,"Analysis of poly (A) + RNA showed dramatic decreases of both the mutant and normal DM kinase RNAs, and these changes were disease-specific.",7543316_6,-1,2922,-1,0.35744888
2923,myotonic dystrophy,11,13,78,96,"Our findings are consistent with a novel molecular pathogenetic mechanism for myotonic dystrophy  both the normal and expanded DM kinase genes are transcribed in patient muscle, but the abnormal expansion-containing RNA has a dominant effect on RNA metabolism by preventing the accumulation of poly (A) + RNA.",7543316_7,-1,2923,-1,0.3663193
2924,DM,19,20,127,129,"Our findings are consistent with a novel molecular pathogenetic mechanism for myotonic dystrophy  both the normal and expanded DM kinase genes are transcribed in patient muscle, but the abnormal expansion-containing RNA has a dominant effect on RNA metabolism by preventing the accumulation of poly (A) + RNA.",7543316_7,-1,2924,-1,0.37187064
2925,myotonic dystrophy,20,22,101,119,The ability of the expansion mutation to alter accumulation of poly (A) + RNA in trans suggests that myotonic dystrophy may be the first example of a dominant-negative mutation manifested at the RNA level..,7543316_8,-1,2925,-1,0.37032452
2928,amino acids,21,23,117,128,"The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids.",7545954_4,-1,2928,-1,0.37974447
2929,zinc,4,5,24,28,"This protein contains a zinc finger domain in its amino-terminal region, but is otherwise unrelated to previously described proteins.",7545954_5,-1,2929,-1,0.3702288
2932,nucleotide,13,14,68,78,"The other was a splicing mutation, an A-to-G transition at the 38th nucleotide in exon 3 (318A-- > G), resulting in a 38-bp deletion in the GALT cDNA by activating a cryptic splice acceptor site.",7550229_4,-1,2932,-1,0.420448
2933,aniridia,2,3,12,20,Three novel aniridia mutations in the human PAX6 gene.,7550230_0,-1,2933,-1,0.37875846
2934,Aniridia,0,1,1,9,"
Aniridia (iris hypoplasia) is an autosomal dominant congenital disorder of the eye.",7550230_1,-1,2934,-1,0.3881673
2935,aniridia,4,5,23,31,Mutations in the human aniridia (PAX6) gene have now been identified in many patients from various ethnic groups.,7550230_2,-1,2935,-1,0.37062815
2936,aniridia,17,18,99,107,In the study reported here we describe PAX6 mutations in one sporadic and five familial cases with aniridia.,7550230_3,-1,2936,-1,0.3540098
2937,C--,16,17,97,100,"Of the four different mutations identified, one was identical to a previously reported mutation (C-- > T transition at codon 240), and three were novel  two in the glycine-rich region and one in the proline/serine/threonine-rich (PST) region.",7550230_4,-1,2937,-1,0.35351965
2939,an aniridia,13,15,75,86,One PAX6 mutation found in the PST region was associated with cataracts in an aniridia family.,7550230_5,-1,2939,-1,0.35178196
2940,aniridia,10,11,57,65,Another splice mutation in the PST domain occurred in an aniridia patient with anosmia (inability to smell).,7550230_6,-1,2940,-1,0.37610754
2941,anosmia,13,14,79,86,Another splice mutation in the PST domain occurred in an aniridia patient with anosmia (inability to smell).,7550230_6,-1,2941,-1,0.36869174
2942,aniridia,3,4,12,20,The six new aniridia cases reported here have mutations predicted to generate incomplete PAX6 proteins.,7550230_7,-1,2942,-1,0.36802432
2943,aniridia,7,8,44,52,These results support the theory that human aniridia is caused by haploinsufficiency of PAX6..,7550230_8,-1,2943,-1,0.36389285
2952,Huntington disease,1,3,5,23,"
The Huntington disease (HD) phenotype is associated with expansion of a trinucleotide repeat in the IT15 gene, which is predicted to encode a 348-kDa protein named huntington.",7568002_1,-1,2952,-1,0.36969176
2955,cerebellar ataxia,13,15,73,90,"
The spinocerebellar ataxia 3 locus (SCA3) for type I autosomal dominant cerebellar ataxia (ADCA type I), a clinically and genetically heterogeneous group of neurodegenerative disorders, has been mapped to chromosome 14q32.",7573040_1,-1,2955,-1,0.3388062
2956,neurodegenerative disorders,28,30,158,185,"
The spinocerebellar ataxia 3 locus (SCA3) for type I autosomal dominant cerebellar ataxia (ADCA type I), a clinically and genetically heterogeneous group of neurodegenerative disorders, has been mapped to chromosome 14q32.",7573040_1,-1,2956,-1,0.33457646
2957,Machado-Joseph disease,19,21,107,129,"1 1. ADCA type I patients from families segregating SCA3 share clinical features in common with those with Machado-Joseph disease (MJD), the gene of which maps to the same region.",7573040_2,-1,2957,-1,0.39316532
2958,disease,5,6,22,29,We show here that the disease gene segregating in each of three French ADCA type I kindreds and in a French family with neuropathological findings suggesting the ataxochoreic form of dentatorubropallidoluysian atrophy carries an expanded CAG repeat sequence located at the same locus as that for MJD.,7573040_3,-1,2958,-1,0.3989701
2960,disease,25,26,148,155,Analysis of the mutation in these families shows a strong negative correlation between size of the expanded CAG repeat and age at onset of clinical disease.,7573040_4,-1,2960,-1,0.37948552
2961,Pelizaeus-Merzbacher disease,9,11,58,86,Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease.,7574457_0,-1,2961,-1,0.3571129
2962,Pelizaeus-Merzbacher disease,0,2,1,29,"
Pelizaeus-Merzbacher disease is a rare, sex-linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene.",7574457_1,-1,2962,-1,0.37894368
2963,disease,10,11,78,85,"
Pelizaeus-Merzbacher disease is a rare, sex-linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene.",7574457_1,-1,2963,-1,0.36557454
2964,Pelizaeus-Merzbacher disease,7,9,34,62,"Only 25% of patients studied with Pelizaeus-Merzbacher disease have exonic mutations in this gene, the underlying cause of the disease in the remaining patients is unknown.",7574457_2,-1,2964,-1,0.3551861
2965,disease,21,22,127,134,"Only 25% of patients studied with Pelizaeus-Merzbacher disease have exonic mutations in this gene, the underlying cause of the disease in the remaining patients is unknown.",7574457_2,-1,2965,-1,0.3476063
2966,Pelizaeus-Merzbacher disease,9,11,58,86,We studied cultured skin fibroblasts from 2 brothers with Pelizaeus-Merzbacher disease who exhibited no detectable exonic mutation of the PLP gene.,7574457_5,-1,2966,-1,0.3549073
2967,Pelizaeus-Merzbacher disease,8,10,44,72,"Our findings suggest that in some patients, Pelizaeus-Merzbacher disease is caused by overexpression of PLP gene transcripts, and that in these families a 50% increase of DM20 messenger RNA in females, relative to the increase in affected males, can identify a female carrier..",7574457_8,-1,2967,-1,0.37375847
2968,Wiskott-Aldrich syndrome,1,3,4,28,The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.,7579347_0,-1,2968,-1,0.39824617
2970,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, small platelets, eczema, recurrent infections, and immunodeficiency.",7579347_1,-1,2970,-1,0.38875112
2972,eczema,18,19,122,128,"
The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, small platelets, eczema, recurrent infections, and immunodeficiency.",7579347_1,-1,2972,-1,0.35774294
2974,immunodeficiency,24,25,156,172,"
The Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, small platelets, eczema, recurrent infections, and immunodeficiency.",7579347_1,-1,2974,-1,0.33009222
2976,eczema,26,27,156,162,"Besides the classic WAS phenotype, there is a group of patients with congenital X-linked thrombocytopenia (XLT) who have small platelets but only transient eczema, if any, and minimal immune deficiency.",7579347_2,-1,2976,-1,0.34828904
2977,amino acid,33,35,220,230,"Direct sequence analysis of cDNA and genomic DNA obtained from patient-derived cell lines showed 12 unique mutations distributed throughout the WAS gene, including insertions, deletions, and point mutations resulting in amino acid substitutions, termination, exon skipping, or splicing defects.",7579347_5,-1,2977,-1,0.36563152
2978,Myotonia,0,1,0,8,Myotonia levior is a chloride channel disorder.,7581380_0,-1,2978,-1,0.3591732
2979,chloride,4,5,21,29,Myotonia levior is a chloride channel disorder.,7581380_0,-1,2979,-1,0.38370436
2980,myotonia congenita,1,3,9,27,"Dominant myotonia congenita (Thomsens disease) is linked to CLCN1, the gene encoding the major muscle chloride channel, localized on chromosome 7q35.",7581380_2,-1,2980,-1,0.3618002
2981,disease,5,6,38,45,"Dominant myotonia congenita (Thomsens disease) is linked to CLCN1, the gene encoding the major muscle chloride channel, localized on chromosome 7q35.",7581380_2,-1,2981,-1,0.36361197
2982,chloride,18,19,102,110,"Dominant myotonia congenita (Thomsens disease) is linked to CLCN1, the gene encoding the major muscle chloride channel, localized on chromosome 7q35.",7581380_2,-1,2982,-1,0.37839794
2983,contrast,1,2,3,11,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2983,-1,0.35171187
2984,myotonias,4,5,22,31,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2984,-1,0.33988044
2985,potassium,7,8,45,54,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2985,-1,0.33195946
2986,sodium,30,31,173,179,"In contrast, dominant myotonias sensitive to potassium are caused by point mutations in SCN4A on chromosome 17q, the gene for the alpha subunit of the adult skeletal muscle sodium channel.",7581380_3,-1,2986,-1,0.34956732
2987,myotonia,11,12,61,69,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2987,-1,0.33314756
2988,myotonia,21,22,129,137,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2988,-1,0.2905143
2989,disease,25,26,155,162,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2989,-1,0.36845684
2990,muscle hypertrophy,30,32,179,197,"No linkage or molecular genetic data are as yet available on myotonia levior characterized by milder symptoms and later onset of myotonia than in Thomsens disease, and absence of muscle hypertrophy.",7581380_4,-1,2990,-1,0.3616265
2991,myotonia,16,17,111,119,We report a CLCN1 Gln-552-Arg substitution for a family with dominant inheritance previously diagnosed to have myotonia levior.,7581380_5,-1,2991,-1,0.3236233
2992,disease,10,11,53,60,"Thus, this disorder appears as a variant of Thomsens disease due to mutations leading to low clinical expressivity.",7581380_6,-1,2992,-1,0.33838552
2993,disease,8,9,58,65,"In another family previously diagnosed as having Thomsens disease, we unexpectedly found a CLCN1 14 bp deletion known to cause recessive myotonia, and a rare Trp-118-Gly polymorphism..",7581380_8,-1,2993,-1,0.34897715
2994,myotonia,22,23,137,145,"In another family previously diagnosed as having Thomsens disease, we unexpectedly found a CLCN1 14 bp deletion known to cause recessive myotonia, and a rare Trp-118-Gly polymorphism..",7581380_8,-1,2994,-1,0.3112259
2995,Lesch-Nyhan syndrome,15,17,113,133,Southern analysis reveals a large deletion at the hypoxanthine phosphoribosyltransferase locus in a patient with Lesch-Nyhan syndrome.,7586656_0,-1,2995,-1,0.41123447
2996,Lesch-Nyhan syndrome,30,32,173,193,"
Whole genomic hprt clones were used in Southern analysis to screen the integrity of the hprt gene in a family that includes a patient with HPRT enzyme deficiency causal to Lesch-Nyhan syndrome.",7586656_1,-1,2996,-1,0.40058136
2997,amelogenesis imperfecta,6,8,50,73,Characterisation of molecular defects in X-linked amelogenesis imperfecta (AIH1).,7599636_0,-1,2997,-1,0.31887734
2998,amelogenesis imperfecta,6,8,42,65,"Disturbances of enamel formation occur in amelogenesis imperfecta, a clinically heterogenous group of inherited disorders characterised by defective enamel biomineralisation.",7599636_2,-1,2998,-1,0.3186766
2999,amelogenesis imperfecta,12,14,66,89,3) and has been implicated in the molecular pathology of X-linked amelogenesis imperfecta (AIH1).,7599636_4,-1,2999,-1,0.29679275
3000,cytosine,19,20,103,111,"Three novel mutations were identified  a C-T substitution in exon 5, and a G-T substitution and single cytosine deletion in exon 6, confirming the existence of extensive allelic heterogeneity in this condition.",7599636_6,-1,3000,-1,0.33821106
3001,disease,25,26,196,203,The identification of family-specific mutations will enable early identification of affected individuals and correlation of clinical phenotype with genotype will facilitate an objective system of disease classification.,7599636_7,-1,3001,-1,0.35170066
3002,cholesteryl ester,12,14,51,68,Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.,7605382_0,-1,3002,-1,0.3411197
3003,Cholesteryl ester,0,2,1,18,"
Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester from high density lipoprotein (HDL) to apo B-containing lipoproteins.",7605382_1,-1,3003,-1,0.37924567
3004,cholesteryl ester,8,10,53,70,"
Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester from high density lipoprotein (HDL) to apo B-containing lipoproteins.",7605382_1,-1,3004,-1,0.32983112
3005,corneal opacity,21,23,132,147,One of the homozygotes for the 442D  G mutation was the patient previously described by us as having hyperalphalipoproteinemia with corneal opacity and coronary heart disease.,7605382_9,-1,3005,-1,0.3469556
3006,coronary heart disease,24,27,152,174,One of the homozygotes for the 442D  G mutation was the patient previously described by us as having hyperalphalipoproteinemia with corneal opacity and coronary heart disease.,7605382_9,-1,3006,-1,0.35776177
3008,IVA,2,3,27,30,Mucopolysaccharidosis type IVA: common double deletion in the N-acetylgalactosamine-6-sulfatase gene (GALNS).,7607677_0,-1,3008,-1,0.36207977
3009,N-acetylgalactosamine-6-sulfatase,9,10,62,95,Mucopolysaccharidosis type IVA: common double deletion in the N-acetylgalactosamine-6-sulfatase gene (GALNS).,7607677_0,-1,3009,-1,0.38290852
3010,IVA,1,2,23,26,"
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency in N-acetylgalactosamine-6-sulfatase (GALNS).",7607677_1,-1,3010,-1,0.36273402
3011,IVA,4,5,32,35,"
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency in N-acetylgalactosamine-6-sulfatase (GALNS).",7607677_1,-1,3011,-1,0.35535845
3012,N-acetylgalactosamine-6-sulfatase,16,17,98,131,"
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency in N-acetylgalactosamine-6-sulfatase (GALNS).",7607677_1,-1,3012,-1,0.37142232
3020,carcinomatosis,11,12,73,87,A 40-bp deletion was detected in a patient who developed intra-abdominal carcinomatosis 1 year after prophylactic oophorectomy.,7611277_8,-1,3020,-1,0.3089332
3023,severe malaria,14,16,92,106,Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.,7617034_0,-1,3023,-1,0.3246694
3024,malaria,11,12,83,90,The geographical correlation of its distribution with the historical endemicity of malaria suggests that this disorder has risen in frequency through natural selection by malaria.,7617034_2,-1,3024,-1,0.34574088
3025,malaria,24,25,171,178,The geographical correlation of its distribution with the historical endemicity of malaria suggests that this disorder has risen in frequency through natural selection by malaria.,7617034_2,-1,3025,-1,0.34701246
3026,malaria,14,15,91,98,"However, attempts to confirm that G6PD deficiency is protective in case-control studies of malaria have yielded conflicting results.",7617034_3,-1,3026,-1,0.35507253
3027,severe malaria,41,43,190,204,"Here we report that, in two large case-control studies of over 2, 000 African children, the common African form of G6PD deficiency (G6PD A-) is associated with a 46-58% reduction in risk of severe malaria for both female heterozygotes and male hemizygotes.",7617034_6,-1,3027,-1,0.36840492
3028,malaria,9,10,76,83,"A mathematical model incorporating the measured selective advantage against malaria suggests that a counterbalancing selective disadvantage, associated with this enzyme deficiency, has retarded its rise in frequency in malaria-endemic regions.",7617034_7,-1,3028,-1,0.34592873
3029,rhabdomyosarcoma,2,3,13,29,The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.,7630639_0,-1,3029,-1,0.3019374
3031,rhabdomyosarcoma,21,22,72,88,"The PAX3/FKHR fusion gene, formed by a t (2; 13) (q35; q14) in alveolar rhabdomyosarcoma, encodes a hybrid protein that contains both PAX3 DNA binding domains, the paired box and homeodomain, linked to the bisected DNA binding domain of FKHR, a member of the forkhead family of transcription factors.",7630639_2,-1,3031,-1,0.29668212
3033,melanoma,12,13,82,90,A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.,7652577_0,-1,3033,-1,0.26624328
3034,melanoma,11,12,66,74,1-restricted autologous cytolytic T lymphocytes (CTLs) in a human melanoma.,7652577_2,-1,3034,-1,0.30010733
3035,melanoma,9,10,59,67,"The mutated CDK4 allele was present in autologous cultured melanoma cells and metastasis tissue, but not in the patients lymphocytes.",7652577_3,-1,3035,-1,0.28280082
3036,metastasis,12,13,78,88,"The mutated CDK4 allele was present in autologous cultured melanoma cells and metastasis tissue, but not in the patients lymphocytes.",7652577_3,-1,3036,-1,0.30217308
3037,melanoma,8,9,46,54,The same mutation was found in one additional melanoma among 28 melanomas analyzed.,7652577_5,-1,3037,-1,0.28193223
3041,nucleotide,17,18,99,109,"In 45 patients from breast and/or ovarian cancer families we found six novel mutations  two single nucleotide insertions, three small deletions (1-5 bp) and a nonsense mutation identified two unrelated families.",7663517_3,-1,3041,-1,0.38014933
3042,amino acids,22,24,113,124,"The cDNA inserts of these clones together encompass a region of 2, 177 bases, encoding the entire protein of 655 amino acids, including a 40-amino acid leader peptide and a 615-amino acid mature polypeptide.",7668252_2,-1,3042,-1,0.37241483
3043,VLCAD deficiency,9,11,54,70,This is the first demonstration of a mutation causing VLCAD deficiency.,7668252_6,-1,3043,-1,0.3780257
3044,vaccinia,15,16,100,108,"Quantitative cDNA expression of normal human VLCAD was performed in the patients fibroblasts, using vaccinia viral system, which demonstrated that the deficiency of the normal VLCAD protein causes impaired long-chain fatty acid beta-oxidation activity in the patients fibroblasts.",7668252_7,-1,3044,-1,0.36760953
3045,fatty acid,32,34,217,227,"Quantitative cDNA expression of normal human VLCAD was performed in the patients fibroblasts, using vaccinia viral system, which demonstrated that the deficiency of the normal VLCAD protein causes impaired long-chain fatty acid beta-oxidation activity in the patients fibroblasts.",7668252_7,-1,3045,-1,0.37495062
3046,VLCAD deficiency,44,46,287,303,"In patient fibroblasts, raising VLCAD activity to approximately 20% of normal control fibroblast activity raised palmitic acid beta-oxidation flux to the level found in control fibroblasts, which may offer important information for the rational design of future somatic gene therapy for VLCAD deficiency..",7668252_8,-1,3046,-1,0.36342385
3047,disease,1,2,6,13,Brain disease and molecular analysis in myotonic dystrophy.,7696601_0,-1,3047,-1,0.41778687
3048,myotonic dystrophy,6,8,40,58,Brain disease and molecular analysis in myotonic dystrophy.,7696601_0,-1,3048,-1,0.3532653
3049,myotonic dystrophy,14,16,83,101,"
Abnormal amplification of a CTG repeat on chromosome 19 is the molecular basis of myotonic dystrophy (DM).",7696601_1,-1,3049,-1,0.35335115
3050,DM,17,18,103,105,"
Abnormal amplification of a CTG repeat on chromosome 19 is the molecular basis of myotonic dystrophy (DM).",7696601_1,-1,3050,-1,0.35216826
3051,disease,15,16,94,101,Expansion of the repeat has been correlated with severity of several clinical features of the disease.,7696601_2,-1,3051,-1,0.35596406
3052,DM,21,22,124,126,"We performed extensive cognitive testing, cerebral magnetic resonance imaging (MRI) and a molecular analysis in 28 cases of DM to determine the relationship between the molecular defect and brain disease.",7696601_3,-1,3052,-1,0.34440637
3053,disease,32,33,196,203,"We performed extensive cognitive testing, cerebral magnetic resonance imaging (MRI) and a molecular analysis in 28 cases of DM to determine the relationship between the molecular defect and brain disease.",7696601_3,-1,3053,-1,0.37780485
3055,Disease,0,1,0,7,Disease duration influenced the appearance and amount of white matter lesions on MRI.,7696601_8,-1,3055,-1,0.38920003
3056,DM,17,18,105,107,Quantification of CTG repeat size may allow an early estimate on the probability of brain involvement in DM; cognitive dysfunction is associated with white matter lesions and cerebral atrophy later on in the course..,7696601_9,-1,3056,-1,0.32491982
3057,cognitive dysfunction,19,21,109,130,Quantification of CTG repeat size may allow an early estimate on the probability of brain involvement in DM; cognitive dysfunction is associated with white matter lesions and cerebral atrophy later on in the course..,7696601_9,-1,3057,-1,0.4053409
3058,adrenoleukodystrophy,6,7,35,55,Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.,7717396_0,-1,3058,-1,0.33714503
3059,adrenoleukodystrophy,12,13,71,91,"
Recently, the gene for the most common peroxisomal disorder, X-linked adrenoleukodystrophy (X-ALD), has been described encoding a peroxisomal membrane transporter protein.",7717396_1,-1,3059,-1,0.35858443
3060,Addison disease,48,50,298,313,"We analyzed the entire protein-coding sequence of this gene by reverse-transcription PCR, SSCP, and DNA sequencing in five patients with different clinical expression of X-ALD and in their female relatives; these clinical expressions were cerebral childhood ALD, adrenomyeloneuropathy (AMN), and "" Addison disease only "" (ADO) phenotype.",7717396_2,-1,3060,-1,0.3812684
3061,amino acid,40,42,224,234,"In the three patients exhibiting the classical picture of severe childhood ALD we identified in the 5 portion of the X-ALD gene a 38-bp deletion that causes a frameshift mutation, a 3-bp deletion leading to a deletion of an amino acid in the ATP-binding domain of the ALD protein, and a missense mutation.",7717396_3,-1,3061,-1,0.35732156
3062,muscular dystrophy,1,3,9,27,Duchenne muscular dystrophy and myotonic dystrophy in the same patient.,7726234_0,-1,3062,-1,0.361722
3063,myotonic dystrophy,4,6,32,50,Duchenne muscular dystrophy and myotonic dystrophy in the same patient.,7726234_0,-1,3063,-1,0.34749958
3064,myotonic dystrophy,8,10,48,66,"
We report on the first patient identified with myotonic dystrophy and Duchenne muscular dystrophy (DMD).",7726234_1,-1,3064,-1,0.36652637
3065,muscular dystrophy,12,14,80,98,"
We report on the first patient identified with myotonic dystrophy and Duchenne muscular dystrophy (DMD).",7726234_1,-1,3065,-1,0.33564565
3066,myotonic dystrophy,10,12,53,71,"The family of the propositus had a strong history of myotonic dystrophy, and there was an intrafamilial pathological expansion of the responsible CTG repeat between the mildly affected mother (160 repeats; normal 27 repeats) and her more severely affected son (650 repeats), and his sister (650 repeats).",7726234_2,-1,3066,-1,0.3514371
3067,muscular dystrophy,8,10,48,66,The propositus was an isolated case of Duchenne muscular dystrophy with marked dystrophin deficiency in muscle biopsy.,7726234_3,-1,3067,-1,0.3285309
3068,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy could interfere to some extent with the progression of Duchenne dystrophy.,7726234_5,-1,3068,-1,0.37018374
3081,contrast,1,2,3,11,"In contrast, there was no overall evidence of linkage in the group of 10 families with breast cancer without ovarian cancer.",7759076_3,-1,3081,-1,0.34341267
3089,melanoma,23,24,149,157,"Other cancers of interest that appeared in the BRCA1-linked families included primary peritoneal cancer, cancer of the fallopian tube, and malignant melanoma..",7759076_5,-1,3089,-1,0.2661025
3090,Huntington disease,11,13,56,74,Structural analysis of the 5' region of mouse and human Huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphisms.,7759106_0,-1,3090,-1,0.37022427
3091,Huntington disease,11,13,73,91,"
We have previously cloned and characterized the murine homologue of the Huntington disease (HD) gene and shown that it maps to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.",7759106_1,-1,3091,-1,0.38689274
3092,CA,15,16,89,91,Two dinucleotide (CT) and one trinucleotide intronic polymorphism in Hdh and an intronic CA polymorphism in the HD gene were identified.,7759106_5,-1,3092,-1,0.36611637
3093,nucleotide,21,22,113,123,Comparison of 940-bp sequence 5 to the putative translation start site reveals a highly conserved region (78. 8% nucleotide identity) between Hdh and the HD gene from nucleotide -56 to -206 (of Hdh).,7759106_6,-1,3093,-1,0.35153735
3094,Huntington disease,34,36,200,218,The high sequence identity between Hdh and the HD gene for approximately 200 bp 5 to the putative translation start site indicates that these sequences may play a role in regulating expression of the Huntington disease gene,7759106_8,-1,3094,-1,0.34088132
3095,syndrome,5,6,30,38,"The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.",7761412_0,-1,3095,-1,0.30379567
3096,syndrome,1,2,6,14,"
Lowe syndrome, also known as oculocerebrorenal syndrome, is caused by mutations in the X chromosome-encoded OCRL gene.",7761412_1,-1,3096,-1,0.3060577
3097,oculocerebrorenal syndrome,6,8,30,56,"
Lowe syndrome, also known as oculocerebrorenal syndrome, is caused by mutations in the X chromosome-encoded OCRL gene.",7761412_1,-1,3097,-1,0.3501568
3098,inositol,8,9,37,45,"The OCRL protein is 51% identical to inositol polyphosphate 5-phosphatase II (5-phosphatase II) from human platelets over a span of 744 aa, suggesting that OCRL may be a similar enzyme.",7761412_2,-1,3098,-1,0.3529828
3099,amino acids,10,12,56,67,We engineered a construct of the OCRL cDNA that encodes amino acids homologous to the platelet 5-phosphatase for expression in baculovirus-infected Sf9 insect cells.,7761412_3,-1,3099,-1,0.37204853
3100,inositol,3,4,19,27,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3100,-1,0.33607283
3101,inositol,10,11,53,61,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3101,-1,0.30856565
3102,inositol,18,19,97,105,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3102,-1,0.30738723
3103,inositol,27,28,138,146,"Thus OCRL converts inositol 1, 4, 5-trisphosphate to inositol 1, 4-bisphosphate, and it converts inositol 1, 3, 4, 5-tetrakisphosphate to inositol 1, 3, 4-trisphosphate.",7761412_6,-1,3103,-1,0.29495102
3104,syndrome,11,12,79,87,Deficiency of this enzyme apparently causes the protean manifestations of Lowe syndrome..,7761412_11,-1,3104,-1,0.32241613
3105,myotonic dystrophy,5,7,30,48,New founder haplotypes at the myotonic dystrophy locus in southern Africa.,7762560_0,-1,3105,-1,0.371058
3106,myotonic dystrophy,26,28,172,190,"
The association between normal alleles at the CTG repeat and two nearby polymorphisms in the myotonin protein kinase gene, the Alu insertion/deletion polymorphism and the myotonic dystrophy kinase (DMK) (G/T) intron 9/HinfI polymorphism, has been analyzed in South African Negroids, a population in which myotonic dystrophy (DM) has not been described.",7762560_1,-1,3106,-1,0.37112787
3107,myotonic dystrophy,51,53,306,324,"
The association between normal alleles at the CTG repeat and two nearby polymorphisms in the myotonin protein kinase gene, the Alu insertion/deletion polymorphism and the myotonic dystrophy kinase (DMK) (G/T) intron 9/HinfI polymorphism, has been analyzed in South African Negroids, a population in which myotonic dystrophy (DM) has not been described.",7762560_1,-1,3107,-1,0.38112336
3108,DM,54,55,326,328,"
The association between normal alleles at the CTG repeat and two nearby polymorphisms in the myotonin protein kinase gene, the Alu insertion/deletion polymorphism and the myotonic dystrophy kinase (DMK) (G/T) intron 9/HinfI polymorphism, has been analyzed in South African Negroids, a population in which myotonic dystrophy (DM) has not been described.",7762560_1,-1,3108,-1,0.36715478
3109,DM,24,25,127,129,"These data provide support for the "" out of Africa "" model for the origin of modern humans and suggest that the rare ancestral DM mutation event may have occurred after the migration from Africa, hence the absence of DM in sub-Saharan Negroid peoples..",7762560_6,-1,3109,-1,0.32628775
3110,DM,40,41,217,219,"These data provide support for the "" out of Africa "" model for the origin of modern humans and suggest that the rare ancestral DM mutation event may have occurred after the migration from Africa, hence the absence of DM in sub-Saharan Negroid peoples..",7762560_6,-1,3110,-1,0.32137978
3111,myotonic dystrophy,4,6,31,49,Discordant clinical outcome in myotonic dystrophy relatives showing (CTG)n > 700 repeats.,7767095_0,-1,3111,-1,0.35264716
3112,(CTG)n,8,9,68,74,Discordant clinical outcome in myotonic dystrophy relatives showing (CTG)n > 700 repeats.,7767095_0,-1,3112,-1,0.39427978
3113,myotonic dystrophy,1,3,3,21,"
A myotonic dystrophy (DM) family is described in which discordant DM phenotypes were found in the children of two affected sisters with similar CTG expansion and clinical manifestations.",7767095_1,-1,3113,-1,0.38844213
3114,DM,4,5,23,25,"
A myotonic dystrophy (DM) family is described in which discordant DM phenotypes were found in the children of two affected sisters with similar CTG expansion and clinical manifestations.",7767095_1,-1,3114,-1,0.41032404
3115,DM,12,13,67,69,"
A myotonic dystrophy (DM) family is described in which discordant DM phenotypes were found in the children of two affected sisters with similar CTG expansion and clinical manifestations.",7767095_1,-1,3115,-1,0.35004106
3116,DM,15,16,87,89,"In this family, congenital as well as early severe childhood and later childhood onset DM coexist.",7767095_2,-1,3116,-1,0.35280496
3117,DM,17,18,140,142,This observation strengthens the limited ability of lymphocytes CTG repeat number analysis in predicting genotype-phenotype correlations in DM patients..,7767095_3,-1,3117,-1,0.34151277
3118,VLCAD deficiency,31,33,229,245,"The seven deficient fibroblast lines were characterized by measuring acyl-coenzyme A dehydrogenation activities, overall palmitic acid oxidation, and VLCAD protein synthesis using pulse-chase, further confirming the diagnosis of VLCAD deficiency.",7769092_5,-1,3118,-1,0.37364167
3119,VLCAD deficiency,5,7,30,46,"Clinically, all patients with VLCAD deficiency exhibited cardiac disease.",7769092_7,-1,3119,-1,0.38574138
3120,cardiac disease,8,10,57,72,"Clinically, all patients with VLCAD deficiency exhibited cardiac disease.",7769092_7,-1,3120,-1,0.35750005
3121,hypertrophic cardiomyopathy,7,9,37,64,At least four of them presented with hypertrophic cardiomyopathy.,7769092_8,-1,3121,-1,0.36918324
3122,fatty acid,21,23,119,129,This frequency (> 57%) was much higher than that observed in patients with other disorders of mitochondrial long-chain fatty acid oxidation that may be accompanied by cardiac disease in infants..,7769092_9,-1,3122,-1,0.37281495
3123,cardiac disease,29,31,167,182,This frequency (> 57%) was much higher than that observed in patients with other disorders of mitochondrial long-chain fatty acid oxidation that may be accompanied by cardiac disease in infants..,7769092_9,-1,3123,-1,0.34211406
3124,systemic lupus erythematosus,6,9,30,58,"The proband, who has inactive systemic lupus erythematosus is completely lacking C5, while her healthy half-sister has 1-2% of normal levels.",777027_4,-1,3124,-1,0.31517282
3125,hemoglobinuria,16,17,109,123,"The probands serum was incapable of mediating lysis of erythrocytes from a patient with paroxysmal nocturnal hemoglobinuria in both the sucrose hemolysia and acid hemolysis tests, and also lacked bactericidal activity against sensitized or unsensitized Salmonella typhi.",777027_10,-1,3125,-1,0.34633327
3126,sucrose,20,21,136,143,"The probands serum was incapable of mediating lysis of erythrocytes from a patient with paroxysmal nocturnal hemoglobinuria in both the sucrose hemolysia and acid hemolysis tests, and also lacked bactericidal activity against sensitized or unsensitized Salmonella typhi.",777027_10,-1,3126,-1,0.3472256
3128,peroxisomal disorders,15,17,116,137,Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders.,7790377_0,-1,3128,-1,0.29406944
3129,adrenoleukodystrophy,25,26,167,187,The PTS1R cDNA also complements the PTS1 protein-import defect in skin fibroblasts from patients--belonging to complementation group two--diagnosed as having neonatal adrenoleukodystrophy or Zellweger syndrome.,7790377_13,-1,3129,-1,0.3102692
3130,Zellweger syndrome,27,29,191,209,The PTS1R cDNA also complements the PTS1 protein-import defect in skin fibroblasts from patients--belonging to complementation group two--diagnosed as having neonatal adrenoleukodystrophy or Zellweger syndrome.,7790377_13,-1,3130,-1,0.29159433
3131,map,19,20,115,118,The PTS1R gene has been localized to a chromosomal location where no other peroxisomal disorder genes are known to map.,7790377_14,-1,3131,-1,0.37738246
3132,peroxisomal disorders,17,19,108,129,Our findings represent the only case in which the molecular basis of the protein-import deficiency in human peroxisomal disorders is understood.,7790377_15,-1,3132,-1,0.30083027
3133,RB1,6,7,38,41,Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma.,7795591_0,-1,3133,-1,0.30835855
3134,retinoblastoma,19,20,107,121,Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma.,7795591_0,-1,3134,-1,0.2807119
3135,RB1,4,5,27,30,"
Germline mutations in the RB1 gene confer hereditary predisposition to retinoblastoma.",7795591_1,-1,3135,-1,0.31005746
3136,retinoblastoma,10,11,72,86,"
Germline mutations in the RB1 gene confer hereditary predisposition to retinoblastoma.",7795591_1,-1,3136,-1,0.28840417
3137,RB1,8,9,43,46,We have performed a mutation survey of the RB1 gene in 232 patients with hereditary or non hereditary retinoblastoma.,7795591_2,-1,3137,-1,0.30895707
3138,retinoblastoma,18,19,102,116,We have performed a mutation survey of the RB1 gene in 232 patients with hereditary or non hereditary retinoblastoma.,7795591_2,-1,3138,-1,0.2752206
3139,RB1,14,15,91,94,All types of point mutations are represented and are found unequally distributed along the RB1 gene sequence.,7795591_4,-1,3139,-1,0.31919834
3140,RB1,21,22,124,127,"The range of frequency of detection of germline mutations is about 20%, indicating that other mechanisms of inactivation of RB1 should be involved.",7795591_6,-1,3140,-1,0.31199503
3141,retinoblastoma,14,15,91,105,The spectrum of mutations presented here should help to improve the clinical management of retinoblastoma and to understand the molecular mechanisms leading to tumorigenesis..,7795591_7,-1,3141,-1,0.3021208
3142,aniridia,4,5,32,40,"
Current evidence suggests that aniridia (absence of iris) is caused by loss of function of one copy of the PAX6 gene, which maps to 11p13.",7795596_1,-1,3142,-1,0.37286052
3143,aniridia,7,8,47,55,We present the further characterisation of two aniridia pedigrees in which the disease segregates with chromosomal rearrangements which involve 11p13 but do not disrupt the PAX6 gene.,7795596_2,-1,3143,-1,0.38757813
3144,disease,12,13,79,86,We present the further characterisation of two aniridia pedigrees in which the disease segregates with chromosomal rearrangements which involve 11p13 but do not disrupt the PAX6 gene.,7795596_2,-1,3144,-1,0.34331146
3145,disease,31,32,197,204,We propose that the PAX6 gene on the rearranged chromosome 11 is in an inappropriate chromatin environment for normal expression and therefore that a position effect is the underlying mechanism of disease in these families..,7795596_5,-1,3145,-1,0.33848858
3146,tumours,9,10,56,63,Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.,7795652_0,-1,3146,-1,0.30350265
3147,syndrome,12,13,77,85,"
The BRCA1 gene on chromosome 17q21 is responsible for an autosomal dominant syndrome of increased susceptibility to breast and ovarian cancer but no somatic mutations in tumours have yet been described.",7795652_1,-1,3147,-1,0.3545101
3149,tumours,26,27,171,178,"
The BRCA1 gene on chromosome 17q21 is responsible for an autosomal dominant syndrome of increased susceptibility to breast and ovarian cancer but no somatic mutations in tumours have yet been described.",7795652_1,-1,3149,-1,0.27928662
3151,tumour,17,18,96,102,"To study the potential role of BRCA1 in sporadic carcinogenesis, we analysed the genomic DNA of tumour and normal fractions of 47 ovarian cancers for mutations in BRCA1 using the single-strand conformation polymorphism technique.",7795652_2,-1,3151,-1,0.3003501
3153,tumours,10,11,53,60,We now describe somatic mutations in the DNA of four tumours which also had loss of heterozygosity (LOH) at a BRCA1 intragenic marker.,7795652_3,-1,3153,-1,0.30018017
3154,tumour,4,5,19,25,Our data support a tumour suppressor mechanism for BRCA1; somatic mutations and LOH may result in inactivation of BRCA1 in at least a small number of ovarian cancers..,7795652_4,-1,3154,-1,0.33612314
3159,carcinoma in situ,10,13,68,85,BRCA1 mRNA levels are markedly decreased during the transition from carcinoma in situ to invasive cancer.,7795653_2,-1,3159,-1,0.3143747
3162,muscular dystrophy,13,15,99,117,Additional case of female monozygotic twins discordant for the clinical manifestations of Duchenne muscular dystrophy due to opposite X-chromosome inactivation.,7802009_0,-1,3162,-1,0.32422608
3163,MZ,6,7,31,33,"
A pair of female monozygotic (MZ) twins, heterozygous carriers for a deletion in the DMD gene and discordant for the clinical manifestations of Duchenne muscular dystrophy, were analyzed by molecular studies, in situ hybridization, and methylation pattern of X chromosomes to search for opposite X inactivation as an explanation of their clinical discordance.",7802009_1,-1,3163,-1,0.3835443
3164,muscular dystrophy,27,29,154,172,"
A pair of female monozygotic (MZ) twins, heterozygous carriers for a deletion in the DMD gene and discordant for the clinical manifestations of Duchenne muscular dystrophy, were analyzed by molecular studies, in situ hybridization, and methylation pattern of X chromosomes to search for opposite X inactivation as an explanation of their clinical discordance.",7802009_1,-1,3164,-1,0.33087084
3165,MZ,4,5,20,22,A review shows that MZ female twins discordant for X-linked diseases are not uncommon.,7802009_3,-1,3165,-1,0.35769698
3166,diseases,10,11,60,68,A review shows that MZ female twins discordant for X-linked diseases are not uncommon.,7802009_3,-1,3166,-1,0.34648
3167,adrenoleukodystrophy,1,2,9,29,X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes.,7811247_0,-1,3167,-1,0.3631597
3168,adrenoleukodystrophy,3,4,18,38,"
Fragments of the adrenoleukodystrophy (ALD) cDNA from a patient with adolescent ALD were amplified by polymerase chain reaction and subcloned.",7811247_1,-1,3168,-1,0.35467225
3169,cytosine,10,11,67,75,"Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine.",7811247_2,-1,3169,-1,0.35759532
3170,nucleotide,15,16,103,113,"Bidirectional sequencing of the entire coding ALD gene disclosed a cytosine to guanine transversion at nucleotide 1451 in exon five, resulting in substitution of proline 484 by arginine.",7811247_2,-1,3170,-1,0.34172454
3171,fatty acids,31,33,179,190,"Five of nine siblings of the patient, comprising two cerebral ALD, one adrenomyeloneuropathy, one Addison only as well as the symptomatic mother (all accumulating very long chain fatty acids) carried this mutation, which was not found in the unaffected persons, in five unrelated ALD patients, and in twenty controls.",7811247_3,-1,3171,-1,0.3304342
3172,disease,8,9,53,60,"We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors..",7811247_4,-1,3172,-1,0.36281013
3173,se,10,11,65,67,"We propose that this missense mutation generated the disease per se as well as the metabolic defect; the different phenotypes, however, must have originated by means of additional pathogenetic factors..",7811247_4,-1,3173,-1,0.37893993
3174,Norrie disease,8,10,46,60,Novel mutation at the initiation codon in the Norrie disease gene in two Japanese families.,7814011_0,-1,3174,-1,0.38839364
3175,Norrie disease,7,9,38,52,"
We have identified a new mutation of Norrie disease (ND) gene in two Japanese males from unrelated families; they showed typical ocular features of ND but no mental retardation or hearing impairment.",7814011_1,-1,3175,-1,0.36938065
3176,mental retardation,30,32,159,177,"
We have identified a new mutation of Norrie disease (ND) gene in two Japanese males from unrelated families; they showed typical ocular features of ND but no mental retardation or hearing impairment.",7814011_1,-1,3176,-1,0.3292611
3177,hearing impairment,33,35,181,199,"
We have identified a new mutation of Norrie disease (ND) gene in two Japanese males from unrelated families; they showed typical ocular features of ND but no mental retardation or hearing impairment.",7814011_1,-1,3177,-1,0.34282246
3178,nucleotide,27,28,123,133,"A mutation was found in both patients at the initiation codon of exon 2 of the ND gene (ATG to GTG), with otherwise normal nucleotide sequences.",7814011_2,-1,3178,-1,0.3599481
3179,disease,19,20,103,110,"Their mothers had the normal and mutant types of the gene, which was expected for heterozygotes of the disease.",7814011_3,-1,3179,-1,0.36776873
3180,amino,22,23,133,138,The mutation of the initiation codon would cause the failure of ND gene expression or a defect in translation thereby truncating the amino terminus of ND protein.,7814011_4,-1,3180,-1,0.4163838
3181,myotonic dystrophy,6,8,45,63,Anticipation resulting in elimination of the myotonic dystrophy gene: a follow up study of one extended family.,7815415_0,-1,3181,-1,0.38161838
3182,myotonic dystrophy,5,7,33,51,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3182,-1,0.37994435
3183,DM,8,9,53,55,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3183,-1,0.3906745
3184,DM,28,29,154,156,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3184,-1,0.33844694
3185,disease,39,40,222,229,"
We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease.",7815415_1,-1,3185,-1,0.36270395
3186,disease,16,17,87,94,"Clinical anticipation, defined as the cascade of mild, adult, childhood, or congenital disease in subsequent generations, appeared to be a relentless process, occurring in all affected branches of the family.",7815415_3,-1,3186,-1,0.349831
3187,disease,22,23,136,143,"The cascade was found to proceed asynchronously in the different branches, mainly because of an unequal number of generations with mild disease.",7815415_4,-1,3187,-1,0.35012957
3188,infertility,11,12,54,65,"Gene loss in the patient group was complete, owing to infertility of the male patients with adult onset disease and the fact that mentally retarded patients did not procreate.",7815415_8,-1,3188,-1,0.43673024
3189,disease,19,20,104,111,"Gene loss in the patient group was complete, owing to infertility of the male patients with adult onset disease and the fact that mentally retarded patients did not procreate.",7815415_8,-1,3189,-1,0.34054708
3190,DM,7,8,41,43,Therefore it is highly probable that the DM gene will be eliminated from this pedigree within one generation.,7815415_12,-1,3190,-1,0.37177932
3191,DM,5,6,33,35,"The high population frequency of DM can at present not be explained by the contribution of asymptomatic cases in the younger generations of known families, but is probably caused by the events in the ancestral generations..",7815415_13,-1,3191,-1,0.34118667
3192,cerebellar ataxia,4,6,20,37,The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2.,7825578_0,-1,3192,-1,0.37063968
3193,cM,18,19,89,91,The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2.,7825578_0,-1,3193,-1,0.37771854
3194,cerebellar ataxia,6,8,27,44,"
SCA3, the gene for spinal cerebellar ataxia 3, was recently mapped to a 15-cM interval between D14S67 and D14S81 on chromosome 14q, by linkage analysis in two families of French ancestry.",7825578_1,-1,3194,-1,0.35456964
3195,disease,8,9,48,55,The same allele for D14S280 segregates with the disease locus in the three kindreds.,7825578_6,-1,3195,-1,0.39579767
3196,Machado-Joseph disease,6,8,30,52,"2 containing the gene for the Machado-Joseph disease, which is clinically related to the phenotype determined by SCA3, but it cannot yet be concluded that both diseases result from alterations of the same gene",7825578_10,-1,3196,-1,0.40733045
3197,diseases,29,30,160,168,"2 containing the gene for the Machado-Joseph disease, which is clinically related to the phenotype determined by SCA3, but it cannot yet be concluded that both diseases result from alterations of the same gene",7825578_10,-1,3197,-1,0.3394231
3200,syndrome,3,4,32,40,"
The breast-ovary cancer-family syndrome is a dominant predisposition to cancer of the breast and ovaries which has been mapped to chromosome region 17q12-q21.",7825586_2,-1,3200,-1,0.32946742
3210,syndrome,7,8,57,65,These data suggest that the breast-ovarian cancer-family syndrome is genetically heterogeneous.,7825586_9,-1,3210,-1,0.3198815
3213,fructosuria,4,5,29,40,Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase).,7833921_0,-1,3213,-1,0.32624766
3214,fructosuria,1,2,11,22,"
Essential fructosuria is one of the oldest known inborn errors of metabolism.",7833921_1,-1,3214,-1,0.34447926
3215,fructosuria,20,21,120,131,"Despite the early recognition of this disorder, the primary structure of human KHK and the molecular basis of essential fructosuria have not been previously defined.",7833921_5,-1,3215,-1,0.32599908
3216,fructosuria,14,15,83,94,Direct evidence that mutation of the KHK structural gene is the cause of essential fructosuria was also obtained.,7833921_9,-1,3216,-1,0.3482347
3217,fructosuria,12,13,70,81,"In a well-characterized family, in which three of eight siblings have fructosuria, all affected individuals are compound heterozygotes for two mutations Gly40Arg and Ala43Thr.",7833921_10,-1,3217,-1,0.36606604
3218,amino acid,3,5,27,37,An additional conservative amino acid change (Val49IIe) was present on the KHK allele bearing Ala43Thr,7833921_13,-1,3218,-1,0.38832784
3219,Gaucher disease,15,17,84,99,"Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model?
Gaucher disease (GD) is an inherited deficiency of beta-glucocerebrosidase (EC 3. 1. 2. 45, gene symbol GBA).",7857677_0,-1,3219,-1,0.3643168
3220,Gaucher disease,29,31,163,178,"Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model?
Gaucher disease (GD) is an inherited deficiency of beta-glucocerebrosidase (EC 3. 1. 2. 45, gene symbol GBA).",7857677_0,-1,3220,-1,0.4153088
3221,nucleotide,22,23,123,133,"It may occur alone as a single base-pair mutation but often is found as part of a complex allele containing additional GBA nucleotide substitutions, G6468C (A456P) and G6482C (V460V), without (recNciI) or with (recTL) G5957C (D409H).",7857677_3,-1,3221,-1,0.35323548
3222,disease,13,14,85,92,"Neonates showing a severe clinical phenotype, analogous to the early neonatal lethal disease occurring in mice homozygous for a null allele produced by targeted disruption of GBA, have been described elsewhere, but the specific mutations in these cases have not yet been characterized.",7857677_11,-1,3222,-1,0.3772099
3223,neurodegenerative disease,7,9,41,66,"
Metachromatic Leukodystrophy (MLD) is a neurodegenerative disease in which the lysosomal enzyme, Aryl sulfatase A (ARSA) is deficient.",7858169_1,-1,3223,-1,0.37636033
3224,disease,1,2,4,11,"The disease is inherited as an autosomal recessive trait and its frequency is estimated to be 1/40, 000 live births.",7858169_2,-1,3224,-1,0.35149258
3225,PD,3,4,18,20,"Another mutation, PD, leads to the deficiency of the enzyme in vitro (pseudodeficiency) without any known clinical effect.",7858169_4,-1,3225,-1,0.3521042
3226,PD,1,2,4,6,The PD mutation is frequent in all populations.,7858169_5,-1,3226,-1,0.37481725
3227,PD,18,19,114,116,"The molecular analysis demonstrated that in the Habbanite population, the mutation occurred on an allele with the PD mutation.",7858169_7,-1,3227,-1,0.3488519
3228,C,11,12,53,54,The loss of ARSA activity is due to a point mutation C > T leading to a change of proline to leucine.,7858169_8,-1,3228,-1,0.4141913
3229,leucine,21,22,93,100,The loss of ARSA activity is due to a point mutation C > T leading to a change of proline to leucine.,7858169_8,-1,3229,-1,0.33219793
3230,disease,12,13,64,71,"The Christian Arabs in Israel also have a high incidence of the disease (1/10, 000 live births); the mutation in this population is still unknown.",7858169_12,-1,3230,-1,0.34646013
3231,amino acid,2,4,9,19,A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia.,7874117_0,-1,3231,-1,0.37051448
3232,Kniest dysplasia,16,18,87,103,A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia.,7874117_0,-1,3232,-1,0.3415191
3233,Kniest dysplasia,0,2,1,17,"
Kniest dysplasia is a moderately severe chondrodysplasia phenotype that results from mutations in the gene for type II collagen, COL2A1.",7874117_1,-1,3233,-1,0.3671792
3234,cleft palate,14,16,92,104,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3234,-1,0.36005476
3235,myopia,17,18,106,112,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3235,-1,0.3836363
3236,retinal detachment,19,21,114,132,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3236,-1,0.36187991
3237,hearing loss,23,25,138,150,"Characteristics of the disorder include a short trunk and extremities, mid-face hypoplasia, cleft palate, myopia, retinal detachment, and hearing loss.",7874117_2,-1,3237,-1,0.37686738
3238,Kniest dysplasia,16,18,87,103,"Recently, deletions of all or part of exon 12 have been identified in individuals with Kniest dysplasia, suggesting that mutations within this region of the protein may primarily result in the Kniest dysplasia phenotype.",7874117_3,-1,3238,-1,0.33908314
3239,Kniest dysplasia,33,35,193,209,"Recently, deletions of all or part of exon 12 have been identified in individuals with Kniest dysplasia, suggesting that mutations within this region of the protein may primarily result in the Kniest dysplasia phenotype.",7874117_3,-1,3239,-1,0.34972736
3240,Kniest dysplasia,17,19,105,121,We used SSCP to analyze an amplified genomic DNA fragment containing exon 12 from seven individuals with Kniest dysplasia.,7874117_4,-1,3240,-1,0.3177892
3241,aspartate,26,27,165,174,DNA sequence analysis demonstrated that the patient was heterozygous for a G to A transition that implied substitution of glycine103 of the triple helical domain by aspartate.,7874117_6,-1,3241,-1,0.33303156
3242,amino acid,10,12,67,77,"These data demonstrate that point mutations which result in single amino acid substitutions can produce Kniest dysplasia and further support the hypothesis that alteration of a domain, which includes the region encoded by exon 12, in the type II collagen protein leads to this disorder..",7874117_9,-1,3242,-1,0.37922367
3243,Kniest dysplasia,15,17,104,120,"These data demonstrate that point mutations which result in single amino acid substitutions can produce Kniest dysplasia and further support the hypothesis that alteration of a domain, which includes the region encoded by exon 12, in the type II collagen protein leads to this disorder..",7874117_9,-1,3243,-1,0.33637765
3244,Machado-Joseph disease,7,9,35,57,CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.,7874163_0,-1,3244,-1,0.3786808
3245,Machado-Joseph disease,6,8,25,47,"1, the genetic locus for Machado-Joseph disease (MJD).",7874163_2,-1,3245,-1,0.3757199
3246,diseases,15,16,97,105,These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to MJD.,7874163_5,-1,3246,-1,0.3375954
3249,cysteine,15,16,77,85,"In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine.",7894491_3,-1,3249,-1,0.35465717
3250,zinc,19,20,99,103,"In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine.",7894491_3,-1,3250,-1,0.3621448
3251,glycine,23,24,120,127,"In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine.",7894491_3,-1,3251,-1,0.3355041
3252,tumour,6,7,33,39,"These data are consistent with a tumour suppressor model, and support the notion that this candidate gene is in fact BRCA1.",7894491_4,-1,3252,-1,0.32716623
3257,lead,2,3,16,20,Seven mutations lead to protein truncations at sites throughout the gene.,7894493_3,-1,3257,-1,0.4352775
3258,cysteine,16,17,88,96,One missense mutation (which occurred independently in two families) leads to loss of a cysteine in the zinc binding domain.,7894493_4,-1,3258,-1,0.3678444
3259,zinc,19,20,104,108,One missense mutation (which occurred independently in two families) leads to loss of a cysteine in the zinc binding domain.,7894493_4,-1,3259,-1,0.3735295
3261,myotonic dystrophy,14,16,101,119,High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation.,7909252_0,-1,3261,-1,0.34375685
3262,myotonic dystrophy,3,5,22,40,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3262,-1,0.38916582
3263,DM,6,7,42,44,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3263,-1,0.3735663
3264,n,21,22,121,122,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3264,-1,0.38179913
3265,DM,30,31,156,158,"
The mutation causing myotonic dystrophy (DM) has been identified as an amplification of an unstable trinucleotide (CTG) n repeat in over 99% of the global DM population.",7909252_1,-1,3265,-1,0.33732322
3266,DM,13,14,85,87,"It is in complete linkage disequilibrium with an Alu element polymorphism within the DM kinase gene, suggesting that DM is a consequence of one or few ancestral mutations.",7909252_2,-1,3266,-1,0.33849815
3267,DM,19,20,117,119,"It is in complete linkage disequilibrium with an Alu element polymorphism within the DM kinase gene, suggesting that DM is a consequence of one or few ancestral mutations.",7909252_2,-1,3267,-1,0.3501614
3268,Fragile X syndrome,18,21,115,133,"A recent analysis utilizing this polymorphism as well as a flanking dinucleotide marker, suggested that similar to Fragile X syndrome, DM exhibited a founder effect (Imbert et al., 1993 Nature Genet. 4, 72-76).",7909252_3,-1,3268,-1,0.32478982
3269,DM,22,23,135,137,"A recent analysis utilizing this polymorphism as well as a flanking dinucleotide marker, suggested that similar to Fragile X syndrome, DM exhibited a founder effect (Imbert et al., 1993 Nature Genet. 4, 72-76).",7909252_3,-1,3269,-1,0.364637
3270,contrast,1,2,3,11,"In contrast, the low reproductive fitness of individuals with congenital DM (the endpoint of genetic anticipation in myotonic dystrophy) suggests a higher rate of new mutations.",7909252_4,-1,3270,-1,0.3562386
3271,DM,11,12,73,75,"In contrast, the low reproductive fitness of individuals with congenital DM (the endpoint of genetic anticipation in myotonic dystrophy) suggests a higher rate of new mutations.",7909252_4,-1,3271,-1,0.34045637
3272,myotonic dystrophy,19,21,117,135,"In contrast, the low reproductive fitness of individuals with congenital DM (the endpoint of genetic anticipation in myotonic dystrophy) suggests a higher rate of new mutations.",7909252_4,-1,3272,-1,0.3456252
3273,DM,9,10,53,55,"We present a high resolution genetic analysis of the DM locus using PCR based assays of nine polymorphisms, spanning a physical distance of 30 kb, within and immediately flanking the DM kinase gene.",7909252_5,-1,3273,-1,0.38794583
3274,DM,32,33,183,185,"We present a high resolution genetic analysis of the DM locus using PCR based assays of nine polymorphisms, spanning a physical distance of 30 kb, within and immediately flanking the DM kinase gene.",7909252_5,-1,3274,-1,0.3287805
3275,DM,7,8,51,53,The persistent complete allelic association of the DM mutation with all these polymorphisms provides further support to previous observations and suggests more strongly that the DM mutation occurred on the background of a particular haplotype in which the (CTG) n repeat became inherently unstable and therefore predisposed to amplification.,7909252_6,-1,3275,-1,0.3449242
3276,DM,25,26,178,180,The persistent complete allelic association of the DM mutation with all these polymorphisms provides further support to previous observations and suggests more strongly that the DM mutation occurred on the background of a particular haplotype in which the (CTG) n repeat became inherently unstable and therefore predisposed to amplification.,7909252_6,-1,3276,-1,0.34553978
3280,cystadenocarcinoma,16,17,84,102,"In clones and subclones derived serially from one of these cell lines (2774; serous cystadenocarcinoma), a very high proportion of microsatellites distributed in many different regions of the genome change their size in a mercurial fashion.",7937795_2,-1,3280,-1,0.33513877
3281,genomic instability,3,5,17,36,We conclude that genomic instability in ovarian tumors is a dynamic and ongoing process whose high frequency may have been previously underestimated by PCR-based allelotyping of bulk tumor tissue.,7937795_3,-1,3281,-1,0.29468673
3285,colorectal cancer,43,45,246,263,"We have identified the source of the genetic instability in one ovarian tumor as a point mutation (R524P) in the human mismatch-repair gene MSH2 (Salmonella MutS homologue), which has recently been shown to be involved in hereditary nonpolyposis colorectal cancer.",7937795_4,-1,3285,-1,0.25543752
3298,aniridia,11,12,63,71,"PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.",7951315_0,-1,3298,-1,0.36922333
3299,anophthalmia,13,14,73,85,"PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.",7951315_0,-1,3299,-1,0.35113183
3300,aniridia,4,5,28,36,"
The human eye malformation aniridia results from haploinsufficiency of PAX6, a paired box DNA-binding protein.",7951315_1,-1,3300,-1,0.37122795
3301,aniridia,15,16,89,97,"To study this dosage effect, we characterized two PAX6 mutations in a family segregating aniridia and a milder syndrome consisting of congenital cataracts and late onset corneal dystrophy.",7951315_2,-1,3301,-1,0.38001743
3302,syndrome,19,20,111,119,"To study this dosage effect, we characterized two PAX6 mutations in a family segregating aniridia and a milder syndrome consisting of congenital cataracts and late onset corneal dystrophy.",7951315_2,-1,3302,-1,0.29054978
3304,malformations,3,4,15,28,The pattern of malformations is similar to that in homozygous Sey mice and suggests a critical role for PAX6 in controlling the migration and differentiation of specific neuronal progenitor cells in the brain..,7951315_6,-1,3304,-1,0.32926825
3305,map,2,3,11,14,A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21.,7951316_0,-1,3305,-1,0.40993667
3306,map,5,6,32,35,"
We have constructed a physical map of a 4 cM region on chromosome 17q12-21 that contains the hereditary breast and ovarian cancer gene BRCA1.",7951316_1,-1,3306,-1,0.40309304
3307,cM,9,10,43,45,"
We have constructed a physical map of a 4 cM region on chromosome 17q12-21 that contains the hereditary breast and ovarian cancer gene BRCA1.",7951316_1,-1,3307,-1,0.3590057
3309,map,1,2,4,7,"The map comprises a contig of 137 overlapping yeast artificial chromosomes and P1 clones, onto which we have placed 112 PCR markers.",7951316_2,-1,3309,-1,0.36172682
3310,map,9,10,45,48,"We have localized more than 20 genes on this map, ten of which had not been mapped to the region previously, and have isolated 30 cDNA clones representing partial sequences of as yet unidentified genes.",7951316_3,-1,3310,-1,0.37339273
3312,copper,8,9,34,40,The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene.,7951327_0,-1,3312,-1,0.35499257
3313,Wilson disease,15,17,84,98,The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene.,7951327_0,-1,3313,-1,0.31344885
3314,Wilson disease,10,12,55,69,"
The Long-Evans Cinnamon (LEC) rat shows similarity to Wilson disease in many clinical and biochemical features.",7951327_1,-1,3314,-1,0.3277936
3315,Wilson disease,15,17,70,84,We have cloned cDNAs for the rat gene (Atp7b) homologous to the human Wilson disease gene (ATP7B) and have used them to identify a partial deletion in the Atp7b gene in the LEC rat.,7951327_2,-1,3315,-1,0.3541091
3316,ATP,19,20,93,96,"The deletion removes at least 900 bp of the coding region at the 3 end, includes the crucial ATP binding domain and extends downstream of the gene.",7951327_3,-1,3316,-1,0.35198957
3317,Wilson disease,15,17,88,102,Our results provide convincing evidence for defining the LEC rat as an animal model for Wilson disease.,7951327_4,-1,3317,-1,0.31594807
3318,Wilson disease,14,16,92,106,"This model will be important for studying liver pathophysiology, for developing therapy for Wilson disease and for studying the pathway of copper transport and its possible interaction with other heavy metals..",7951327_5,-1,3318,-1,0.33837
3319,copper,22,23,139,145,"This model will be important for studying liver pathophysiology, for developing therapy for Wilson disease and for studying the pathway of copper transport and its possible interaction with other heavy metals..",7951327_5,-1,3319,-1,0.3415225
3320,adrenoleukodystrophy,4,5,28,48,Genomic organization of the adrenoleukodystrophy gene.,7959759_0,-1,3320,-1,0.35361776
3321,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is a severe neurodegenerative disease associated with an impairment of very long chain fatty acids beta-oxidation.",7959759_1,-1,3321,-1,0.37270093
3322,neurodegenerative disease,14,16,81,106,"
Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is a severe neurodegenerative disease associated with an impairment of very long chain fatty acids beta-oxidation.",7959759_1,-1,3322,-1,0.39418638
3323,fatty acids,24,26,156,167,"
Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is a severe neurodegenerative disease associated with an impairment of very long chain fatty acids beta-oxidation.",7959759_1,-1,3323,-1,0.39477935
3324,map,9,10,51,54,"The ALD gene has been positioned on a pulsed-field map between DXS15 and the L1CAM gene, about 650 kb upstream from the color pigment genes.",7959759_8,-1,3324,-1,0.37453383
3325,syndrome,27,28,170,178,The frequent occurrence of color vision anomalies observed in patients with adrenomyeloneuropathy (the adult onset form of ALD) thus does not represent a contiguous gene syndrome but a secondary manifestation of ALD..,7959759_9,-1,3325,-1,0.34674338
3326,Huntington disease,5,7,29,47,The murine homologues of the Huntington disease gene (Hdh) and the alpha-adducin gene (Add1) map to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.3.,7959767_0,-1,3326,-1,0.38180903
3327,map,18,19,93,96,The murine homologues of the Huntington disease gene (Hdh) and the alpha-adducin gene (Add1) map to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.3.,7959767_0,-1,3327,-1,0.40395147
3328,Huntington disease,0,2,1,19,"
Huntington disease (HD) is a severe autosomal dominant neurodegenerative disorder associated with a novel gene (IT15).",7959767_1,-1,3328,-1,0.3561715
3329,neurodegenerative,10,11,56,73,"
Huntington disease (HD) is a severe autosomal dominant neurodegenerative disorder associated with a novel gene (IT15).",7959767_1,-1,3329,-1,0.36914477
3330,map,4,5,20,23,"Both of these genes map in the same position on mouse chromosome 5 in a region associated with ancestral chromosomal rearrangements and show no recombination with D5H4S43, D5H4S115, and D5H4S62, the murine homologues of D4S43, D4S115, and D4S62, respectively.",7959767_4,-1,3330,-1,0.38761953
3331,cholesteryl ester transfer protein deficiency,1,6,8,53,Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.,7962532_0,-1,3331,-1,0.3733208
3332,cholesterol,22,23,159,170,Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.,7962532_0,-1,3332,-1,0.32136163
3333,cholesterol,4,5,29,40,"
Genetic determinants of HDL cholesterol (HDL-C) levels in the general population are poorly understood.",7962532_1,-1,3333,-1,0.34946787
3334,cholesteryl ester,4,6,31,48,We previously described plasma cholesteryl ester transfer protein (CETP) deficiency due to an intron 14 G (+ 1) -to-A mutation (Int14 A) in several families with very high HDL-C levels in Japan.,7962532_2,-1,3334,-1,0.3631208
3335,n,9,10,38,39,Subjects with HDL-C > or = 100 mg/dl (n = 130) were screened by PCR single strand conformational polymorphism analysis of the CETP gene.,7962532_3,-1,3335,-1,0.41678706
3336,map,11,12,85,88,Two other mutations were identified by DNA sequencing or primer-mediated restriction map modification of PCR products  a novel intron 14 splice donor site mutation caused by a T insertion at position + 3 from the exon14/intron14 boundary (Int14 T) and a missense mutation (Asp442 to Gly) within exon 15 (D442G).,7962532_4,-1,3336,-1,0.36982578
3337,n,22,23,117,118,"Furthermore, prevalences of the D442G and Int14 A mutations were extremely high in a general sample of Japanese men (n = 236), with heterozygote frequencies of 7% and 2%, respectively.",7962532_7,-1,3337,-1,0.39216584
3338,xanthomatosis,3,4,30,43,"Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.",7964884_0,-1,3338,-1,0.32240292
3339,pravastatin,10,11,79,90,"Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.",7964884_0,-1,3339,-1,0.40579376
3340,pravastatin,20,21,132,143,"
Treatments by oral administration of chenodeoxycholic acid (CDCA) alone, 3-hydroxy-3-methylglutaryl (HMG) CoA reductase inhibitor (pravastatin) alone, and combination of the two drugs were attempted for 7 patients with cerebrotendinous xanthomatosis (CTX).",7964884_1,-1,3340,-1,0.3860329
3341,xanthomatosis,37,38,237,250,"
Treatments by oral administration of chenodeoxycholic acid (CDCA) alone, 3-hydroxy-3-methylglutaryl (HMG) CoA reductase inhibitor (pravastatin) alone, and combination of the two drugs were attempted for 7 patients with cerebrotendinous xanthomatosis (CTX).",7964884_1,-1,3341,-1,0.2987201
3342,CTX,39,40,252,255,"
Treatments by oral administration of chenodeoxycholic acid (CDCA) alone, 3-hydroxy-3-methylglutaryl (HMG) CoA reductase inhibitor (pravastatin) alone, and combination of the two drugs were attempted for 7 patients with cerebrotendinous xanthomatosis (CTX).",7964884_1,-1,3342,-1,0.35642767
3343,cholesterol,15,16,71,82,"However, the sera of the patients changed to be "" atherogenic ""; total cholesterol, triglyceride and low-density lipoprotein (LDL) -cholesterol were increased, while high-density lipoprotein (HDL) -cholesterol was decreased.",7964884_3,-1,3343,-1,0.3368471
3344,triglyceride,17,18,84,96,"However, the sera of the patients changed to be "" atherogenic ""; total cholesterol, triglyceride and low-density lipoprotein (LDL) -cholesterol were increased, while high-density lipoprotein (HDL) -cholesterol was decreased.",7964884_3,-1,3344,-1,0.3299712
3345,pravastatin,2,3,12,23,"Contrarily, pravastatin at a dose of 10 mg/day improved the sera of the patients to be markedly "" anti-atherogenic "", but the reductions of cholestanol (30. 4%), lathosterol (44. 0%), campesterol (22. 9%) and sitosterol (9. 6%) were inadequate.",7964884_4,-1,3345,-1,0.4458336
3346,pravastatin,5,6,33,44,Combined treatment with CDCA and pravastatin showed good overlapping of the effects of each drug alone.,7964884_5,-1,3346,-1,0.39829063
3347,cholesterol,31,32,182,193,"Serum cholestanol concentration was still 2. 7 times higher than in controls, but the serum lathosterol level was within the normal range, indicating that the enhancement of overall cholesterol synthesis in the patients was sufficiently suppressed.",7964884_7,-1,3347,-1,0.34926638
3348,sterol,1,2,6,12,Plant sterol levels were also within the normal range.,7964884_8,-1,3348,-1,0.37410697
3349,pravastatin,5,6,28,39,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3349,-1,0.39756647
3350,CTX,11,12,65,68,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3350,-1,0.3600823
3351,cholesterol,25,26,147,158,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3351,-1,0.37229994
3352,sterol,34,35,210,216,"The combination of CDCA and pravastatin was a good treatment for CTX, based on the improvement of serum lipoprotein metabolism, the suppression of cholesterol synthesis, and reductions of cholestanol and plant sterol levels.",7964884_9,-1,3352,-1,0.3099351
3353,disease,9,10,41,48,"In all of 7 patients, the progression of disease was arrested, but dramatic effects on clinical manifestations, xanthoma, and electrophysiological findings could not be found after the treatment of these drugs",7964884_10,-1,3353,-1,0.34765998
3354,choroideremia,10,11,56,69,Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients.,7981671_0,-1,3354,-1,0.339086
3355,choroideremia,11,12,64,77,"
The recent isolation of the complete open reading frame of the choroideremia (CHM) gene and the characterization of the exon-intron boundaries has paved the way to mutation detection in patients with classical choroideremia.",7981671_1,-1,3355,-1,0.33231118
3356,choroideremia,34,35,211,224,"
The recent isolation of the complete open reading frame of the choroideremia (CHM) gene and the characterization of the exon-intron boundaries has paved the way to mutation detection in patients with classical choroideremia.",7981671_1,-1,3356,-1,0.27629423
3357,map,25,26,153,156,Mapping of the deletion endpoints in these four patients and in another 11 male patients with sizeable deletions enabled us to construct a very detailed map of intervals 2 and 3 of Xq21.,7981671_6,-1,3357,-1,0.37728408
3358,choroideremia,10,11,59,72,"Interestingly, all CHM gene mutations detected thus far in choroideremia patients give rise to the introduction of a premature stop codon..",7981671_8,-1,3358,-1,0.31237724
3359,adrenoleukodystrophy,7,8,64,84,Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.,7991123_0,-1,3359,-1,0.34188193
3360,adrenoleukodystrophy,1,2,10,30,"
X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal beta-oxidation associated with accumulation of saturated very long-chain fatty acids, which results in central and peripheral demyelination and in impaired function of adrenal cortex and testes.",7991123_1,-1,3360,-1,0.37722135
3361,fatty acids,19,21,152,163,"
X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal beta-oxidation associated with accumulation of saturated very long-chain fatty acids, which results in central and peripheral demyelination and in impaired function of adrenal cortex and testes.",7991123_1,-1,3361,-1,0.33908018
3362,Adrenoleukodystrophy,0,1,0,20,Adrenoleukodystrophy gene encodes an 80 kDa membrane protein.,8002973_0,-1,3362,-1,0.35196397
3363,adrenoleukodystrophy,17,18,114,134,"
An antibody against the synthetic C-terminal peptides deduced from the cDNA of the gene responsible for X-linked adrenoleukodystrophy (ALD) was produced to characterize the product of the ALD gene.",8002973_1,-1,3363,-1,0.3441873
3364,syndrome,6,7,33,41,Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein.,8004674_0,-1,3364,-1,0.31367177
3365,syndrome,1,2,8,16,"
McLeod syndrome is an X-linked multisystem disorder characterized by abnormalities in the neuromuscular and hematopoietic systems.",8004674_1,-1,3365,-1,0.31941184
3366,Nucleotide,0,1,0,10,Nucleotide sequence analysis of XK from two unrelated McLeod patients has identified point mutations at conserved splice donor and acceptor sites.,8004674_6,-1,3366,-1,0.3653546
3367,syndrome,11,12,73,81,These findings provide direct evidence that XK is responsible for McLeod syndrome..,8004674_7,-1,3367,-1,0.3307273
3368,paraplegia,2,3,17,27,X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.,8012387_0,-1,3368,-1,0.3333186
3369,Pelizaeus-Merzbacher disease,4,6,32,60,X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.,8012387_0,-1,3369,-1,0.36966604
3370,paraplegia,5,6,33,43,"
Three forms of X-linked spastic paraplegia (SPG) have been defined.",8012387_1,-1,3370,-1,0.31222135
3371,maps,6,7,18,22,One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2).,8012387_2,-1,3371,-1,0.37210578
3372,map,14,15,67,70,One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2).,8012387_2,-1,3372,-1,0.38968062
3373,Pelizaeus-Merzbacher disease,11,13,71,99,"A rare X-linked dysmyelinating disorder of the central nervous system, Pelizaeus-Merzbacher disease (PMD), has also been mapped to Xq21-q22, and is caused by mutations in the proteolipid protein gene (PLP) which encodes two myelin proteins, PLP and DM20.",8012387_3,-1,3373,-1,0.37254727
3374,disease,22,23,122,129,"While narrowing the genetic interval containing SPG2 in a large pedigree, we found that PLP was the closest marker to the disease locus, implicating PLP as a possible candidate gene.",8012387_4,-1,3374,-1,0.38813815
3375,disease,30,31,144,151,"We have found that a point mutation (His139Tyr) in exon 3B of an affected male produces a mutant PLP but a normal DM20, and segregates with the disease (Zmax = 6.",8012387_5,-1,3375,-1,0.3658386
3376,Canavan disease,0,2,0,15,Canavan disease: mutations among Jewish and non-Jewish patients.,8023850_0,-1,3376,-1,0.4172078
3377,Canavan disease,0,2,1,16,"
Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA).",8023850_1,-1,3377,-1,0.37564898
3378,C,8,9,44,45,"Three point mutations--693C-- > A, 854A-- > C, and 914C-- > A--were identified in the coding sequence.",8023850_3,-1,3378,-1,0.39387086
3379,glu,25,26,105,108,"The 693C-- > A and 914C-- > A base changes, resulting in nonsense tyr231-- > ter and missense ala305-- > glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies.",8023850_4,-1,3379,-1,0.37725872
3380,lead,30,31,134,138,"The 693C-- > A and 914C-- > A base changes, resulting in nonsense tyr231-- > ter and missense ala305-- > glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies.",8023850_4,-1,3380,-1,0.39601657
3381,C,3,4,13,14,The 854A-- > C transversion converted glu to ala in codon 285.,8023850_5,-1,3381,-1,0.38462508
3382,glu,6,7,38,41,The 854A-- > C transversion converted glu to ala in codon 285.,8023850_5,-1,3382,-1,0.38285312
3383,lead,4,5,31,35,"The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA.",8023850_8,-1,3383,-1,0.37040457
3384,glu,5,6,15,18,The ala305-- > glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes.,8023850_13,-1,3384,-1,0.38782606
3385,Canavan disease,12,14,96,111,Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes,8023850_14,-1,3385,-1,0.3757005
3386,myotonic dystrophy,4,6,33,51,"Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification.",8071955_0,-1,3386,-1,0.3595633
3387,myotonic dystrophy,23,25,152,170,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3387,-1,0.35029662
3388,DM,26,27,172,174,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3388,-1,0.34646356
3389,disease,33,34,200,207,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3389,-1,0.35582122
3390,DM,45,46,260,262,"
An abbreviated Wechsler Adult Intelligence Scale Revised (WAIS-R) was used to assess verbal and arithmetical cognitive performance in 55 subjects with myotonic dystrophy (DM), covering all grades of disease severity, and 31 controls at 50% risk of inheriting DM.",8071955_1,-1,3390,-1,0.31746632
3391,DM,12,13,58,60,"Significant IQ differences were found between  (1) all 55 DM subjects (mean 90. 2, SD 16.",8071955_3,-1,3391,-1,0.35708386
3392,SD,20,21,83,85,"Significant IQ differences were found between  (1) all 55 DM subjects (mean 90. 2, SD 16.",8071955_3,-1,3392,-1,0.45655152
3393,SD,10,11,28,30,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3393,-1,0.43165052
3394,SD,35,36,111,113,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3394,-1,0.428787
3395,SD,49,50,157,159,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3395,-1,0.4310656
3396,SD,79,80,273,275,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3396,-1,0.44402155
3397,SD,93,94,314,316,"1) and 31 controls (102. 6, SD 9. 4), with no sex differences in either group; (2) 15 affected parents (99. 3, SD 12. 2) and their affected children (88. 1, SD 17. 2), where significance was dependent on parental sex being female; and (3) 15 pairs of affected sibs (89. 6, SD 13. 2) and their normal sibs (100. 2, SD 7. 6).",8071955_4,-1,3397,-1,0.43110162
3398,signs and symptoms,12,15,48,66,"IQ steadily declined as (1) the age of onset of signs and symptoms decreased, and (2) the CTG expansion size increased.",8071955_5,-1,3398,-1,0.3743005
3399,DM,12,13,74,76,"The correlation of IQ difference and CTG expansion difference in both the DM parent-child pairs and normal sib-affected sib pairs was poor, indicating that CTG expansion is not a reliable predictor of IQ either in individual persons or families.",8071955_7,-1,3399,-1,0.36929277
3400,DM,6,7,42,44,Further analysis of cognitive function in DM is required to clarify specific deficits characteristic of this patient group,8071955_8,-1,3400,-1,0.33038294
3401,Adenomatous polyposis coli,0,3,0,26,Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion.,8071957_0,-1,3401,-1,0.3240658
3402,autism,15,16,111,117,"
We present the clinical and laboratory findings in an institutionalised adult patient originally referred for autism.",8071957_1,-1,3402,-1,0.30669478
3403,colorectal cancer,4,6,15,32,"A high risk of colorectal cancer was predicted when an interstitial deletion of the long arm of chromosome 5, del (5) (q15q22. 3), was detected in her lymphocytes and deletion of the MCC and APC genes confirmed by molecular analysis.",8071957_2,-1,3403,-1,0.27773404
3404,Adenomatous polyposis coli,0,3,0,26,Adenomatous polyposis coli and carcinoma of the rectum were subsequently diagnosed in the patient.,8071957_3,-1,3404,-1,0.33558238
3414,melanoma,12,13,60,68,"The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.",8084618_0,-1,3414,-1,0.25677112
3417,sarcoma,26,27,130,137,"
The EWS gene, which maps to band q12 of human chromosome 22, is involved in a wide variety of human solid tumors including Ewing sarcoma, related primitive neuroectodermal tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors.",8084618_1,-1,3417,-1,0.28339005
3418,neuroectodermal tumors,30,32,157,179,"
The EWS gene, which maps to band q12 of human chromosome 22, is involved in a wide variety of human solid tumors including Ewing sarcoma, related primitive neuroectodermal tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors.",8084618_1,-1,3418,-1,0.32467735
3419,melanoma,34,35,191,199,"
The EWS gene, which maps to band q12 of human chromosome 22, is involved in a wide variety of human solid tumors including Ewing sarcoma, related primitive neuroectodermal tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors.",8084618_1,-1,3419,-1,0.25322938
3422,amino acids,13,15,94,105,Sequence analysis of this cDNA revealed differential splicing involving two exons encoding 72 amino acids.,8084618_4,-1,3422,-1,0.35481712
3423,amino acids,29,31,147,158,"The EWS-b protein binds to RNA in vitro and, specifically, to poly G and poly U. The RNA binding activity was localized to the carboxy terminal 86 amino acids, which constitute RGG box.",8084618_7,-1,3423,-1,0.3931841
3424,amino,2,3,9,14,"Thus the amino terminal domain of EWS (NTD-EWS), which is involved in chromosome translocation may regulate the specificity of RNA binding activity of EWS.",8084618_8,-1,3424,-1,0.398702
3425,sarcoma,10,11,54,61,"An EWS-erg chimeric protein, which is found in Ewings sarcoma cells, functions as a transcriptional activator.",8084618_9,-1,3425,-1,0.2720296
3426,Canavan disease,0,2,0,15,Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.,8088831_0,-1,3426,-1,0.4067415
3427,Canavan disease,0,2,1,16,"
Canavan disease, or spongy degeneration of the brain, is a severe leukodystrophy caused by the deficiency of aspartoacylase (ASPA).",8088831_1,-1,3427,-1,0.38860545
3428,Canavan disease,15,17,94,109,"Recently, a missense mutation was identified in human ASPA coding sequence from patients with Canavan disease.",8088831_2,-1,3428,-1,0.36815226
3429,gt/ag,7,8,49,54,The exon/intron splice junction sites follow the gt/ag consensus sequence rule.,8088831_6,-1,3429,-1,0.38940132
3430,lead,14,15,88,92,It should now be possible to identify mutations in the noncoding genomic sequences that lead to Canavan disease and to study the regulation of ASPA..,8088831_13,-1,3430,-1,0.42302552
3431,Canavan disease,16,18,96,111,It should now be possible to identify mutations in the noncoding genomic sequences that lead to Canavan disease and to study the regulation of ASPA..,8088831_13,-1,3431,-1,0.33498177
3432,Myotonic dystrophy,0,2,0,18,"Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism.",8098180_0,-1,3432,-1,0.37246707
3433,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is a progressive neuromuscular disorder which results from elongations of an unstable (CTG) n repeat, located in the 3 untranslated region of the DM gene.",8098180_1,-1,3433,-1,0.37039518
3434,DM,3,4,21,23,"
Myotonic dystrophy (DM) is a progressive neuromuscular disorder which results from elongations of an unstable (CTG) n repeat, located in the 3 untranslated region of the DM gene.",8098180_1,-1,3434,-1,0.3855855
3435,DM,31,32,171,173,"
Myotonic dystrophy (DM) is a progressive neuromuscular disorder which results from elongations of an unstable (CTG) n repeat, located in the 3 untranslated region of the DM gene.",8098180_1,-1,3435,-1,0.33779663
3436,disease,20,21,119,126,A correlation has been demonstrated between the increase in the repeat number of this sequence and the severity of the disease.,8098180_2,-1,3436,-1,0.3713762
3437,DM,8,9,56,58,Our observation of differently sized repeats in various DM tissues from the same individual may explain why the size of the mutation observed in lymphocytes does not necessarily correlate with the severity and nature of symptoms.,8098180_5,-1,3437,-1,0.38443574
3438,DM,11,12,68,70,"Through a molecular and genetic study of 142 families including 418 DM patients, we have investigated the dynamics of the CTG repeat meiotic instability.",8098180_6,-1,3438,-1,0.3426665
3439,phenylalanine,4,5,34,47,Illegitimate transcription of the phenylalanine hydroxylase gene in lymphocytes for identification of mutations in phenylketonuria.,8098245_0,-1,3439,-1,0.33851296
3440,phenylalanine,8,9,59,72,"
Taking advantage of the illegitimate transcription of the phenylalanine hydroxylase (PAH) gene, we have been able to analyse the PAH cDNA sequence of hyperphenylalaninemic children in circulating lymphocytes.",8098245_1,-1,3440,-1,0.36731076
3441,PAH,11,12,86,89,"
Taking advantage of the illegitimate transcription of the phenylalanine hydroxylase (PAH) gene, we have been able to analyse the PAH cDNA sequence of hyperphenylalaninemic children in circulating lymphocytes.",8098245_1,-1,3441,-1,0.3541454
3442,PAH,22,23,130,133,"
Taking advantage of the illegitimate transcription of the phenylalanine hydroxylase (PAH) gene, we have been able to analyse the PAH cDNA sequence of hyperphenylalaninemic children in circulating lymphocytes.",8098245_1,-1,3442,-1,0.32101092
3443,C,17,18,91,92,"One mutation, detected by the abnormal pattern of migration of an amplified fragment, is a C to T transition in the splice acceptor site of intron 10, which resulted in the skipping of exon 11 with the premature termination of RNA translation downstream from exon 12 (-3 IVS10).",8098245_3,-1,3443,-1,0.4143982
3444,PAH,13,14,85,88,The present study supports the view that circulating lymphocytes give easy access to PAH gene transcripts whose nucleotide sequence is identical to that reported in liver and therefore represent a useful tool for molecular genetic studies in phenylketonuria..,8098245_5,-1,3444,-1,0.32873437
3445,nucleotide,17,18,112,122,The present study supports the view that circulating lymphocytes give easy access to PAH gene transcripts whose nucleotide sequence is identical to that reported in liver and therefore represent a useful tool for molecular genetic studies in phenylketonuria..,8098245_5,-1,3445,-1,0.39847198
3446,C,22,23,121,122,"Analysis of the ARSA gene in this patient revealed heterozygosity for two new mutant alleles  in one allele, deletion of C 447 in exon 2 leads to a frameshift and to a premature stop codon at amino acid position 105; in the second allele, a G-- > A transition in exon 5 causes a Gly309-- > Ser substitution.",8101038_3,-1,3446,-1,0.43362513
3447,amino acid,38,40,192,202,"Analysis of the ARSA gene in this patient revealed heterozygosity for two new mutant alleles  in one allele, deletion of C 447 in exon 2 leads to a frameshift and to a premature stop codon at amino acid position 105; in the second allele, a G-- > A transition in exon 5 causes a Gly309-- > Ser substitution.",8101038_3,-1,3447,-1,0.38906974
3448,contrast,4,5,22,30,These findings are in contrast to previous results showing that the late-infantile type of MLD is always associated with the complete absence of ARSA activity.,8101038_6,-1,3448,-1,0.3392828
3449,C--,9,10,45,48,The patient was found to be homozygous for a C-- > T transition in exon IV that results in the substitution of a highly conserved threonine residue at amino acid 274 with a methionine (T274M).,8104633_5,-1,3449,-1,0.37824628
3450,amino acid,28,30,151,161,The patient was found to be homozygous for a C-- > T transition in exon IV that results in the substitution of a highly conserved threonine residue at amino acid 274 with a methionine (T274M).,8104633_5,-1,3450,-1,0.41355014
3451,methionine,33,34,173,183,The patient was found to be homozygous for a C-- > T transition in exon IV that results in the substitution of a highly conserved threonine residue at amino acid 274 with a methionine (T274M).,8104633_5,-1,3451,-1,0.3055877
3452,amino acid,2,4,12,22,"The altered amino acid is rigidly conserved among 10 sulfatases from Escherichia coli to humans; therefore, it is most likely that the resultant mutant protein will have little or no enzyme activity.",8104633_8,-1,3452,-1,0.33926216
3453,aniridia,9,10,55,63,Mutations in the PAX6 gene in patients with hereditary aniridia.,8111379_0,-1,3453,-1,0.36108384
3454,aniridia,15,16,79,87,"
The 14 exons of the PAX6 gene have been analysed exon-by-exon using SSCP in 6 aniridia families.",8111379_1,-1,3454,-1,0.37335944
3455,C--,3,4,23,26,Two mutations involved C-- > T transitions in CGAarg codons in exons 9 and 11.,8111379_3,-1,3455,-1,0.37433562
3456,C--,1,2,8,11,Another C-- > T transition converted a CAG-glutamine to a TAG-stop in exon 7.,8111379_4,-1,3456,-1,0.37787852
3457,aniridia,14,15,91,99,This data strongly supports the candidature of PAX6 as the gene responsible for hereditary aniridia..,8111379_9,-1,3457,-1,0.35187513
3458,protein S deficiency,9,12,65,85,"Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I.
A panel of eight unrelated subjects with inherited type I protein S deficiency was screened for mutations in the PROS1 gene.",8113388_0,-1,3458,-1,0.34418803
3459,protein S deficiency,24,27,152,172,"Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I.
A panel of eight unrelated subjects with inherited type I protein S deficiency was screened for mutations in the PROS1 gene.",8113388_0,-1,3459,-1,0.34249187
3460,amino acids,31,33,165,176,Also in two subjects an A-- > T transversion was detected in the stopcodon of the PROS1 gene; this transversion predicts a protein S molecule that is extended by 14 amino acids.,8113388_3,-1,3460,-1,0.35093126
3461,protein S deficiency,16,19,92,112,The latter indicates that a mRNA based approach is not feasible for the genetic analysis of protein S deficiency type I..,8113388_9,-1,3461,-1,0.33860445
3462,myotonic dystrophy,9,11,71,89,Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy.,8116611_0,-1,3462,-1,0.36003155
3463,myotonic dystrophy,1,3,4,22,"
In myotonic dystrophy (DM), the size of a CTG repeat in the DM kinase gene generally increases in successive generations with clinical evidence of anticipation.",8116611_1,-1,3463,-1,0.3604471
3464,DM,4,5,24,26,"
In myotonic dystrophy (DM), the size of a CTG repeat in the DM kinase gene generally increases in successive generations with clinical evidence of anticipation.",8116611_1,-1,3464,-1,0.3716445
3465,DM,15,16,61,63,"
In myotonic dystrophy (DM), the size of a CTG repeat in the DM kinase gene generally increases in successive generations with clinical evidence of anticipation.",8116611_1,-1,3465,-1,0.35547438
3466,DM,5,6,19,21,"We examined 1, 489 DM parent-offspring pairs, of which 95 (6. 4%) showed such contractions in peripheral blood leukocytes (PBL).",8116611_3,-1,3466,-1,0.37653378
3467,DM,25,26,118,120,"It is surprising that anticipation occurred in 27 (48%) of these 56 pairs, while none clearly showed a later onset of DM in the symptomatic offspring.",8116611_5,-1,3467,-1,0.3581643
3468,P,20,21,98,99,Anticipation was observed more frequently in maternal (85%) than in paternal (37%) transmissions (P <. 001).,8116611_7,-1,3468,-1,0.44247317
3469,P,17,18,94,95,"The parental repeat size correlated with the size of intergenerational contraction (r2 =. 50, P < <. 001), and the slope of linear regression was steeper in paternal (-. 62) than in maternal (-. 30) transmissions (P < <. 001).",8116611_8,-1,3469,-1,0.4479033
3470,P,49,50,214,215,"The parental repeat size correlated with the size of intergenerational contraction (r2 =. 50, P < <. 001), and the slope of linear regression was steeper in paternal (-. 62) than in maternal (-. 30) transmissions (P < <. 001).",8116611_8,-1,3470,-1,0.4377338
3471,DM,1,2,8,10,Sixteen DM parents had multiple DM offspring with the CTG repeat contractions.,8116611_9,-1,3471,-1,0.40162018
3472,DM,5,6,32,34,Sixteen DM parents had multiple DM offspring with the CTG repeat contractions.,8116611_9,-1,3472,-1,0.35456026
3473,DM,25,26,126,128,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3473,-1,0.3439208
3474,DM,32,33,151,153,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3474,-1,0.41392198
3475,DM,35,36,168,170,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3475,-1,0.40489742
3476,DM,40,41,186,188,"This frequency was higher than the frequency expected from the probability of the repeat contractions (6. 4%) and the size of DM sib population (1. 54 DM offspring per DM parent, in 968 DM parents).",8116611_10,-1,3476,-1,0.41007027
3477,DM,22,23,149,151,"We conclude that (1) intergenerational contractions of the CTG repeat in leukocyte DNA frequently accompanies apparent anticipation, especially when DM is maternally transmitted, and (2) the paternal origin of the repeat and the presence of the repeat contraction in a sibling increase the probability of the CTG repeat contraction",8116611_11,-1,3477,-1,0.3470386
3478,myotonic dystrophy,3,5,23,41,Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm.,8128954_0,-1,3478,-1,0.35771972
3479,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG) n repeat, located in the DM protein kinase gene.",8128954_1,-1,3479,-1,0.3809137
3480,DM,3,4,21,23,"
Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG) n repeat, located in the DM protein kinase gene.",8128954_1,-1,3480,-1,0.3805982
3481,DM,22,23,105,107,"
Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG) n repeat, located in the DM protein kinase gene.",8128954_1,-1,3481,-1,0.3464421
3482,n,6,7,24,25,"We determined the (CTG) n repeat lengths in a broad range of tissue DNAs from patients with mild, classical, or congenital manifestation of DM.",8128954_2,-1,3482,-1,0.40644643
3483,DM,27,28,140,142,"We determined the (CTG) n repeat lengths in a broad range of tissue DNAs from patients with mild, classical, or congenital manifestation of DM.",8128954_2,-1,3483,-1,0.3178268
3484,DM,12,13,74,76,Differences in the repeat length were seen in somatic tissues from single DM individuals and twins.,8128954_3,-1,3484,-1,0.3962738
3485,contrast,1,2,3,11,"In contrast, male patients with large allele expansions in blood (> 700 CTGs) had similar or smaller repeats in sperm, when detectable.",8128954_6,-1,3485,-1,0.3554616
3486,DM,3,4,17,19,"We conclude that DM patients can be considered gonosomal mosaics, i. e e., combined somatic and germ-line tissue mosaics.",8128954_8,-1,3486,-1,0.35756546
3487,e e.,12,14,69,73,"We conclude that DM patients can be considered gonosomal mosaics, i. e e., combined somatic and germ-line tissue mosaics.",8128954_8,-1,3487,-1,0.4079582
3488,DM,10,11,82,84,A model explaining mitotic instability and sex-dependent segregation phenomena in DM manifestation is discussed,8128954_12,-1,3488,-1,0.32324037
3489,adenomatous polyposis coli,21,24,129,155,Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli.,8162051_0,-1,3489,-1,0.30075482
3490,syndrome adenomatous polyposis coli,13,17,73,108,"
Germline mutation in APC at 5q21-22 results in the dominantly inherited syndrome adenomatous polyposis coli (APC).",8162051_1,-1,3490,-1,0.29982415
3491,disease,8,9,47,54,"Eighteen patients had no family history of the disease; of these 11 were classified as having a severe phenotype, based on an early age at presentation or cancer development.",8162051_5,-1,3491,-1,0.37315097
3493,contrast,1,2,3,11,In contrast all of the APC mutations detected in affected individuals with an average phenotype were located prior to codon 1309.,8162051_9,-1,3493,-1,0.34897104
3494,malformations,11,12,72,85,Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly.,8162071_0,-1,3494,-1,0.28925794
3495,aniridia,11,12,63,71,"
Mutation or deletion of the PAX6 gene underlies many cases of aniridia.",8162071_1,-1,3495,-1,0.35169685
3496,malformations,14,15,87,100,Three lines of evidence now converge to implicate PAX6 more widely in anterior segment malformations including Peters anomaly.,8162071_2,-1,3496,-1,0.30151907
3497,Peters anomaly,16,18,111,125,Three lines of evidence now converge to implicate PAX6 more widely in anterior segment malformations including Peters anomaly.,8162071_2,-1,3497,-1,0.31076574
3498,Peters anomaly,5,7,20,34,"First, a child with Peters anomaly is deleted for one copy of PAX6.",8162071_3,-1,3498,-1,0.3156326
3499,malformations,12,13,80,93,"Second, affected members of a family with dominantly inherited anterior segment malformations, including Peters anomaly are heterozygous for an R26G mutation in the PAX6 paired box.",8162071_4,-1,3499,-1,0.28805408
3500,Peters anomaly,15,17,105,119,"Second, affected members of a family with dominantly inherited anterior segment malformations, including Peters anomaly are heterozygous for an R26G mutation in the PAX6 paired box.",8162071_4,-1,3500,-1,0.33103493
3501,Peters anomaly,23,25,134,148,"Third, a proportion of Sey/+ Smalleye mice, heterozygous for a nonsense mutation in murine Pax-6, have an ocular phenotype resembling Peters anomaly.",8162071_5,-1,3501,-1,0.32865542
3502,Huntington disease,0,2,0,18,"Huntington disease without CAG expansion: phenocopies or errors in assignment?
Huntington disease (HD) has been shown to be associated with an expanded CAG repeat within a novel gene on 4p16.",8178825_0,-1,3502,-1,0.32905218
3503,Huntington disease,12,14,79,97,"Huntington disease without CAG expansion: phenocopies or errors in assignment?
Huntington disease (HD) has been shown to be associated with an expanded CAG repeat within a novel gene on 4p16.",8178825_0,-1,3503,-1,0.36963233
3504,disease,27,28,99,106,"A total of 30 of 1, 022 affected persons (2. 9% of our cohort) did not have an expanded CAG in the disease range.",8178825_2,-1,3504,-1,0.37927407
3505,androgen,8,9,48,56,Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.,8187068_0,-1,3505,-1,0.35747388
3508,androgen,24,25,185,193,"
Prostatic tissue specimens derived from transurethral resections of patients with metastatic prostate cancer were analyzed for genetic alterations in the hormone-binding domain of the androgen receptor (AR) gene.",8187068_1,-1,3508,-1,0.33864865
3510,estrogens,33,34,202,211,"This same AR mutation has been reported previously in a metastatic prostate cancer cell line, LNCaP, where this mutation confers upon the AR an altered ligand-binding specificity which is stimulated by estrogens, progestagens, and antiandrogens.",8187068_3,-1,3510,-1,0.29648983
3511,progestagens,35,36,213,225,"This same AR mutation has been reported previously in a metastatic prostate cancer cell line, LNCaP, where this mutation confers upon the AR an altered ligand-binding specificity which is stimulated by estrogens, progestagens, and antiandrogens.",8187068_3,-1,3511,-1,0.3222728
3513,estrogens,1,2,9,18,"Although estrogens are used infrequently, antiandrogens are used increasingly in hormonal therapy for patients with advanced prostate cancer.",8187068_5,-1,3513,-1,0.32557794
3515,disease,27,28,180,187,The stimulatory effect of these therapeutic agents on the codon 877 mutant AR further suggests that this frequently observed AR mutation may contribute to the treatment refractory disease..,8187068_6,-1,3515,-1,0.36319378
3516,alkaptonuria,4,5,19,31,The human gene for alkaptonuria (AKU) maps to chromosome 3q.,8188241_0,-1,3516,-1,0.32845414
3517,Alkaptonuria,0,1,1,13,"
Alkaptonuria (AKU; McKusick no. 203500) is a rare autosomal recessive disorder caused by the lack of homogentisic acid oxidase activity.",8188241_1,-1,3517,-1,0.34545678
3518,Ochronosis,0,1,0,10,"Ochronosis is the predominant clinical complication of the disease leading to ochronotic arthropathy, dark urine, pigment changes of the skin, and other clinical features.",8188241_3,-1,3518,-1,0.32298332
3519,disease,8,9,59,66,"Ochronosis is the predominant clinical complication of the disease leading to ochronotic arthropathy, dark urine, pigment changes of the skin, and other clinical features.",8188241_3,-1,3519,-1,0.35725892
3520,alkaptonuria,3,4,19,31,A mutation causing alkaptonuria in the mouse has mapped to chromosome 16.,8188241_4,-1,3520,-1,0.3381811
3521,map,8,9,47,50,"Considering conserved synteny, we were able to map the human gene to chromosome 3q in six alkaptonuria pedigrees of Slovak origin..",8188241_5,-1,3521,-1,0.38061213
3522,alkaptonuria,17,18,90,102,"Considering conserved synteny, we were able to map the human gene to chromosome 3q in six alkaptonuria pedigrees of Slovak origin..",8188241_5,-1,3522,-1,0.31839198
3523,glucose,4,5,30,37,"
Intestinal uptake of dietary glucose and galactose is mediated by the SGLT1 Na +/glucose cotransporter of the brush border.",8195156_1,-1,3523,-1,0.30245966
3524,galactose,6,7,42,51,"
Intestinal uptake of dietary glucose and galactose is mediated by the SGLT1 Na +/glucose cotransporter of the brush border.",8195156_1,-1,3524,-1,0.29926017
3525,Na,12,13,77,79,"
Intestinal uptake of dietary glucose and galactose is mediated by the SGLT1 Na +/glucose cotransporter of the brush border.",8195156_1,-1,3525,-1,0.39002237
3528,Na,7,8,38,40,We have mapped the entire human SGLT1 Na +/glucose cotransporter gene from cosmid and lambda phage clones representing a genomic region of 112 kilobases.,8195156_3,-1,3528,-1,0.35730457
3529,Na,4,5,18,20,This is the first Na (+) -dependent cotransporter gene structure reported.,8195156_8,-1,3529,-1,0.38841486
3530,Na,24,25,181,183,These data facilitate the search for new glucose/galactose malabsorption-related mutations in this important gene and provide a basis for future evolutionary comparisons with other Na (+) -dependent cotransporters..,8195156_9,-1,3530,-1,0.3775579
3531,prolidase deficiency,5,7,32,52,Four novel PEPD alleles causing prolidase deficiency.,8198124_0,-1,3531,-1,0.36726287
3532,prolidase deficiency,6,8,35,55,"
Mutations at the PEPD locus cause prolidase deficiency (McKusick 170100), a rare autosomal recessive disorder characterized by iminodipeptiduria, skin ulcers, mental retardation, and recurrent infections.",8198124_1,-1,3532,-1,0.40378448
3533,ulcers,23,24,152,158,"
Mutations at the PEPD locus cause prolidase deficiency (McKusick 170100), a rare autosomal recessive disorder characterized by iminodipeptiduria, skin ulcers, mental retardation, and recurrent infections.",8198124_1,-1,3533,-1,0.35696054
3534,mental retardation,25,27,160,178,"
Mutations at the PEPD locus cause prolidase deficiency (McKusick 170100), a rare autosomal recessive disorder characterized by iminodipeptiduria, skin ulcers, mental retardation, and recurrent infections.",8198124_1,-1,3534,-1,0.33109343
3536,C,24,25,155,156,Conventional PCR and direct sequencing then established the intron-exon borders of the mutant genomic DNA revealing two splice acceptor mutations  a G-- > C substitution at position -1 of intron 4 and an A-- > G substitution at position -2 of intron 6.,8198124_8,-1,3536,-1,0.39383122
3537,prolidase deficiency,8,10,45,65,Our results indicate that the severe form of prolidase deficiency is caused by multiple PEPD alleles.,8198124_9,-1,3537,-1,0.3648693
3538,Friedreich ataxia,8,10,65,82,Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval.,8198128_0,-1,3538,-1,0.3505609
3539,Friedreich ataxia,3,5,15,32,"
The locus for Friedreich ataxia (FRDA), a severe neurodegenerative disease, is tightly linked to markers D9S5 and D9S15, and analysis of rare recombination events has suggested the order cen-FRDA-D9S5-D9S15-qter.",8198128_1,-1,3539,-1,0.36140645
3540,neurodegenerative disease,11,13,50,75,"
The locus for Friedreich ataxia (FRDA), a severe neurodegenerative disease, is tightly linked to markers D9S5 and D9S15, and analysis of rare recombination events has suggested the order cen-FRDA-D9S5-D9S15-qter.",8198128_1,-1,3540,-1,0.4212497
3541,map,3,4,12,15,"In order to map these markers with respect to the FRDA locus, all within a 1-cM confidence interval, we sought to increase the genetic information of available FRDA families by considering homozygosity by descent and association with founder haplotypes in isolated populations.",8198128_3,-1,3541,-1,0.39244628
3542,map,5,6,35,38,A detailed rare cutter restriction map and a cosmid contig covering this interval were constructed and should facilitate the search of genes in this region..,8198128_8,-1,3542,-1,0.34563008
3543,Prader-Willi syndrome,7,9,67,88,Investigation of thermoregulatory characteristics in patients with Prader-Willi syndrome.,8209890_0,-1,3543,-1,0.42135054
3544,Prader-Willi syndrome,13,15,95,116,"
A survey instrument is used to assess temperature regulation characteristics in children with Prader-Willi syndrome (PWS) compared to 3 control groups  sibs of PWS patients (SIB), neurodevelopmentally handicapped children (ND), and age and gender matched well children (WC).",8209890_1,-1,3544,-1,0.3973892
3546,retinitis pigmentosa,3,5,31,51,"Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene.",8240110_0,-1,3546,-1,0.34511226
3547,retinitis pigmentosa,15,17,106,126,"
BACKGROUND AND OBJECTIVES  Mutations of the peripherin/RDS gene have been reported in autosomal dominant retinitis pigmentosa, pattern macular dystrophy, and retinitis punctata albescens.",8240110_1,-1,3547,-1,0.32569912
3548,retinitis,23,24,159,168,"
BACKGROUND AND OBJECTIVES  Mutations of the peripherin/RDS gene have been reported in autosomal dominant retinitis pigmentosa, pattern macular dystrophy, and retinitis punctata albescens.",8240110_1,-1,3548,-1,0.3580356
3549,retinitis pigmentosa,19,21,113,133,"RESULTS  The mother presented at age 63 years with a profoundly abnormal electroretinogram (ERG) and adult-onset retinitis pigmentosa that progressed dramatically over 12 years, with marked loss of peripheral visual field.",8240110_6,-1,3549,-1,0.3449673
3550,disease,13,14,66,73,"At age 44 years, her ERG was moderately abnormal but her clinical disease was limited to the macula.",8240110_8,-1,3550,-1,0.3676546
3551,macular degeneration,8,10,48,68,Another daughter presented at age 42 years with macular degeneration and over 10 years developed the clinical picture of fundus flavimaculatus.,8240110_9,-1,3551,-1,0.3443661
3552,Na,1,2,5,7,"
The Na +/glucose cotransporter gene SGLT1 encodes the primary carrier protein responsible for the uptake of the dietary sugars glucose and galactose from the intestinal lumen.",8244393_1,-1,3552,-1,0.37820083
3553,glucose,20,21,128,135,"
The Na +/glucose cotransporter gene SGLT1 encodes the primary carrier protein responsible for the uptake of the dietary sugars glucose and galactose from the intestinal lumen.",8244393_1,-1,3553,-1,0.2968247
3554,galactose,22,23,140,149,"
The Na +/glucose cotransporter gene SGLT1 encodes the primary carrier protein responsible for the uptake of the dietary sugars glucose and galactose from the intestinal lumen.",8244393_1,-1,3554,-1,0.31405866
3555,disease,7,8,45,52,"In two patients with the autosomal recessive disease glucose/galactose malabsorption, the underlying cause was found to be a missense mutation in SGLT1, and the Asp28-- > Asn change was demonstrated in vitro to eliminate SGLT1 transport activity.",8244393_4,-1,3555,-1,0.35811257
3556,diseases,18,19,88,96,"1, and provide an example of the utility of the SGLT1 probe as a diagnostic for genetic diseases associated with translocations of chromosome 22.",8244393_7,-1,3556,-1,0.3550413
3557,adenomatous polyposis coli,13,16,80,106,Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.,8252631_0,-1,3557,-1,0.29998416
3559,adenomatous polyposis coli,13,16,65,91,"
In humans, alteration of the tumor suppressor gene, APC, causes adenomatous polyposis coli, a condition causing predisposition to colorectal cancer.",8252631_1,-1,3559,-1,0.3148526
3560,colorectal cancer,22,24,131,148,"
In humans, alteration of the tumor suppressor gene, APC, causes adenomatous polyposis coli, a condition causing predisposition to colorectal cancer.",8252631_1,-1,3560,-1,0.267099
3561,syndrome,1,2,4,12,The syndrome inconsistently associates characteristic patches of congenital hypertrophy of the retinal pigment epithelium (CHRPE).,8252631_2,-1,3561,-1,0.32154474
3563,lead,8,9,47,51,In all cases these mutations were predicted to lead to the synthesis of a truncated protein.,8252631_5,-1,3563,-1,0.4089113
3564,muscular dystrophy,16,18,90,108,The authors earlier findings of a negative electroretinogram (ERG) in a boy with Duchenne muscular dystrophy (DMD) led them to investigate dystrophin gene deletions and ERGs in five boys with DMD.,8258524_2,-1,3564,-1,0.33872932
3566,colorectal cancer,12,14,75,92,"
Mutations of APC appear to initiate sporadic and inherited forms of human colorectal cancer.",8259519_1,-1,3566,-1,0.26299042
3567,nucleotide,10,11,65,75,Two cellular proteins that associate with APC were identified by nucleotide sequence analysis and peptide mapping as the E-cadherin-associated proteins alpha- and beta-catenin.,8259519_3,-1,3567,-1,0.3714119
3569,Angelman syndrome,17,19,104,121,Difference in methylation patterns within the D15S9 region of chromosome 15q11-13 in first cousins with Angelman syndrome and Prader-Willi syndrome.,8266996_0,-1,3569,-1,0.3266601
3570,Prader-Willi syndrome,20,22,126,147,Difference in methylation patterns within the D15S9 region of chromosome 15q11-13 in first cousins with Angelman syndrome and Prader-Willi syndrome.,8266996_0,-1,3570,-1,0.39745787
3571,Angelman syndrome,10,12,65,82,"
Abnormalities of chromosome region 15q11-13 are associated with Angelman syndrome (AS) and Prader-Willi syndrome (PWS).",8266996_1,-1,3571,-1,0.32508424
3572,Prader-Willi syndrome,16,18,92,113,"
Abnormalities of chromosome region 15q11-13 are associated with Angelman syndrome (AS) and Prader-Willi syndrome (PWS).",8266996_1,-1,3572,-1,0.38137412
3573,Wilson disease,3,5,21,35,Haplotype studies in Wilson disease.,8279472_0,-1,3573,-1,0.33367896
3574,Wilson disease,4,6,21,35,"
In 51 families with Wilson disease, we have studied DNA haplotypes of dinucleotide repeat polymorphisms (CA repeats) in the 13q14.",8279472_1,-1,3574,-1,0.3178567
3575,CA,17,18,106,108,"
In 51 families with Wilson disease, we have studied DNA haplotypes of dinucleotide repeat polymorphisms (CA repeats) in the 13q14.",8279472_1,-1,3575,-1,0.39679378
3576,Wilson disease,11,13,60,74,"3 region, to examine these markers for association with the Wilson disease gene (WND).",8279472_2,-1,3576,-1,0.34985766
3577,Wilson disease,14,16,107,121,These findings have important implications for mutation detection and molecular diagnosis in families with Wilson disease.,8279472_6,-1,3577,-1,0.2930898
3579,disease,24,25,156,163,"
We have analyzed a single multi-affected breast/ovarian cancer pedigree (BOV3) and have shown consistent inheritance of markers on chromosome 17q with the disease confirming that this family is due to the BRCA1 gene.",8281142_1,-1,3579,-1,0.3361041
3581,Mb,1,2,2,4,5 Mb in length.,8281142_4,-1,3581,-1,0.3853293
3582,tumours,15,16,97,104,All seven breast tumour/blood pairs examined from this family show loss of heterozygosity in the tumours.,8281142_5,-1,3582,-1,0.28623924
3583,tumour,5,6,27,33,The allel retained in each tumour was from the disease-bearing chromosome implicating BRCA1 as a tumour suppressor gene.,8281142_6,-1,3583,-1,0.3038926
3584,tumour,15,16,97,103,The allel retained in each tumour was from the disease-bearing chromosome implicating BRCA1 as a tumour suppressor gene.,8281142_6,-1,3584,-1,0.30805126
3585,Myotonic dystrophy,0,2,0,18,Myotonic dystrophy kinase is a component of neuromuscular junctions.,8281152_0,-1,3585,-1,0.36393192
3586,myotonic dystrophy,4,6,31,49,"
The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable [CTG] n DNA motif.",8281152_1,-1,3586,-1,0.36299902
3587,DM,7,8,51,53,"
The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable [CTG] n DNA motif.",8281152_1,-1,3587,-1,0.37032965
3588,n,22,23,117,118,"
The clinical manifestation of myotonic dystrophy (DM) is correlated to the extent of expansion of an unstable [CTG] n DNA motif.",8281152_1,-1,3588,-1,0.3865307
3589,myotonic dystrophy,32,34,207,225,"Recent studies have demonstrated that this trinucleotide motif forms part of the last, 3 untranslated exon of a gene which potentially encodes multiple protein isoforms of a serine/threonine protein kinase (myotonic dystrophy protein kinase, DM-PK).",8281152_2,-1,3589,-1,0.36764935
3590,DM,18,19,110,112,Immunoreactive DM-kinase protein of 53 kD is present at low levels in skeletal and cardiac muscle extracts of DM patients and normal controls.,8281152_4,-1,3590,-1,0.34912792
3591,DM,21,22,123,125,"Strikingly, presence of the protein can also be demonstrated for NMJs of muscular tissues of adult and congenital cases of DM, with no gross changes in structural organisation.",8281152_7,-1,3591,-1,0.32173067
3592,DM,34,35,223,225,Our findings provide a basis for further characterisation of the role of the kinase in protein assembly processes or signal mediation at synaptic sites and ultimately for the understanding of the complex pathophysiology of DM..,8281152_8,-1,3592,-1,0.3547865
3593,cholesterol,19,20,135,146,Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.,8282802_0,-1,3593,-1,0.37413454
3594,disease,24,25,187,194,Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.,8282802_0,-1,3594,-1,0.3622847
3595,cholesterol,6,7,30,41,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3595,-1,0.38269636
3596,disease,14,15,89,96,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3596,-1,0.35650128
3597,cholesterol,36,37,228,239,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3597,-1,0.3289041
3598,atherosclerotic cardiovascular disease,44,47,274,312,"
Classic (complete) lecithin  cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are genetic syndromes associated with markedly decreased plasma levels of high density lipoprotein (HDL) cholesterol but not with an increased risk of atherosclerotic cardiovascular disease.",8282802_1,-1,3598,-1,0.32396966
3599,disease,33,34,189,196,"We investigated the metabolism of the HDL apolipoproteins (apo) apoA-I and apoA-II in a total of five patients with LCAT deficiency, one with classic LCAT deficiency and four with Fish-eye disease.",8282802_2,-1,3599,-1,0.34942955
3601,disease,39,40,242,249,"Because LpA-I has been proposed to be more protective than LpA-I  A-II against atherosclerosis, this selective effect on the metabolism of LpA-I  A-II may provide a potential explanation why patients with classic LCAT deficiency and Fish-eye disease are not at increased risk for premature atherosclerosis despite markedly decreased levels of HDL cholesterol and apoA-I",8282802_10,-1,3601,-1,0.3264099
3602,premature atherosclerosis,46,48,280,305,"Because LpA-I has been proposed to be more protective than LpA-I  A-II against atherosclerosis, this selective effect on the metabolism of LpA-I  A-II may provide a potential explanation why patients with classic LCAT deficiency and Fish-eye disease are not at increased risk for premature atherosclerosis despite markedly decreased levels of HDL cholesterol and apoA-I",8282802_10,-1,3602,-1,0.34064096
3603,cholesterol,54,55,347,358,"Because LpA-I has been proposed to be more protective than LpA-I  A-II against atherosclerosis, this selective effect on the metabolism of LpA-I  A-II may provide a potential explanation why patients with classic LCAT deficiency and Fish-eye disease are not at increased risk for premature atherosclerosis despite markedly decreased levels of HDL cholesterol and apoA-I",8282802_10,-1,3603,-1,0.31332514
3606,Wiskott-Aldrich syndrome,38,40,195,219,Results of DNA analysis with the probe M27 beta are consistent with X linkage and indicate also that the locus of the relevant gene lies close to or is identical to the locus of the gene for the Wiskott-Aldrich syndrome (WAS).,8301658_4,-1,3606,-1,0.39396676
3608,retinal degeneration,11,13,70,90,Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene.,8302543_0,-1,3608,-1,0.37990177
3609,retinal degeneration,7,9,40,60,"
BACKGROUND  Recently, mutations in the retinal degeneration slow (rds) gene which codes for peripherin-rds have been implicated as a cause of autosomal dominant retinitis pigmentosa.",8302543_1,-1,3609,-1,0.38497266
3610,retinitis pigmentosa,27,29,162,182,"
BACKGROUND  Recently, mutations in the retinal degeneration slow (rds) gene which codes for peripherin-rds have been implicated as a cause of autosomal dominant retinitis pigmentosa.",8302543_1,-1,3610,-1,0.32525623
3612,scotoma,27,28,156,163,"RESULTS  In all but one affected member, symptoms of progressive central visual loss developed in the third or fourth decade of life accompanied by central scotoma and well-demarcated atrophy of the retinal pigment epithelium and choriocapillaris of the macula.",8302543_5,-1,3612,-1,0.32177866
3614,hemochromatosis,15,16,100,115,"Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)
The hemochromatosis gene (HFE) maps to 6p21.",8304342_0,-1,3614,-1,0.32743165
3615,hemochromatosis,21,22,131,146,"Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)
The hemochromatosis gene (HFE) maps to 6p21.",8304342_0,-1,3615,-1,0.34661162
3616,cM,6,7,21,23,"3 and is less than 1 cM from the HLA class I genes; however, the precise physical location of the gene has remained elusive and controversial.",8304342_1,-1,3616,-1,0.36921033
3617,hemochromatosis,8,9,59,74,The unambiguous identification of a crossover event within hemochromatosis families is very difficult; it is particularly hampered by the variability of the phenotypic expression as well as by the sex- and age-related penetrance of the disease.,8304342_2,-1,3617,-1,0.31792378
3618,disease,36,37,236,243,The unambiguous identification of a crossover event within hemochromatosis families is very difficult; it is particularly hampered by the variability of the phenotypic expression as well as by the sex- and age-related penetrance of the disease.,8304342_2,-1,3618,-1,0.34605035
3619,hemochromatosis,6,7,26,41,"In the present report, 66 hemochromatosis families yielding 151 hemochromatosis chromosomes and 182 normal chromosomes were RFLP-typed with a battery of probes, including two newly derived polymorphic markers from the 6.",8304342_5,-1,3619,-1,0.34023416
3620,hemochromatosis,10,11,64,79,"In the present report, 66 hemochromatosis families yielding 151 hemochromatosis chromosomes and 182 normal chromosomes were RFLP-typed with a battery of probes, including two newly derived polymorphic markers from the 6.",8304342_5,-1,3620,-1,0.3093885
3621,disease,24,25,132,139,"7 locus, both of which are comprised by the major ancestral or founder HFE haplotype in Brittany, supports the possibility that the disease gene may reside immediately telomeric to the 6.",8304342_11,-1,3621,-1,0.37028414
3622,hemochromatosis,2,3,14,29,"Additionally, hemochromatosis haplotypes possessing HLA-A11 and the low-frequency HLA-F polymorphism (allele 2) are supportive of a separate founder chromosome containing a second, independently arising mutant allele.",8304342_13,-1,3622,-1,0.33721524
3623,hemochromatosis,8,9,41,56,"Overall, the establishment of a likely "" hemochromatosis critical region "" centromeric boundary and the identification of a linkage-disequilibrium zone both significantly contribute to a reduction in the amount of DNA required to be searched for novel coding sequences constituting the HFE defect",8304342_14,-1,3623,-1,0.30621624
3624,sarcoma,32,33,156,163,"
The EWS gene has been identified based on its location at the chromosome 22 breakpoint of the t (11; 22) (q24; q12) translocation that characterizes Ewing sarcoma and related neuroectodermal tumors.",8307570_1,-1,3624,-1,0.27756733
3625,neuroectodermal tumors,35,37,176,198,"
The EWS gene has been identified based on its location at the chromosome 22 breakpoint of the t (11; 22) (q24; q12) translocation that characterizes Ewing sarcoma and related neuroectodermal tumors.",8307570_1,-1,3625,-1,0.31518394
3626,nucleotide,1,2,4,14,The nucleotide sequence of the exons is identical to that of the previously described cDNA.,8307570_3,-1,3626,-1,0.37318885
3627,tyrosine,25,26,136,144,"The first 7 exons encode the N-terminal domain of EWS, which consists of a repeated degenerated polypeptide of 7 to 12 residues rich in tyrosine, serine, threonine, glycine, and glutamine.",8307570_4,-1,3627,-1,0.32994437
3628,glycine,31,32,165,172,"The first 7 exons encode the N-terminal domain of EWS, which consists of a repeated degenerated polypeptide of 7 to 12 residues rich in tyrosine, serine, threonine, glycine, and glutamine.",8307570_4,-1,3628,-1,0.3230523
3629,glutamine,34,35,178,187,"The first 7 exons encode the N-terminal domain of EWS, which consists of a repeated degenerated polypeptide of 7 to 12 residues rich in tyrosine, serine, threonine, glycine, and glutamine.",8307570_4,-1,3629,-1,0.3001568
3631,Norrie disease,0,2,0,14,Norrie disease gene: characterization of deletions and possible function.,8314592_0,-1,3631,-1,0.38674468
3632,Norrie disease,14,16,96,110,"
Positional cloning experiments have resulted recently in the isolation of a candidate gene for Norrie disease (pseudoglioma; NDP), a severe X-linked neurodevelopmental disorder.",8314592_1,-1,3632,-1,0.33864063
3633,neurodevelopmental disorder,25,27,150,177,"
Positional cloning experiments have resulted recently in the isolation of a candidate gene for Norrie disease (pseudoglioma; NDP), a severe X-linked neurodevelopmental disorder.",8314592_1,-1,3633,-1,0.34578156
3634,Huntington disease,2,4,11,29,"The normal Huntington disease (HD) allele, or a closely linked gene, influences age at onset of HD.",8317477_0,-1,3634,-1,0.37536865
3635,Huntington disease,5,7,34,52,"
We evaluated the hypothesis that Huntington disease (HD) is influenced by the normal HD allele by comparing transmission patterns of genetically linked markers at the D4S10 locus in the normal parent against age at onset in the affected offspring.",8317477_1,-1,3635,-1,0.35651523
3636,Tay-Sachs disease,16,18,106,123,Further investigation of the HEXA gene intron 9 donor splice site mutation frequently found in non-Jewish Tay-Sachs disease patients from the British Isles.,8326491_0,-1,3636,-1,0.41792473
3637,Tay-Sachs disease,8,10,37,54,"
In a previous study we found that a Tay-Sachs disease (TSD) causing mutation in the intron 9 donor splice site of the HEXA gene occurs at high frequency in non-Jewish patients and carriers from the British Isles.",8326491_1,-1,3637,-1,0.4644281
3638,p,22,23,106,107,"All six had Irish ancestry, compared with nine of the 20 other (intron 9 mutation negative) TSD carriers (p < 0. 05).",8326491_5,-1,3638,-1,0.40901828
3640,retinoblastoma,13,14,98,112,Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma.,8346255_0,-1,3640,-1,0.28189883
3641,RB1,1,2,5,8,"
The RB1 gene from 12 human retinoblastoma tumors has been analyzed exon-by-exon with the single-strand conformation polymorphism technique.",8346255_1,-1,3641,-1,0.30661342
3642,retinoblastoma tumors,6,8,28,49,"
The RB1 gene from 12 human retinoblastoma tumors has been analyzed exon-by-exon with the single-strand conformation polymorphism technique.",8346255_1,-1,3642,-1,0.2752382
3646,aniridia,3,4,18,26,PAX6 mutations in aniridia.,8364574_0,-1,3646,-1,0.35482782
3647,Aniridia,0,1,1,9,"
Aniridia is a congenital malformation of the eye, chiefly characterised by iris hypoplasia, which can cause blindness.",8364574_1,-1,3647,-1,0.3925946
3648,blindness,18,19,109,118,"
Aniridia is a congenital malformation of the eye, chiefly characterised by iris hypoplasia, which can cause blindness.",8364574_1,-1,3648,-1,0.33340862
3649,aniridia,8,9,42,50,The PAX6 gene was isolated as a candidate aniridia gene by positional cloning from the smallest region of overlap of aniridia-associated deletions.,8364574_2,-1,3649,-1,0.38651597
3650,aniridia,18,19,114,122,"Subsequently PAX6 intragenic mutations were demonstrated in Smalleye, a mouse mutant which is an animal model for aniridia, and six human aniridia patients.",8364574_3,-1,3650,-1,0.37833935
3651,aniridia,23,24,138,146,"Subsequently PAX6 intragenic mutations were demonstrated in Smalleye, a mouse mutant which is an animal model for aniridia, and six human aniridia patients.",8364574_3,-1,3651,-1,0.37394014
3652,aniridia,11,12,66,74,"In this paper we describe four additional PAX6 point mutations in aniridia patients, both sporadic and familial.",8364574_4,-1,3652,-1,0.37962374
3653,aniridia,23,24,126,134,"In addition, the frequency at which we have found PAX6 mutations suggests that lesions in PAX6 will account for most cases of aniridia..",8364574_6,-1,3653,-1,0.3612205
3654,arginine vasopressin,4,6,21,41,Detection of a novel arginine vasopressin defect by dideoxy fingerprinting.,8370681_0,-1,3654,-1,0.33827135
3655,diabetes insipidus,3,5,37,55,"
Autosomal dominant neurohypophyseal diabetes insipidus is a familial form of diabetes insipidus.",8370681_1,-1,3655,-1,0.33389324
3656,diabetes insipidus,10,12,78,96,"
Autosomal dominant neurohypophyseal diabetes insipidus is a familial form of diabetes insipidus.",8370681_1,-1,3656,-1,0.30694333
3657,arginine vasopressin,8,10,52,72,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3657,-1,0.3066325
3658,AVP,11,12,74,77,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3658,-1,0.3041794
3659,diabetes insipidus,14,16,83,101,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3659,-1,0.3206509
3660,AVP,24,25,151,154,"This disorder is associated with variable levels of arginine vasopressin (AVP) and diabetes insipidus of varying severity, which responds to exogenous AVP.",8370681_2,-1,3660,-1,0.29888886
3661,diabetes insipidus,9,11,72,90,"To determine the molecular basis of autosomal dominant neurohypophyseal diabetes insipidus, the AVP genes of members of a large kindred were analyzed.",8370681_3,-1,3661,-1,0.33267382
3662,AVP,13,14,96,99,"To determine the molecular basis of autosomal dominant neurohypophyseal diabetes insipidus, the AVP genes of members of a large kindred were analyzed.",8370681_3,-1,3662,-1,0.35381156
3663,AVP,13,14,67,70,"A new method, called dideoxy fingerprinting, was used to detect an AVP mutation that was characterized by DNA sequencing.",8370681_4,-1,3663,-1,0.3349931
3664,AVP,10,11,53,56,"The novel defect found changes the last codon of the AVP signal peptide from alanine to threonine, which should perturb cleavage of mature AVP from its precursor protein and inhibit its secretion or action..",8370681_5,-1,3664,-1,0.30390745
3665,alanine,14,15,77,84,"The novel defect found changes the last codon of the AVP signal peptide from alanine to threonine, which should perturb cleavage of mature AVP from its precursor protein and inhibit its secretion or action..",8370681_5,-1,3665,-1,0.39866537
3666,AVP,24,25,139,142,"The novel defect found changes the last codon of the AVP signal peptide from alanine to threonine, which should perturb cleavage of mature AVP from its precursor protein and inhibit its secretion or action..",8370681_5,-1,3666,-1,0.3001418
3667,muscular dystrophy,5,7,33,51,Germinal mosaicism in a Duchenne muscular dystrophy family: implications for genetic counselling.,8375105_0,-1,3667,-1,0.36427394
3668,muscular dystrophy,16,18,101,119,"
In this study we describe a three-generation family in which two siblings were affected by Duchenne muscular dystrophy (DMD).",8375105_1,-1,3668,-1,0.3277907
3669,cancer syndrome,5,7,38,53,Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA.,8401501_0,-1,3669,-1,0.31731182
3671,estradiol,10,11,62,71,"Candidate genes in this region include EDH17B2, which encodes estradiol 17 beta-hydroxysteroid dehydrogenase II (17 beta-HSD II), and RARA, the gene for retinoic acid receptor alpha.",8401501_2,-1,3671,-1,0.37190026
3674,map,4,5,23,26,Both BRCA1 and EDH17B2 map to a 6 cM interval (between THRA1 and D17S579) and no recombination was observed between the two genes.,8401501_5,-1,3674,-1,0.42439696
3675,cM,8,9,34,36,Both BRCA1 and EDH17B2 map to a 6 cM interval (between THRA1 and D17S579) and no recombination was observed between the two genes.,8401501_5,-1,3675,-1,0.39482537
3676,cancer syndrome,17,19,107,122,"Mutations in the EDH17B2 gene, therefore do not appear to be responsible for the hereditary breast-ovarian cancer syndrome.",8401501_7,-1,3676,-1,0.30150452
3677,cholesteryl ester,5,7,27,44,A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.,8408659_0,-1,3677,-1,0.35872668
3679,Cholesteryl ester,0,2,0,17,Cholesteryl ester transfer protein (CETP; 476 amino acids) transfers cholesteryl ester from HDL to other lipoproteins.,8408659_2,-1,3679,-1,0.37909067
3680,amino acids,8,10,46,57,Cholesteryl ester transfer protein (CETP; 476 amino acids) transfers cholesteryl ester from HDL to other lipoproteins.,8408659_2,-1,3680,-1,0.38455933
3681,cholesteryl ester,12,14,69,86,Cholesteryl ester transfer protein (CETP; 476 amino acids) transfers cholesteryl ester from HDL to other lipoproteins.,8408659_2,-1,3681,-1,0.3232431
3682,Familial Mediterranean fever,0,3,0,28,Familial Mediterranean fever in the colchicine era: the fate of one family.,8434621_0,-1,3682,-1,0.3557419
3683,familial Mediterranean fever,15,18,99,127,"
In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF.",8434621_1,-1,3683,-1,0.3520796
3684,kidney disease,9,11,61,75,Each patient represents a different stage of the amyloidotic kidney disease of FMF and the effect of continuous colchicine treatment on its course.,8434621_2,-1,3684,-1,0.3331123
3685,disease,21,22,124,131,"Considered together, the members of this family present an almost complete clinical, genetic, and behavioral picture of the disease..",8434621_3,-1,3685,-1,0.33800992
3686,Norrie disease,5,7,34,48,Detection of a new submicroscopic Norrie disease deletion interval with a novel DNA probe isolated by differential Alu PCR fingerprint cloning.,8440142_0,-1,3686,-1,0.3642365
3687,p11,4,5,6,9,4-- > p11.,8440142_2,-1,3687,-1,0.408414
3688,Norrie disease,17,19,93,107,"This novel sequence, cpXr318 (DXS742), detects a new submicroscopic deletion interval at the Norrie disease locus (NDP).",8440142_4,-1,3688,-1,0.3753127
3689,map,7,8,46,49,"Combining our data with the consensus genetic map of the proximal short arm of the X chromosome, we propose the physical order Xcen-DXS14-DXS255- (DXS426, TIMP) - (DXS742- ([MAOB-MAOA-DXS7], NDP) -DXS77-DXS228) -DXS209-DXS148-DXS196- + + + Xpter.",8440142_5,-1,3689,-1,0.39335454
3690,map,15,16,71,74,"Finally, DXS742, DSX7, DXS77, and MAOA were integrated into a physical map spanning the Norrie disease locus",8440142_7,-1,3690,-1,0.38171825
3691,Norrie disease,18,20,88,102,"Finally, DXS742, DSX7, DXS77, and MAOA were integrated into a physical map spanning the Norrie disease locus",8440142_7,-1,3691,-1,0.3740841
3692,adrenoleukodystrophy,2,3,18,38,Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.,8441467_0,-1,3692,-1,0.35189357
3693,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD) is an X-linked disease affecting 1/20, 000 males either as cerebral ALD in childhood or as adrenomyeloneuropathy (AMN) in adults.",8441467_1,-1,3693,-1,0.3515832
3694,disease,7,8,43,50,"
Adrenoleukodystrophy (ALD) is an X-linked disease affecting 1/20, 000 males either as cerebral ALD in childhood or as adrenomyeloneuropathy (AMN) in adults.",8441467_1,-1,3694,-1,0.3537994
3695,neurological,11,12,53,65,"Childhood ALD is the more severe form, with onset of neurological symptoms between 5-12 years of age.",8441467_2,-1,3695,-1,0.31832272
3697,disease,7,8,28,35,AMN is a milder form of the disease with onset at 15-30 years of age and a more progressive course.,8441467_4,-1,3697,-1,0.34377733
3698,Adrenal insufficiency,0,2,0,21,Adrenal insufficiency (Addisons disease) may remain the only clinical manifestation of ALD.,8441467_5,-1,3698,-1,0.35023165
3699,disease,4,5,32,39,Adrenal insufficiency (Addisons disease) may remain the only clinical manifestation of ALD.,8441467_5,-1,3699,-1,0.3608903
3700,fatty acids,11,13,84,95,The principal biochemical abnormality of ALD is the accumulation of very-long-chain fatty acids (VLCFA) because of impaired beta-oxidation in peroxisomes.,8441467_6,-1,3700,-1,0.3434973
3701,disease,9,10,53,60,"In familial cases, the deletions segregated with the disease.",8441467_9,-1,3701,-1,0.35930786
3702,K,19,20,110,111,The deduced protein sequence shows significant sequence identity to a peroxisomal membrane protein of M (r) 70K that is involved in peroxisome biogenesis and belongs to the ATP-binding cassette superfamily of transporters..,8441467_12,-1,3702,-1,0.32974663
3703,cholesterol,22,23,156,167,"
Familial hypobetalipoproteinemia is an autosomal codominant disorder resulting in a dramatic reduction in plasma concentrations of apolipoprotein (apo) B, cholesterol, and beta-migrating lipoproteins.",8460149_1,-1,3703,-1,0.3005356
3704,disease,15,16,113,120,A benefit of hypobetalipoproteinemia is that mildly affected individuals may be protected from coronary vascular disease.,8460149_2,-1,3704,-1,0.34691587
3705,cholesterol,35,36,226,237,"Mice containing this allele display all of the hallmarks of human hypobetalipoproteinemia  they produce a truncated apoB protein, apoB70, and have markedly decreased plasma concentrations of apoB, beta-lipoproteins, and total cholesterol.",8460149_4,-1,3705,-1,0.29023597
3706,triglyceride,19,20,145,157,"In addition, the mice manifest several characteristics that are occasionally observed in human hypobetalipoproteinemia, including reduced plasma triglyceride concentrations, fasting chylomicronemia, and reduced high density lipoprotein cholesterol.",8460149_5,-1,3706,-1,0.33793026
3707,cholesterol,30,31,236,247,"In addition, the mice manifest several characteristics that are occasionally observed in human hypobetalipoproteinemia, including reduced plasma triglyceride concentrations, fasting chylomicronemia, and reduced high density lipoprotein cholesterol.",8460149_5,-1,3707,-1,0.2940574
3708,hydrocephalus,15,16,100,113,An unexpected finding is that the modified Apob allele is strongly associated with exencephalus and hydrocephalus.,8460149_6,-1,3708,-1,0.3615634
3709,hydrocephalus,18,19,130,143,"These mice should help increase our understanding of hypobetalipoproteinemia, atherogenesis, and the etiology of exencephalus and hydrocephalus..",8460149_7,-1,3709,-1,0.3731007
3710,disease,2,3,8,15,A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.,8466512_0,-1,3710,-1,0.34439334
3711,fatty acid,13,15,107,117,"
Palmitoyl-CoA dehydrogenase activity in skin fibroblasts from seven patients with unidentified defects of fatty acid oxidation was measured in the presence and absence of antibodies against medium-chain, long-chain, and very-long-chain acyl-CoA dehydrogenases (VLCAD).",8466512_1,-1,3711,-1,0.3710455
3712,disease,18,19,68,75,"Two of the patients, 4-5 month old boys, were found to have a novel disease, VLCAD deficiency, as judged from the results of very low palmitoyl-CoA dehydrogenase activity and the lack of immunoreactivity toward antibody raised to purified VLCAD..",8466512_2,-1,3712,-1,0.35090563
3713,VLCAD deficiency,20,22,77,93,"Two of the patients, 4-5 month old boys, were found to have a novel disease, VLCAD deficiency, as judged from the results of very low palmitoyl-CoA dehydrogenase activity and the lack of immunoreactivity toward antibody raised to purified VLCAD..",8466512_2,-1,3713,-1,0.3760066
3714,nucleotide,12,13,66,76,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3714,-1,0.37703636
3715,C,49,50,205,206,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3715,-1,0.4133378
3716,Phe,55,56,220,223,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3716,-1,0.3349582
3717,Val,68,69,258,261,"From these 43 samples, we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A (Arg to His); at cDNA 1376 from G to T (Arg to Leu); at cDNA 1024 from C to T (Leu to Phe); at cDNA 392 from G to T (Gly to Val); at cDNA 95 from A to G (His to Arg).",8471773_4,-1,3717,-1,0.35098162
3718,nucleotide,2,3,11,21,These five nucleotide substitutions account for over 83% of our 43 G6PD-deficient samples and these substitutions have not been reported in non-Asians.,8471773_5,-1,3718,-1,0.36537966
3719,choroideremia,5,6,38,51,Identification of mutations in Danish choroideremia families.,8477262_0,-1,3719,-1,0.34694463
3720,choroideremia,7,8,39,52,"
We have searched for mutations in the choroideremia gene (CHM) in patients from 12 Danish families in which CHM is segregating.",8477262_1,-1,3720,-1,0.34553483
3721,myotonic dystrophy,6,8,38,56,Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene.,8499920_0,-1,3721,-1,0.38046348
3722,DM,9,10,58,60,Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene.,8499920_0,-1,3722,-1,0.36104372
3723,myotonic dystrophy,3,5,22,40,"
The mutation causing myotonic dystrophy (DM) has recently been identified as an unstable CTG trinucleotide repeat located in the 3 untranslated region of a gene encoding for a protein with putative serine-threonine protein kinase activity.",8499920_1,-1,3723,-1,0.3943101
3724,DM,6,7,42,44,"
The mutation causing myotonic dystrophy (DM) has recently been identified as an unstable CTG trinucleotide repeat located in the 3 untranslated region of a gene encoding for a protein with putative serine-threonine protein kinase activity.",8499920_1,-1,3724,-1,0.38969693
3725,DM,13,14,72,74,In this report we present the genomic sequences of the human and murine DM kinase gene.,8499920_2,-1,3725,-1,0.36599314
3726,DM,34,35,192,194,"A comparison of these sequences with each other and with known cDNA sequences from both species, led us to predict a translation initiation codon, as well as determine the organization of the DM kinase gene.",8499920_3,-1,3726,-1,0.38506147
3727,DM,5,6,39,41,"Several polymorphisms within the human DM kinase gene have been identified, and PCR assays to detect two of these are described.",8499920_4,-1,3727,-1,0.37766176
3728,DM,10,11,67,69,"The complete sequence and characterization of the structure of the DM kinase gene, as well as the identification of novel polymorphisms within the gene, represent an important step in a further understanding of the genetics of myotonic dystrophy and the molecular biology of the gene..",8499920_5,-1,3728,-1,0.3793286
3729,myotonic dystrophy,38,40,227,245,"The complete sequence and characterization of the structure of the DM kinase gene, as well as the identification of novel polymorphisms within the gene, represent an important step in a further understanding of the genetics of myotonic dystrophy and the molecular biology of the gene..",8499920_5,-1,3729,-1,0.35100326
3730,hemophilia A,4,6,36,48,Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation.,8500791_0,-1,3730,-1,0.32782072
3732,hemophilia A,9,11,63,75,"
The differential diagnosis of the genetic bleeding disorders, hemophilia A and von Willebrand disease, is occasionally confounded by the close molecular relationship of coagulation factor VIII and von Willebrand factor (vWF).",8500791_1,-1,3732,-1,0.35794193
3733,disease,14,15,95,102,"
The differential diagnosis of the genetic bleeding disorders, hemophilia A and von Willebrand disease, is occasionally confounded by the close molecular relationship of coagulation factor VIII and von Willebrand factor (vWF).",8500791_1,-1,3733,-1,0.30193388
3734,coagulation factor VIII,25,28,170,193,"
The differential diagnosis of the genetic bleeding disorders, hemophilia A and von Willebrand disease, is occasionally confounded by the close molecular relationship of coagulation factor VIII and von Willebrand factor (vWF).",8500791_1,-1,3734,-1,0.29769233
3735,hemophilia A,8,10,53,65,This report describes the autosomal inheritance of a hemophilia A phenotype due to a mutation of vWF that results in defective factor VIII binding.,8500791_2,-1,3735,-1,0.32515445
3736,factor VIII,21,23,127,138,This report describes the autosomal inheritance of a hemophilia A phenotype due to a mutation of vWF that results in defective factor VIII binding.,8500791_2,-1,3736,-1,0.28696075
3737,factor VIII,10,12,52,63,The proband was a female patient with low levels of factor VIII activity.,8500791_3,-1,3737,-1,0.28789154
3738,factor VIII,18,20,118,129,Polymerase chain reaction (PCR) amplification and DNA sequencing were employed to examine exons encoding the putative factor VIII binding domain of vWF.,8500791_4,-1,3738,-1,0.29346812
3739,amino acid,19,21,105,115,The patient was found to be homozygous for a single point mutation causing a Thr-- > Met substitution at amino acid position 28 in the mature vWF subunit.,8500791_5,-1,3739,-1,0.38608864
3740,amino acid,5,7,40,50,Recombinant vWF containing the observed amino acid substitution was expressed in COS-1 cells.,8500791_7,-1,3740,-1,0.35543394
3741,factor VIII,7,9,35,46,"However, the mutant failed to bind factor VIII, demonstrating that the mutation was functionally related to the observed hemophilia phenotype.",8500791_9,-1,3741,-1,0.28906888
3743,cystadenoma,8,9,59,70,Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis.,8522307_0,-1,3743,-1,0.36003432
3744,cystadenoma,1,2,11,22,"
Papillary cystadenoma of the epididymis is an uncommon benign lesion that may occur sporadically or as a manifestation of von Hippel-Lindau (VHL) disease.",8522307_1,-1,3744,-1,0.3593271
3745,disease,24,25,147,154,"
Papillary cystadenoma of the epididymis is an uncommon benign lesion that may occur sporadically or as a manifestation of von Hippel-Lindau (VHL) disease.",8522307_1,-1,3745,-1,0.31242332
3746,cystadenoma,9,10,55,66,"The authors describe two cases of clear cell papillary cystadenoma of the epididymis, both of which were initially confused with metastatic renal cell carcinoma.",8522307_3,-1,3746,-1,0.3690227
3747,renal cell carcinoma,22,25,140,160,"The authors describe two cases of clear cell papillary cystadenoma of the epididymis, both of which were initially confused with metastatic renal cell carcinoma.",8522307_3,-1,3747,-1,0.30196232
3748,cystadenoma,4,5,29,40,"Because clear cell papillary cystadenoma is similar to renal cell carcinoma histologically, and because both occur as components of the von Hippel-Lindau disease complex, the authors analyzed both cases for the presence of mutations in the VHL gene.",8522307_6,-1,3748,-1,0.3093311
3749,renal cell carcinoma,8,11,55,75,"Because clear cell papillary cystadenoma is similar to renal cell carcinoma histologically, and because both occur as components of the von Hippel-Lindau disease complex, the authors analyzed both cases for the presence of mutations in the VHL gene.",8522307_6,-1,3749,-1,0.2975913
3750,von Hippel-Lindau disease,21,24,136,161,"Because clear cell papillary cystadenoma is similar to renal cell carcinoma histologically, and because both occur as components of the von Hippel-Lindau disease complex, the authors analyzed both cases for the presence of mutations in the VHL gene.",8522307_6,-1,3750,-1,0.32410857
3752,cytosine,4,5,29,37,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3752,-1,0.3589011
3753,thymine,6,7,41,48,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3753,-1,0.37841144
3754,nucleotide,9,10,63,73,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3754,-1,0.34637
3755,amino acid,26,28,157,167,"Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3.",8522307_8,-1,3755,-1,0.35938394
3757,Wiskott-Aldrich syndrome,7,9,50,74,Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus.,8528198_0,-1,3757,-1,0.3899173
3759,Wiskott-Aldrich syndrome,22,24,141,165,"
Mutation in the gene encoding the recently isolated WASP protein has now been identified as the genetic defect responsible for the X-linked Wiskott-Aldrich syndrome (WAS), a primary immunodeficiency disease associated with extensive phenotypic variability.",8528198_1,-1,3759,-1,0.37556386
3760,immunodeficiency disease,30,32,183,207,"
Mutation in the gene encoding the recently isolated WASP protein has now been identified as the genetic defect responsible for the X-linked Wiskott-Aldrich syndrome (WAS), a primary immunodeficiency disease associated with extensive phenotypic variability.",8528198_1,-1,3760,-1,0.3494643
3767,Wiskott-Aldrich syndrome,4,6,23,47,WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.,8528199_0,-1,3767,-1,0.3829236
3769,Wiskott-Aldrich syndrome,11,13,54,78,23 and shown to be mutated in three patients with the Wiskott-Aldrich syndrome (WAS).,8528199_2,-1,3769,-1,0.39185163
3770,amino acid,1,3,5,15,"Four amino acid substitutions, Leu27Phe, Thr48Ile, Val75Met and Arg477Lys, were found in patients with congenital thrombocytopenia and no clinically evident immune defect indicating that the WASP gene is the site for mutations in X-linked thrombocytopenia as well as in WAS.",8528199_6,-1,3770,-1,0.38296962
3773,amino acids,10,12,78,89,"The distribution of eight missense mutations provides valuable information on amino acids which are essential for normal protein function, and suggests that sites in the first two exons are hot-spots for mutation.",8528199_8,-1,3773,-1,0.38352582
3774,Machado-Joseph disease,25,27,173,195,Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease.,8528200_0,-1,3774,-1,0.37393814
3775,(CAG)n,4,5,17,23,"
The size of the (CAG)n repeat array in the 3' end of the MJD1 gene and the haplotype at a series of microsatellite markers surrounding the MJD1 gene were examined in a large cohort of Japanese and Caucasian subjects affected with Machado-Joseph disease (MJD).",8528200_1,-1,3775,-1,0.4107854
3776,Machado-Joseph disease,42,44,231,253,"
The size of the (CAG)n repeat array in the 3' end of the MJD1 gene and the haplotype at a series of microsatellite markers surrounding the MJD1 gene were examined in a large cohort of Japanese and Caucasian subjects affected with Machado-Joseph disease (MJD).",8528200_1,-1,3776,-1,0.388963
3777,p,23,24,114,115,"Third, the size of the expanded allele is not only inversely correlated with the age-of-onset of MJD (r = -0.738, p < 0.001), but is also correlated with the frequency of other clinical features [e.g. pseudoexophthalmos and pyramidal signs were more frequent in subjects with large repeats (p < 0.001 and p < 0.05 respectively)].",8528200_5,-1,3777,-1,0.4411827
3778,p,54,55,291,292,"Third, the size of the expanded allele is not only inversely correlated with the age-of-onset of MJD (r = -0.738, p < 0.001), but is also correlated with the frequency of other clinical features [e.g. pseudoexophthalmos and pyramidal signs were more frequent in subjects with large repeats (p < 0.001 and p < 0.05 respectively)].",8528200_5,-1,3778,-1,0.44190982
3779,p,58,59,305,306,"Third, the size of the expanded allele is not only inversely correlated with the age-of-onset of MJD (r = -0.738, p < 0.001), but is also correlated with the frequency of other clinical features [e.g. pseudoexophthalmos and pyramidal signs were more frequent in subjects with large repeats (p < 0.001 and p < 0.05 respectively)].",8528200_5,-1,3779,-1,0.43653607
3780,disease,3,4,12,19,"Fourth, the disease phenotype is significantly more severe and had an early age of onset (16 years) in a subject homozygous for the expanded allele, which contrasts with Huntington disease and suggests that the expanded allele in the MJD1 gene could exert its effect either by a dominant negative effect (putatively excluded in HD) or by a gain of function effect as proposed for HD.",8528200_6,-1,3780,-1,0.40696862
3781,Huntington disease,32,34,170,188,"Fourth, the disease phenotype is significantly more severe and had an early age of onset (16 years) in a subject homozygous for the expanded allele, which contrasts with Huntington disease and suggests that the expanded allele in the MJD1 gene could exert its effect either by a dominant negative effect (putatively excluded in HD) or by a gain of function effect as proposed for HD.",8528200_6,-1,3781,-1,0.35563424
3782,Langer-Giedion syndrome,7,9,39,62,A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1).,8530105_0,-1,3782,-1,0.34674054
3783,syndrome,23,24,156,164,A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1).,8530105_0,-1,3783,-1,0.30293056
3784,exostoses,26,27,178,187,A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1).,8530105_0,-1,3784,-1,0.30860028
3785,map,5,6,32,35,"
We have constructed a physical map covering over 4 Mb of human chromosome 8q24.",8530105_1,-1,3785,-1,0.38455158
3786,Mb,9,10,52,54,"
We have constructed a physical map covering over 4 Mb of human chromosome 8q24.",8530105_1,-1,3786,-1,0.3630873
3787,map,4,5,16,19,1 and used this map to refine the locations of the genes responsible for Langer-Giedion syndrome.,8530105_2,-1,3787,-1,0.36883777
3788,Langer-Giedion syndrome,14,16,73,96,1 and used this map to refine the locations of the genes responsible for Langer-Giedion syndrome.,8530105_2,-1,3788,-1,0.36458367
3789,map,1,2,4,7,The map is composed of overlapping YAC clones that were identified and ordered in relation to sequence tagged sites mapped to the Langer-Giedion chromosomal region on somatic cell hybrids.,8530105_3,-1,3789,-1,0.36228743
3790,Langer-Giedion syndrome,6,8,33,56,"The minimal region of overlap of Langer-Giedion syndrome deletions, previously identified by analysis of 15 patients, was placed on the map by analysis of 2 patients whose deletions define the endpoints.",8530105_4,-1,3790,-1,0.35913637
3791,map,22,23,136,139,"The minimal region of overlap of Langer-Giedion syndrome deletions, previously identified by analysis of 15 patients, was placed on the map by analysis of 2 patients whose deletions define the endpoints.",8530105_4,-1,3791,-1,0.36380404
3792,syndrome,8,9,59,67,3) translocation from a patient with trichorhinophalangeal syndrome (TRPS I) was found to be located just within the proximal end of the minimal deletion region.,8530105_6,-1,3792,-1,0.2965593
3793,exostoses,6,7,29,38,"3 in a patient with multiple exostoses was found to overlap the distal end of the LGS deletion region, indicating that the EXT1 gene is distal to the TRPS1 gene and supporting the hypothesis that Langer-Giedion syndrome is due to loss of functional copies of both the TRPS1 and the EXT1 genes",8530105_9,-1,3793,-1,0.2979022
3794,Langer-Giedion syndrome,36,38,196,219,"3 in a patient with multiple exostoses was found to overlap the distal end of the LGS deletion region, indicating that the EXT1 gene is distal to the TRPS1 gene and supporting the hypothesis that Langer-Giedion syndrome is due to loss of functional copies of both the TRPS1 and the EXT1 genes",8530105_9,-1,3794,-1,0.35874018
3810,prostatic cancer,22,24,140,156,"In one family, penetrance was complete, with females developing early-onset breast cancer or ovarian cancer and the male carrier developing prostatic cancer, whereas, in the other family, penetrance was incomplete and only breast cancer occurred, diagnosed at ages 38-81 years.",8533757_6,-1,3810,-1,0.27182415
3815,malaria,19,20,121,128,"
Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is usually found at high frequencies in areas of the world where malaria has been endemic.",8533762_1,-1,3815,-1,0.3479675
3816,Phe,53,54,280,283,"Remarkably, a previously unreported deficient variant, G6PD Orissa (44 Ala-- > Gly), is responsible for most of the G6PD deficiency in tribal Indian populations but is not found in urban populations, where most of the G6PD deficiency is due to the G6PD Mediterranean (188 Ser-- > Phe) variant.",8533762_5,-1,3816,-1,0.38604066
3817,alanine,9,10,37,44,This may be due to the fact that the alanine residue that is replaced by glycine is part of a putative coenzyme-binding site..,8533762_7,-1,3817,-1,0.37500387
3818,glycine,15,16,73,80,This may be due to the fact that the alanine residue that is replaced by glycine is part of a putative coenzyme-binding site..,8533762_7,-1,3818,-1,0.34125683
3820,bipolar affective disorder,14,17,94,120,"
A susceptibility gene on chromosome 18 and a parent-of-origin effect have been suggested for bipolar affective disorder (BPAD).",8533768_1,-1,3820,-1,0.3023361
3822,P,20,21,91,92,The greatest sharing was at D18S37  64% in bipolar and recurrent unipolar (RUP) sib pairs (P =. 0006).,8533768_5,-1,3822,-1,0.4116333
3824,P,45,46,247,248,"In addition, excess sharing of the paternally, but not maternally, transmitted alleles was observed at three markers on 18q  at D18S41, 51 bipolar and RUP sib pairs were concordant for paternally transmitted alleles, and 21 pairs were discordant (P = 0004).",8533768_6,-1,3824,-1,0.38372073
3825,e,20,21,100,101,"The evidence for linkage to loci on both 18p and 18q was strongest in the 11 paternal pedigrees, i. e e., those in which the father or one of the fathers sibs is affected.",8533768_7,-1,3825,-1,0.45589373
3826,P,12,13,54,55,"In these pedigrees, the greatest allele sharing (81%; P =. 00002) and the highest LOD score (3. 51; phi = 0. 0) were observed at D18S41.",8533768_8,-1,3826,-1,0.40804315
3827,C--,9,10,46,49,METHODS  We discovered a mutation caused by a C-- > T transition at base-pair 1158 of the GALT gene that results in a serine-to-leucine substitution at codon 135 (S135L).,8551426_2,-1,3827,-1,0.37556583
3832,syndrome,12,13,73,81,It is expected that the majority of clear examples of the breast-ovarian syndrome will be associated with germ-line mutations in the coding region of BRCA1..,8554067_9,-1,3832,-1,0.3049555
3836,tumours,6,7,31,38,The loss of wild-type BRCA1 in tumours of individuals carrying one nonfunctional BRCA1 allele suggests that BRCA1 encodes a tumour suppressor that may inhibit the proliferation of mammary epithelial cells.,8563759_3,-1,3836,-1,0.30095068
3837,tumour,19,20,124,130,The loss of wild-type BRCA1 in tumours of individuals carrying one nonfunctional BRCA1 allele suggests that BRCA1 encodes a tumour suppressor that may inhibit the proliferation of mammary epithelial cells.,8563759_3,-1,3837,-1,0.3072999
3839,spina bifida,23,25,138,150,"Abnormalities in Brca1-deficient embryos were most evident in the neural tube, with 40% of the embryos presenting with varying degrees of spina bifida and anencephaly.",8563759_6,-1,3839,-1,0.360785
3841,Adrenoleukodystrophy,0,1,1,21,"
Adrenoleukodystrophy (ALD), an X-linked inherited metabolic disorder, is the most frequent inborn peroxisomal disease.",8566952_1,-1,3841,-1,0.35846376
3842,disease,17,18,111,118,"
Adrenoleukodystrophy (ALD), an X-linked inherited metabolic disorder, is the most frequent inborn peroxisomal disease.",8566952_1,-1,3842,-1,0.33224478
3843,fatty acids,7,9,54,65,"Defective beta-oxidation of saturated very long chain fatty acids (VLCFAs; C22  0-C26  0) in peroxisomes has been shown to lead to an accumulation of VLCFAs in leukoid areas of the central nervous system, peripheral nerves, adrenal gland, and blood.",8566952_3,-1,3843,-1,0.34882978
3844,lead,24,25,123,127,"Defective beta-oxidation of saturated very long chain fatty acids (VLCFAs; C22  0-C26  0) in peroxisomes has been shown to lead to an accumulation of VLCFAs in leukoid areas of the central nervous system, peripheral nerves, adrenal gland, and blood.",8566952_3,-1,3844,-1,0.3843875
3847,amino acid,25,27,122,132,4 kb of the region of these clones corresponding to part of human exon 11 revealed 72% nucleic acid identity but only 50% amino acid identity with the human gene.,8566965_6,-1,3847,-1,0.3414894
3848,diastrophic dysplasia,9,11,55,76,Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.,8571951_0,-1,3848,-1,0.37586084
3849,diastrophic dysplasia,27,29,187,208,"
Atelosteogenesis type II (AO II) is a neonatally lethal chondrodysplasia whose clinical and histological characteristics resemble those of another chondrodysplasia, the much less severe diastrophic dysplasia (DTD).",8571951_1,-1,3849,-1,0.3612683
3850,diastrophic dysplasia,9,11,54,75,DTD is caused by mutations in the recently identified diastrophic dysplasia sulfate-transporter gene (DTDST).,8571951_3,-1,3850,-1,0.391062
3851,lead,13,14,68,72,"Here, we report that AOII patients also have DTDST mutations, which lead to defective uptake of inorganic sulfate and insufficient sulfation of macromolecules by patient mesenchymal cells in vitro.",8571951_4,-1,3851,-1,0.4400885
3852,achondrogenesis,13,14,85,100,"Together with our recent observation that a third even more severe chondrodysplasia, achondrogenesis type IB, is also caused by mutations in DTDST, these results demonstrate a phenotypic series of three chondrodysplasias of increasing severity caused by lesions in a single sulfate-transporter gene.",8571951_5,-1,3852,-1,0.34954083
3856,P,23,24,129,130,"A comparison of the six mutations in the relative proportions of cases of breast and ovarian cancer was suggestive of an effect (P =. 069), with 57% of women presumed affected because of the 1294 del 40 BRCA1 mutation having ovarian cancer, compared with 14% of affected women with the splice-site mutation in intron 5 of BRCA1.",8571953_4,-1,3856,-1,0.39266077
3859,nucleotide,17,18,96,106,DNA sequence analysis revealed that the mouse and human coding regions are 75% identical at the nucleotide level while the predicted amino acid identity is only 58%.,8575748_4,-1,3859,-1,0.37774768
3860,amino,22,23,133,138,DNA sequence analysis revealed that the mouse and human coding regions are 75% identical at the nucleotide level while the predicted amino acid identity is only 58%.,8575748_4,-1,3860,-1,0.3574521
3861,map,13,14,69,72,A DNA sequence variant in the Brca1 locus was identified and used to map this gene on a (Mus m. musculus Czech II x C57BL/KsJ) F1 x C57BL/KsJ intersubspecific backcross to distal mouse chromosome 11.,8575748_5,-1,3861,-1,0.3755077
3862,muscular dystrophy,10,12,74,92,Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy.,8589715_0,-1,3862,-1,0.3312711
3863,X-linked Emery-Dreifuss muscular dystrophy,15,19,78,120,"
Mutations in the STA gene at the Xq28 locus have been found in patients with X-linked Emery-Dreifuss muscular dystrophy (EDMD).",8589715_1,-1,3863,-1,0.38051346
3864,neuromuscular diseases,25,27,149,171,"Using both antisera, we found positive nuclear membrane staining in skeletal, cardiac and smooth muscles in the normal controls and in patients with neuromuscular diseases other than EDMD.",8589715_4,-1,3864,-1,0.34354502
3865,contrast,1,2,3,11,"In contrast, a deficiency in immunofluorescent staining of skeletal and cardiac muscle from EDMD patients was observed.",8589715_5,-1,3865,-1,0.3489161
3866,Growth retardation,0,2,0,18,Growth retardation and tumour inhibition by BRCA1.,8589721_0,-1,3866,-1,0.3846305
3867,tumour,3,4,23,29,Growth retardation and tumour inhibition by BRCA1.,8589721_0,-1,3867,-1,0.33695224
3871,lung cancer,30,32,161,172,"Here, we show that retroviral transfer of the wild-type BRCA1 gene inhibits growth in vitro of all breast and ovarian cancer cell lines tested, but not colon or lung cancer cells or fibroblasts.",8589721_2,-1,3871,-1,0.3144406
3874,tumours,3,4,21,28,"Development of MCF-7 tumours in nude mice is inhibited when MCF-7 cells are transfected with wild-type, but not mutant, BRCA1.",8589721_4,-1,3874,-1,0.3033616
3875,tumours,8,9,52,59,"Most importantly, among mice with established MCF-7 tumours, peritoneal treatment with a retroviral vector expressing wild-type BRCA1 significantly inhibits tumour growth and increased survival..",8589721_5,-1,3875,-1,0.3055805
3876,tumour,21,22,157,163,"Most importantly, among mice with established MCF-7 tumours, peritoneal treatment with a retroviral vector expressing wild-type BRCA1 significantly inhibits tumour growth and increased survival..",8589721_5,-1,3876,-1,0.31435993
3878,C,14,15,82,83,"Interestingly, BRCA2 also includes a motif similar to the granin consensus at the C terminus of the protein.",8589722_4,-1,3878,-1,0.44793597
3879,tumour,17,18,104,110,"As a regulated secretory protein, BRCA1 appears to function by a mechanism not previously described for tumour suppressor gene products..",8589722_6,-1,3879,-1,0.2864294
3888,P,30,31,160,161,"The risk for ovarian cancer was 2. 11 times greater for BRCA1 carriers harbouring one or two rare HRAS1 alleles, compared to carriers with only common alleles (P = 0. 015).",8589723_8,-1,3888,-1,0.42673403
3892,myotonic dystrophy,14,16,91,109,A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat.,8595416_0,-1,3892,-1,0.38745213
3893,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is associated with a (CTG) n trinucleotide repeat expansion in the 3-untranslated region of a protein kinase-encoding gene, DMPK, which maps to chromosome 19q13.",8595416_1,-1,3893,-1,0.39132935
3894,DM,3,4,21,23,"
Myotonic dystrophy (DM) is associated with a (CTG) n trinucleotide repeat expansion in the 3-untranslated region of a protein kinase-encoding gene, DMPK, which maps to chromosome 19q13.",8595416_1,-1,3894,-1,0.40265092
3895,n,12,13,52,53,"
Myotonic dystrophy (DM) is associated with a (CTG) n trinucleotide repeat expansion in the 3-untranslated region of a protein kinase-encoding gene, DMPK, which maps to chromosome 19q13.",8595416_1,-1,3895,-1,0.42794973
3896,DM,1,2,4,6,"The DM region of chromosome 19 is gene rich, and it is possible that the repeat expansion may lead to dysfunction of a number of transcription units in the vicinity, perhaps as a consequence of chromatin disruption.",8595416_4,-1,3896,-1,0.44223335
3897,lead,19,20,94,98,"The DM region of chromosome 19 is gene rich, and it is possible that the repeat expansion may lead to dysfunction of a number of transcription units in the vicinity, perhaps as a consequence of chromatin disruption.",8595416_4,-1,3897,-1,0.41580853
3898,RB1,4,5,26,29,Germline mutations in the RB1 gene in patients with hereditary retinoblastoma.,8605116_0,-1,3898,-1,0.31430367
3899,retinoblastoma,10,11,63,77,Germline mutations in the RB1 gene in patients with hereditary retinoblastoma.,8605116_0,-1,3899,-1,0.3006642
3900,RB1,12,13,62,65,"
We have analyzed the 27 exons and the promoter region of the RB1 gene in familial or sporadic bilateral retinoblastoma by using single-strand conformation polymorphism analysis.",8605116_1,-1,3900,-1,0.30621877
3901,retinoblastoma,19,20,105,119,"
We have analyzed the 27 exons and the promoter region of the RB1 gene in familial or sporadic bilateral retinoblastoma by using single-strand conformation polymorphism analysis.",8605116_1,-1,3901,-1,0.2693423
3902,amino acid,1,3,16,26,Allele-specific amino acid substitutions (Ser189 --> Phe; Gly444 --> Arg) cause impaired C2 secretion.,8621452_1,-1,3902,-1,0.37615603
3903,Phe,8,9,53,56,Allele-specific amino acid substitutions (Ser189 --> Phe; Gly444 --> Arg) cause impaired C2 secretion.,8621452_1,-1,3903,-1,0.37550342
3904,nucleotide,6,7,18,28,"One is in exon 5 (nucleotide C566 -- > T; Ser189 -- > Phe) of the C2Q0 gene linked to the MHC haplotype A11, B35, DRw1, BFS, C4A0B1.",8621452_6,-1,3904,-1,0.36130425
3905,Phe,15,16,54,57,"One is in exon 5 (nucleotide C566 -- > T; Ser189 -- > Phe) of the C2Q0 gene linked to the MHC haplotype A11, B35, DRw1, BFS, C4A0B1.",8621452_6,-1,3905,-1,0.3527041
3906,disease,19,20,112,119,Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.,8622978_0,-1,3906,-1,0.30240858
3907,C,6,7,29,30,"
The same heterozygous T - > C transition at nt 8567 of the von Willebrand factor (vWF) transcript was found in two unrelated patients with type IID von Willebrand disease, with no other apparent abnormality.",8622978_1,-1,3907,-1,0.38225085
3908,disease,31,32,164,171,"
The same heterozygous T - > C transition at nt 8567 of the von Willebrand factor (vWF) transcript was found in two unrelated patients with type IID von Willebrand disease, with no other apparent abnormality.",8622978_1,-1,3908,-1,0.28893617
3909,contrast,1,2,3,11,"In contrast, cells expressing the mutant fragment secreted a monomeric molecule of apparent molecular mass of 80 kDa, which remained unchanged after reduction.",8622978_6,-1,3909,-1,0.37107036
3910,disease,38,39,268,275,We conclude that CyS2010 is essential for normal dimerization of vWF subunits through disulfide bonding of carboxyl-terminal domains and that a heterozygous mutation in the corresponding codon is responsible for defective multimer formation in type IID von Willebrand disease..,8622978_7,-1,3910,-1,0.28183186
3911,Wiskott-Aldrich syndrome,0,2,0,24,"Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization.",8625410_0,-1,3911,-1,0.38273337
3912,Wiskott-Aldrich syndrome,11,13,58,82,"We have identified WASP, the protein that is defective in Wiskott-Aldrich syndrome (WAS), as a novel effector for CDC42Hs, but not for the other Rho family members, Rac and Rho.",8625410_2,-1,3912,-1,0.36920285
3913,adrenoleukodystrophy,1,2,9,29,X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.,8636252_0,-1,3913,-1,0.34476787
3914,disease,10,11,74,81,X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.,8636252_0,-1,3914,-1,0.3497864
3915,adrenoleukodystrophy,1,2,10,30,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3915,-1,0.36779505
3916,disease,8,9,50,57,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3916,-1,0.36465183
3917,adrenal insufficiency,18,20,119,140,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3917,-1,0.35310647
3918,fatty acids,27,29,178,189,"
X-Linked adrenoleukodystrophy (ALD) is a genetic disease associated with demyelination of the central nervous system, adrenal insufficiency, and accumulation of very long chain fatty acids in tissue and body fluids.",8636252_1,-1,3918,-1,0.3427216
3919,Adrenal insufficiency,0,2,0,21,Adrenal insufficiency (Addisons disease) is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD (8% of cases).,8636252_5,-1,3919,-1,0.34532642
3920,disease,4,5,32,39,Adrenal insufficiency (Addisons disease) is frequently associated with AMN or cerebral ALD and may remain the only clinical expression of ALD (8% of cases).,8636252_5,-1,3920,-1,0.3550704
3921,disease,8,9,49,56,The prevalence of ALD among adults with Addisons disease remains unknown.,8636252_6,-1,3921,-1,0.3210943
3922,fatty acids,13,15,82,93,"To evaluate this prevalence, we performed biochemical analysis of very long chain fatty acids in 14 male patients (age ranging from 12-45 yr at diagnosis) previously diagnosed as having primary idiopathic adrenocortical insufficiency.",8636252_7,-1,3922,-1,0.35318238
3923,fatty acids,17,19,77,88,"In 5 of 14 patients (35%), elevated plasma concentrations of very long chain fatty acids were detected.",8636252_8,-1,3923,-1,0.35448426
3924,disease,14,15,84,91,Our data support the hypothesis that ALD is a frequent cause of idiopathic Addisons disease in children and adults..,8636252_11,-1,3924,-1,0.32614157
3928,cancer deaths,9,11,53,66,"
Prostate cancer is the second leading cause of male cancer deaths in the United States. Yet, despite a large international effort, little is known about the molecular mechanisms that underlie this devastating disease.",8637912_1,-1,3928,-1,0.32788953
3929,disease,35,36,210,217,"
Prostate cancer is the second leading cause of male cancer deaths in the United States. Yet, despite a large international effort, little is known about the molecular mechanisms that underlie this devastating disease.",8637912_1,-1,3929,-1,0.32959956
3930,androgen,13,14,112,120,"Prostate secretory epithelial cells and androgen-dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and, furthermore, most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression.",8637912_2,-1,3930,-1,0.3733473
3931,androgen,23,24,183,191,"Prostate secretory epithelial cells and androgen-dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and, furthermore, most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression.",8637912_2,-1,3931,-1,0.3752812
3932,disease,32,33,263,270,"Prostate secretory epithelial cells and androgen-dependent prostate carcinomas undergo apoptosis in response to androgen deprivation and, furthermore, most prostate carcinomas become androgen independent and refractory to further therapeutic manipulations during disease progression.",8637912_2,-1,3932,-1,0.33269495
3934,prostatic adenocarcinoma,26,28,167,191,We report the functional definition of a novel genetic locus within human chromosome 10pter-q11 that mediates both in vivo tumor suppression and in vitro apoptosis of prostatic adenocarcinoma cells.,8637912_4,-1,3934,-1,0.34554777
3935,adenocarcinoma,15,16,95,109,A defined fragment of human chromosome 10 was transferred via microcell fusion into a prostate adenocarcinoma cell line.,8637912_5,-1,3935,-1,0.35088125
3937,adenocarcinoma,14,15,84,98,"These data functionally define a novel genetic locus, designated PAC1, for prostate adenocarcinoma 1, involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma..",8637912_8,-1,3937,-1,0.40231174
3941,prostatic adenocarcinoma,39,41,253,277,"These data functionally define a novel genetic locus, designated PAC1, for prostate adenocarcinoma 1, involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma..",8637912_8,-1,3941,-1,0.33677077
3944,tumour,5,6,38,44,"
Inherited mutant alleles of familial tumour suppressor genes predispose individuals to particular types of cancer.",8640236_1,-1,3944,-1,0.30897123
3947,tumour,12,13,75,81,"In addition to an involvement in inherited susceptibility to cancer, these tumour suppressor genes are targets for somatic mutations in sporadic cancers of the same type found in the familial forms.",8640236_2,-1,3947,-1,0.31579307
3954,tumour,9,10,52,58,"Like BRCA1, BRCA2 behaves as a dominantly inherited tumour suppressor gene.",8640236_6,-1,3954,-1,0.2980154
3956,tumours,16,17,91,98,"Individuals who inherit one mutant allele are at increased risk for breast cancer, and the tumours they develop lose the wild-type allele by heterozygous deletion.",8640236_7,-1,3956,-1,0.30844155
3958,tumour,23,24,129,135,Here we investigate the rate of BRCA2 mutation in sporadic breast cancers and in a set of cell lines that represent twelve other tumour types.,8640236_9,-1,3958,-1,0.28182307
3961,tumour,9,10,54,60,"However, a probable germline mutation in a pancreatic tumour cell line suggests a role for BRCA2 in susceptibility to pancreatic cancer..",8640236_11,-1,3961,-1,0.3231137
3965,nucleotide,9,10,59,69,"Four novel Swedish founding mutations were identified  the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families.",8644702_4,-1,3965,-1,0.37606785
3966,C,20,21,118,119,"Four novel Swedish founding mutations were identified  the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families.",8644702_4,-1,3966,-1,0.4421806
3967,nucleotide,39,40,216,226,"Four novel Swedish founding mutations were identified  the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families.",8644702_4,-1,3967,-1,0.34074885
3974,melanoma,21,22,126,134,"Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma.",8644702_8,-1,3974,-1,0.2651245
3975,oligodendroglioma,24,25,139,156,"Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma.",8644702_8,-1,3975,-1,0.34301302
3976,carcinosarcoma,28,29,164,178,"Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma.",8644702_8,-1,3976,-1,0.308707
3978,P,27,28,144,145,"In all, 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer, as compared with only 6 of the remaining 31 families (P <.",8644702_9,-1,3978,-1,0.39849266
3979,disease,9,10,55,62,The present study confirms the involvement of BRCA1 in disease predisposition for a subset of hereditary breast cancer families often characterized by ovarian cancers.,8644702_11,-1,3979,-1,0.38195315
3986,Li-Fraumeni syndrome,14,16,93,113,A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome.,8649785_0,-1,3986,-1,0.39145902
3987,Li-Fraumeni syndrome,8,10,44,64,"
We report details of a family with classic Li-Fraumeni syndrome in which there is a mutation in codon 344 of the tumour suppressor gene TP53.",8649785_1,-1,3987,-1,0.39475155
3988,tumour,21,22,114,120,"
We report details of a family with classic Li-Fraumeni syndrome in which there is a mutation in codon 344 of the tumour suppressor gene TP53.",8649785_1,-1,3988,-1,0.30233416
3989,amino acid,13,15,70,80,"Codon 344 is a key residue within the tetramerisation domain, and the amino acid substitution of a proline for a leucine is predicted to have profound implications for tetramerisation and potentially DNA binding.",8649785_2,-1,3989,-1,0.39501804
3990,leucine,21,22,113,120,"Codon 344 is a key residue within the tetramerisation domain, and the amino acid substitution of a proline for a leucine is predicted to have profound implications for tetramerisation and potentially DNA binding.",8649785_2,-1,3990,-1,0.33028206
3991,tumours,14,15,74,81,This is the first report of a mutation at this residue in either sporadic tumours or in the germline and the first report of a germline mutation within the tetramerisation domain.,8649785_3,-1,3991,-1,0.28957
3992,tumours,12,13,63,70,"The family does not appear to be remarkable in the spectrum of tumours, and there is loss of the wild-type allele in a leiomyosarcoma from the proband.",8649785_4,-1,3992,-1,0.27993208
3993,leiomyosarcoma,24,25,119,133,"The family does not appear to be remarkable in the spectrum of tumours, and there is loss of the wild-type allele in a leiomyosarcoma from the proband.",8649785_4,-1,3993,-1,0.3192741
3994,tumour,8,9,42,48,"A cell line has been established from the tumour of the proband and cytogenetic and molecular studies carried out, providing an extensive analysis in this family..",8649785_5,-1,3994,-1,0.28541622
3995,RB1,3,4,16,19,The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.,8651278_0,-1,3995,-1,0.3143154
3996,retinoblastoma,8,9,54,68,The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.,8651278_0,-1,3996,-1,0.29979596
3997,RB1,5,6,32,35,"
We have searched for germ-line RB1 mutations in 119 patients with hereditary retinoblastoma.",8651278_1,-1,3997,-1,0.31169868
3998,retinoblastoma,12,13,78,92,"
We have searched for germ-line RB1 mutations in 119 patients with hereditary retinoblastoma.",8651278_1,-1,3998,-1,0.28250703
3999,RB1,4,5,17,20,No region of the RB1 gene was preferentially involved in single base substitutions.,8651278_6,-1,3999,-1,0.3188232
4000,RB1,12,13,72,75,Recurrent transitions were observed at most of the 14 codons within the RB1.,8651278_7,-1,4000,-1,0.3204339
4001,RB1,10,11,65,68,This suggests that mutations within the 3-terminal region of the RB1 gene may not be oncogenic.,8651278_9,-1,4001,-1,0.31072232
4004,Huntington disease,12,14,73,91,Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.,8659522_0,-1,4004,-1,0.38933843
4005,Huntington disease,10,12,63,81,"
Abnormal CAG expansions in the IT-15 gene are associated with Huntington disease (HD).",8659522_1,-1,4005,-1,0.34315756
4006,disease,11,12,66,73,Many of these experiments found an overlap between the normal and disease size ranges.,8659522_4,-1,4006,-1,0.32093197
4007,disease,19,20,117,124,Subsequent findings that the CCG repeats vary by 8 trinucleotide lengths suggested that the limits of the normal and disease size ranges should be reevaluated with assays that exclude the CCG polymorphism.,8659522_5,-1,4007,-1,0.33273095
4008,disease,15,16,85,92,"Seven HD patients had 36 repeats, which confirms that this allele is associated with disease.",8659522_9,-1,4008,-1,0.35623023
4009,Canavan disease,11,13,86,101,Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.,8659549_0,-1,4009,-1,0.3864313
4010,Canavan disease,0,2,1,16,"
Canavan disease is inherited as an autosomal recessive trait that is caused by the deficiency of aspartoacylase (ASPA).",8659549_1,-1,4010,-1,0.39337078
4011,Canavan disease,5,7,30,45,The majority of patients with Canavan disease are from an Ashkenazi Jewish background.,8659549_2,-1,4011,-1,0.3710238
4012,lead,4,5,23,27,"Mutations in ASPA that lead to loss of enzymatic activity have been identified, and E285A and Y231X are the two predominant mutations that account for 97% of the mutant chromosomes in Ashkenazi Jewish patients.",8659549_3,-1,4012,-1,0.43308693
4013,Canavan disease,11,13,62,77,The current study was aimed at finding the molecular basis of Canavan disease in 25 independent patients of non-Jewish background.,8659549_4,-1,4013,-1,0.39930114
4014,Canavan disease,16,18,107,122,The homozygous 32 deltaT deletion was identified in the only known patient of African-American origin with Canavan disease.,8659549_8,-1,4014,-1,0.37964186
4015,Canavan disease,24,26,142,157,In vitro expression of mutant cDNA clones demonstrated that all of these mutations led to a deficiency of ASPA and should therefore result in Canavan disease..,8659549_12,-1,4015,-1,0.3933825
4016,amino acids,23,25,130,141,The entire coding sequence of the Atm transcript was cloned and found to contain an open reading frame encoding a protein of 3066 amino acids with 84% overall identity and 91% similarity to the human ATM protein.,8661102_2,-1,4016,-1,0.36842278
4017,Wiskott-Aldrich syndrome,5,7,25,49,The mouse homolog of the Wiskott-Aldrich syndrome protein (WASP) gene is highly conserved and maps near the scurfy (sf) mutation on the X chromosome.,8666397_0,-1,4017,-1,0.3325493
4018,Wiskott-Aldrich syndrome,12,14,57,81,"
The mouse WASP gene, the homolog of the gene mutated in Wiskott-Aldrich syndrome, has been isolated and sequenced.",8666397_1,-1,4018,-1,0.3795356
4019,amino acid,2,4,14,24,the predicted amino acid sequence is 86% identical to the human WASP sequence.,8666397_2,-1,4019,-1,0.3508258
4020,disease,16,17,108,115,"This localization makes Wasp a candidate for involvement in scurfy, a T cell-mediated fatal lymphoreticular disease of mice that has previously been proposed as a mouse homolog of Wiskott-Aldrich syndrome.",8666397_7,-1,4020,-1,0.37897062
4021,Wiskott-Aldrich syndrome,29,31,180,204,"This localization makes Wasp a candidate for involvement in scurfy, a T cell-mediated fatal lymphoreticular disease of mice that has previously been proposed as a mouse homolog of Wiskott-Aldrich syndrome.",8666397_7,-1,4021,-1,0.37262425
4022,familial Mediterranean fever,7,10,43,71,Colchicine in breast milk of patients with familial Mediterranean fever.,8670333_0,-1,4022,-1,0.3316631
4023,familial Mediterranean fever,26,29,149,177,"To clarify whether colchicine is excreted in breast milk, and to compare its concentrations in the serum and breast milk of lactating women who have familial Mediterranean fever (FMF).",8670333_2,-1,4023,-1,0.33686623
4024,myotonic dystrophy,1,3,9,27,Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice.,8673131_0,-1,4024,-1,0.3624691
4026,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is commonly associated with CTG repeat expansions within the gene for DM-protein kinase (DMPK).",8673131_1,-1,4026,-1,0.3725096
4027,DM,3,4,21,23,"
Myotonic dystrophy (DM) is commonly associated with CTG repeat expansions within the gene for DM-protein kinase (DMPK).",8673131_1,-1,4027,-1,0.38066563
4028,hypertrophic cardiomyopathy,30,32,174,201,"Nullizygous (-/-) mice showed only inconsistent and minor size changes in head and neck muscle fibres at older age, animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality.",8673131_3,-1,4028,-1,0.34030432
4029,DM,7,8,41,43,"However, both models lack other frequent DM symptoms including the fibre-type dependent atrophy, myotonia, cataract and male-infertility.",8673131_4,-1,4029,-1,0.3866117
4030,myotonia,15,16,97,105,"However, both models lack other frequent DM symptoms including the fibre-type dependent atrophy, myotonia, cataract and male-infertility.",8673131_4,-1,4030,-1,0.3436935
4032,disease,22,23,147,154,These results strengthen the contention that simple loss- or gain-of-expression of DMPK is not the only crucial requirement for development of the disease..,8673131_5,-1,4032,-1,0.35997227
4033,myotonic dystrophy,3,5,17,35,Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy.,8673132_0,-1,4033,-1,0.3758646
4035,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase (DMPK).",8673132_1,-1,4035,-1,0.3759582
4036,DM,3,4,21,23,"
Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3 untranslated region of a putative protein kinase (DMPK).",8673132_1,-1,4036,-1,0.39038163
4037,DM,7,8,33,35,To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient (Dmpk-/-) mice.,8673132_2,-1,4037,-1,0.3601082
4039,DM,14,15,108,110,"Dmpk-/-mice develop a late-onset, progressive skeletal myopathy that shares some pathological features with DM.",8673132_3,-1,4039,-1,0.32089433
4041,DM,28,29,171,173,Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to DM pathology..,8673132_6,-1,4041,-1,0.34712034
4045,E,21,22,141,142,"In vivo, mutant embryos do not exhibit increased apoptosis but show reduced cell proliferation accompanied by decreased expression of cyclin E and mdm-2, a regulator of p53 activity.",8674108_7,-1,4045,-1,0.3745879
4047,coronary heart disease,1,4,10,32,Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.,8675707_0,-1,4047,-1,0.36166054
4048,cholesteryl ester,11,13,79,96,Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.,8675707_0,-1,4048,-1,0.36207935
4049,coronary heart disease,19,22,127,149,"
Plasma high density lipoprotein (HDL) levels are strongly genetically determined and show a general inverse relationship with coronary heart disease (CHD).",8675707_1,-1,4049,-1,0.35348353
4050,cholesteryl ester,1,3,4,21,The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver.,8675707_2,-1,4050,-1,0.36796513
4051,cholesteryl esters,12,14,71,89,The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver.,8675707_2,-1,4051,-1,0.32160312
4052,cholesterol,29,30,174,185,The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver.,8675707_2,-1,4052,-1,0.33309698
4053,P,6,7,26,27,"43 in men with mutations (P <. 05); after adjustment for CHD risk factors, the RR was 1.",8675707_6,-1,4053,-1,0.4155831
4054,P,2,3,4,5,"55 (P =. 02); after additional adjustment for HDL levels, the RR was 1.",8675707_7,-1,4054,-1,0.42151606
4055,P,2,3,4,5,68 (P =. 008).,8675707_8,-1,4055,-1,0.38634843
4056,cholesterol,11,12,69,80,"The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL (i. e., reverse cholesterol transport) determine the anti-atherogenicity of the HDL fraction.",8675707_12,-1,4056,-1,0.37106413
4057,cholesterol,20,21,119,130,"The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL (i. e., reverse cholesterol transport) determine the anti-atherogenicity of the HDL fraction.",8675707_12,-1,4057,-1,0.36808994
4058,Rb1,6,7,33,36,Mapping the homolog of the human Rb1 gene to chromosome 14 of higher primates.,8678979_0,-1,4058,-1,0.3174237
4059,Rb1,1,2,5,8,"
The Rb1 gene has been implicated with retinoblastoma and is located on human Chromosome (Chr) 13q14.",8678979_1,-1,4059,-1,0.3136982
4060,retinoblastoma,7,8,39,53,"
The Rb1 gene has been implicated with retinoblastoma and is located on human Chromosome (Chr) 13q14.",8678979_1,-1,4060,-1,0.30553505
4061,Rb1,7,8,29,32,2 2. A unique sequence human Rb1 cosmid DNA probe has been used to localize this region on apes Chr 14 by the FISH technique.,8678979_2,-1,4061,-1,0.32419807
4062,Rb1,4,5,24,27,The conservation of the Rb1 gene in higher primates at the corresponding equivalent chromosome locus (14q14) of the human may serve as a phylogenetic marker to further trace the evolutionary pathway of human descent.,8678979_3,-1,4062,-1,0.31962657
4063,Wiskott-Aldrich syndrome,0,2,0,24,Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product.,8682510_0,-1,4063,-1,0.40051505
4064,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome protein (WASP) gene was found to be mutated in patients presenting with WAS and in patients showing X-linked thrombocytopenia.",8682510_1,-1,4064,-1,0.36620447
4066,disease,13,14,79,86,A substitution at codon 86 resulted in an extremely variable expression of the disease in a large Swiss family.,8682510_6,-1,4066,-1,0.3643067
4067,Aniridia,0,1,1,9,"
Aniridia in man and Small eye in mice are semidominant developmental disorders caused by mutations within the paired box gene PAX6.",8689689_1,-1,4067,-1,0.38606834
4068,cysteine,8,9,50,58,"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.",8696339_0,-1,4068,-1,0.3525839
4070,Huntington disease,12,14,67,85,"
Apoptosis has recently been recognized as a mode of cell death in Huntington disease (HD).",8696339_1,-1,4070,-1,0.34197357
4071,cysteine,8,9,45,53,"Apopain, a human counterpart of the nematode cysteine protease death-gene product, CED-3, has a key role in proteolytic events leading to apoptosis.",8696339_2,-1,4071,-1,0.36585853
4072,cysteine proteases,8,10,47,65,Our results show that huntingtin is cleaved by cysteine proteases and suggest that HD might be a disorder of inappropriate apoptosis..,8696339_5,-1,4072,-1,0.3474779
4074,nucleotide,27,28,157,167,"Sequence analysis of the duplicated exons of BRCA1 and 1A1-3B and flanking genomic DNA reveals maintenance of the intron-exon structure and a high degree of nucleotide sequence identity, suggesting that these are non-processed pseudogenes and that the duplication is a recent event in evolutionary terms.",8700509_3,-1,4074,-1,0.35679182
4075,N,6,7,56,57,Deletion of small nuclear ribonucleoprotein polypeptide N (SNRPN) in Prader-Willi syndrome detected by fluorescence in situ hybridization: two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q.,8723064_0,-1,4075,-1,0.3665274
4076,Prader-Willi syndrome,11,13,69,90,Deletion of small nuclear ribonucleoprotein polypeptide N (SNRPN) in Prader-Willi syndrome detected by fluorescence in situ hybridization: two sibs with the typical phenotype without a cytogenetic deletion in chromosome 15q.,8723064_0,-1,4076,-1,0.40000442
4077,N,5,6,49,50,"
The small nuclear ribonucleoprotein polypeptide N (SNRPN) gene is regarded as one of the candidates for Prader-Willi syndrome (PWS).",8723064_1,-1,4077,-1,0.3535585
4078,Prader-Willi syndrome,18,20,105,126,"
The small nuclear ribonucleoprotein polypeptide N (SNRPN) gene is regarded as one of the candidates for Prader-Willi syndrome (PWS).",8723064_1,-1,4078,-1,0.40974882
4079,von Hippel-Lindau disease tumour,3,7,18,50,Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.,8733131_0,-1,4079,-1,0.3182056
4080,disease,6,7,29,36,"
The von Hippel-Lindau (VHL) disease product is thought to down-regulate transcription by antagonizing elongin-enhanced transcriptional elongation.",8733131_1,-1,4080,-1,0.3552834
4081,renal cell carcinoma,16,19,112,132,"Germline VHL gene mutations predispose to the development of retinal, cerebellar and spinal haemangioblastomas, renal cell carcinoma and phaeochromocytoma.",8733131_2,-1,4081,-1,0.29473686
4082,renal cell carcinoma,13,16,74,94,"In addition, somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and haemangioblastoma.",8733131_3,-1,4082,-1,0.28854927
4094,disease,19,20,113,120,An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease).,8755645_0,-1,4094,-1,0.34745255
4095,nucleotide,3,4,20,30,"A distinct intronic nucleotide sequence, known as the branchpoint region, plays a central role in this process.",8755645_2,-1,4095,-1,0.34386927
4096,disease,8,9,49,56,"Three sisters were shown to suffer from fish-eye disease (FED), a disorder which is caused by mutations in the gene coding for lecithin  cholesterol acyltransferase (LCAT).",8755645_4,-1,4096,-1,0.3690642
4097,cholesterol,27,28,137,148,"Three sisters were shown to suffer from fish-eye disease (FED), a disorder which is caused by mutations in the gene coding for lecithin  cholesterol acyltransferase (LCAT).",8755645_4,-1,4097,-1,0.3628122
4098,cerebellar ataxia,21,23,116,133,The level of the 137-bp PCR product containing the insertion was lowest in two patients who showed a later onset of cerebellar ataxia.,8755918_5,-1,4098,-1,0.31527704
4099,tumours,21,22,124,131,"
To define the possible role of the VHL gene in the development of sporadic renal cell carcinomas, 91 different parenchymal tumours of the kidney have been investigated for mutation of the VHL gene by single strand conformation polymorphism (SSCP) and/or heteroduplex (HD) techniques.",8758207_1,-1,4099,-1,0.32037616
4100,tumours,7,8,37,44,"In addition, 15 papillary renal cell tumours and ten renal oncocytomas, which are characterized by genetic changes other than loss of chromosome 3p sequences, were analysed for mutation of the VHL gene.",8758207_5,-1,4100,-1,0.29703784
4101,tumours,3,4,14,21,None of these tumours showed abnormal migration patterns.,8758207_6,-1,4101,-1,0.30393627
4102,renal cell carcinoma,17,20,115,135,The results indicate that mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinoma..,8758207_7,-1,4102,-1,0.2791273
4103,muscular dystrophy,2,4,19,37,"The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein.",8776595_0,-1,4103,-1,0.34114662
4104,muscular dystrophy,6,8,39,57,"A muscle biopsy from an Emery-Dreifuss muscular dystrophy (EMDM) patient showed complete absence of emerin by both Western blotting and immunohistochemistry, suggesting a simple diagnostic antibody test for EDMD families.",8776595_5,-1,4104,-1,0.37262544
4105,sucrose,20,21,133,140,"Biochemical fractionation of brain and liver tissues showed that emerin was present in nuclei purified by centrifugation through 65% sucrose and was absent from soluble fractions (post-100, 000 g).",8776595_6,-1,4105,-1,0.3536822
4107,tumours,2,3,12,19,"
Many human tumours have length alterations in repetitive sequence elements.",8782829_1,-1,4107,-1,0.32615516
4108,microsatellite instability,2,4,14,40,"Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) kindreds, many sporadic tumours exhibit instability but no detectable mutations in these genes.",8782829_2,-1,4108,-1,0.35128456
4109,colorectal cancer,18,20,135,152,"Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) kindreds, many sporadic tumours exhibit instability but no detectable mutations in these genes.",8782829_2,-1,4109,-1,0.26801792
4110,tumours,27,28,185,192,"Although this microsatellite instability has been attributed to mutations in four DNA mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) kindreds, many sporadic tumours exhibit instability but no detectable mutations in these genes.",8782829_2,-1,4110,-1,0.3021766
4111,microsatellite instability,14,16,68,94,"In yeast, mutations in several genes, including RTH and MSH3, cause microsatellite instability.",8782829_4,-1,4111,-1,0.3321341
4112,microsatellite instability,8,10,49,75,"Thus, we screened 16 endometrial carcinomas with microsatellite instability for alterations in FEN1 (the human homolog of RTH) and in MSH3 (refs 12-14).",8782829_5,-1,4112,-1,0.3074453
4113,endometrial carcinoma,16,18,86,107,"Although we found no FEN1 mutations, a frameshift mutation in MSH3 was observed in an endometrial carcinoma and in an endometrial carcinoma cell line.",8782829_6,-1,4113,-1,0.3000356
4114,endometrial carcinoma,21,23,118,139,"Although we found no FEN1 mutations, a frameshift mutation in MSH3 was observed in an endometrial carcinoma and in an endometrial carcinoma cell line.",8782829_6,-1,4114,-1,0.284437
4115,tumours,26,27,154,161,"Together the data suggest that the MSH3 gene encodes a product that functions in repair of some but not all pre-mutational intermediates, its mutation in tumours can result in genomic instability and, as in yeast, MSH3 and MSH6 are partially redundant for mismatch repair..",8782829_11,-1,4115,-1,0.31888053
4116,genomic instability,30,32,176,195,"Together the data suggest that the MSH3 gene encodes a product that functions in repair of some but not all pre-mutational intermediates, its mutation in tumours can result in genomic instability and, as in yeast, MSH3 and MSH6 are partially redundant for mismatch repair..",8782829_11,-1,4116,-1,0.2954215
4117,cM,24,25,106,108,"No recombinations were found among the Atm, Npat, Acat1, and D9Mit6 loci, and these loci were mapped 2. 0 cM distal to D9Mit99 and 1.",8786135_7,-1,4117,-1,0.40835857
4118,cM,1,2,2,4,3 cM proximal to D9Mit102.,8786135_8,-1,4118,-1,0.3779015
4119,map,4,5,26,29,Comparison of the linkage map of mouse chromosome 9 (MMU9) and that of human chromosome 11 (HSA11) indicates that there is a chromosomal rearrangement due to an inversion between Ets1 and Atm-Npat-Acat1 and that the inversion of MMU9 originated from the chromosomal breakage at the boundary between Gria4 and Atm-Npat-Acat1 on HSA11.,8786135_9,-1,4119,-1,0.3832565
4120,Norrie disease,4,6,20,34,An animal model for Norrie disease (ND): gene targeting of the mouse ND gene.,8789439_0,-1,4120,-1,0.38118246
4121,Norrie disease,13,15,82,96,"
In order to elucidate the cellular and molecular processes which are involved in Norrie disease (ND), we have used gene targeting technology to generate ND mutant mice.",8789439_1,-1,4121,-1,0.38580602
4122,amino acid,21,23,104,114,The murine homologue of the ND gene was cloned and shown to encode a polypeptide that shares 94% of the amino acid sequence with its human counterpart.,8789439_2,-1,4122,-1,0.3804989
4123,retinal ganglion,27,29,172,188,Hemizygous mice carrying a replacement mutation in exon 2 of the ND gene developed retrolental structures in the vitreous body and showed an overall disorganization of the retinal ganglion cell layer.,8789439_4,-1,4123,-1,0.3258296
4124,rhabdomyosarcoma,7,8,48,64,The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.,8790412_0,-1,4124,-1,0.2838112
4125,rhabdomyosarcoma,2,3,20,36,"
Pediatric alveolar rhabdomyosarcoma is characterized by a chromosomal translocation that fuses parts of the PAX3 and FKHR genes.",8790412_1,-1,4125,-1,0.29086474
4127,myotonic dystrophy,13,15,81,99,"Analysis of meiotic segregation, using single-sperm typing: meiotic drive at the myotonic dystrophy locus.",8808606_0,-1,4127,-1,0.37395394
4128,myotonic dystrophy,4,6,22,40,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4128,-1,0.3915737
4129,DM,7,8,42,44,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4129,-1,0.39270476
4130,DM,28,29,160,162,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4130,-1,0.36394894
4131,disease,35,36,203,210,"
Meiotic drive at the myotonic dystrophy (DM) locus has recently been suggested as being responsible for maintaining the frequency, in the human population, of DM chromosomes capable of expansion to the disease state.",8808606_1,-1,4131,-1,0.36088154
4132,DM,20,21,117,119,"In order to test this hypothesis, we have studied samples of single sperm from three individuals heterozygous at the DM locus, each with one allele larger and one allele smaller than 19 CTG repeats.",8808606_2,-1,4132,-1,0.3898883
4133,DM,40,41,232,234,"To guard against the possible problem of differential PCR amplification rates based on the lengths of the alleles, the sperm were also typed at another closely linked marker whose allele size was unrelated to the allele size at the DM locus.",8808606_3,-1,4133,-1,0.39380488
4134,myotonic dystrophy,11,13,71,89,This suggests that any greater amount of segregation distortion at the myotonic dystrophy locus must result from events following sperm ejaculation.,8808606_6,-1,4134,-1,0.368769
4135,chromosome aberrations,10,12,71,93,"
A major cytogenetic subgroup of lipomas is characterized by recurrent chromosome aberrations, mainly translocations, that involve chromosome segment 12q13-q15.",8812423_1,-1,4135,-1,0.3272984
4136,lipoma,22,23,142,148,"Here, we report the identification and characterization of the chromosome 3-derived translocation partner gene, which we have designated LPP (lipoma preferred partner gene).",8812423_4,-1,4136,-1,0.35070276
4137,lipoma,8,9,53,59,"Using 3-RACE analysis of HMGIC fusion transcripts in lipoma cell line Li-501/SV40, ectopic genetic sequences were obtained, which by CASH (chromosome assignment using somatic cell hybrids) and FISH (fluorescence in situ hybridization) analysis were found to originate from chromosome segment 3q27-q28.",8812423_5,-1,4137,-1,0.3338279
4138,Nucleotide,0,1,0,10,Nucleotide sequence analysis of a composite cDNA of LPP revealed an open reading frame of 1836 nucleotides encoding a proline-rich protein containing a leucine-zipper motif in its amino-terminal region and three LIM domains in its carboxy-terminal region.,8812423_9,-1,4138,-1,0.38415056
4139,lipoma,15,16,100,106,"Using reverse transcriptase combined with polymerase chain reactions in the analysis of a number of lipoma cell lines and primary lipomas, it appeared that LPP is frequently rearranged also in cases without a cytogenetically detectable involvement of 3q27-q28.",8812423_11,-1,4139,-1,0.32432202
4140,disease,2,3,11,18,Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript.,8824873_0,-1,4140,-1,0.3716995
4141,Huntington disease,17,19,119,137,Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript.,8824873_0,-1,4141,-1,0.3405388
4142,Huntington disease,3,5,25,43,"
The mutation underlying Huntington disease (HD) is CAG expansion in the first exon of the HD gene.",8824873_1,-1,4142,-1,0.34296927
4143,behavioral abnormalities,8,10,30,54,"By 1 year, these mice have no behavioral abnormalities and morphometric analysis at 6 (one animal) and 9 (two animals) months age revealed no changes.",8824873_3,-1,4143,-1,0.37094256
4144,nucleotide,27,28,149,159,In vitro transfection studies indicated that the inclusion of 120 bp of the 5 UTR in the cDNA construct and the presence of a frameshift mutation at nucleotide 2349 prevented expression of the HD cDNA.,8824873_5,-1,4144,-1,0.3647756
4145,disease,31,32,196,203,These findings suggest that the pathogenesis of HD is not mediated through DNA-protein interaction and that presence of the RNA transcript with an expanded CAG repeat is insufficient to cause the disease.,8824873_6,-1,4145,-1,0.3580269
4146,contrast,1,2,3,11,"In contrast to that seen in humans, the CAG repeat in these mice was remarkably stable in 97 meioses.",8824873_8,-1,4146,-1,0.3868129
4147,aniridia,7,8,40,48,FISH studies in a patient with sporadic aniridia and t(7;11) (q31.2;p13).,8825052_0,-1,4147,-1,0.37010926
4148,aniridia,9,10,56,64,"
A 2 year old female presenting with bilateral sporadic aniridia was found to have an apparently balanced reciprocal translocation with a chromosome 11 breakpoint within band p13.",8825052_1,-1,4148,-1,0.36088932
4149,aniridia,22,23,142,150,Fluorescence in situ hybridisation (FISH) studies with distal 11p13 specific cosmids showed that the chromosome 11 breakpoint lay between the aniridia (PAX6) locus and a region approximately 100 kb distal to PAX6 defined by the cosmid FO2121.,8825052_2,-1,4149,-1,0.40508434
4150,aniridia,13,14,74,82,"Although this patient did not have a detectable deletion within PAX6, her aniridia may have resulted from a disruption of the distal chromatin domain containing either enhancers or regulators for PAX6.",8825052_3,-1,4150,-1,0.36473224
4151,aniridia,8,9,46,54,This case may therefore be another example of aniridia caused by a position effect as recently described in two familial aniridia patients in which the phenotype cosegregated with chromosome abnormalities with 11p13 breakpoints..,8825052_4,-1,4151,-1,0.3776133
4152,aniridia,20,21,121,129,This case may therefore be another example of aniridia caused by a position effect as recently described in two familial aniridia patients in which the phenotype cosegregated with chromosome abnormalities with 11p13 breakpoints..,8825052_4,-1,4152,-1,0.3688397
4153,p,26,27,141,142,A statistically significant relationship was found in the activity of G6PD between erythrocytes and muscle of the male subjects (r = 0. 968; p = 0. 00008).,8825599_5,-1,4153,-1,0.3979359
4154,phenylalanine,16,17,102,115,"
Classical phenylketonuria (PKU) is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",8828602_1,-1,4154,-1,0.36417785
4155,PAH,19,20,129,132,"
Classical phenylketonuria (PKU) is an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH).",8828602_1,-1,4155,-1,0.35411772
4156,PAH,14,15,101,104,"Vectors derived from a recombinant retrovirus or a DNA/protein complex can efficiently transduce the PAH cDNA into PAH-deficient hepatocytes in vitro, but the application of these vector systems is presently limited by their low transduction efficiency in vivo.",8828602_4,-1,4156,-1,0.31382474
4157,contrast,1,2,3,11,"In contrast, a vector derived from a recombinant adenovirus can restore 10% -80% of normal hepatic PAH activity into PAH-deficient mice, which completely normalizes serum phenylalanine levels.",8828602_5,-1,4157,-1,0.36159024
4158,PAH,19,20,99,102,"In contrast, a vector derived from a recombinant adenovirus can restore 10% -80% of normal hepatic PAH activity into PAH-deficient mice, which completely normalizes serum phenylalanine levels.",8828602_5,-1,4158,-1,0.30904055
4159,phenylalanine,29,30,171,184,"In contrast, a vector derived from a recombinant adenovirus can restore 10% -80% of normal hepatic PAH activity into PAH-deficient mice, which completely normalizes serum phenylalanine levels.",8828602_5,-1,4159,-1,0.3415332
4160,acetylcholine,7,8,54,67,Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4).,8833159_0,-1,4160,-1,0.3742264
4161,acetylcholine,4,5,30,43,"
The human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) is located in the candidate region for three different phenotypes  benign familial neonatal convulsions, autosomal dominant nocturnal frontal lobe epilepsy, and low-voltage EEG.",8833159_1,-1,4161,-1,0.4179835
4163,nocturnal frontal lobe epilepsy,31,35,207,238,"
The human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) is located in the candidate region for three different phenotypes  benign familial neonatal convulsions, autosomal dominant nocturnal frontal lobe epilepsy, and low-voltage EEG.",8833159_1,-1,4163,-1,0.3424766
4164,frontal lobe epilepsy,20,23,127,148,"Recently, a missense mutation in transmembrane domain 2 of CHRNA4 was found to be associated with autosomal dominant nocturnal frontal lobe epilepsy in one extended pedigree.",8833159_2,-1,4164,-1,0.3404126
4165,nucleotide,1,2,4,14,The nucleotide sequence obtained from the genomic regions adjacent to the exon boundaries enabled us to develop a set of primer pairs for PCR amplification of the complete coding region.,8833159_4,-1,4165,-1,0.36059693
4166,epilepsies,24,25,166,176,The sequence analysis provides the basis for a comprehensive mutation screening of CHRNA4 in the above-mentioned phenotypes and possibly in other types of idiopathic epilepsies..,8833159_5,-1,4166,-1,0.33887145
4177,growth retardation,6,8,36,54,"Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.",8843194_0,-1,4177,-1,0.3414993
4178,lymphoma,19,20,125,133,"Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.",8843194_0,-1,4178,-1,0.33307108
4179,infertility,1,2,4,15,The infertility of ATM-/- mice results from meiotic failure.,8843194_5,-1,4179,-1,0.45723745
4180,behavioral abnormalities,21,23,113,137,The cerebella of ATM-/- mice appear normal by histologic examination at 3 to 4 months and the mice have no gross behavioral abnormalities.,8843194_8,-1,4180,-1,0.34226096
4181,lymphomas,8,9,51,60,The majority of mutant mice rapidly develop thymic lymphomas and die before 4 months of age.,8843194_9,-1,4181,-1,0.3199922
4183,fatty acid,30,32,205,215,"
Very-long-chain acyl-CoA dehydrogenase (VLCAD) is one of four straight-chain acyl-CoA dehydrogenase (ACD) enzymes, which are all nuclear encoded mitochondrial flavoproteins catalyzing the initial step in fatty acid beta-oxidation.",8845838_1,-1,4183,-1,0.37503046
4184,amino acid,4,6,27,37,Alignment of the predicted amino acid sequence of human VLCAD with those of the other human ACD enzymes revealed extensive sequence homology.,8845838_3,-1,4184,-1,0.36733457
4185,VLCAD deficiency,16,18,101,117,This agrees well with the fact that cardiac and muscle symptoms are characteristic for patients with VLCAD deficiency.,8845838_7,-1,4185,-1,0.37748197
4186,VLCAD deficiency,16,18,107,123,Northern blot analysis and sequencing of cloned PCR amplified VLCAD cDNA from four unrelated patients with VLCAD deficiency showed that VLCAD mRNA was undetectable in one patient and that the other three have mutations in both VLCAD alleles.,8845838_8,-1,4186,-1,0.35530788
4187,lead,17,18,110,114,"The haplotype has been found in combination with a number of other haplotypes containing defective genes that lead either to C6 or C7 deficiency, but with different consequences.",8871666_6,-1,4187,-1,0.4061691
4188,contrast,1,2,3,11,"In contrast, where the C7 genes are both defective (but still partially functional), there may be a profound deficit of circulating C7 because there is ample C6 to produce C56 and consume the already small amount of C7.",8871666_8,-1,4188,-1,0.3323998
4189,bacterial infections,11,13,72,92,"
Complement C7 deficiency (C7D) is associated frequently with recurrent bacterial infections, especially meningitis caused by Neisseria meningitidis.",8892662_1,-1,4189,-1,0.27767918
4191,nucleotide,13,14,63,73,"The mutation of case 1 was a homozygous T to A transversion at nucleotide 2250, the third nucleotide of the codon TGT for Cys728, leading to a stop codon TGA (C728X).",8892662_5,-1,4191,-1,0.3418674
4192,nucleotide,18,19,90,100,"The mutation of case 1 was a homozygous T to A transversion at nucleotide 2250, the third nucleotide of the codon TGT for Cys728, leading to a stop codon TGA (C728X).",8892662_5,-1,4192,-1,0.39172447
4193,lesch-nyhan syndrome,7,9,45,65,HPRT-APRT-deficient mice are not a model for lesch-nyhan syndrome.,8894695_0,-1,4193,-1,0.42064437
4194,Lesch-Nyhan syndrome,12,14,101,121,"
Complete hypoxanthine-guanine phosphoribosyl-transferase (HPRT) deficiency in humans results in the Lesch-Nyhan syndrome which is characterized, among other features, by compulsive self-injurious behavior.",8894695_1,-1,4194,-1,0.43444094
4195,Lesch-Nyhan syndrome,17,19,123,143,HPRT-deficient mice generated using mouse embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch-Nyhan syndrome.,8894695_2,-1,4195,-1,0.4225249
4196,lead,28,29,201,205,Administration of drugs that inhibit adenine phosphoribosyltransferase (APRT) in HPRT-deficient mice has produced the suggestion that deficiency of APRT in combination with HPRT-deficiency in mice may lead to self-mutilation behavior [C. L. Wu and D. W. Melton (1993) Nature Genet.,8894695_3,-1,4196,-1,0.36886978
4197,purine,10,11,56,62,"Thus, APRT-HPRT-deficient mice, which are devoid of any purine salvage pathways, show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch-Nyhan syndrome as previously suggested",8894695_7,-1,4197,-1,0.30129528
4198,behavioral abnormalities,25,27,133,157,"Thus, APRT-HPRT-deficient mice, which are devoid of any purine salvage pathways, show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch-Nyhan syndrome as previously suggested",8894695_7,-1,4198,-1,0.3283913
4199,Lesch-Nyhan syndrome,30,32,178,198,"Thus, APRT-HPRT-deficient mice, which are devoid of any purine salvage pathways, show no novel phenotype and are not a model for the behavioral abnormalities associated with the Lesch-Nyhan syndrome as previously suggested",8894695_7,-1,4199,-1,0.3913776
4204,colorectal cancer,17,19,104,121,"METHODS  Mutation analyses of the DPC4 gene were performed on complementary DNA samples from 31 primary colorectal cancer specimens using a combination of polymerase chain reaction, single-strand conformation polymorphism, and DNA sequencing.",8898652_4,-1,4204,-1,0.27447405
4205,amino acid,6,8,43,53,RESULTS  Four missense mutations producing amino acid substitutions and a somatic 12-base pair deletion in the coding region of the DPC4 gene were detected in the 31 cancers (16%; 5 of 31).,8898652_5,-1,4205,-1,0.3787217
4209,lead,26,27,136,140,"Furthermore, we demonstrate that the Atm protein exists as two discrete molecular species, and that loss of one or of both of these can lead to the development of the disease..",8917548_6,-1,4209,-1,0.371398
4210,disease,32,33,167,174,"Furthermore, we demonstrate that the Atm protein exists as two discrete molecular species, and that loss of one or of both of these can lead to the development of the disease..",8917548_6,-1,4210,-1,0.33888102
4211,colorectal cancer,6,8,33,50,The DCC protein and prognosis in colorectal cancer.,8929264_0,-1,4211,-1,0.2934754
4212,colorectal cancer,16,18,94,111,"
BACKGROUND  Allelic loss of chromosome 18q predicts a poor outcome in patients with stage II colorectal cancer.",8929264_1,-1,4212,-1,0.25455126
4213,colorectal cancer,19,21,105,122,"Although the specific gene inactivated by this allelic loss has not been elucidated, the DCC (deleted in colorectal cancer) gene is a candidate.",8929264_2,-1,4213,-1,0.30417886
4215,colorectal carcinoma,17,19,99,119,We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker in colorectal carcinoma.,8929264_3,-1,4215,-1,0.28986716
4218,disease,5,6,26,33,"In patients with stage II disease whose tumors expressed DCC, the five-year survival rate was 94. 3 percent, whereas in patients with DCC-negative tumors, the survival rate was 61. 6 percent (P < 0. 001).",8929264_7,-1,4218,-1,0.34994796
4221,P,37,38,192,193,"In patients with stage II disease whose tumors expressed DCC, the five-year survival rate was 94. 3 percent, whereas in patients with DCC-negative tumors, the survival rate was 61. 6 percent (P < 0. 001).",8929264_7,-1,4221,-1,0.41892606
4222,disease,5,6,27,34,"In patients with stage III disease, the respective survival rates were 59. 3 percent and 33. 2 percent (P = 0. 03).",8929264_8,-1,4222,-1,0.344291
4223,P,22,23,104,105,"In patients with stage III disease, the respective survival rates were 59. 3 percent and 33. 2 percent (P = 0. 03).",8929264_8,-1,4223,-1,0.4128161
4224,colorectal cancer,15,17,79,96,CONCLUSIONS  DCC is a prognostic marker in patients with stage II or stage III colorectal cancer.,8929264_9,-1,4224,-1,0.2577251
4226,serotonin,9,10,65,74,Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.,8929413_0,-1,4226,-1,0.3592195
4227,serotonin,3,4,35,44,"
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake-inhibiting antidepressant and antianxiety drugs.",8929413_1,-1,4227,-1,0.32869756
4228,anxiety,13,14,98,105,"
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake-inhibiting antidepressant and antianxiety drugs.",8929413_1,-1,4228,-1,0.39541593
4229,antidepressant,29,30,193,207,"
Transporter-facilitated uptake of serotonin (5-hydroxytryptamine or 5-HT) has been implicated in anxiety in humans and animal models and is the site of action of widely used uptake-inhibiting antidepressant and antianxiety drugs.",8929413_1,-1,4229,-1,0.33615747
4230,5-HT,1,2,6,10,Human 5-HT transporter (5-HTT) gene transcription is modulated by a common polymorphism in its upstream regulatory region.,8929413_2,-1,4230,-1,0.35259095
4231,5-HT,22,23,149,153,"The short variant of the polymorphism reduces the transcriptional efficiency of the 5-HTT gene promoter, resulting in decreased 5-HTT expression and 5-HT uptake in lymphoblasts.",8929413_3,-1,4231,-1,0.34794378
4232,atelosteogenesis type 2,5,8,41,64,Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.,8931695_0,-1,4232,-1,0.36653733
4233,diastrophic dysplasia,9,11,69,90,Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.,8931695_0,-1,4233,-1,0.3482106
4234,diastrophic dysplasia,3,5,18,39,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4234,-1,0.34701538
4235,diastrophic dysplasia,26,28,176,197,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4235,-1,0.34524468
4236,atelosteogenesis type 2,32,35,205,228,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4236,-1,0.3772908
4237,achondrogenesis type 1B,40,43,240,263,"
Mutations in the diastrophic dysplasia sulfate transporter gene DTDST have been associated with a family of chondrodysplasias that comprises, in order of increasing severity, diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis type 1B (ACG1B).",8931695_1,-1,4237,-1,0.3352679
4238,cytosine,20,21,102,110,"The third patient (with AO2) had the R279W mutation compounded with a novel mutation, the deletion of cytosine 418 (delta c418), predicting a frameshift with premature termination.",8931695_6,-1,4238,-1,0.4093524
4239,Wiskott-Aldrich syndrome,15,17,111,135,"Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome.",8931701_0,-1,4239,-1,0.37994957
4240,Wiskott-Aldrich syndrome,1,3,5,29,"
The Wiskott-Aldrich syndrome (WAS), an X-linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein (WASP), is known to be associated with extensive clinical heterogeneity.",8931701_1,-1,4240,-1,0.37970185
4241,immunodeficiency disease,9,11,49,73,"
The Wiskott-Aldrich syndrome (WAS), an X-linked immunodeficiency disease caused by mutation in the recently isolated gene encoding WAS protein (WASP), is known to be associated with extensive clinical heterogeneity.",8931701_1,-1,4241,-1,0.37807816
4242,disease,25,26,160,167,"Cumulative mutation data have revealed that WASP genotypes are also highly variable among WAS patients, but the relationship of phenotype with genotype in this disease remains unclear.",8931701_2,-1,4242,-1,0.34969005
4243,disease,29,30,168,175,"To address this issue we characterized WASP mutations in 24 unrelated WAS patients, including 18 boys with severe classical WAS and 6 boys expressing mild forms of the disease, and then examined the degree of correlation of these as well as all previously published WASP mutations with disease severity.",8931701_3,-1,4243,-1,0.32485896
4244,disease,49,50,286,293,"To address this issue we characterized WASP mutations in 24 unrelated WAS patients, including 18 boys with severe classical WAS and 6 boys expressing mild forms of the disease, and then examined the degree of correlation of these as well as all previously published WASP mutations with disease severity.",8931701_3,-1,4244,-1,0.36149022
4245,disease,15,16,83,90,"These characteristics were observed, however, in both severe and mild cases of the disease.",8931701_5,-1,4245,-1,0.36365628
4247,disease,55,56,341,348,"Similarly, while the cumulative data revealed a predominance of missense mutations among the WASP gene lesions observed in boys with isolated thrombocytopenia, missense mutations were not exclusively associated with milder WAS phenotypes, but also comprised a substantial portion (38%) of the WASP gene defects found in patients with severe disease.",8931701_6,-1,4247,-1,0.32139045
4248,disease,36,37,215,222,"These findings, as well as the detection of identical WASP mutations in patients with disparate phenotypes, reveal a lack of phenotype concordance with genotype in WAS and thus imply that phenotypic outcome in this disease cannot be reliably predicted solely on the basis of WASP genotypes..",8931701_7,-1,4248,-1,0.35811573
4249,adenomatous polyposis coli,22,25,120,146,Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli.,8931709_0,-1,4249,-1,0.32409653
4250,colorectal cancer,11,13,72,89,"
Familial adenomatous polyposis (FAP) is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region.",8931709_1,-1,4250,-1,0.27906796
4251,adenomatous polyps,19,21,135,153,"
Familial adenomatous polyposis (FAP) is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region.",8931709_1,-1,4251,-1,0.35117117
4252,adenomatous polyposis coli,4,7,26,52,Germline mutations in the adenomatous polyposis coli (APC) gene are responsible for most cases of FAP.,8931709_2,-1,4252,-1,0.3222713
4253,disease,19,20,92,99,"Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease, called attenuated adenomatous polyposis coli (AAPC).",8931709_3,-1,4253,-1,0.322377
4254,adenomatous polyposis coli,23,26,119,145,"Mutations at the 5 end of APC are known to be associated with a relatively mild form of the disease, called attenuated adenomatous polyposis coli (AAPC).",8931709_3,-1,4254,-1,0.3220118
4259,chromosomal instability,13,15,81,104,"To identify possible features of the BRCA1 genomic region that may contribute to chromosomal instability as well as potential transcriptional regulatory elements, a 117, 143-bp DNA sequence encompassing BRCA1 was obtained by random sequencing of four cosmids identified from a human chromosome 17 specific library.",8938427_4,-1,4259,-1,0.35349688
4260,interferon,15,16,72,82,"Partial sequences of the 1A1-3B B-box protein pseudogene and IFP 35, an interferon induced leucine zipper protein, reside within the contig.",8938427_8,-1,4260,-1,0.32017606
4261,leucine,17,18,91,98,"Partial sequences of the 1A1-3B B-box protein pseudogene and IFP 35, an interferon induced leucine zipper protein, reside within the contig.",8938427_8,-1,4261,-1,0.37277374
4263,C,36,37,232,233,"This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1.",8944023_3,-1,4263,-1,0.43640307
4265,tumour,24,25,170,176,"The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1..",8944023_4,-1,4265,-1,0.30432084
4267,nucleotide,2,3,13,23,Eight single nucleotide polymorphisms were also readily detected.,8944024_6,-1,4267,-1,0.39002988
4268,primary hyperparathyroidism,2,4,19,46,Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.,8954016_0,-1,4268,-1,0.358607
4269,tumor syndrome,6,8,55,69,Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.,8954016_0,-1,4269,-1,0.2918791
4270,kidney disease,14,16,114,128,Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.,8954016_0,-1,4270,-1,0.32657734
4271,tumor syndrome,2,4,36,50,"
Hereditary hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease (OMIM 145001) that has recently been mapped to chromosomal region 1q21-q32 (HRPT2).",8954016_1,-1,4271,-1,0.3051932
4272,disease,11,12,85,92,"
Hereditary hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease (OMIM 145001) that has recently been mapped to chromosomal region 1q21-q32 (HRPT2).",8954016_1,-1,4272,-1,0.35344827
4273,syndrome,7,8,40,48,"Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome.",8954016_2,-1,4273,-1,0.27465403
4274,kidney disease,15,17,91,105,"Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome.",8954016_2,-1,4274,-1,0.3421897
4275,syndrome,31,32,203,211,"Here we report two families with HPT-JT syndrome in which adult renal hamartomas or cystic kidney disease were prominent associated features, possibly representing a new phenotypic variant of the HPT-JT syndrome.",8954016_2,-1,4275,-1,0.27242047
4276,kidney disease,22,24,128,142,"In the second family, JT was found in three of the five affected individuals and two affected members also exhibited polycystic kidney disease.",8954016_4,-1,4276,-1,0.35089773
4277,multiple endocrine neoplasia,16,19,92,120,"Twenty microsatellite markers in the HRPT2 region were typed, in addition to markers in the multiple endocrine neoplasia (MEN) types 1 and 2 regions at 11q13 and 10q11.",8954016_7,-1,4277,-1,0.3411494
4278,disease,1,2,4,11,The disease in these two kindreds was linked to five markers in the 1q21-q32 region (logarithm-of-odds scores  3. 2-4 2-4.,8954016_8,-1,4278,-1,0.3625275
4282,glucose,10,11,63,70,Independent origin of single and double mutations in the human glucose 6-phosphate dehydrogenase gene.,8956035_0,-1,4282,-1,0.3396603
4283,favism,53,54,269,275,"In the four polymorphic variants that have two point mutations, one of the mutations is always 376 A-- > G (126 Asn-- > Asp), which on its own gives rise to the nondeficient polymorphic variant, G6PD A. In a study of G6PD deficient patients who presented with clinical favism in Spain, we have found a new polymorphic variant that we have called G6PD Malaga, whose only abnormality is a 542 A-- > T (181 Asp-- > Val) mutation.",8956035_2,-1,4283,-1,0.36128306
4284,T,79,80,397,398,"In the four polymorphic variants that have two point mutations, one of the mutations is always 376 A-- > G (126 Asn-- > Asp), which on its own gives rise to the nondeficient polymorphic variant, G6PD A. In a study of G6PD deficient patients who presented with clinical favism in Spain, we have found a new polymorphic variant that we have called G6PD Malaga, whose only abnormality is a 542 A-- > T (181 Asp-- > Val) mutation.",8956035_2,-1,4284,-1,0.41873148
4285,Val,84,85,412,415,"In the four polymorphic variants that have two point mutations, one of the mutations is always 376 A-- > G (126 Asn-- > Asp), which on its own gives rise to the nondeficient polymorphic variant, G6PD A. In a study of G6PD deficient patients who presented with clinical favism in Spain, we have found a new polymorphic variant that we have called G6PD Malaga, whose only abnormality is a 542 A-- > T (181 Asp-- > Val) mutation.",8956035_2,-1,4285,-1,0.36958402
4289,C--,10,11,49,52,"We report a novel missense change in BRCA1, 2640 C-- > T (R841W), found in 3 cases from a subject group of 305 breast and 79 ovarian cancer cases from Orange County, CA.",8968716_4,-1,4289,-1,0.39006573
4291,CA,37,38,166,168,"We report a novel missense change in BRCA1, 2640 C-- > T (R841W), found in 3 cases from a subject group of 305 breast and 79 ovarian cancer cases from Orange County, CA.",8968716_4,-1,4291,-1,0.29049388
4298,immunodeficiency,20,21,137,153,"
The ATM gene is responsible for the autosomal recessive disorder ataxia-telangiectasia (A-T), characterized by cerebellar degeneration, immunodeficiency and cancer predisposition.",8968760_1,-1,4298,-1,0.3486151
4311,Los,5,6,31,34,Molecular basis for Duarte and Los Angeles variant galactosemia.,9012409_0,-1,4311,-1,0.33902016
4312,Los,13,14,81,84,"The characteristic Duarte isoform is also associated with a variant called the "" Los Angeles (LA) phenotype, "" which has increased GALT enzyme activity.",9012409_3,-1,4312,-1,0.3764303
4313,LA,16,17,94,96,"The characteristic Duarte isoform is also associated with a variant called the "" Los Angeles (LA) phenotype, "" which has increased GALT enzyme activity.",9012409_3,-1,4313,-1,0.41047138
4314,LA,5,6,24,26,"We found seven with the LA biochemical phenotype, and all had a 1721C-- > T transition in exon 7 in cis with the N314D missense mutation.",9012409_5,-1,4314,-1,0.39584613
4315,leucine,10,11,57,64,The 1721C-- > T transition is a neutral polymorphism for leucine at amino acid 218 (L218L).,9012409_6,-1,4315,-1,0.34010163
4316,amino acid,12,14,68,78,The 1721C-- > T transition is a neutral polymorphism for leucine at amino acid 218 (L218L).,9012409_6,-1,4316,-1,0.3657606
4317,LA,12,13,70,72,"In pedigree analyses, this 1721C-- > T transition segregated with the LA phenotype of increased GALT activity in three different biochemical phenotypes (LA/N, LA/G, and LA/D).",9012409_7,-1,4317,-1,0.4005129
4318,LA,9,10,57,59,"To determine the mechanism for increased activity of the LA variant, we compared GALT mRNA, protein abundance, and enzyme thermal stability in lymphoblast cell lines of D and LA phenotypes with comparable genotypes.",9012409_8,-1,4318,-1,0.3876874
4319,LA,31,32,175,177,"To determine the mechanism for increased activity of the LA variant, we compared GALT mRNA, protein abundance, and enzyme thermal stability in lymphoblast cell lines of D and LA phenotypes with comparable genotypes.",9012409_8,-1,4319,-1,0.3668554
4320,LA,6,7,40,42,"GALT protein abundance was increased in LA compared to D alleles, but mRNA was similar among all genotypes.",9012409_9,-1,4320,-1,0.3642828
4321,C,46,47,234,235,"When LA/D and D/D GALT biochemical phenotypes were compared to N/N GALT phenotypes, both had 50%, as compared to 21%, reduction in GALT activity in the wild type (N/N) after exposure at identical initial enzyme activity to 50 degrees C for 15 min.",9012409_10,-1,4321,-1,0.37019458
4322,LA,18,19,102,104,We conclude that the codon change N314D in cis with the base-pair transition 1721C-- > T produces the LA variant of galactosemia and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability.,9012409_11,-1,4322,-1,0.38452837
4323,nucleotide,25,26,143,153,We conclude that the codon change N314D in cis with the base-pair transition 1721C-- > T produces the LA variant of galactosemia and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability.,9012409_11,-1,4323,-1,0.35749522
4331,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4331,-1,0.3828102
4332,DM,3,4,21,23,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4332,-1,0.38676986
4333,n,15,16,69,70,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4333,-1,0.41462007
4334,DM,28,29,134,136,"
Myotonic dystrophy (DM) is associated with the expansion of a (CTG) n trinucleotide repeat in the 3 untranslated region (UTR) of the DM protein kinase gene (DMPK).",9020847_1,-1,4334,-1,0.36274755
4335,n,7,8,22,23,"The size of the (CTG) n repeat, which increases through generations, generally correlates with clinical severity and age of onset.",9020847_3,-1,4335,-1,0.3978909
4336,DM,8,9,58,60,"Moreover, mitotic instability analysis of different human DM tissues shows length mosaicism between different cell lineages.",9020847_5,-1,4336,-1,0.35820895
4337,contrast,1,2,3,11,"In contrast to other mouse models containing CAG repeats within cDNAs, these mice showed both intergenerational and somatic repeat instability..",9020847_8,-1,4337,-1,0.3577554
4338,autoimmune lymphoproliferative syndrome,8,11,48,87,Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.,9028321_0,-1,4338,-1,0.34320167
4340,autoimmune lymphoproliferative syndrome,25,28,165,204,"The Fas/Apo-1 receptor plays a crucial role in the regulation of apoptosis, as demonstrated by lymphoproliferation in MRL-lpr/lpr mice and by the recently described autoimmune lymphoproliferative syndrome (ALPS) in humans, both of which are due to mutations in the Fas gene.",9028321_2,-1,4340,-1,0.3568022
4341,splenomegaly,7,8,54,66,"The children share common clinical features including splenomegaly and lymphadenopathy, but only one developed severe autoimmune manifestations.",9028321_4,-1,4341,-1,0.36378655
4343,amino acid,23,25,142,152,"
The product of the ataxia-telangiectasia gene (ATM) was identified by using an antiserum developed to a peptide corresponding to the deduced amino acid sequence.",9050866_1,-1,4343,-1,0.4015051
4344,contrast,21,22,135,143,"Exposure of normal human cells to gamma-irradiation and the radiomimetic drug neocarzinostatin had no effect on ATM protein levels, in contrast to a noted rise in p53 levels over the same time interval.",9050866_5,-1,4344,-1,0.36931416
4345,Ehlers-Danlos syndrome,14,16,72,94,"Mutations in the COL3A1 gene have been implicated as a cause of type IV Ehlers-Danlos syndrome, a disease leading to aortic rupture in early adult life.",9050868_3,-1,4345,-1,0.33585644
4346,disease,18,19,98,105,"Mutations in the COL3A1 gene have been implicated as a cause of type IV Ehlers-Danlos syndrome, a disease leading to aortic rupture in early adult life.",9050868_3,-1,4346,-1,0.3595208
4347,aortic rupture,21,23,117,131,"Mutations in the COL3A1 gene have been implicated as a cause of type IV Ehlers-Danlos syndrome, a disease leading to aortic rupture in early adult life.",9050868_3,-1,4347,-1,0.3359873
4348,disease,10,11,56,63,"To directly study the role of Col3a1 in development and disease, we have inactivated the Col3a1 gene in embryonic stem cells by homologous recombination.",9050868_4,-1,4348,-1,0.33148944
4350,rupture,9,10,44,51,"The major cause of death of mutant mice was rupture of the major blood vessels, similar to patients with type IV Ehlers-Danlos syndrome.",9050868_7,-1,4350,-1,0.36597493
4351,Ehlers-Danlos syndrome,22,24,113,135,"The major cause of death of mutant mice was rupture of the major blood vessels, similar to patients with type IV Ehlers-Danlos syndrome.",9050868_7,-1,4351,-1,0.32729468
4352,Pelizaeus-Merzbacher disease,21,23,102,130,Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease.,9056547_0,-1,4352,-1,0.34343907
4353,nucleotide,8,9,35,45,"
We report a G-- > A transition at nucleotide 431 of the proteolipid protein gene (PLP) results in a nonsense codon in a family with an unusual form of Pelizaeus-Merzbacher disease (PMD).",9056547_1,-1,4353,-1,0.3292065
4354,Pelizaeus-Merzbacher disease,31,33,152,180,"
We report a G-- > A transition at nucleotide 431 of the proteolipid protein gene (PLP) results in a nonsense codon in a family with an unusual form of Pelizaeus-Merzbacher disease (PMD).",9056547_1,-1,4354,-1,0.35527682
4355,paraplegia,9,10,65,75,The clinical picture resembles somewhat that of X-linked spastic paraplegia (SPG).,9056547_3,-1,4355,-1,0.3116382
4356,nystagmus,30,31,146,155,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4356,-1,0.35191095
4358,mental retardation,38,40,190,208,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4358,-1,0.36957023
4360,personality disorders,49,51,255,276,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4360,-1,0.37181252
4361,disease,53,54,282,289,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4361,-1,0.3754173
4362,disease,68,69,367,374,"It differs from this and both the classical and connatal forms of PMD in that it is relatively mild in form, onset is delayed beyond age 2 years, nystagmus is absent, tremors are prominent, mental retardation is not severe, some patients show dementia or personality disorders, the disease is progressive rather than static in some, and several females show signs of disease.",9056547_4,-1,4362,-1,0.35364386
4363,disease,33,34,185,192,"The nonsense mutation, which is in exon 3B, should block the synthesis of normal PLP but spare DM20, the isoform whose persistence has been associated with mild forms of PLP-associated disease in both humans and mice..",9056547_5,-1,4363,-1,0.34676954
4369,amino acid,11,13,72,82,There are several common polymorphisms in the BRCA1 gene which generate amino acid substitutions.,9063749_4,-1,4369,-1,0.3490576
4373,P,34,35,201,202,"However, our data suggest that the Arg356 allele may have a different genotype distribution in breast cancer patients from that in controls (Arg356 homozygotes are more frequent in the control groups, P = 0. 01), indicating that it may be protective against breast cancer.",9063749_10,-1,4373,-1,0.4290975
4375,Kniest,0,1,1,7,"
Kniest dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen.",9066888_1,-1,4375,-1,0.40255854
4376,dysplasia,1,2,8,17,"
Kniest dysplasia is a severe chondrodysplasia caused by the defective formation of type II collagen.",9066888_1,-1,4376,-1,0.32865298
4377,blindness,38,39,191,200,"We report about Dr. Kniest, who first described the condition in 1952, and his patient, who, at the age of 50 years is severely handicapped with short stature, restricted joint mobility, and blindness but is mentally alert and leads an active life.",9066888_2,-1,4377,-1,0.33154374
4378,Kniest dysplasia,11,13,69,85,"This is in accordance with molecular findings in other patients with Kniest dysplasia and confirms, in the original patient, that the disorder is caused by small inframe deletions often due to exon skipping as a result of COL2A1 splice site mutations..",9066888_4,-1,4378,-1,0.33799186
4379,alkaptonuria,11,12,69,81,"Cloning of the homogentisate 1,2-dioxygenase gene, the key enzyme of alkaptonuria in mouse.",9069115_0,-1,4379,-1,0.3221689
4380,amino acid,3,5,18,28,"
We determined 48 amino acid residues from five peptides from the homogeneous monomer of homogentisate 1, 2-dioxygenase (HGO; E. C. 1. 13. 11. 15) of mouse liver.",9069115_1,-1,4380,-1,0.38728365
4381,amino acid,13,15,91,101,"After digestion with trypsin, peptides were separated by reversed phase chromatography and amino acid sequenced.",9069115_2,-1,4381,-1,0.36021423
4382,amino acids,5,7,31,42,The positions of 122 conserved amino acids could be determined by multiple sequence alignment.,9069115_10,-1,4382,-1,0.36731997
4383,alkaptonuria,13,14,76,88,This corresponds well to the previous assignment of the locus for the human alkaptonuria gene (AKU) to the same chromosomal region by multipoint linkage analysis.,9069115_15,-1,4383,-1,0.3274333
4384,alkaptonuria,12,13,73,85,We therefore conclude that the HGO cDNA encodes the gene responsible for alkaptonuria.,9069115_16,-1,4384,-1,0.32157925
4385,tyrosine,5,6,25,33,"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.",9072974_0,-1,4385,-1,0.38779947
4392,glioblastomas,54,55,236,249,"In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.",9072974_2,-1,4392,-1,0.27343544
4393,tyrosine,7,8,41,49,"The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin, a protein that interacts with actin filaments at focal adhesions.",9072974_3,-1,4393,-1,0.39408904
4395,tyrosine,13,14,90,98,These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions..,9072974_4,-1,4395,-1,0.3648412
4397,metastasis,22,23,148,158,These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions..,9072974_4,-1,4397,-1,0.2893329
4398,myotonia,4,5,51,59,Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia.,9083764_0,-1,4398,-1,0.33059675
4399,syndrome,2,3,21,29,"
The Schwartz-Jampel syndrome (SJS; chondrodystrophic myotonia; McK 255, 800) is a recessively inherited condition defined by myotonia, short stature, and bone dysplasia.",9083764_1,-1,4399,-1,0.3041839
4400,myotonia,7,8,54,62,"
The Schwartz-Jampel syndrome (SJS; chondrodystrophic myotonia; McK 255, 800) is a recessively inherited condition defined by myotonia, short stature, and bone dysplasia.",9083764_1,-1,4400,-1,0.351518
4401,myotonia,21,22,126,134,"
The Schwartz-Jampel syndrome (SJS; chondrodystrophic myotonia; McK 255, 800) is a recessively inherited condition defined by myotonia, short stature, and bone dysplasia.",9083764_1,-1,4401,-1,0.3304367
4402,myotonia,17,18,100,108,"We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia, while another group of patients appear to have primary bone dysplasia with myotonia.",9083764_5,-1,4402,-1,0.30071023
4403,myotonia,31,32,185,193,"We found that a group of patients have mild skeletal changes which may be secondary consequences of myotonia, while another group of patients appear to have primary bone dysplasia with myotonia.",9083764_5,-1,4403,-1,0.2867558
4404,Kniest dysplasia,52,54,304,320,"We tentatively isolate three different types of SJS  type 1A, usually recognized in childhood, with moderate bone dysplasia, corresponding to the original descriptions of Schwartz, Jampel and Aberfeld; type 1B, similar to type 1A but recognizable at birth, with more pronounced bone dysplasia resembling Kniest dysplasia; and type 2, manifest at birth, with increased mortality and bone dysplasia resembling Pyle disease.",9083764_7,-1,4404,-1,0.3410966
4405,Pyle disease,70,72,408,420,"We tentatively isolate three different types of SJS  type 1A, usually recognized in childhood, with moderate bone dysplasia, corresponding to the original descriptions of Schwartz, Jampel and Aberfeld; type 1B, similar to type 1A but recognizable at birth, with more pronounced bone dysplasia resembling Kniest dysplasia; and type 2, manifest at birth, with increased mortality and bone dysplasia resembling Pyle disease.",9083764_7,-1,4405,-1,0.4432017
4406,kidney cancer,15,17,90,103,"
Mutations in the WT1 gene were anticipated to explain the genetic basis of the childhood kidney cancer, Wilms tumour (WT).",9090524_1,-1,4406,-1,0.29030734
4407,tumour,19,20,111,117,"
Mutations in the WT1 gene were anticipated to explain the genetic basis of the childhood kidney cancer, Wilms tumour (WT).",9090524_1,-1,4407,-1,0.2895022
4408,tumours,7,8,32,39,"While only 5% of sporadic Wilms tumours have intragenic WT1 mutations, > 90% of patients with the Denys-Drash syndrome (renal nephropathy, gonadal anomaly, predisposition to WT) carry constitutional intragenic WT1 mutations.",9090524_3,-1,4408,-1,0.31142867
4409,Denys-Drash syndrome,20,22,98,118,"While only 5% of sporadic Wilms tumours have intragenic WT1 mutations, > 90% of patients with the Denys-Drash syndrome (renal nephropathy, gonadal anomaly, predisposition to WT) carry constitutional intragenic WT1 mutations.",9090524_3,-1,4409,-1,0.40530074
4411,tumour,10,11,65,71,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4411,-1,0.29422963
4412,mesothelioma,14,15,94,106,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4412,-1,0.30368903
4413,tumour,20,21,138,144,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4413,-1,0.28530613
4414,acute myeloid leukemia,26,29,165,187,"WT1 mutations have also been reported in juvenile granulosa cell tumour, non-asbestos related mesothelioma, desmoplastic small round cell tumour and, most recently, acute myeloid leukemia..",9090524_4,-1,4414,-1,0.34057772
4415,myotonia congenita,5,7,33,51,A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel.,9122265_0,-1,4415,-1,0.37563968
4416,chloride,13,14,90,98,A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel.,9122265_0,-1,4416,-1,0.38892782
4417,myotonia congenita,2,4,20,38,"
Autosomal dominant myotonia congenita is an inherited disorder of skeletal muscle caused by mutations in a voltage-gated Cl- channel gene (CLCN1, 7q35).",9122265_1,-1,4417,-1,0.3735995
4418,glutamic acid,14,16,74,87,"Here, we report that a mutation predicting the substitution of Gly 230 by glutamic acid (G230E) between segments D3 and D4 dramatically alters the pore properties of a recombinant human muscle Cl- channel (hCIC-1) expressed in a mammalian cell line (tsA201).",9122265_2,-1,4418,-1,0.38471997
4419,Cl,11,12,86,88,"Whereas wild-type channels are characterized by pronounced inward rectification and a Cl > thiocyanate > Br > NO (3) > I > CH (3) SO (3) selectivity, G230E exhibits outward rectification at positive potentials and a thiocyanate > NO (3) > I > Br > Cl > CH (3) SO (3) selectivity.",9122265_4,-1,4419,-1,0.36813933
4420,Cl,54,55,248,250,"Whereas wild-type channels are characterized by pronounced inward rectification and a Cl > thiocyanate > Br > NO (3) > I > CH (3) SO (3) selectivity, G230E exhibits outward rectification at positive potentials and a thiocyanate > NO (3) > I > Br > Cl > CH (3) SO (3) selectivity.",9122265_4,-1,4420,-1,0.3247571
4421,aniridia,9,10,55,63,The incidence of PAX6 mutation in patients with simple aniridia: an evaluation of mutation detection in 12 cases.,9138149_0,-1,4421,-1,0.35866863
4422,aniridia,1,2,8,16,"
Twelve aniridia patients, five with a family history and seven presumed to be sporadic, were exhaustively screened in order to test what proportion of people with aniridia, uncomplicated by associated anomalies, carry mutations in the human PAX6 gene.",9138149_1,-1,4422,-1,0.38490248
4423,aniridia,28,29,164,172,"
Twelve aniridia patients, five with a family history and seven presumed to be sporadic, were exhaustively screened in order to test what proportion of people with aniridia, uncomplicated by associated anomalies, carry mutations in the human PAX6 gene.",9138149_1,-1,4423,-1,0.36559615
4424,diabetes mellitus,18,20,113,130,"Insulin gene region contributes to genetic susceptibility to, but may not to low incidence of, insulin-dependent diabetes mellitus in Japanese.",9144439_0,-1,4424,-1,0.30427396
4425,diabetes mellitus,20,22,121,138,"
In the Caucasian population, it has been demonstrated that the insulin gene (INS) region contains the insulin-dependent diabetes mellitus locus (IDDM2).",9144439_1,-1,4425,-1,0.34399465
4426,IDDM,21,22,125,129,"In the Japanese population, however, there has been no report demonstrating the contribution of IDDM2 to the pathogenesis of IDDM.",9144439_2,-1,4426,-1,0.3372126
4427,IDDM,6,7,37,41,We conducted an association study of IDDM in a large number of Japanese subjects with multiple polymorphisms in INS region.,9144439_3,-1,4427,-1,0.35942677
4428,IDDM,10,11,58,62,We found a significant association of the INS region with IDDM.,9144439_4,-1,4428,-1,0.34248948
4429,IDDM,4,5,35,39,"Alleles positively associated with IDDM in INS region were the same as those positively-associated with IDDM in Caucasian population, although positively-associated alleles are very common (allele frequencies > 0.",9144439_5,-1,4429,-1,0.3368845
4430,IDDM,15,16,104,108,"Alleles positively associated with IDDM in INS region were the same as those positively-associated with IDDM in Caucasian population, although positively-associated alleles are very common (allele frequencies > 0.",9144439_5,-1,4430,-1,0.33481956
4431,IDDM,12,13,75,79,These data suggest that IDDM2 is involved in the genetic susceptibility to IDDM in Japanese.,9144439_7,-1,4431,-1,0.3456187
4432,IDDM,22,23,146,150,The high frequencies of disease-associated alleles in the general population suggest that IDDM2 locus is not responsible for the low incidence of IDDM in Japanese.,9144439_8,-1,4432,-1,0.33611143
4434,C9 deficiency,9,11,62,75,We studied a previously described Swiss family with inherited C9 deficiency.,9144525_4,-1,4434,-1,0.35647118
4435,C9 deficiency,6,8,33,46,"To identify the genetic basis of C9 deficiency, we developed an approach using exon-specific PCR and direct DNA sequencing.",9144525_5,-1,4435,-1,0.36347
4436,C9 deficiency,4,6,14,27,"As a cause of C9 deficiency , we found two different point mutations, both generating TGA stop codons in the coding sequence.",9144525_6,-1,4436,-1,0.38299313
4437,C,4,5,16,17,"One mutation, a C to A exchange, was detected in exon 2 at cDNA position 166, the other, a C to T exchange, was located in exon 4 (cDNA position 464).",9144525_7,-1,4437,-1,0.4196444
4438,C,23,24,91,92,"One mutation, a C to A exchange, was detected in exon 2 at cDNA position 166, the other, a C to T exchange, was located in exon 4 (cDNA position 464).",9144525_7,-1,4438,-1,0.3845628
4439,C9 deficiency,9,11,68,81,"In family studies of three first-degree relatives with heterozygous C9 deficiency, we demonstrated that the two mutations are segregating independently.",9144525_8,-1,4439,-1,0.3649808
4454,disease,13,14,72,79,"CONCLUSIONS  Among women with breast cancer and a family history of the disease, the percentage with BRCA1 coding-region mutations is less than the 45 percent predicted by genetic-linkage analysis.",9145677_9,-1,4454,-1,0.361349
4465,C9 deficiency,5,7,37,50,Difficulties in the ascertainment of C9 deficiency: lessons to be drawn from a compound heterozygote C9-deficient subject.,9182899_0,-1,4465,-1,0.34661126
4466,C9 deficiency,32,34,177,190,"The patient was shown to be heterozygous for DNA markers in the C6, C7 and C9 region of chromosome 5 and therefore appears to be a compound heterozygote for two uncharacterized C9 deficiency genes.",9182899_4,-1,4466,-1,0.33304733
4467,C9 deficiency,4,6,21,34,We also suggest that C9 deficiency may be more common among Caucasians than has been reported..,9182899_8,-1,4467,-1,0.33786553
4470,tumour,19,20,116,122,"
In the present study, leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene (ESR).",9195227_1,-1,4470,-1,0.26873726
4471,estrogen,32,33,193,201,"
In the present study, leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 breast carcinomas were screened for base mutations in the estrogen receptor gene (ESR).",9195227_1,-1,4471,-1,0.28772566
4475,glycine,8,9,47,54,"Hence, a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated.",9195227_5,-1,4475,-1,0.38852024
4476,cysteine,10,11,60,68,"Hence, a possible clinical significance of the glycine into cysteine cannot be completely ruled out and should be further investigated.",9195227_5,-1,4476,-1,0.3297472
4477,tumours,9,10,50,57,"Somatic mutations were not detected in any of the tumours studied, and the present data do not provide support for somatic ESR base mutations as an important mechanism for hormonal therapy resistance in estrogen receptor-positive breast carcinomas..",9195227_6,-1,4477,-1,0.28195685
4478,estrogen,34,35,203,211,"Somatic mutations were not detected in any of the tumours studied, and the present data do not provide support for somatic ESR base mutations as an important mechanism for hormonal therapy resistance in estrogen receptor-positive breast carcinomas..",9195227_6,-1,4478,-1,0.3099766
4479,chromosome aberrations,21,23,140,162,"Overexpression of ATM cDNA in A-T cells enhanced the survival of these cells in response to radiation exposure, decreased radiation-induced chromosome aberrations, reduced radio-resistant DNA synthesis, and partially corrected defective cell cycle checkpoints and induction of stress-activated protein kinase.",9223307_4,-1,4479,-1,0.33328775
4480,rhabdomyosarcoma,14,15,125,141,Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.,9223312_0,-1,4480,-1,0.28148192
4483,rhabdomyosarcoma,6,7,38,54,"In the pediatric solid tumor alveolar rhabdomyosarcoma, a consistent t (2; 13) (q35; q14) or variant t (1; 13) (p36; q14) translocation generates PAX3-FKHR or PAX7-FKHR fusion proteins, respectively.",9223312_2,-1,4483,-1,0.27773738
4484,t,10,11,69,70,"In the pediatric solid tumor alveolar rhabdomyosarcoma, a consistent t (2; 13) (q35; q14) or variant t (1; 13) (p36; q14) translocation generates PAX3-FKHR or PAX7-FKHR fusion proteins, respectively.",9223312_2,-1,4484,-1,0.39762038
4485,contrast,1,2,3,11,"In contrast, PAX7-FKHR overexpression results from fusion gene amplification.",9223312_6,-1,4485,-1,0.35528943
4486,rhabdomyosarcoma,13,14,96,112,"Thus, gene-specific mechanisms were selected to overexpress PAX3-FKHR and PAX7-FKHR in alveolar rhabdomyosarcoma, presumably due to differences in regulation between the wild-type loci.",9223312_7,-1,4486,-1,0.2726239
4488,diseases,9,10,60,68,"
Mutations in atm and p53 cause the human cancer-associated diseases ataxia-telangiectasia and Li-Fraumeni syndrome, respectively.",9241281_1,-1,4488,-1,0.40019763
4489,Li-Fraumeni syndrome,12,14,95,115,"
Mutations in atm and p53 cause the human cancer-associated diseases ataxia-telangiectasia and Li-Fraumeni syndrome, respectively.",9241281_1,-1,4489,-1,0.4010765
4490,lymphomas,14,15,68,77,"Atm-null mice, as well as those null for p53, develop mainly T-cell lymphomas, supporting the view that these genes have similar roles in thymocyte development.",9241281_3,-1,4490,-1,0.29069376
4491,tumour,12,13,70,76,"Mice doubly null for atm and p53 exhibited a dramatic acceleration of tumour formation relative to singly null mice, indicating that both genes collaborate in a significant manner to prevent tumorigenesis.",9241281_5,-1,4491,-1,0.29291552
4492,contrast,2,3,15,23,"Finally-and in contrast to prior predictions-atm and p53 do not appear to interact in acute radiation toxicity, suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human tumours..",9241281_8,-1,4492,-1,0.4212561
4494,tumours,39,40,249,256,"Finally-and in contrast to prior predictions-atm and p53 do not appear to interact in acute radiation toxicity, suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human tumours..",9241281_8,-1,4494,-1,0.27096426
4495,myotonic dystrophy,5,7,38,56,Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP.,9241282_0,-1,4495,-1,0.3677082
4496,Myotonic dystrophy,0,2,1,19,"
Myotonic dystrophy, or dystrophia myotonica (DM), is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13.",9241282_1,-1,4496,-1,0.35800502
4497,DM,7,8,46,48,"
Myotonic dystrophy, or dystrophia myotonica (DM), is an autosomal dominant multisystem disorder caused by the expansion of a CTG trinucleotide repeat in the 3 untranslated region of the DMPK protein kinase gene on chromosome 19q13.",9241282_1,-1,4497,-1,0.41755095
4498,DM,2,3,13,15,"Although the DM mutation was identified more than five years ago, the pathogenic mechanisms underlying this most prevalent form of hereditary adult neuromuscular disease remain elusive.",9241282_3,-1,4498,-1,0.37721378
4499,neuromuscular disease,23,25,148,169,"Although the DM mutation was identified more than five years ago, the pathogenic mechanisms underlying this most prevalent form of hereditary adult neuromuscular disease remain elusive.",9241282_3,-1,4499,-1,0.29771215
4500,DM,8,9,45,47,Analysis of DMAHP expression in the cells of DM patients with loss of the hypersensitive site revealed a two- to fourfold reduction in steady-state DMAHP transcript levels relative to wild-type controls.,9241282_6,-1,4500,-1,0.3500508
4501,DM,17,18,121,123,"Together, these results demonstrate that CTG-repeat expansions can suppress local gene expression and implicate DMAHP in DM pathogenesis.",9241282_8,-1,4501,-1,0.35205638
4502,retinoblastoma,10,11,73,87,Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).,9245987_0,-1,4502,-1,0.30932745
4503,RB1,13,14,94,97,Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).,9245987_0,-1,4503,-1,0.30388513
4504,retinoblastoma,19,20,107,121,"
A wide spectrum of mutations, ranging from point mutations to large deletions, have been described in the retinoblastoma gene (RB1).",9245987_1,-1,4504,-1,0.30961522
4505,RB1,22,23,128,131,"
A wide spectrum of mutations, ranging from point mutations to large deletions, have been described in the retinoblastoma gene (RB1).",9245987_1,-1,4505,-1,0.31584686
4506,RB1,9,10,55,58,"Such recurrent CpG mutations, including those found in RB1, are likely the result of the deamination of 5-methylcytosine within these CpGs.",9245987_4,-1,4506,-1,0.3039022
4507,cytosine,13,14,78,86,"In the present study, we used the sodiumbisulfite conversion method to detect cytosine methylation in representative exons of RB1.",9245987_5,-1,4507,-1,0.35931745
4508,RB1,19,20,126,129,"In the present study, we used the sodiumbisulfite conversion method to detect cytosine methylation in representative exons of RB1.",9245987_5,-1,4508,-1,0.30428421
4509,RB1,14,15,82,85,"We analyzed DNA from a variety of tissues and specifically targeted CGA codons in RB1, where recurrent premature termination mutations have been reported.",9245987_6,-1,4509,-1,0.29849526
4510,RB1,6,7,37,40,"We found that DNA methylation within RB1 exons 8, 14, 25, and 27 appeared to be restricted to CpGs, including six CGA codons.",9245987_7,-1,4510,-1,0.33599427
4511,RB1,7,8,48,51,"Therefore, disease-causing mutations at CpGs in RB1 appear to be determined by several factors, including the constitutive presence of DNA methylation at cytosines within CpGs, the specific codon within which the methylated cytosine is located, and the particular region of the gene within which that codon resides..",9245987_9,-1,4511,-1,0.30801788
4512,cytosine,35,36,224,232,"Therefore, disease-causing mutations at CpGs in RB1 appear to be determined by several factors, including the constitutive presence of DNA methylation at cytosines within CpGs, the specific codon within which the methylated cytosine is located, and the particular region of the gene within which that codon resides..",9245987_9,-1,4512,-1,0.3317228
4515,renal cell carcinoma,18,21,105,125,"
The von Hippel-Lindau tumor suppressor gene (VHL) has a critical role in the pathogenesis of clear-cell renal cell carcinoma (RCC), as VHL mutations have been found in both von Hippel-Lindau disease-associated and sporadic RCCs.",9271438_1,-1,4515,-1,0.27241874
4517,von Hippel-Lindau,31,33,205,222,These observations support a new mechanism for VHL-mediated transcriptional repression via a direct inhibitory action on Sp1 and suggest that loss of Sp1 inhibition may be important in the pathogenesis of von Hippel-Lindau disease and RCC..,9271438_11,-1,4517,-1,0.31261572
4518,disease,33,34,223,230,These observations support a new mechanism for VHL-mediated transcriptional repression via a direct inhibitory action on Sp1 and suggest that loss of Sp1 inhibition may be important in the pathogenesis of von Hippel-Lindau disease and RCC..,9271438_11,-1,4518,-1,0.27334854
4519,disease,7,8,48,55,Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients.,9272171_0,-1,4519,-1,0.3237341
4520,disease,19,20,125,132,"
We examined galactosylceramidase (GALC) cDNA in four Japanese patients with adult onset globoid cell leukodystrophy (Krabbe disease; AO-GLD) by polymerase chain reaction/single-strand conformation polymorphism (PCR-SSCP) analysis, subsequent sequence determination, and restriction enzyme digestion of PCR products, initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade, and all patients had diminished GALC activity in their leukocytes.",9272171_1,-1,4520,-1,0.3407035
4521,paraplegia,55,56,379,389,"
We examined galactosylceramidase (GALC) cDNA in four Japanese patients with adult onset globoid cell leukodystrophy (Krabbe disease; AO-GLD) by polymerase chain reaction/single-strand conformation polymorphism (PCR-SSCP) analysis, subsequent sequence determination, and restriction enzyme digestion of PCR products, initial symptoms were the onset of slowly progressive spastic paraplegia from the middle of the second decade, and all patients had diminished GALC activity in their leukocytes.",9272171_1,-1,4521,-1,0.33060786
3290,breast cancer,20,22,132,145,"
Loss of heterozygosity data from familial tumors suggest that BRCA1, a gene that confers susceptibility to ovarian and early-onset breast cancer, encodes a tumor suppressor.",7939630_1,0,3290,-1,0.26273227
1477,tumor,4,5,27,32,"
Germline mutations in the tumor suppressor gene, BRCA1, predispose individuals to breast and ovarian cancers.",10943845_1,0,1477,-1,0.33421254
3294,tumors,13,14,81,87,The BRCA1 coding region was examined for mutations in primary breast and ovarian tumors that show allele loss at the BRCA1 locus.,7939630_3,0,3294,-1,0.28250158
1154,glaucoma,16,17,92,100,"Mutations in the human homolog of Foxc1, FKHL7, cause dominant anterior segment defects and glaucoma in various families.",10767326_4,0,1154,-1,0.29219618
4309,breast cancer,10,12,40,53,The remaining eight cases (89%) of male breast cancer with a family history of breast/ovarian cancer in first-degree relatives remain unaccounted for by mutations in either the BRCA1 gene or the BRCA2 gene..,9012404_7,0,4309,-1,0.26032588
259,ovarian cancer,16,18,118,132,"
Germ-line mutations in the BRCA1 tumor-suppressor gene are associated with an increased susceptibility to breast and ovarian cancer.",10220405_1,0,259,-1,0.2733665
2872,cataracts,11,12,65,74,"In the G6PD-deficient group, the incidence of cortical and total cataracts was also increased.",7458742_3,0,2872,-1,0.30212018
3087,cancer,13,14,97,103,"Other cancers of interest that appeared in the BRCA1-linked families included primary peritoneal cancer, cancer of the fallopian tube, and malignant melanoma..",7759076_5,0,3087,-1,0.31284836
785,tumor,23,24,132,137,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,0,785,-1,0.2855114
4388,cancers,32,33,190,197,"
Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers.",9072974_1,0,4388,-1,0.2818514
2870,cataracts,3,4,23,32,Increased incidence of cataracts in male subjects deficient in glucose-6-phosphate dehydrogenase.,7458742_0,0,2870,-1,0.32135656
3084,cancer,6,7,42,48,"A genetic recombinant in a breast-ovarian cancer family indicates a placement of BRCA1 telomeric to D17S776, and helps to define the region of assignment of the cancer susceptibility gene.",7759076_4,0,3084,-1,0.32858267
1856,death,6,7,45,50,Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene.,1380672_0,0,1856,-1,0.3575893
1346,cancer,18,19,121,127,"
Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are recessive genetic disorders with susceptibility to cancer and similar cellular phenotypes.",10839544_1,0,1346,-1,0.29481336
4389,glioblastoma,16,17,74,86,"In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.",9072974_2,0,4389,-1,0.31826648
1471,toxicity,13,14,107,115,Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity.,10932179_0,0,1471,-1,0.3645781
4293,cancer,33,34,173,179,"In all three cases, there is a strong family history of breast, ovarian, or other cancers possibly related to a BRCA1 defect and family members showed a high concordance of cancer incidence with the presence of R841W.",8968716_6,0,4293,-1,0.3007878
1768,tumors,1,2,11,17,Twenty-two tumors had frameshift mutations due to deletion or insertion; nineteen of them were deletions of one to 31 bp and three were a 1-bp insertion.,1338904_4,0,1768,-1,0.3282105
4460,tumors,12,13,69,75,The frequency of codon 50 mutation is roughly the same in pancreatic tumors as in the other types of tumors previously examined.,9174057_6,0,4460,-1,0.28807187
4046,death,3,4,10,15,"Thus, the death of Brca1 (5-6) mutant embryos prior to gastrulation may be due to a failure of the proliferative burst required for the development of the different germ layers.",8674108_10,0,4046,-1,0.3864911
2901,ovarian cancer,9,11,51,65,Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.,7493024_0,0,2901,-1,0.30138895
1811,tumors,42,43,245,251,"The present results and our previous data on LOH in a recurring desmoid tumor suggest that the heterozygous mutant/wild-type condition of the APC gene may give rise to benign tumors, and that functional loss of this gene leads to development of tumors not only in the colon but also in other various parts of the body in FAP patients..",1351034_5,0,1811,-1,0.2813502
3938,tumor,19,20,114,119,"These data functionally define a novel genetic locus, designated PAC1, for prostate adenocarcinoma 1, involved in tumor suppression of human prostate carcinoma and furthermore strongly suggest that the cell death pathway can be functionally restored in prostatic adenocarcinoma..",8637912_8,0,3938,-1,0.3155051
2927,ovarian cancer,15,17,97,111,"
A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been identified by positional cloning methods.",7545954_1,0,2927,-1,0.28548008
3297,cataracts,9,10,52,61,"PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.",7951315_0,0,3297,-1,0.29681724
529,breast cancer,5,7,32,45,Both penetrance and expression (breast cancer vs. ovarian cancer) were different from those in reports of the Ashkenazi founder mutations.,10441573_9,0,529,-1,0.30859086
1720,carcinogenesis,17,18,96,110,These results suggest that the mutation of the APC gene also plays an important role during the carcinogenesis of at least some gastric cancers..,1317264_5,0,1720,-1,0.30773476
2811,hemolysis,1,2,18,27,Infection-induced hemolysis and chronic hemolytic anemia seem to be due to markedly impaired enzyme activity and thermal instability.,7166314_8,0,2811,-1,0.33052254
3802,breast cancer,16,18,100,113,Alterations in BRCA1 were identified in approximately 10 percent of this cohort of young women with breast cancer.,8531967_15,0,3802,-1,0.25936896
3963,ovarian cancer,7,9,50,64,Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.,8644702_0,0,3963,-1,0.31148303
3830,ovarian cancer,6,8,46,60,"BRCA1 mutations cosegregating with breast and ovarian cancer susceptibility were identified in 16 families, including 1 family with a case of male breast cancer.",8554067_2,0,3830,-1,0.3046497
1432,epilepsy,27,28,154,162,"The sodium channel beta1 subunit gene (SCN1B) maps to this candidate region and has been shown to be involved in one Australian pedigree with generalized epilepsy and febrile seizures "" plus "" (GEFS +).",10923035_6,0,1432,-1,0.36053455
379,breast cancer,9,11,58,71,"
BACKGROUND  Families with a high incidence of hereditary breast cancer, and subsequently shown to have terminating mutations in BRCA1 or BRCA2, appear to have a higher incidence of prostate cancer among male relatives.",10398279_1,0,379,-1,0.26487502
3884,cancers,16,17,89,96,"Individuals who have rare alleles of the VNTR have an increased risk of certain types of cancers, including breast cancer (2-4).",8589723_6,0,3884,-1,0.27683932
1279,cancers,14,15,86,93,"DESIGN AND SETTING  Retrospective cohort study of a consecutive series of 933 ovarian cancers diagnosed and treated at our institution, which is a comprehensive cancer center as designated by the National Cancer Institute, over a 12-year period (December 1986 to August 1998).",10807385_4,0,1279,-1,0.29783213
778,tumors,21,22,137,143,"Mutations were retrieved in most rhabdoid tumors, whatever their sites of occurrence, indicating the common pathogenetic origin of these tumors.",10556283_6,0,778,-1,0.27447405
2799,infections,34,35,216,226,"
Molecular, kinetic, and functional studies were carried out on erythrocytes and leukocytes in a Spanish male with G6PD deficiency, congenital nonspherocytic hemolytic anemia (CNSHA), and increased susceptibility to infections.",7055648_1,0,2799,-1,0.29688317
583,tumor,8,9,35,40,"APC is not, therefore, a classical tumor suppressor.",10470088_9,0,583,-1,0.30503953
1815,tumors,25,26,175,181,"Certain families, however, show an unusual low-penetrance phenotype with many individuals being unaffected, unilaterally affected, or with evidence of spontaneously regressed tumors.",1352883_2,0,1815,-1,0.2932845
320,prostate cancer,24,26,144,159,"In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer.",10364525_0,0,320,-1,0.28944182
3855,ovarian cancer,15,17,85,99,"A comparison of the six mutations in the relative proportions of cases of breast and ovarian cancer was suggestive of an effect (P =. 069), with 57% of women presumed affected because of the 1294 del 40 BRCA1 mutation having ovarian cancer, compared with 14% of affected women with the splice-site mutation in intron 5 of BRCA1.",8571953_4,0,3855,-1,0.29397172
1205,cancer,9,10,53,59,"The study group consisted of 66 Polish families with cancer who have at least three related females affected with breast or ovarian cancer and who had cancer diagnosed, in at least one of the three affected females, at age < 50 years.",10788334_2,0,1205,-1,0.32408345
620,hepatomegaly,21,22,136,148,"Eight of the 16 homozygous subjects had clinical findings that were consistent with the presence of hereditary hemochromatosis, such as hepatomegaly, skin pigmentation, and arthritis.",10471457_13,0,620,-1,0.3677777
4091,cancer,4,5,26,32,The pattern of hereditary cancer in 14 (61%) of the 23 families studied was attributed to BRCA1 by a combination of linkage and mutation analyses.,8751855_7,0,4091,-1,0.3173327
1292,cancers,20,21,160,167,"CONCLUSIONS  Although BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients.",10807385_15,0,1292,-1,0.2823114
1666,tumors,26,27,158,164,"
High level expression of the nm23-H1 gene, which encodes for a nucleoside diphosphate kinase, has been found to correlate with diminished metastasis in some tumors but not in others.",1311721_1,0,1666,-1,0.2804411
3152,cancers,24,25,138,145,"To study the potential role of BRCA1 in sporadic carcinogenesis, we analysed the genomic DNA of tumour and normal fractions of 47 ovarian cancers for mutations in BRCA1 using the single-strand conformation polymorphism technique.",7795652_2,0,3152,-1,0.2684847
1476,breast cancer,13,15,90,103,BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.,10943845_0,0,1476,-1,0.2861735
3969,ovarian cancer,19,21,126,140,"Eleven of the 15 kindreds manifesting BRCA1 mutations were breast-ovarian cancer families, several of them with a predominant ovarian cancer phenotype.",8644702_6,0,3969,-1,0.28901213
2946,breast cancer,18,20,91,104,"In high-risk pedigrees, female carriers of BRCA1 mutations have an 80-90% lifetime risk of breast cancer, and a 40-50% risk of ovarian cancer.",7550349_2,0,2946,-1,0.271679
326,prostate cancer,17,19,97,112,"These results are consistent with the hypothesis of linkage to HPC1 in a subset of families with prostate cancer, particularly those with an early age at diagnosis.",10364525_12,0,326,-1,0.3035307
383,prostate cancer,19,21,86,101,RESULTS  Our study should have been able to detect a 4-5-fold increase in the risk of prostate cancer due to mutation of BRCA1 or BRCA2.,10398279_4,0,383,-1,0.29207858
323,prostate cancer,19,21,107,122,"In the present report we analyze 40 (12 original and 28 newly identified) Swedish families with hereditary prostate cancer (HPC) that, on the basis of 40 markers spanning a 25-cM interval within 1q24-25, have evidence of linkage.",10364525_3,0,323,-1,0.31741664
3411,breast cancer,30,32,159,172,Our results indicate that there is a gene (s) other than BRCA1 which predisposes to early-onset breast cancer in women and which confers a higher risk of male breast cancer.,8075631_4,0,3411,-1,0.24860191
2856,Nephropathy,0,1,1,12,"
Nephropathy was detected in five of 32 patients with the Wiskott-Aldrich syndrome who were participating in a study of transfer factor (TF) therapy.",7422429_1,0,2856,-1,0.34442222
223,cancer,12,13,86,92,The frequency distribution of common polymorphisms was determined in the 91 Caucasian cancer cases in this series and 24 sister controls using allele-specific amplification.,10196379_8,0,223,-1,0.2981647
3083,cancer,21,22,117,123,"In contrast, there was no overall evidence of linkage in the group of 10 families with breast cancer without ovarian cancer.",7759076_3,0,3083,-1,0.28908324
3834,ovarian cancer,15,17,77,91,"Mutations in BRCA1 account for at least 80% of families with both breast and ovarian cancer, as well as some non-familial sporadic ovarian cancers.",8563759_2,0,3834,-1,0.2719734
1033,prostate cancer,4,6,32,47,"Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
A previous linkage study provided evidence for a prostate cancer-susceptibility locus at 1q24-25.",10712209_0,0,1033,-1,0.3259733
2409,polyneuropathy,35,36,231,245,"
A new glucose-6-phosphate dehydrogenase (G6PD) variant with severe erythrocytic G6PD deficiency and a unique pH optimum is described in a young patient with chronic nonspherocytic hemolytic anemia (CNSHA) and familial amyloidotic polyneuropathy (FAP).",2912886_2,0,2409,-1,0.3385724
1109,dystonia,29,30,171,179,"Mutations in a gene coding for an ATP-binding protein were detected in idiopathic torsion dystonia (DYT1), and the GTP cyclohydrolase 1 gene is mutated in dopa-responsive dystonia (DYT5).",10737119_11,0,1109,-1,0.31085628
2173,meningitis,5,6,29,39,"This first case of recurrent meningitis in a white patient with complete C9 deficiency suggests that this complement defect may also be a risk factor for bacterial, especially neisserial, infections..",2241452_7,0,2173,-1,0.33651456
4455,cancer,11,12,64,70,Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer.,9174057_0,0,4455,-1,0.29325038
355,neuronal damage,25,27,167,182,"All published mutations affect the signal peptide or the neurophysin-II carrier protein and are presumed to interfere with processing of the preprohormone, leading to neuronal damage.",10369876_2,0,355,-1,0.3786537
716,myalgia,19,20,112,119,"None had chronic or prolonged manifestations of FMF, for example, amyloidosis, chronic arthritis, or protracted myalgia, P < 0. 001.",10528243_9,0,716,-1,0.3407315
4482,tumor,4,5,23,28,"In the pediatric solid tumor alveolar rhabdomyosarcoma, a consistent t (2; 13) (q35; q14) or variant t (1; 13) (p36; q14) translocation generates PAX3-FKHR or PAX7-FKHR fusion proteins, respectively.",9223312_2,0,4482,-1,0.29153615
4216,tumor,15,16,89,94,"The Cox proportional-hazards model was used to adjust for covariates including age, sex, tumor site, degree of tumor differentiation, and use of adjuvant therapy.",8929264_5,0,4216,-1,0.30735987
4093,breast cancer,17,19,98,111,"However, one or more additional genes may yet be found that explain some proportion of hereditary breast cancer..",8751855_13,0,4093,-1,0.2892395
3813,ovarian cancer,24,26,137,151,Two novel nonsense mutations led to the loss of mutant BRCA1 transcript in families with 10 and 6 cases of early-onset breast cancer and ovarian cancer.,8533757_7,0,3813,-1,0.27509975
4292,cancers,18,19,82,89,"In all three cases, there is a strong family history of breast, ovarian, or other cancers possibly related to a BRCA1 defect and family members showed a high concordance of cancer incidence with the presence of R841W.",8968716_6,0,4292,-1,0.29828665
3835,cancers,25,26,139,146,"Mutations in BRCA1 account for at least 80% of families with both breast and ovarian cancer, as well as some non-familial sporadic ovarian cancers.",8563759_2,0,3835,-1,0.27288088
988,breast cancer,10,12,71,84,The finding that ATM-heterozygotes have an increased relative risk for breast cancer was supported by some studies but not confirmed by others.,10677309_3,0,988,-1,0.28418896
4306,breast cancer,6,8,25,38,"Only one of the two male breast cancer patients carrying a BRCA2 mutation had a family history of cancer, with one case of ovarian cancer in a first-degree relative.",9012404_6,0,4306,-1,0.27751985
322,prostate cancer,27,29,142,157,We previously reported evidence of linkage to the 1q24-25 region (HPC1) in 91 North American and Swedish families each with multiple cases of prostate cancer (Smith et al. 1996).,10364525_2,0,322,-1,0.29615292
781,cancers,11,12,68,75,"In contrast, hSNF5/INI1 point mutations were not detected in breast cancers, Wilms tumors, gliomas, ependymomas, sarcomas and other tumor types, even though most analyzed cases harbored loss of heterozygosity at 22q11.",10556283_8,0,781,-1,0.31664973
3545,convulsions,19,20,116,127,"Significant differences were found between PWS patients, SIB controls, and WC controls in the prevalence of febrile convulsions, fever-associated symptoms, and temperature less than 94 degrees F. No differences were noted in any variable between the PWS patients and the ND controls, suggesting that these abnormalities are not unique to PWS, but can occur in any neurodevelopmentally handicapped individual, further suggesting these do not necessarily reflect syndrome-specific hypothalamic abnormalities..",8209890_2,0,3545,-1,0.34630653
4440,breast cancer,11,13,69,82,BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.,9145677_0,0,4440,-1,0.2796337
3980,breast cancer,16,18,105,118,The present study confirms the involvement of BRCA1 in disease predisposition for a subset of hereditary breast cancer families often characterized by ovarian cancers.,8644702_11,0,3980,-1,0.28161156
3038,tumor,21,22,137,142,These results suggest that mutation of CDK4 can create a tumor-specific antigen and can disrupt the cell-cycle regulation exerted by the tumor suppressor p16INK4a..,7652577_6,0,3038,-1,0.29200125
1977,thrombocytopenia,11,12,61,77,"While this is the first complete report on the occurrence of thrombocytopenia in a carrier female of WAS as the result of atypical lyonization, it also suggests that expression of the WAS gene occurs at (or extends up to) a later stage than the multipotent stem cell along the hematopoietic differentiation pathway..",1684569_5,0,1977,-1,0.33009943
3295,cancers,25,26,147,154,Mutations were detected in 3 of 32 breast and 1 of 12 ovarian carcinomas; all four mutations were germline alterations and occurred in early-onset cancers.,7939630_4,0,3295,-1,0.26524025
4162,convulsions,27,28,175,186,"
The human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) is located in the candidate region for three different phenotypes  benign familial neonatal convulsions, autosomal dominant nocturnal frontal lobe epilepsy, and low-voltage EEG.",8833159_1,0,4162,-1,0.30803168
2702,infections,11,12,93,103,Absent bacteriolysis remains the only consistent defect associated with recurrent neisserial infections and absence of one of the late-acting complement components..,492812_5,0,2702,-1,0.29472893
3291,tumor,25,26,157,162,"
Loss of heterozygosity data from familial tumors suggest that BRCA1, a gene that confers susceptibility to ovarian and early-onset breast cancer, encodes a tumor suppressor.",7939630_1,0,3291,-1,0.3266365
2790,arthritis,9,10,61,70,"
A previously healthy 40-year-old man presenting with fever, arthritis, and cutaneous vasculitis was found to have chronic meningococcemia.",6859721_1,0,2790,-1,0.37027577
2883,cardiomyopathy,26,27,165,179,"Defects in enzymes of the beta-oxidation pathway cause sudden, unexplained death in childhood, acute hepatic encephalopathy or liver failure, skeletal myopathy, and cardiomyopathy.",7479827_2,0,2883,-1,0.3489901
1179,death,20,21,130,135,"Surprisingly, in the frataxin knockout mouse, no iron accumulation was observed during embryonic resorption, suggesting that cell death could be due to a mechanism independent of iron accumulation..",10767347_7,0,1179,-1,0.32880944
990,breast cancer,13,15,90,103,A high percentage of ATM germline mutations was demonstrated among patients with sporadic breast cancer.,10677309_6,0,990,-1,0.24914126
